parA Resolved · high auto-curated

H37Rv Rv3918c · MTBC0 mtbc0_004152 · 347 aa · 4430739–4431782 MTBC0 (-) · RefSeq NP_218434.2

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)chromosome partitioning protein ParA
MTBC0 PGAP re-annotationchromosome partitioning protein ParA
Revised (this work)Chromosome partitioning protein ParA. Pfam: ParA (PF10609.16), AAA_31 (PF13614.13), MipZ (PF09140.18), CbiA (PF01656.30), ArsA_ATPase (PF02374.22).
Functional category (TubercuList)cell wall and cell processes

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 2435 publications

2435 TB publications mention this gene. 2435 publications discuss this gene. Queried separately, 2349 records carry a M. tuberculosis context and 55 a non-TB mycobacterial context (species named in the 40-record verified sample: M. smegmatis (21), M. abscessus (4), M. marinum (3), M. leprae (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 2435: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Granulomatous breast mastitis in pregnancy secondary to Mycobacterium avium complex: a case report. doi:10.1097/RC9.0000000000000607 2026
Rational Design, Synthesis, Molecular Docking, and Evaluation of Thioridazine-modified Tetrahydrocarbazole Derivatives as Antitubercular Agents. doi:10.2174/0127724344447896260611074636 2026
Fenestrated endovascular aneurysm repair addressing para-aortic ulcers in the setting of tuberculous aortitis. doi:10.1016/j.jvscit.2026.102282 2026
[LYMPH NODE TUBERCULOSIS AFTER INTRAVESICAL BACILLUS CALMETTE-GUÉRIN THERAPY FOR BLADDER CARCINOMA IN SITU : A CASE REPORT]. doi:10.82687/actaurojp.72.5_171 2026
Clinical characteristics, susceptibility profiles and treatment outcomes of pulmonary disease caused by Mycobacterium paraense. doi:10.1016/j.diagmicrobio.2026.117406 2026
3739 records returned by the alias sweep (a separate sweep from the 2435 above; both are shown, neither is exhaustive)

Searched as: Rv3918c, parA, Mb3949c, ML2707c, MMAR_5482, MSMEG_6939, MAB_4950c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Catastrophic systemic reaction and fatal disseminated intravascular coagulation following high-pressure intrapelvic povidone-iodine instillation: A case report and review of possible mechanisms. doi:10.1016/j.eucr.2026.103573 Urol Case Rep 2026
Drug Resistance Patterns, Temporal Trends, and Risk Factors Among Elderly Tuberculosis Patients in Anhui, China: A Retrospective Study (2020-2024). doi:10.2147/IDR.S628064 Infect Drug Resist 2026
Exploiting Multicomponent Reactions to Drive the Development of Novel Antitubercular Agents: An Overview. doi:10.1002/cmdc.70423 ChemMedChem 2026
MIC-based tuberculosis drug susceptibility testing using Sensititre MYCOTB: a diagnostic accuracy meta-analysis. doi:10.1128/jcm.00813-26 J Clin Microbiol 2026
Measuring the composition and availability of human resources for health by sex in 204 countries and territories, 1990-2023, and workforce gaps for universal health coverage: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S2468-2667(26)00145-3 Lancet Public Health 2026
The burden of tuberculosis in Latin America: Immunogenetic and socioepidemiological determinants. doi:10.1016/j.smim.2026.102054 Semin Immunol 2026
Trends and Characteristics of Drug-Resistant Tuberculosis: A Five-Year Study at a Major Specialized Hospital in Guizhou, China (2018-2023). doi:10.2147/IDR.S599100 Infect Drug Resist 2026
Latent tuberculosis infection among undergraduate nursing students: a study of social representations. doi:10.1590/0034-7167-2025-0282 Rev Bras Enferm 2026
Sociodemographic profile of tuberculosis and treatment difficulties in light of health literacy. doi:10.1590/0034-7167-2025-0200 Rev Bras Enferm 2026
Apo and substrate-bound dihydropteroate synthase crystal structures from Thermus thermophilus HB8. doi:10.1007/s00249-026-01857-0 Eur Biophys J 2026
Optimizing HIV Spending Among Key Populations in Five Latin American and Caribbean Countries: A Mathematical Modelling Study. doi:10.1002/jia2.70171 J Int AIDS Soc 2026
Multifocal Skeletal Tuberculosis Mimicking Metastatic Malignancy: A Case Report. doi:10.7759/cureus.111029 Cureus 2026
Population-level and longitudinal MIC distributions for antimicrobials against drug-resistant Mycobacterium tuberculosis in Wuxi, a low-epidemic city in China, from 2019 to 2023. doi:10.3389/fcimb.2026.1866051 Front Cell Infect Microbiol 2026
Empirical treatment with valganciclovir in infants living with HIV and hospitalised with severe pneumonia in Africa: a multicentre, open-label, factorial, randomised, controlled, superiority trial. doi:10.1016/S0140-6736(26)00754-3 Lancet 2026
Brain iron deposition mediates cognitive impairment in COPD: A possible imaging marker linking systemic inflammation to neurodegeneration. doi:10.1080/25310429.2026.2704429 Pulmonology 2026
Determinants of HIV-1 virologic suppression in HIV-associated tuberculosis in Brazil. doi:10.1590/0074-02760250090 Mem Inst Oswaldo Cruz 2026
Multilevel determinants of knowledge on TB transmission among women of reproductive age. doi:10.5588/ijtldopen.26.0137 IJTLD Open 2026
Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis. doi:10.1084/jem.20252236 J Exp Med 2026
Granulomatous breast mastitis in pregnancy secondary to Mycobacterium avium complex: a case report. doi:10.1097/RC9.0000000000000607 Int J Surg Case Rep 2026
Effects of coenzyme Q10 on oxidative stress biomarkers in printing workers with low-level exposure to toluene and xylene: a randomized, double-blind, placebo-controlled crossover clinical trial. doi:10.1038/s41598-026-61025-4 Sci Rep 2026
Rational Design, Synthesis, Molecular Docking, and Evaluation of Thioridazine-modified Tetrahydrocarbazole Derivatives as Antitubercular Agents. doi:10.2174/0127724344447896260611074636 Recent Adv Antiinfect Drug Discov 2026
Measuring scientific coherence between global neglected tropical disease research and population health indicators: a 25-year meta-research study. doi:10.3389/frma.2026.1766718 Front Res Metr Anal 2026
Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S1473-3099(26)00295-1 Lancet Infect Dis 2026
Genetic interference of distinctive Mycobacterium tuberculosis peptidoglycan modifications enhances β-lactam susceptibility and reveals expression-sensitive host immune dynamics. doi:10.1038/s41598-026-59172-9 Sci Rep 2026
Fenestrated endovascular aneurysm repair addressing para-aortic ulcers in the setting of tuberculous aortitis. doi:10.1016/j.jvscit.2026.102282 names it J Vasc Surg Cases Innov Tech 2026
Genotyping of Mycobacterium leprae in humans and six-banded armadillos suggests lack of inter-species transmission in Rio Grande do Norte, northeast Brazil. doi:10.1016/j.actatropica.2026.108186 Acta Trop 2026
Interventions to reduce the impact of post-tuberculosis lung disease: a scoping review of the literature. doi:10.1186/s12890-026-04355-3 BMC Pulm Med 2026
Detection of heteroresistance in Mycobacterium tuberculosis using nanopore-based amplicon sequencing and adaptive sampling. doi:10.1038/s41598-026-53258-0 Sci Rep 2026
[LYMPH NODE TUBERCULOSIS AFTER INTRAVESICAL BACILLUS CALMETTE-GUÉRIN THERAPY FOR BLADDER CARCINOMA IN SITU : A CASE REPORT]. doi:10.82687/actaurojp.72.5_171 Hinyokika Kiyo 2026
Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S1473-3099(26)00194-5 Lancet Infect Dis 2026
Investigating a Skin Disease in Guinea Baboons (Papio papio) Using Non-invasive Methods. doi:10.1007/s10393-026-01799-1 Ecohealth 2026
Patient's perceived quality as a strategy for the identification of opportunities for improvement in the care of the tuberculosis service in a health center in Ecuador. Rev Esp Salud Publica 2026
Chronic granulomatous disease: Clinical, microbial, and genetic findings in 39 Colombian patients. doi:10.70962/jhi.20250257 J Hum Immun 2026
Updated trends in the global prevalence and burden of mental disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(26)00519-2 Lancet 2026
The host immune response to Mycobacterium tuberculosis determining protection or disease progression. doi:10.1038/s41590-026-02529-z Nat Immunol 2026
Draft genome sequence of Legionella pneumophila strains isolated from engineered water systems in Brazil. doi:10.1128/mra.01332-25 Microbiol Resour Announc 2026
Interferon-gamma release assay positivity in populations at high risk of TB infection. doi:10.5588/ijtldopen.25.0684 IJTLD Open 2026
Factors associated with unsuccessful tuberculosis treatment outcome in children in four provinces of Mozambique: a retrospective cohort study, 2018-2021. doi:10.1186/s12879-026-13290-x BMC Infect Dis 2026
Clinical characteristics, susceptibility profiles and treatment outcomes of pulmonary disease caused by Mycobacterium paraense. doi:10.1016/j.diagmicrobio.2026.117406 Diagn Microbiol Infect Dis 2026
Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S1474-4422(26)00101-8 Lancet Neurol 2026
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments. doi:10.1111/all.70305 Allergy 2026
Long-term risk of death after tuberculosis diagnosis and treatment. doi:10.1038/s41591-026-04294-w Nat Med 2026
Acinetobacter spp. with lower susceptibility to quaternary ammonium compounds enriched in microbial communities of frequently used sinks. doi:10.1128/aem.01968-25 Appl Environ Microbiol 2026
Synthesis, characterization, and in silico studies on new series of hydrazide-hydrazones for potential anti-tubercular agents. doi:10.1016/j.ijtb.2025.03.003 Indian J Tuberc 2026
Towards universal social protection for people affected by tuberculosis in the Western Pacific Region: a social protection baseline assessment and policy entry points. doi:10.1186/s41182-025-00887-2 Trop Med Health 2026
Primary Pericardial Angiosarcoma Demonstrating Initial Response Followed by Progression on First-Line Chemotherapy: A Case Report. doi:10.1002/ccr3.72131 Clin Case Rep 2026
Combined Oral Contraceptive Drug-Drug Interaction Study With Ganfeborole, a New Anti-Tuberculosis Agent. doi:10.1002/jcph.70161 J Clin Pharmacol 2026
Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S1470-2045(25)00730-2 Lancet Oncol 2026
Spatiotemporal trends in and challenges of addressing tuberculosis in Brazil before and after the COVID-19 pandemic, 2001-2023. doi:10.26633/RPSP.2026.10 Rev Panam Salud Publica 2026
Synthesis and Anti-Tubercular Activity of Novel Furan-Based Triazole-Acrylamide Hybrids: Experimental and Computational Insights. doi:10.1002/cbdv.202503298 Chem Biodivers 2026
Potential urine NMR Metabolomic signatures for early diagnosis of paediatric tuberculosis. doi:10.1038/s41598-026-40619-y Sci Rep 2026
Thoracic Surgery - notes for its history in Brazil (Part II): Lung transplantation. doi:10.48729/pjctvs.600 Port J Card Thorac Vasc Surg 2026
Hemophagocytic Lymphohistiocytosis Secondary to Extrapulmonary Tuberculosis in an HIV Patient: A Case Report. doi:10.7759/cureus.101529 Cureus 2026
Case report: CNS tuberculoma in a patient with prior pulmonary tuberculosis. doi:10.1093/qjmed/hcaf310 QJM 2026
The effectiveness of preventive tuberculosis treatment in children. doi:10.1186/s12879-026-12726-8 BMC Infect Dis 2026
Spatial and epidemiological mapping of tuberculosis on an Amazon island: effect of the COVID-19 pandemic. doi:10.1590/1414-431X2025e14015 Braz J Med Biol Res 2026
The bedaquiline market for drug-resistant tuberculosis treatment and the challenges for public production in Brazil. doi:10.1590/1413-81232026311.14162025 Cien Saude Colet 2026
A pragmatic trial with an optimized dose of rifampicin and moxifloxacin for the treatment of drug-susceptible pulmonary tuberculosis: a study protocol for open-label, randomized phase III trial (OptiRiMoxTB). doi:10.1186/s13063-026-09466-0 Trials 2026
Humanization of care in Primary Health Care: social representations of people with pulmonary tuberculosis. doi:10.1590/1980-220X-REEUSP-2025-0008en Rev Esc Enferm USP 2026
Serum geoepidemiology of leprosy biomarkers in a city-wide COVID-19 survey in Brazil. doi:10.1186/s12879-025-12483-0 BMC Infect Dis 2026
Genetic ancestry proportion influences risk of adverse events from tuberculosis treatment in Brazil. doi:10.1007/s00439-025-02809-y Hum Genet 2026
Tuberculosis in children under 5 years of age in a low-burden setting: sociodemographic and epidemiological characteristics and healthcare utilization over a 10-year period (2010-2021). doi:10.1007/s00431-025-06704-6 Eur J Pediatr 2026
Immunoinformatics-driven design of a multi-epitope vaccine targeting non-typhoidal Salmonella's type IV secretion system VirB4, VirB5, and VirB6 proteins. doi:10.1016/j.ijbiomac.2025.149973 Int J Biol Macromol 2026
Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study. doi:10.1016/j.lanmic.2025.101217 Lancet Microbe 2026
Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)02503-6 Lancet 2026
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments. doi:10.1111/all.70131 Allergy 2026
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024-2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms. doi:10.1111/all.70100 Allergy 2026
Hybrid Video-Assisted Fistula Treatment With Seton Tie for Management of Fistula-in-Ano: Results of a Novel Technique. doi:10.1097/DCR.0000000000004004 Dis Colon Rectum 2026
Climate change and tuberculosis: an analytical framework. doi:10.1016/S2213-2600(25)00329-7 Lancet Respir Med 2026
First Molecular Detection of Mycobacterium ulcerans pseudoshottsii From Gulf Strain Striped Bass (Morone saxatilis). doi:10.1111/jfd.70060 J Fish Dis 2026
Outcomes Following Different Management of Mycotic Infrarenal Abdominal Aortic Aneurysms. doi:10.1177/15266028241253128 J Endovasc Ther 2026
The microevolutionary trajectory of endemic multidrug-resistant tuberculosis strains in Portugal toward increased drug resistance levels and its clinical significance. doi:10.3389/fmicb.2025.1716549 Front Microbiol 2025
Gout of the iliopsoas muscle combined with tuberculosis infection causing persistent fever: a case report and literature review. doi:10.3389/fmed.2025.1601095 Front Med (Lausanne) 2025
[Risk factors for adverse events in patients with multidrug-resistant tuberculosis, HIV-infection and viral hepatitis C]. doi:10.26442/00403660.2025.11.203451 Ter Arkh 2025
A Two-Front Battle: A Case Report of Pulmonary Tuberculosis and Concurrent Peripheral Neuropathy. doi:10.7759/cureus.98778 Cureus 2025
MTBseq-nf: Enabling Scalable Tuberculosis Genomics "Big Data" Analysis Through a User-Friendly Nextflow Wrapper for MTBseq Pipeline. doi:10.3390/microorganisms13122685 Microorganisms 2025
Integrated Artificial Intelligence Framework for Tuberculosis Treatment Abandonment Prediction: A Multi-Paradigm Approach. doi:10.3390/jcm14248646 J Clin Med 2025
Intraperitoneal tuberculous abscess mimicking a para-gastric mass: A case report and literature review. doi:10.1097/MD.0000000000046555 names it Medicine (Baltimore) 2025
Mycobacterium tuberculosis transmission among child and adolescent contacts of people with pulmonary tuberculosis in Brazil: a multi-center prospective cohort study. doi:10.1186/s12879-025-12268-5 BMC Infect Dis 2025
Genome Sequences of Cluster A Mycobacteriophages Dorothea and LappelDuVide, Isolated on Mycobacterium smegmatis mc (2) 155. doi:10.17912/micropub.biology.001881 MicroPubl Biol 2025
Clinical standards for antimicrobial stewardship in TB care. doi:10.5588/ijtldopen.25.0522 IJTLD Open 2025
Proceedings from the Third International Post-Tuberculosis Symposium: expanding the circle. doi:10.5588/ijtldopen.25.0637 IJTLD Open 2025
Community health workers' knowledge, attitudes and practices in the detection of respiratory symptomatic patients. doi:10.1590/0034-7167-2024-0610 Rev Bras Enferm 2025
Effects of CwlM, a peptidoglycan synthesis regulator, on beta-lactam tolerance and host-pathogen interactions. doi:10.1186/s12866-025-04548-6 BMC Microbiol 2025
Essential redundancies fuel Mycobacterium tuberculosis adaptation to the host. doi:10.1371/journal.ppat.1013749 PLoS Pathog 2025
Clinical and CT Features of HIV-Negative and HIV-Positive Patients with Abdominal Tuberculous Lymphadenopathy. doi:10.3390/diagnostics15222931 Diagnostics (Basel) 2025
Space-Time scan of tuberculosis indicators in Northeast Brazil: an ecological and time-series study over 20 years (2001-2020). doi:10.1186/s12889-025-24307-6 BMC Public Health 2025
N-Glycosylation of Antibodies: Biological Effects During Infections and Therapeutic Applications. doi:10.3390/antib14040093 Antibodies (Basel) 2025
RBMX2 links Mycobacterium bovis infection to epithelial-mesenchymal transition and lung cancer progression. doi:10.7554/eLife.107132 Elife 2025
Thymoma in Ectopic Thymus: An Overlooked Differential and a Pathologist's Dilemma. doi:10.7759/cureus.94195 Cureus 2025
Design and synthesis of isoxazole-functionalized benzene sulphonamides as novel inhibitors of Mycobacterium tuberculosis β-carbonic anhydrases. doi:10.1039/d5md00744e RSC Med Chem 2025
rBCG-LTAK63 enhances protection against tuberculosis by inducing autophagy and circadian gene regulation. doi:10.3389/fimmu.2025.1695560 Front Immunol 2025
Treatment completion rates and adverse effects of three months of once-weekly isoniazid plus rifapentine for latent tuberculosis infection. doi:10.36416/1806-3756/e20250234 J Bras Pneumol 2025
Standardization and Clinical Evaluation of a Real-Time PCR Assay for the Diagnosis of Pneumocystis jirovecii Pneumonia. doi:10.1007/s11046-025-01016-7 Mycopathologia 2025
Consolidation of a genomic epidemiological surveillance network for tuberculosis (REVIGET) in northern and northeastern Brazil: a study protocol. doi:10.3389/fpubh.2025.1668926 Front Public Health 2025
The Mycobacterium avium Complex: Genomics, Disease, and Beyond. doi:10.3390/microorganisms13102329 Microorganisms 2025
Unilateral Dacryoadenitis and Contralateral Solitary Choroidal Granuloma as the Initial Presentation of Systemic Sarcoidosis: A Diagnostic Challenge. doi:10.1080/09273948.2025.2577664 Ocul Immunol Inflamm 2025
Incidence and predictors of mortality among persons with rifampicin-resistant tuberculosis and HIV in Mozambique. doi:10.1038/s41598-025-20658-7 Sci Rep 2025
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01917-8 Lancet 2025
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01330-3 Lancet 2025
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01637-X Lancet 2025
Effect of specific and sensitive interventions for the social protection of people affected by tuberculosis: a meta-analysis. doi:10.1186/s13690-025-01659-4 Arch Public Health 2025
Risk factors and drug resistance of non-tuberculous mycobacteria in HIV/AIDS patients: a retrospective study in southern China. doi:10.3389/fpubh.2025.1660472 Front Public Health 2025
[Effectiveness of a community strategy for the treatment of tuberculosis in vulnerable contexts in the city of Buenos AiresEfetividade de uma estratégia de base comunitária para o tratamento da tuberculose em contextos vulneráveis da Cidade de Buenos Aires]. doi:10.26633/RPSP.2025.100 names it Rev Panam Salud Publica 2025
Preparation of Lipophilic Derivatives of para-Aminosalicylic Acid for Antimicrobial Drug Design. doi:10.1021/acsomega.5c08092 names it ACS Omega 2025
Molecular docking and pharmacokinetics of benzimidazole-based FtsZ inhibitors for tuberculosis. doi:10.1038/s41598-025-18084-w Sci Rep 2025
[10 years of the Strategic Plan for Tackling Hepatitis C in the Spanish National Health System (PEAHC): A national project for the elimination of Hepatitis C as a Public Health problem]. Rev Esp Salud Publica 2025
SIPrEP: A tool to monitor HIV pre-exposure prophylaxis in Spain. doi:10.1016/j.eimce.2025.06.012 Enferm Infecc Microbiol Clin (Engl Ed) 2025
Genetic and environmental control of parasexual reproduction in the pathogenic Candida species. doi:10.1128/mmbr.00002-25 Microbiol Mol Biol Rev 2025
The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01635-6 Lancet 2025
N-Myristoyltransferase Inhibition in Parasitic Pathogens: Insights from Computer-Aided Drug Design. doi:10.3390/molecules30183703 Molecules 2025
Exploring microbial dynamics in ferruginous caves: taxonomic and functional diversity across seasons and cave zones. doi:10.3389/fmicb.2025.1619203 Front Microbiol 2025
Type I IFN drives neutrophil swarming, impeding lung T cell-macrophage interactions and TB control. doi:10.1084/jem.20250466 J Exp Med 2025
Information on latent tuberculosis infection in higher education: social representations of nursing students. doi:10.1590/1980-220X-REEUSP-2025-0029en Rev Esc Enferm USP 2025
Diagnostic Delay and its Predictors among Tuberculosis Patients in Kandahar, Afghanistan: A Cross-sectional Analytical Study. doi:10.4103/ijmy.ijmy_91_25 Int J Mycobacteriol 2025
In Vitro Antimycobacterial Activity Evaluation of a New Lead Compound (LQFM326) against Clinical Strains of Mycobacterium sp. doi:10.1021/acsomega.5c04174 ACS Omega 2025
A Case of Advanced Urothelial Carcinoma Requiring Treatment Following a Positive Interferon-Gamma Release Assay Prior to Avelumab Administration. doi:10.1002/iju5.70063 IJU Case Rep 2025
Leprosy in blood donors. doi:10.1111/tmi.70007 Trop Med Int Health 2025
[Factores asociados al tratamiento no exitoso para tuberculosis en pacientes previamente tratados en Cali, Colombia, en el periodo 2015-2019]]. doi:10.7705/biomedica.8104 names it Biomedica 2025
Spatial and social determinants of tuberculosis in the Brazilian Amazon: a five-year multilevel and cluster-based analysis in Pará state, 2018-2022. doi:10.1590/1519-6984.296615 Braz J Biol 2025
Exploring Indole-Linked Triazole Sulfonamide Derivatives as Potent Mycobacterial Carbonic Anhydrase Inhibitors: Leveraging a Tail Approach for the Design, Synthesis, and In Silico Studies─An In-Depth Multidisciplinary Study. doi:10.1021/acs.jmedchem.5c01026 J Med Chem 2025
The Empty Medicine Cabinet: Urgent Action Needed to Resolve TB Drug Shortages in Europe. doi:10.1016/j.ijid.2025.108022 Int J Infect Dis 2025
Time from arrival in Chile to tuberculosis diagnosis in migrants treated at primary care centers in two Metropolitan Region municipalities, Chile. doi:10.5867/medwave.2025.07.3088 Medwave 2025
Anti-TB treatment non-adherence predictors: A multi-center cross-sectional study in Kandahar, Afghanistan. doi:10.1016/j.ijtb.2024.05.005 Indian J Tuberc 2025
[Social protection strategies for people with tuberculosis in Latin America: (re)thinking policies and practicesEstrategias de protección social para las personas con tuberculosis en América Latina: (re)pensar las políticas y las prácticas]. doi:10.26633/RPSP.2025.78 names it Rev Panam Salud Publica 2025
Aetiology of fever of unknown origin in people living with HIV: A systematic review and meta-analysis. doi:10.1111/hiv.70080 HIV Med 2025
Correlation of Radiographic and High-Resolution Computed Tomography (HRCT) Features in Lower Lobe Tuberculosis With Microbiological Findings: A Study in the Konaseema Region. doi:10.7759/cureus.85976 Cureus 2025
Regulation and function of microRNA-152 in various types of cancers: its upstream regulators and downstream targets. doi:10.1007/s10238-025-01775-z Clin Exp Med 2025
Inhalable N-Acetylcysteine-loaded Lactose-coated PLGA Nanoparticles for Tuberculosis Treatment. doi:10.1007/s11095-025-03889-1 Pharm Res 2025
Development and validation of a digital health application to support tuberculosis treatment adherence. doi:10.1590/1519-6984.296271 Braz J Biol 2025
Genomic survey reveals no detectable bacteriophage activity in Mycobacterium bovis across a large population. doi:10.1093/femsec/fiaf072 FEMS Microbiol Ecol 2025
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01037-2 Lancet 2025
Phase 2/3 study evaluating safety, immunogenicity, and noninferiority of single booster dose of AVX/COVID-12 vaccine. doi:10.1126/sciadv.adq2887 Sci Adv 2025
Mycobacterium appelbergii sp. nov., a Novel Species Isolated from a Drinking Water Fountain in a Rural Community. doi:10.3390/microorganisms13061259 Microorganisms 2025
Clinical practice guideline for the evaluation, treatment, and follow-up of children in contact with patients with pulmonary tuberculosis in Colombia. doi:10.25100/cm.v56i1.5918 Colomb Med (Cali) 2025
WHO online guide on the use of digital technologies for tuberculosis programmes. doi:10.1183/13993003.01126-2024 Eur Respir J 2025
Unilateral pulmonary miliary tuberculosis with abdominal tubercular lymphadenitis in an apparently immunocompetent adult: A case report. doi:10.1016/j.idcr.2025.e02257 IDCases 2025
[Latent Mycobacterium tuberculosis infection in primary health care professionals]. doi:10.1590/1413-81232025305.14222023 Cien Saude Colet 2025
Pre-European contact leprosy in the Americas and its current persistence. doi:10.1126/science.adu7144 Science 2025
Host-Directed Therapies Based on Protease Inhibitors to Control Mycobacterium tuberculosis and HIV Coinfection. doi:10.3390/microorganisms13051040 Microorganisms 2025
Endoplasmic Reticulum Stress in Tuberculosis: Molecular Bases and Pathophysiological Implications in the Immunopathogenesis of the Disease. doi:10.3390/ijms26104522 Int J Mol Sci 2025
Private Sector Engagement for Tuberculosis Services in Latin America: A Systematic Review. doi:10.3390/ijerph22050681 Int J Environ Res Public Health 2025
Clinical and CT characteristics of abdominal tuberculous lymphadenopathy: a comparative analysis of hematogenous and non-hematogenous dissemination. doi:10.1186/s12879-025-11101-3 BMC Infect Dis 2025
Tuberculosis disease characteristics associated with mortality, severe morbidity and unsuccessful treatment in people living with HIV treated for tuberculosis - a secondary analysis of the ANRS 12300 Reflate TB2 trial. doi:10.1186/s12879-025-10986-4 BMC Infect Dis 2025
β-Aminopropioamidoximes derivatives as potential antitubercular agents against anthropozoonotic infections caused by Mycobacterium tuberculosis and Mycobacterium bovis. doi:10.14202/vetworld.2025.731-745 Vet World 2025
Adherence to treatment for tuberculosis infection in children using a comprehensive care strategy: a prospective cohort study with a historical control group. doi:10.1016/j.lana.2025.101094 Lancet Reg Health Am 2025
Impact of climate change and social determinants on the spatial and epidemiological distribution of tuberculosis in the state of Pará: a perspective for COP 30. doi:10.1590/1519-6984.293623 Braz J Biol 2025
Knowledge and awareness of bovine tuberculosis associated with raw milk and under-cooked meat contamination among cattle farmers in selected parts of zambia. doi:10.1371/journal.pntd.0012870 PLoS Negl Trop Dis 2025
Understanding treatment initiation pathways and associated costs among people with pulmonary tuberculosis in a peri-urban area of Mozambique: a cross-sectional study. doi:10.1186/s12889-025-22333-y BMC Public Health 2025
Gut microbiota diversity among humans, elephants, livestock and wild herbivores in Chitwan National Park bears implications for conservation medicine. doi:10.1038/s41598-025-89402-5 Sci Rep 2025
Impact of allergic symptoms on work productivity in allergic rhinitis: A MASK-air direct patient data study. doi:10.1016/j.alit.2024.12.007 Allergol Int 2025
Dynamic (11)C-Para-Aminobenzoic Acid Positron Emission Tomography/Computed Tomography for Visualizing Pulmonary Mycobacteroides abscessus Infections. doi:10.1164/rccm.202409-1792OC names it Am J Respir Crit Care Med 2025
Cytochemical analysis of cerebrospinal fluid in tuberculous meningitis versus other etiologies. doi:10.1371/journal.pone.0318398 PLoS One 2025
Interaction of the Antibiotic Rifampicin with Lipid Membranes. doi:10.3390/biom15030320 Biomolecules 2025
Mycobacterium tuberculosis FtsB and PerM interact via a C-terminal helix in FtsB to modulate cell division. doi:10.1128/jb.00444-24 J Bacteriol 2025
The influence of sex on pyrazinamide and uric acid serum levels in Brazilian patients treated for pulmonary tuberculosis. doi:10.1590/S1678-9946202567018 Rev Inst Med Trop Sao Paulo 2025
The importance of getting the dose right in the treatment of tuberculosis. doi:10.1183/20734735.0177-2024 Breathe (Sheff) 2025
Musculoskeletal manifestations in Tuberculosis. doi:10.1016/j.berh.2025.102057 Best Pract Res Clin Rheumatol 2025
Cost-effectiveness analysis comparing QuantiFERON test and tuberculin skin test for the diagnosis of latent tuberculosis infection in immunocompetent children under 15 years of age in Colombia. doi:10.1136/bmjopen-2024-087333 BMJ Open 2025
Bacterial Communities and Resistance and Virulence Genes in Hospital and Community Wastewater: Metagenomic Analysis. doi:10.3390/ijms26052051 Int J Mol Sci 2025
The risk of developing depression in tuberculosis survivors: a nationwide cohort study in South Korea. doi:10.3389/fpsyt.2025.1425637 Front Psychiatry 2025
Open Drug Scenes Survey in Brazilian cities: main findings from São Paulo, Fortaleza, and Brasília. doi:10.1590/1980-549720250008 Rev Bras Epidemiol 2025
Vestibular syndrome in dairy heifers associated with Mycobacterium bovis: two case reports and strain characterization. doi:10.1007/s11259-025-10696-x Vet Res Commun 2025
Workshop report: One Health challenges and knowledge gaps in the control of intracellular infections with a focus on tuberculosis and leishmaniasis. doi:10.1016/j.vaccine.2025.126929 Vaccine 2025
Thermodynamic and Structural Characterization of a Mechanochemically Synthesized Pyrazinamide-Acetylsalicylic-Acid Eutectic Mixture. doi:10.3390/ph18020211 Pharmaceuticals (Basel) 2025
Tackling Infectious Diseases in the Caribbean and South America: Epidemiological Insights, Antibiotic Resistance, Associated Infectious Diseases in Immunological Disorders, Global Infection Response, and Experimental Anti-Idiotypic Vaccine Candidates Against Microorganisms of Public Health Importance. doi:10.3390/microorganisms13020282 Microorganisms 2025
Transmission of Mycobacterium tuberculosis in four prisons in Colombia. doi:10.1017/S0950268825000184 Epidemiol Infect 2025
Insights into leprosy epidemiology from an isolated population located in the Brazilian Amazon. doi:10.1038/s41598-025-90399-0 Sci Rep 2025
Access to diagnostic testing for invasive fungal diseases and other opportunistic infections in Mexican health care centers caring for patients living with HIV. doi:10.1186/s12913-025-12405-5 BMC Health Serv Res 2025
Clinical and epidemiological characterization of patients with cutaneous tuberculosis treated at a referral center in the Brazilian Amazon: case series. doi:10.1016/j.abd.2024.05.007 An Bras Dermatol 2025
Perceptions and experiences of directly observed treatment in tuberculosis: insights from a mixed-methods cross-sectional study. doi:10.36416/1806-3756/e20240357 J Bras Pneumol 2025
Safety, Efficacy, and Pharmacokinetics of Daily Optimized Doses of Rifampicin for the Treatment of Tuberculosis: A Systematic Review and Bayesian Network Meta-Analysis. doi:10.1093/cid/ciaf003 Clin Infect Dis 2025
Identification of Potentially Novel Mycobacterium Spp. In Freshwater Ornamental Fish in Trinidad and Tobago. doi:10.1111/jfd.14079 J Fish Dis 2025
Performance of a broth microdilution assay for routine minimum inhibitory concentration determination of 14 anti-tuberculous drugs against the Mycobacterium tuberculosis complex based on the EUCAST reference protocol. doi:10.1128/aac.00946-24 Antimicrob Agents Chemother 2025
Therapeutic BCG vaccine protects against long COVID: The BATTLE randomized clinical trial. doi:10.1111/joim.20033 J Intern Med 2025
Trends in mortality in Spain, with a special focus on respiratory-related conditions in the midst of the COVID-19 pandemic. doi:10.1016/j.medcli.2024.08.004 Med Clin (Barc) 2025
Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort. doi:10.1097/FPC.0000000000000552 Pharmacogenet Genomics 2025
A disposable, portable electrochemical immunosensor for rapid in situ detection of bovine tuberculosis. doi:10.1016/j.talanta.2024.126878 Talanta 2025
Pharmacokinetic-Pharmacodynamic (PK-PD) Analysis of Second-Line Anti-Tubercular Drugs in Indian Children with Multi-Drug Resistance. doi:10.1007/s12098-024-05135-9 Indian J Pediatr 2025
Comprehensive genomic surveillance reveals transmission profiles of extensively drug-resistant tuberculosis cases in Pará, Brazil. doi:10.3389/fmicb.2024.1514862 Front Microbiol 2024
Disseminated tuberculosis masquerading as a psychiatric illness-A case report. doi:10.4103/jfmpc.jfmpc_930_24 J Family Med Prim Care 2024
"You find yourself in a very humiliating situation": experiences of people living with post-tuberculosis lung disease in Brazil. doi:10.3389/fpubh.2024.1431881 Front Public Health 2024
A Lumbar Drug-Resistant Tuberculosis: A Case Report and Review of Literature. doi:10.2147/IDR.S504519 Infect Drug Resist 2024
Diagnostic performance of the Cobas MTB and Logix Smart MTB for diagnosing pulmonary and extrapulmonary tuberculosis: a cross-sectional study of diagnostic tests. doi:10.1177/20499361241304516 Ther Adv Infect Dis 2024
Advances in tuberculosis biomarkers: unravelling risk factors, active disease and treatment success. doi:10.1183/20734735.0003-2024 Breathe (Sheff) 2024
Artificial intelligence in tuberculosis: a new ally in disease control. doi:10.1183/20734735.0056-2024 Breathe (Sheff) 2024
Model for predicting drug resistance based on the clinical profile of tuberculosis patients using machine learning techniques. doi:10.7717/peerj-cs.2246 PeerJ Comput Sci 2024
Epidemiological situation of bovine and bubaline tuberculosis in the state of Pará, Amazon region of Brazil. doi:10.3389/fvets.2024.1466199 Front Vet Sci 2024
Revealing disparities in representation in knowledge generation and guideline development. doi:10.1186/s12913-024-11958-1 BMC Health Serv Res 2024
Prevalence of paucibacillary cases of leprosy in Brazil: a 20-year systematic review and meta-analysis. doi:10.3389/fmed.2024.1401685 Front Med (Lausanne) 2024
Comparison Between Simple Batch and Fed-Batch Bioreactor Cultivation of Recombinant BCG. doi:10.3390/pharmaceutics16111433 Pharmaceutics 2024
Viewpoint on WHO implementation guidance on tuberculosis infection prevention and control. doi:10.1183/13993003.00109-2024 Eur Respir J 2024
Factores asociados al tratamiento no exitoso para tuberculosis en pacientes previamente tratados en Cali, Colombia, en el periodo 2015 -2019. Biomédica, 2023;43360-73. https://doi.org/10.7705/biomedica.6961. doi:10.7705/biomedica.7747 names it Biomedica 2024
Thermodynamic Assessment of the Pyrazinamide Dissolution Process in Some Organic Solvents. doi:10.3390/molecules29215089 Molecules 2024
Comparative analysis of the leprosy detection rate regarding its clinical spectrum through PCR using the 16S rRNA gene: a scientometrics and meta-analysis. doi:10.3389/fmicb.2024.1497319 Front Microbiol 2024
Disseminated Tuberculosis Masquerading as a Uterine Cervical Mass in an Immunocompetent Young Female: A Case Report. doi:10.7759/cureus.70883 Cureus 2024
Mycobacterium tuberculosis evolution from monoresistance to pre-extensive drug resistance during a prolonged household outbreak. doi:10.1016/j.jctube.2024.100482 J Clin Tuberc Other Mycobact Dis 2024
Exploring Benzo[h]chromene Derivatives as Agents against Protozoal and Mycobacterial Infections. doi:10.3390/ph17101375 Pharmaceuticals (Basel) 2024
People with pulmonary tuberculosis in primary health care: social networks and repercussions of illness. doi:10.1590/1983-1447.2024.20230302.en Rev Gaucha Enferm 2024
Depression symptoms among Afghan TB patients: A multi-center study. doi:10.1016/j.ijtb.2024.08.016 Indian J Tuberc 2024
High stigma prevalence and associated factors among TB patients in Southern Afghanistan: A multi-center cross-sectional study. doi:10.1016/j.ijtb.2024.08.005 Indian J Tuberc 2024
Role of histopathological, serological and molecular findings for the early diagnosis of treatment failure in leprosy. doi:10.1186/s12879-024-09937-2 BMC Infect Dis 2024
A Genome-Focused Investigation Reveals the Emergence of a Mycobacterium tuberculosis Strain Related to Multidrug-Resistant Tuberculosis in the Amazon Region of Brazil. doi:10.3390/microorganisms12091817 Microorganisms 2024
Subtracting the background by reducing cell-free DNA's confounding effects on Mycobacterium tuberculosis quantitation and the sputum microbiome. doi:10.1038/s41598-024-73497-3 Sci Rep 2024
Host factor RBMX2 promotes epithelial cell apoptosis by downregulating APAF-1's Retention Intron after Mycobacterium bovis infection. doi:10.3389/fimmu.2024.1431207 Front Immunol 2024
An update on leprosy immunopathogenesis: systematic review. doi:10.3389/fimmu.2024.1416177 Front Immunol 2024
Genetic ancestry proportion influences risk of adverse events from tuberculosis treatment in Brazil. doi:10.1101/2024.08.29.24312595 medRxiv 2024
[Telephone surveys for the study of catastrophic costs due to tuberculosis in Colombia: a novel toolPesquisas telefônicas para um estudo de custos catastróficos da tuberculose na Colômbia: uma ferramenta inovadora]. doi:10.26633/RPSP.2024.88 names it Rev Panam Salud Publica 2024
Treatment for multidrug-resistant tuberculosis: A comparative analysis of programmatic outcome indicators between Buenaventura and other municipalities of Valle del Cauca, Colombia. doi:10.7705/biomedica.7204 Biomedica 2024
Genetic diversity within diagnostic sputum samples is mirrored in the culture of Mycobacterium tuberculosis across different settings. doi:10.1038/s41467-024-51266-0 Nat Commun 2024
Poncet disease in a patient with smear-negative pulmonary tuberculosis: A case report. doi:10.51866/cr.581 Malays Fam Physician 2024
Advancements in Immunology and Microbiology Research: A Comprehensive Exploration of Key Areas. doi:10.3390/microorganisms12081672 Microorganisms 2024
Characterization of novel double-reporter strains of Mycobacterium abscessus for drug discovery: a study in mScarlet. doi:10.1128/spectrum.00362-24 Microbiol Spectr 2024
Barriers to TB detection in Portuguese prisons. doi:10.5588/ijtld.23.0600 Int J Tuberc Lung Dis 2024
Clinical application of whole-genome sequencing in the management of extensively drug-resistant tuberculosis: a case report. doi:10.1186/s12941-024-00737-9 Ann Clin Microbiol Antimicrob 2024
Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project. doi:10.1080/19490976.2024.2379440 Gut Microbes 2024
Manipulation of solid dosage forms for oral administration to paediatric patients for drug-resistant tuberculosis in South Africa: an observation study. doi:10.1186/s12887-024-04985-8 BMC Pediatr 2024
Cystatin F Depletion in Mycobacterium tuberculosis-Infected Macrophages Improves Cathepsin C/Granzyme B-Driven Cytotoxic Effects on HIV-Infected Cells during Coinfection. doi:10.3390/ijms25158141 Int J Mol Sci 2024
Role of Type I Interferons during Mycobacterium tuberculosis and HIV Infections. doi:10.3390/biom14070848 Biomolecules 2024
Improvements in data completeness in health information systems reveal racial inequalities: longitudinal national data from hospital admissions in Brazil 2010-2022. doi:10.1186/s12939-024-02214-3 Int J Equity Health 2024
The T120P or M172V mutation on rv2172c confers high level para-aminosalicylic acid resistance in Mycobacterium tuberculosis. doi:10.1080/22221751.2024.2374030 names it Emerg Microbes Infect 2024
Phylogenomic and genomic analysis reveals unique and shared genetic signatures of Mycobacterium kansasii complex species. doi:10.1099/mgen.0.001266 Microb Genom 2024
Sociobehavioral Risk Factors and Clinical Implications of Late Presentation Among People Living with HIV in the Brazilian Amazon Region. doi:10.1007/s10461-024-04437-5 AIDS Behav 2024
Vulnerability to loss of follow-up and death due to tuberculosis among homeless individuals in Brazil: a retrospective cohort study. doi:10.1590/1413-81232024297.02742024 Cien Saude Colet 2024
Synthesis and characterisation of antimicrobial metal-organic frameworks as multi-drug carriers. doi:10.1039/d4dt01100g Dalton Trans 2024
Antibacterial Prodrugs to Overcome Bacterial Antimicrobial Resistance. doi:10.3390/ph17060718 Pharmaceuticals (Basel) 2024
Presence and Persistence of ESKAPEE Bacteria before and after Hospital Wastewater Treatment. doi:10.3390/microorganisms12061231 Microorganisms 2024
Flow Cytometry Coupled with Resuscitation Assays As a High-Resolution Tool to Inform Environmental Management and Disinfection of Settings Affected by Tuberculous Mycobacteria. doi:10.3390/microorganisms12061068 Microorganisms 2024
The HepHIV 2023 Madrid conference: A call to action for political leadership in reaching the sustainable development goals on earlier testing and linkage to care for HIV, viral hepatitis, and sexually transmitted infections. doi:10.1111/hiv.13683 HIV Med 2024
CD5L is upregulated upon infection with Mycobacterium tuberculosis with no effect on disease progression. doi:10.1111/imm.13825 Immunology 2024
Mycobacterium tuberculosis FadD18 Promotes Proinflammatory Cytokine Secretion to Inhibit the Intracellular Survival of Bacillus Calmette-Guérin. doi:10.3390/cells13121019 Cells 2024
Evaluation of WHO catalog of mutations and five WGS analysis tools for drug resistance prediction of Mycobacterium tuberculosis isolates from China. doi:10.1128/spectrum.03341-23 Microbiol Spectr 2024
Post-tuberculosis in children and adolescents: A good start with a long road ahead. doi:10.1002/ppul.27126 Pediatr Pulmonol 2024
Phenotyping chronic respiratory diseases with airways obstruction. doi:10.5588/ijtld.23.0383 Int J Tuberc Lung Dis 2024
Humoral Immunity across the SARS-CoV-2 Spike after Sputnik V (Gam-COVID-Vac) Vaccination. doi:10.3390/antib13020041 Antibodies (Basel) 2024
Synthesis, Activity, Toxicity, and In Silico Studies of New Antimycobacterial N-Alkyl Nitrobenzamides. doi:10.3390/ph17050608 Pharmaceuticals (Basel) 2024
Development of New Drugs to Treat Tuberculosis Based on the Dinitrobenzamide Scaffold. doi:10.3390/ph17050559 Pharmaceuticals (Basel) 2024
Individual- and Herd-Level Milk ELISA Test Status and Incidence for Paratuberculosis in Hubei Province, China. doi:10.3390/vetsci11050202 Vet Sci 2024
Population structure and history of Mycobacterium bovis European 3 clonal complex reveal transmission across ecological corridors of unrecognized importance in Portugal. doi:10.1128/spectrum.03829-23 Microbiol Spectr 2024
Tuberculosis screening in the European migrant population: a scoping review of current practices. doi:10.1183/20734735.0357-2023 Breathe (Sheff) 2024
Tuberculosis in Wild Pigs from Argentina. doi:10.1007/s10393-024-01681-y Ecohealth 2024
Susceptibility testing of the live attenuated tuberculosis vaccine BCG and the vaccine candidate MTBVAC to currently WHO-recommended anti-tuberculosis drugs by the European committee on antimicrobial susceptibility testing (EUCAST) method. doi:10.1016/j.cmi.2024.04.017 Clin Microbiol Infect 2024
Which health conditions report the most spending on medical imaging? Evidence for Colombia. doi:10.1067/j.cpradiol.2024.05.003 Curr Probl Diagn Radiol 2024
Healthcare professionals perspectives on tuberculosis barriers in Portuguese prisons-a qualitative study. doi:10.1093/pubmed/fdae065 J Public Health (Oxf) 2024
Multidrug-Resistant Staphylococcus sp. and Enterococcus sp. in Municipal and Hospital Wastewater: A Longitudinal Study. doi:10.3390/microorganisms12040645 Microorganisms 2024
Factors associated with patient delay in the diagnosis of TB - a study of health-seeking behaviour. doi:10.5588/ijtld.23.0502 Int J Tuberc Lung Dis 2024
Sustainable Development Goals' health-related indicators for Brazil and Ecuador: an analysis for the period of 1990-2019. doi:10.1016/j.puhe.2024.01.034 Public Health 2024
Protocol for the selection of Mycobacterium tuberculosis spontaneous resistant mutants to d-cycloserine. doi:10.1016/j.mex.2024.102690 MethodsX 2024
Tuberculosis patients face high treatment support costs in Colombia, 2021. doi:10.1371/journal.pone.0296250 PLoS One 2024
Rescue of Mycobacterium bovis DNA Obtained from Cultured Samples during Official Surveillance of Animal TB: Key Steps for Robust Whole Genome Sequence Data Generation. doi:10.3390/ijms25073869 Int J Mol Sci 2024
Diagnostic Dilemma Regarding Postpartum Seizure in the Setting of Preeclampsia. doi:10.7759/cureus.57832 Cureus 2024
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. doi:10.1016/S0140-6736(24)00367-2 Lancet 2024
Tuberculosis in pregnancy and adverse neonatal outcomes in two peruvian hospitals. doi:10.1016/j.eurox.2024.100304 Eur J Obstet Gynecol Reprod Biol X 2024
Why is it necessary to produce a BCG strain in Spain? doi:10.1016/j.acuroe.2024.04.003 Actas Urol Esp (Engl Ed) 2024
Uncovering the roles of Mycobacterium tuberculosis melH in redox and bioenergetic homeostasis: implications for antitubercular therapy. doi:10.1128/msphere.00061-24 mSphere 2024
An evaluation of mental health integration in the neglected tropical diseases program in Zamfara, North-west Nigeria. doi:10.1093/inthealth/ihae003 Int Health 2024
Type 2 diabetes mellitus and recurrent Tuberculosis: A retrospective cohort in Peruvian military workers. doi:10.1016/j.jctube.2024.100432 J Clin Tuberc Other Mycobact Dis 2024
Isoniazid use, effectiveness, and safety for treatment of latent tuberculosis infection: a systematic review. doi:10.1590/0037-8682-0504-2023 Rev Soc Bras Med Trop 2024
Coexistence of ovarian cancer and peritoneal tuberculosis: a case report. doi:10.1007/s13691-023-00649-z Int Cancer Conf J 2024
Epidemiological, clinical, and geographical characterization of Leprosy in the County of Santarém-Pará: Insights for effective control and targeted intervention. doi:10.1371/journal.pntd.0012063 PLoS Negl Trop Dis 2024
Synthesis,Antidiabetic and Antitubercular Evaluation of Quinoline-pyrazolopyrimidine hybrids and Quinoline-4-Arylamines. doi:10.1002/open.202400014 ChemistryOpen 2024
Mitochondrial variants of complex I genes associated with leprosy clinical subtypes. doi:10.1038/s41598-024-57191-y Sci Rep 2024
Mycobacterium tuberculosis latent infection in healthcare students: systematic review of prevalence. doi:10.1590/1980-220X-REEUSP-2023-0238en Rev Esc Enferm USP 2024
Social representations of tuberculosis by people with the disease. doi:10.1590/1983-1447.2024.20230159.en Rev Gaucha Enferm 2024
[Temporal trend in the evaluation of adequate management for diagnosis and treatment of tuberculosis in primary health care in Brazil (2012-2018)]. doi:10.1590/0102-311XPT087723 Cad Saude Publica 2024
Multi-Drug-Resistant Tuberculosis Peritonitis: A Case Report. doi:10.7759/cureus.53975 Cureus 2024
Lipoarabinomannan mediates localized cell wall integrity during division in mycobacteria. doi:10.1038/s41467-024-46565-5 Nat Commun 2024
Discovery of 2,9-diaryl-6-carbamoylpurines as a novel class of antitubercular agents. doi:10.1016/j.ejmech.2024.116297 Eur J Med Chem 2024
Level function levels and oxidative stress markers in patients with multidrug-resistant tuberculosis in the Brazilian Amazon. doi:10.1590/1519-6984.272512 Braz J Biol 2024
Pyrazinoic acid, the active form of the anti-tuberculosis drug pyrazinamide, and aromatic carboxylic acid analogs are protonophores. doi:10.3389/fmolb.2024.1350699 Front Mol Biosci 2024
Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of Mycobacterium tuberculosis. doi:10.1128/aac.01586-23 Antimicrob Agents Chemother 2024
Delays have dangerous ends: Tuberculosis diagnosis delay in Portugal, a qualitative study. doi:10.1016/j.pulmoe.2024.02.006 Pulmonology 2024
[HIV and human rights: political action to achieve ZERO stigma]. Rev Esp Salud Publica 2024
An integrative multi-omics approach to characterize interactions between tuberculosis and diabetes mellitus. doi:10.1016/j.isci.2024.109135 iScience 2024
Preparation and Characterization of a Rifampicin Coamorphous Material with Tromethamine Coformer: An Experimental-Theoretical Study. doi:10.1021/acs.molpharmaceut.3c00947 Mol Pharm 2024
MicroRNA biomarkers in leprosy: insights from the Northern Brazilian Amazon population and their implications in disease immune-physiopathology. doi:10.3389/fgene.2024.1320161 Front Genet 2024
Association of Mycobacterium avium paratuberculosis serostatus with age at first calving, calving interval, and milk production in dairy cows. doi:10.3168/jds.2023-23516 J Dairy Sci 2024
Sociodemographic factors associated with the success or failure of anti-tuberculosis treatment in the Chiapas Highlands, Mexico, 2019-2022. doi:10.1371/journal.pone.0296924 PLoS One 2024
Health Education Initiatives for People Who Have Experienced Prison: A Narrative Review. doi:10.3390/healthcare12020274 Healthcare (Basel) 2024
Beyond goodwill and promises-urgent needs and opportunities to accelerate the fight against tuberculosis in Brazil. doi:10.1016/j.lana.2023.100663 Lancet Reg Health Am 2024
Plantar pressure distribution and altered postural control in multibacillary leprosy patients. doi:10.1186/s12879-023-08749-0 BMC Infect Dis 2024
Drug-induced hypothyroidism in tuberculosis. doi:10.1080/17446651.2024.2307525 Expert Rev Endocrinol Metab 2024
The sound of silent RNA in tuberculosis and the lncRNA role on infection. doi:10.1016/j.isci.2023.108662 iScience 2024
Mutations in the promoter region of methionine transporter gene metM (Rv3253c) confer para-aminosalicylic acid (PAS) resistance in Mycobacterium tuberculosis. doi:10.1128/mbio.02073-23 names it mBio 2024
The Xpert® MTB/RIF cycle threshold value predicts M. tuberculosis transmission to close contacts in a Brazilian prospective multicenter cohort. doi:10.1093/cid/ciad794 Clin Infect Dis 2024
The epidemiological situation of tuberculosis in Spain according to surveillance and hospitalization data, 2012-2020. doi:10.1371/journal.pone.0295918 PLoS One 2024
Spermine enhances the activity of anti-tuberculosis drugs. doi:10.1128/spectrum.03568-23 Microbiol Spectr 2024
Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis. doi:10.1093/infdis/jiad480 J Infect Dis 2024
Uncovering the Roles of Mycobacterium tuberculosis melH in Redox and Bioenergetic Homeostasis: Implications for Antitubercular Therapy. doi:10.1101/2023.10.02.560593 bioRxiv 2024
Incidence and risk factors of tuberculosis among 420 854 household contacts of patients with tuberculosis in the 100 Million Brazilian Cohort (2004-18): a cohort study. doi:10.1016/S1473-3099(23)00371-7 Lancet Infect Dis 2024
The copper P-type ATPase CtpA is involved in the response of Mycobacterium tuberculosis to redox stress. doi:10.1016/j.biochi.2023.10.017 Biochimie 2023
Access of people with pulmonary tuberculosis to government programs: Primary Care professionals' perceptions. doi:10.1590/0034-7167-2022-0716 Rev Bras Enferm 2023
Unveiling the power of neutral and inclusive language in tuberculosis prevention and care. doi:10.1183/20734735.0157-2023 Breathe (Sheff) 2023
Competition between H(4)PteGlu and H(2)PtePAS Confers para-Aminosalicylic Acid Resistance in Mycobacterium tuberculosis. doi:10.3390/antibiotics13010013 names it Antibiotics (Basel) 2023
Oligohexamethylene Guanidine Derivative as a Means to Prevent Biological Fouling of a Polymer-Based Composite Optical Oxygen Sensor. doi:10.3390/polym15234508 Polymers (Basel) 2023
Identification of Differential Circular RNA Expression Profiles and Functional Networks in Human Macrophages Induced by Virulent and Avirulent Mycobacterium tuberculosis Strains. doi:10.3390/ijms242417561 Int J Mol Sci 2023
ncRNAs: an unexplored cellular defense mechanism in leprosy. doi:10.3389/fgene.2023.1295586 Front Genet 2023
[Varela L, Ortiz J, García PK, Luna L, Fuertes-Bucheli JF, Pacheco R. Factores asociados al tratamiento no exitoso para tuberculosis en pacientes previamente tratados en Cali, Colombia, en el periodo 2015-2019. Biomédica. 2023;43:360-73. https://doi.org/10.7705/biomedica.6961]. names it Biomedica 2023
Contents of antenatal care services in Afghanistan: findings from the national health survey 2018. doi:10.1186/s12889-023-17411-y BMC Public Health 2023
Whole mitogenome sequencing uncovers a relation between mitochondrial heteroplasmy and leprosy severity. doi:10.1186/s40246-023-00555-8 Hum Genomics 2023
Whole genome sequencing reveals candidate genes involving in PAS resistance in M. Tuberculosis isolated from patients in Thailand. doi:10.1007/s11274-023-03834-7 World J Microbiol Biotechnol 2023
Investigating the role of symptom valorisation in tuberculosis patient delay in urban areas in Portugal. doi:10.1186/s12889-023-17319-7 BMC Public Health 2023
[The Past in the Present: A Historical Cause as an Indication for Non-Invasive Ventilation]. doi:10.20344/amp.20611 Acta Med Port 2023
Association between mutations in a thyX-hsdS.1 region and para-aminosalicylic acid resistance in Mycobacterium tuberculosis clinical isolates. doi:10.1080/22221751.2023.2276339 names it Emerg Microbes Infect 2023
[Continuing education practices in primary health care for addressing users with tuberculosis]. doi:10.18294/sc.2023.4542 Salud Colect 2023
A Single-Run HPLC-MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis. doi:10.3390/pharmaceutics15112543 Pharmaceutics 2023
The Role of GeneXpert(®) for Tuberculosis Diagnostics in Brazil: An Examination from a Historical and Epidemiological Perspective. doi:10.3390/tropicalmed8110483 Trop Med Infect Dis 2023
Mycobacterium tuberculosis Fatty Acyl-CoA Synthetase fadD33 Promotes Bacillus Calmette-Guérin Survival in Hostile Extracellular and Intracellular Microenvironments in the Host. doi:10.3390/cells12222610 Cells 2023
Histopathological and molecular methods as complementary diagnostic in case of lymphadenopathies suggestive of bovine tuberculosis. doi:10.12834/VetIt.2157.19159.3 Vet Ital 2023
Educational technology on tuberculosis: construction shared with Primary Health Care nurses. doi:10.1590/0034-7167-2023-0025 Rev Bras Enferm 2023
The interplay between the polar growth determinant DivIVA, the segregation protein ParA, and their novel interaction partner PapM controls the Mycobacterium smegmatis cell cycle by modulation of DivIVA subcellular distribution. doi:10.1128/spectrum.01752-23 names it Microbiol Spectr 2023
An update on Mycobacterium tuberculosis lipoproteins. doi:10.2217/fmb-2023-0088 Future Microbiol 2023
Therapeutic Liquid Eutectic Solvents in Lipid Nanoparticles as Drug Vehicles-A Proof of Concept. doi:10.3390/ijms242115648 Int J Mol Sci 2023
Geoprogrammatic disparities in the performance of tuberculosis indicators in the homeless population in Brazil: an ecological approach. doi:10.1590/1980-549720230048.2 Rev Bras Epidemiol 2023
Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies. doi:10.3390/ph16101360 Pharmaceuticals (Basel) 2023
Association of Cytokine Gene Polymorphisms and Their Impact on Active and Latent Tuberculosis in Brazil's Amazon Region. doi:10.3390/biom13101541 Biomolecules 2023
Immunohistochemical Characterization of M1, M2, and M4 Macrophages in Leprosy Skin Lesions. doi:10.3390/pathogens12101225 Pathogens 2023
Influence of sex on the exposure to isoniazid in patients with pulmonary tuberculosis. doi:10.1590/S1678-9946202365056 Rev Inst Med Trop Sao Paulo 2023
Factors associated with unsuccessful treatment outcome for tuberculosis in previously treated patients in Cali, Colombia, during the period 2015-2019. doi:10.7705/biomedica.6961 Biomedica 2023
Identification of a Potential Antimycobacterial Drug Sensitizer Targeting a Flavin-Independent Methylenetetrahydrofolate Reductase. doi:10.1021/acsomega.3c05021 ACS Omega 2023
The geographical distribution and socioeconomic risk factors of COVID-19, tuberculosis and leprosy in Fortaleza, Brazil. doi:10.1186/s12879-023-08627-9 BMC Infect Dis 2023
Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic Stability. doi:10.1002/cmdc.202300410 ChemMedChem 2023
CRISPR-Cas9 assisted non-homologous end joining genome editing system of Halomonas bluephagenesis for large DNA fragment deletion. doi:10.1186/s12934-023-02214-y Microb Cell Fact 2023
Gelatinous Pleural Effusion: A Diagnostic Challenge for Pleural Mesothelioma in an 80-Year-Old Man. doi:10.12659/AJCR.941263 Am J Case Rep 2023
Specialized active leprosy search strategies in an endemic area of the Brazilian Amazon identifies a hypermutated Mycobacterium leprae strain causing primary drug resistance. doi:10.3389/fmed.2023.1243571 Front Med (Lausanne) 2023
Effects of antituberculosis treatment on pregnancy outcomes in infertile women with genital tuberculosis: a systematic review. doi:10.1136/bmjopen-2022-070456 BMJ Open 2023
Drug Resistance in Osteoarticular Tuberculosis: A Study From an Endemic Zone. doi:10.7759/cureus.44173 Cureus 2023
Antioxidant and Anti-Inflammatory Activities of Stellera chamaejasme L. Roots and Aerial Parts Extracts. doi:10.3390/life13081654 Life (Basel) 2023
Spatial Analysis of Tuberculosis Patient Flow in a Neglected Region of Northern Brazil. doi:10.3390/tropicalmed8080397 Trop Med Infect Dis 2023
Quantitative Fit Testing on Filtering Facepiece Respirators in Use by Peruvian Healthcare Workers Caring for Tuberculosis Patients during the COVID-19 Pandemic: PROFIT Study 2020. doi:10.3390/ijerph20166618 Int J Environ Res Public Health 2023
Fixed duration multidrug therapy (12 months) in leprosy patients with high bacillary load - Need to look beyond. doi:10.25259/IJDVL_278_2023 Indian J Dermatol Venereol Leprol 2023
Leprosy and tuberculosis control scenario of the national program for the improvement of access and quality of primary care in Brazil. doi:10.1186/s12913-023-09842-5 BMC Health Serv Res 2023
[Tuberculosis: Meaning for patients cared for at the Primary Care Center]. doi:10.1016/j.aprim.2023.102707 Aten Primaria 2023
A Hidden Condition: Multiple Tarlov Cysts Unveiled in a Young Woman Seeking Primary Care for Debilitating Low Back Pain. doi:10.12659/AJCR.940600 Am J Case Rep 2023
Modulation of Cystatin F in Human Macrophages Impacts Cathepsin-Driven Killing of Multidrug-Resistant Mycobacterium tuberculosis. doi:10.3390/microorganisms11071861 Microorganisms 2023
Genomic Analysis of Mycobacterium tuberculosis Strains Resistant to Second-Line Anti-Tuberculosis Drugs in Lusaka, Zambia. doi:10.3390/antibiotics12071126 Antibiotics (Basel) 2023
Sleep and cardiometabolic comorbidities in the obstructive sleep apnoea-COPD overlap syndrome: data from the European Sleep Apnoea Database. doi:10.1183/23120541.00676-2022 ERJ Open Res 2023
Multipathogen infections and multifactorial pathogenesis involved in noble pen shell (Pinna nobilis) mass mortality events: Background and current pathologic approaches. doi:10.1177/03009858231186737 Vet Pathol 2023
Respirable konjac glucomannan microparticles as antitubercular drug carriers: Effects of in vitro and in vivo interactions. doi:10.1016/j.ijbiomac.2023.125838 Int J Biol Macromol 2023
Evaluation and Forecasting Analysis of the Association of Conditional Cash Transfer With Child Mortality in Latin America, 2000-2030. doi:10.1001/jamanetworkopen.2023.23489 JAMA Netw Open 2023
Target Identification in Anti-Tuberculosis Drug Discovery. doi:10.3390/ijms241310482 Int J Mol Sci 2023
Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes. doi:10.1128/spectrum.01017-23 Microbiol Spectr 2023
Association between concern about COVID-19, social support and knowledge about tuberculosis with adherence to antituberculosis treatment in Lima, Perú. doi:10.7705/biomedica.6667 Biomedica 2023
Leprosy among children in an area without primary health care coverage in Caratateua Island, Brazilian Amazon. doi:10.3389/fmed.2023.1218388 Front Med (Lausanne) 2023
Clinical characteristics of patients with non-tuberculous mycobacterial pulmonary disease: a seven-year follow-up study conducted in a certain tertiary hospital in Beijing. doi:10.3389/fcimb.2023.1205225 Front Cell Infect Microbiol 2023
Impact of the COVID-19 pandemic in mortality due to respiratory diseases: A comparative analysis of 2021 and 2020 vs 2019 in Spain. doi:10.1016/j.medcli.2023.04.020 Med Clin (Barc) 2023
Changes in serum amyloid A, plasma high-density lipoprotein cholesterol and apolipoprotein A-I as useful biomarkers for Mycobacterium tuberculosis infection. doi:10.1099/jmm.0.001726 J Med Microbiol 2023
Antigen-Induced IL-1RA Production Discriminates Active and Latent Tuberculosis Infection. doi:10.3390/microorganisms11061385 Microorganisms 2023
The effect of TB patient delay on loss to follow-up in Portugal. doi:10.5588/ijtld.22.0623 Int J Tuberc Lung Dis 2023
Aldehyde accumulation in Mycobacterium tuberculosis with defective proteasomal degradation results in copper sensitivity. doi:10.1128/mbio.00363-23 mBio 2023
Geographic patterns and hotspots of pediatric tuberculosis: the role of socioeconomic determinants. doi:10.36416/1806-3756/e20230004 J Bras Pneumol 2023
Erratum for van der Laan et al., "Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis". doi:10.1128/aac.00720-23 names it Antimicrob Agents Chemother 2023
Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis. doi:10.1128/spectrum.00465-23 Microbiol Spectr 2023
Systemic aspergillosis in a patient with interferon gamma receptor 1 deficiency; a case report. doi:10.1186/s12887-023-04093-z BMC Pediatr 2023
Impact of Anti-Tuberculosis Drug Use on Treatment Outcomes in Patients with Pulmonary Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: A Nationwide Retrospective Cohort Study with Propensity Score Matching. doi:10.4046/trd.2023.0040 Tuberc Respir Dis (Seoul) 2023
Drug hypersensitivity in drug-resistant tuberculosis. doi:10.1016/j.waojou.2023.100778 World Allergy Organ J 2023
[Bacillus Calmette-Guérin infection and chronic granulomatous disease due to new pathogenic variants in the NCF2 gene in the Mayan ethnic group. Report of two cases.]. doi:10.29262/ram.v69i4.1145 Rev Alerg Mex 2023
Emergence and evolution of drug-resistant Mycobacterium tuberculosis in eastern China: A six-year prospective study. doi:10.1016/j.ygeno.2023.110640 Genomics 2023
A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction. doi:10.1038/s41598-023-34847-9 Sci Rep 2023
Perspectives of economic losses due to condemnation of cattle and buffalo carcasses in the northern region of Brazil. doi:10.1371/journal.pone.0285224 PLoS One 2023
Anemia and anti-tuberculosis treatment outcome in persons with pulmonary tuberculosis: A multi-center prospective cohort study. doi:10.1016/j.jiph.2023.04.009 J Infect Public Health 2023
Acute pancreatitis in pregnancy: how was it determined whether it was caused by pregnancy or by COVID-19? A case report. doi:10.1097/MS9.0000000000000340 Ann Med Surg (Lond) 2023
Nitrobenzoates and Nitrothiobenzoates with Activity against M. tuberculosis. doi:10.3390/microorganisms11040969 Microorganisms 2023
HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an "Emerging Syndemic". doi:10.3390/microorganisms11040853 Microorganisms 2023
Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant Mycobacterium tuberculosis. doi:10.3390/antibiotics12040729 Antibiotics (Basel) 2023
Intervening on Social Determinants for Better Outcomes in Pediatric Tuberculosis Management. doi:10.1164/rccm.202303-0601LE Am J Respir Crit Care Med 2023
Mutual Effects of Coincident Chronic Renal Failure and Chronic Obstructive Pulmonary Disease. Tanaffos 2023
Tuberculosis and COVID-19 Related Stigma: Portuguese Patients Experiences. doi:10.4046/trd.2022.0062 Tuberc Respir Dis (Seoul) 2023
Extracellular vesicles from Mycobacterium tuberculosis-infected neutrophils induce maturation of monocyte-derived dendritic cells and activation of antigen-specific Th1 cells. doi:10.1093/jleuko/qiad037 J Leukoc Biol 2023
Risk Practices for Occupational Zoonotic Exposure to Tuberculosis in a High-Risk Population in Portugal. doi:10.3390/tropicalmed8030167 Trop Med Infect Dis 2023
Novel multi-epitope vaccine against bovine brucellosis: approach from immunoinformatics to expression. doi:10.1080/07391102.2023.2188962 J Biomol Struct Dyn 2023
Evidence for Extensive Duplication and Subfunctionalization of FCRL6 in Armadillo (Dasypus novemcinctus). doi:10.3390/ijms24054531 Int J Mol Sci 2023
Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study. doi:10.1016/j.ijid.2023.02.025 Int J Infect Dis 2023
Report of 16 Years of the BCG Vaccine under the Expanded Program on Immunizations in Mexico (2006-2021). doi:10.3390/vaccines11020337 Vaccines (Basel) 2023
Factors Associated with Tuberculosis Outcome in a Hyperendemic City in the North of Brazil. doi:10.3390/healthcare11040508 Healthcare (Basel) 2023
Oncology in Mozambique: Overview of the Diagnostic, Treatment, and Research Capacity. doi:10.3390/cancers15041163 Cancers (Basel) 2023
New insights on tuberculosis transmission dynamics and drug susceptibility profiles among the prison population in Southern Brazil based on whole-genome sequencing. doi:10.1590/0037-8682-0181-2022 Rev Soc Bras Med Trop 2023
Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa. doi:10.1371/journal.pone.0281097 PLoS One 2023
Genomic Diversity of the Rarely Observed Genotype of the Mycobacterium tuberculosis Central Asian (CAS) Lineage 3 from North Brazil. doi:10.3390/microorganisms11010132 Microorganisms 2023
Improving the Antimycobacterial Drug Clofazimine through Formation of Organic Salts by Combination with Fluoroquinolones. doi:10.3390/ijms24021402 Int J Mol Sci 2023
Implementation of an integrated care strategy for child contacts of tuberculosis patients: a quasi-experimental study protocol. doi:10.1186/s12887-022-03798-x BMC Pediatr 2023
Low levels of TNFA gene expression seem to favor the development of pulmonary tuberculosis in a population from the Brazilian Amazon. doi:10.1016/j.imbio.2023.152333 Immunobiology 2023
Synthesis, Characterization, 'ADMET-SAR' Prediction, DPPH Assay, and Anti-Mycobacterium Study of 4-[(substituted benzyl) amino]benzo hydrazides and its Hydrazones as the Acyl-CoA Carboxylase, AccD5 Inhibitors. doi:10.2174/1573409919666221227091735 Curr Comput Aided Drug Des 2023
Tuberculin skin test and interferon-γ release assays: Can they agree? doi:10.1111/crj.13569 Clin Respir J 2023
New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians. doi:10.1159/000528274 Respiration 2023
Surgical Management of Patients With GI Tuberculosis. doi:10.1097/DCR.0000000000002626 Dis Colon Rectum 2023
Tuberculosis Treatment Outcomes in Brazil: Different Predictors for Each Type of Unsuccessful Outcome. doi:10.1093/cid/ciac541 Clin Infect Dis 2023
Whole exome analysis reveals the genomic profiling related to chemo-resistance in Chinese population with limited-disease small cell lung cancer. doi:10.1002/cam4.4950 Cancer Med 2023
Prognostic Value of Porta-Hepatis Lymphadenopathy in Children with Hepatitis A. doi:10.4103/jmu.jmu_196_21 J Med Ultrasound 2022
Pan-genome association study of Mycobacterium tuberculosis lineage-4 revealed specific genes related to the high and low prevalence of the disease in patients from the North-Eastern area of Medellín, Colombia. doi:10.3389/fmicb.2022.1076797 Front Microbiol 2022
Comparative genome analysis reveals high-level drug resistance markers in a clinical isolate of Mycobacterium fortuitum subsp. fortuitum MF GZ001. doi:10.3389/fcimb.2022.1056007 Front Cell Infect Microbiol 2022
Plasma Levels of sFas-sFasL and FASL Gene Expression Are Associated with Tuberculosis. doi:10.3390/biom13010080 Biomolecules 2022
Comparative genomics of drug-resistant strains of Mycobacterium tuberculosis in Ecuador. doi:10.1186/s12864-022-09042-1 BMC Genomics 2022
Bovine Tuberculosis - Analysis of 10-year cases and impact of visual inspection in the surveillance at the slaughterhouse in Portugal. doi:10.1016/j.onehlt.2022.100451 One Health 2022
Identifying clusters of leprosy patients in India: A comparison of methods. doi:10.1371/journal.pntd.0010972 PLoS Negl Trop Dis 2022
Health conditions of Hitnü indigenous people potentially exposed to crude oil in Arauca, Colombia. doi:10.7705/biomedica.6591 Biomedica 2022
Bibliometric analyses of applications of artificial intelligence on tuberculosis. doi:10.4103/ijmy.ijmy_134_22 Int J Mycobacteriol 2022
Role of Magnetic Resonance Imaging in evaluation of tuberculous tubo ovarian mass. doi:10.1016/j.ijtb.2021.08.031 Indian J Tuberc 2022
Geospatialization of tuberculosis and income transfer programs among Indigenous peoples in an endemic territory. doi:10.1590/0034-7167-2022-0216 Rev Bras Enferm 2022
Social Reproduction as a methodological perspective for contextualized analysis of living and health conditions. doi:10.1590/0102-311XPT150320 Cad Saude Publica 2022
Determinants of losses in the tuberculosis infection cascade of care among children and adolescent contacts of pulmonary tuberculosis cases: A Brazilian multi-centre longitudinal study. doi:10.1016/j.lana.2022.100358 Lancet Reg Health Am 2022
Mass Spectrometry-Based Proteomic and Metabolomic Profiling of Serum Samples for Discovery and Validation of Tuberculosis Diagnostic Biomarker Signature. doi:10.3390/ijms232213733 Int J Mol Sci 2022
Fibrosing mediastinitis in a child with Mendelian susceptibility to mycobacterial disease possibly due to Bacillus Calmette-Guérin. doi:10.1186/s13223-022-00738-3 Allergy Asthma Clin Immunol 2022
Analysis of health care in prisons of Pará state, Brazil. doi:10.1590/1413-812320222712.10212022 Cien Saude Colet 2022
Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations. doi:10.1186/s12941-022-00537-z names it Ann Clin Microbiol Antimicrob 2022
Pharmacological Management of Pulmonary Tuberculosis: A Century of Expert Opinions in Cecil Textbook of Medicine. doi:10.1097/MJT.0000000000001575 Am J Ther 2022
Fluoroquinolone Derivatives in the Treatment of Mycobacterium tuberculosis Infection. doi:10.3390/ph15101213 Pharmaceuticals (Basel) 2022
Epidemiological and Cytokine Profile of Patients with Pulmonary and Extrapulmonary Tuberculosis in a Population of the Brazilian Amazon. doi:10.3390/microorganisms10102075 Microorganisms 2022
Endovascular repair of a bacillus Calmette-Guérin mycotic aortic aneurysm. doi:10.1016/j.jvscit.2022.08.018 J Vasc Surg Cases Innov Tech 2022
Differences in CT imaging signs between patients with tuberculosis and those with tuberculosis and concurrent lung cancer. Am J Transl Res 2022
[Adaptation and validation of EMPODERA-TB to evaluate empowerment of patients with pulmonary tuberculosisAdaptação e validação do instrumento EMPODERA-TB para avaliar o empoderamento em pacientes com tuberculose pulmonar]. doi:10.26633/RPSP.2022.168 names it Rev Panam Salud Publica 2022
Thymus, undernutrition, and infection: Approaching cellular and molecular interactions. doi:10.3389/fnut.2022.948488 Front Nutr 2022
A five-year review of prevalence and treatment outcomes of pre-extensively drug-resistant plus additional drug-resistant tuberculosis in the Henan Provincial Tuberculosis Clinical Medicine Research Centre. doi:10.1016/j.jgar.2022.09.010 J Glob Antimicrob Resist 2022
Systematic identification and characterization of clinical and socio-economical correlates of granulomatous nasal and para-nasal sinuses: A large-scale study among patients of Odisha, India. doi:10.1016/j.heliyon.2022.e10741 names it Heliyon 2022
Point-of-care testing allows successful simultaneous screening of sickle cell disease, HIV, and tuberculosis for households in rural Guinea-Bissau, West Africa. doi:10.1002/pbc.30009 Pediatr Blood Cancer 2022
Molecular Insight into Mycobacterium tuberculosis Resistance to Nitrofuranyl Amides Gained through Metagenomics-like Analysis of Spontaneous Mutants. doi:10.3390/ph15091136 Pharmaceuticals (Basel) 2022
Benzoic Acid Derivatives as Prodrugs for the Treatment of Tuberculosis. doi:10.3390/ph15091118 Pharmaceuticals (Basel) 2022
Association between SNPs in microRNAs and microRNAs-Machinery Genes with Susceptibility of Leprosy in the Amazon Population. doi:10.3390/ijms231810628 Int J Mol Sci 2022
Mitochondria in Mycobacterium Infection: From the Immune System to Mitochondrial Haplogroups. doi:10.3390/ijms23179511 Int J Mol Sci 2022
DFT calculations, structural analysis, solvent effects, and non-covalent interaction study on the para-aminosalicylic acid complex as a tuberculosis drug: AIM, NBO, and NMR analyses. doi:10.1007/s00894-022-05279-5 names it J Mol Model 2022
Evaluation of whole-genome sequence to predict drug resistance of nine anti-tuberculosis drugs and characterize resistance genes in clinical rifampicin-resistant Mycobacterium tuberculosis isolates from Ningbo, China. doi:10.3389/fpubh.2022.956171 Front Public Health 2022
Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study. doi:10.3389/fped.2022.917731 Front Pediatr 2022
Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities. doi:10.3390/pharmaceutics14081671 Pharmaceutics 2022
Surveillance Quality Indicators Highlight the Need for Improving Tuberculosis Diagnostics and Monitoring in a Hyperendemic Area of the Brazilian Amazon Region. doi:10.3390/tropicalmed7080165 Trop Med Infect Dis 2022
Adaptation of Bacteria to Antineoplastic Agents Involves Persister Cells and Increases Resistance to Antibiotics. doi:10.3390/bioengineering9080355 Bioengineering (Basel) 2022
All-cause and cause-specific mortality among people with severe mental illness in Brazil's public health system, 2000-15: a retrospective study. doi:10.1016/S2215-0366(22)00237-1 Lancet Psychiatry 2022
Laboratory-based study of drug resistance and genotypic profile of multidrug-resistant tuberculosis isolates in Salvador, Bahia, Brazil. doi:10.1590/0037-8682-0013-2022 Rev Soc Bras Med Trop 2022
Differential activation of innate and adaptive lymphocytes during latent or active infection with Mycobacterium tuberculosis. doi:10.1111/1348-0421.13019 Microbiol Immunol 2022
Possible sex difference in latent tuberculosis infection risk among close tuberculosis contacts. doi:10.1016/j.ijid.2022.07.031 Int J Infect Dis 2022
The Presence of Mycobacterium leprae in Wild Rodents. doi:10.3390/microorganisms10061114 Microorganisms 2022
Performance evaluation of tuberculosis control in Brazilian municipalities. doi:10.11606/s1518-8787.2022056004020 Rev Saude Publica 2022
Ecological factors associated with areas of high tuberculosis diagnosis delay. doi:10.1016/j.puhe.2022.04.010 Public Health 2022
Metabolic Processing of Selenium-Based Bioisosteres of meso-Diaminopimelic Acid in Live Bacteria. doi:10.1021/acs.biochem.2c00120 Biochemistry 2022
Transcriptional Analysis for Tuberculosis in Pregnant Women From the PRegnancy Associated Changes In Tuberculosis Immunology (PRACHITi) Study. doi:10.1093/cid/ciac437 Clin Infect Dis 2022
BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus. doi:10.3390/vaccines10050721 Vaccines (Basel) 2022
Antimicrobial Resistance Patterns and Clonal Distribution of E. coli, Enterobacter spp. and Acinetobacter spp. Strains Isolated from Two Hospital Wastewater Plants. doi:10.3390/antibiotics11050601 Antibiotics (Basel) 2022
Prediction of drug resistance profile of multidrug-resistant Mycobacterium tuberculosis (MDR-MTB) isolates from newly diagnosed case by whole genome sequencing (WGS): a study from a high tuberculosis burden country. doi:10.1186/s12879-022-07482-4 BMC Infect Dis 2022
Reproducibility of a protocol for standardized reading of chest X-rays of children household contact of patients with tuberculosis. doi:10.1186/s12887-022-03347-6 BMC Pediatr 2022
Association of the rs4646994 in ACE gene with susceptibility to tuberculosis in a region of the Brazilian Amazon. doi:10.1186/s41231-022-00116-6 Transl Med Commun 2022
Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study. doi:10.1016/S1473-3099(21)00811-2 Lancet Infect Dis 2022
Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis. doi:10.1128/aac.02264-21 names it Antimicrob Agents Chemother 2022
Access to government social programs and the tuberculosis control program: a multicenter study. doi:10.1590/0034-7167-2021-0454 Rev Bras Enferm 2022
Characterization of Fluoroquinolone-Resistant and Multidrug-Resistant Mycobacterium tuberculosis Isolates Using Whole-Genome Sequencing in Tianjin, China. doi:10.2147/IDR.S361635 Infect Drug Resist 2022
COVID-19-related healthcare impacts: an uncontrolled, segmented time-series analysis of tuberculosis diagnosis services in Mozambique, 2017-2020. doi:10.1136/bmjgh-2021-007878 BMJ Glob Health 2022
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan. doi:10.1128/aac.02170-21 Antimicrob Agents Chemother 2022
Comparative Analysis on Proteomics Profiles of Intracellular and Extracellular M.tb and BCG From Infected Human Macrophages. doi:10.3389/fgene.2022.847838 Front Genet 2022
Different cell death mechanisms are involved in leprosy pathogenesis. doi:10.1016/j.micpath.2022.105511 Microb Pathog 2022
Characterization of the 2,6-Dimethylphenol Monooxygenase MpdAB and Evaluation of Its Potential in Vitamin E Precursor Synthesis. doi:10.1128/aem.00110-22 Appl Environ Microbiol 2022
A combination screening to identify enhancers of para-aminosalicylic acid against Mycobacterium tuberculosis. doi:10.1038/s41598-022-08209-w names it Sci Rep 2022
HLA-B*13, B*35 and B*39 Alleles Are Closely Associated With the Lack of Response to ART in HIV Infection: A Cohort Study in a Population of Northern Brazil. doi:10.3389/fimmu.2022.829126 Front Immunol 2022
[Epidemiological behavior of leprosy in several Latin American countries, 2011-2020Comportamento epidemiológico da hanseníase em vários países da América Latina, 2011-2020]. doi:10.26633/RPSP.2022.14 Rev Panam Salud Publica 2022
4-Arylthiosemicarbazide Derivatives as Toxoplasmic Aromatic Amino Acid Hydroxylase Inhibitors and Anti-inflammatory Agents. doi:10.3390/ijms23063213 Int J Mol Sci 2022
Surveillance of Antimicrobial Resistance in Hospital Wastewater: Identification of Carbapenemase-Producing Klebsiella spp. doi:10.3390/antibiotics11030288 Antibiotics (Basel) 2022
Intra-urban variation in tuberculosis and community socioeconomic deprivation in Lisbon metropolitan area: a Bayesian approach. doi:10.1186/s40249-022-00949-1 Infect Dis Poverty 2022
Tuberculosis Meningitis in People Living with HIV/AIDS in a Health Center in the Brazilian Amazon: A Silent Disease. doi:10.1155/2022/8048310 Case Rep Infect Dis 2022
Spatio-temporal analysis of tuberculosis and its correlation with the Living Conditions Index in an elderly population in Brazil. doi:10.1590/1414-431X2021e11544 Braz J Med Biol Res 2022
Use of Whole-Genome Sequencing to Predict Mycobacterium tuberculosis Complex Drug Resistance from Early Positive Liquid Cultures. doi:10.1128/spectrum.02516-21 Microbiol Spectr 2022
Genetic Variants of MicroRNA and DROSHA Genes in Association With the Risk of Tuberculosis in the Amazon Population. doi:10.3389/fgene.2022.850058 Front Genet 2022
Molecular detection of mycobacterium tuberculosis complex species in triatomines found in urban households and Peridomiciles in a city with high prevalence of tuberculosis in Northeastern Brazil. doi:10.4103/ijmy.ijmy_230_21 Int J Mycobacteriol 2022
Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis. doi:10.1007/s00415-022-11052-8 J Neurol 2022
Mycobacterium tuberculosis Rv0309 Dampens the Inflammatory Response and Enhances Mycobacterial Survival. doi:10.3389/fimmu.2022.829410 Front Immunol 2022
Impact of the COVID-19 pandemic on tuberculosis services. doi:10.1016/j.pulmoe.2022.01.015 Pulmonology 2022
Synthesis and biological evaluation of orally active prodrugs and analogs of para-aminosalicylic acid (PAS). doi:10.1016/j.ejmech.2022.114201 names it Eur J Med Chem 2022
Tuberculosis drug resistance profiling based on machine learning: A literature review. doi:10.1016/j.bjid.2022.102332 Braz J Infect Dis 2022
Dual RNA Sequencing of Mycobacterium tuberculosis-Infected Human Splenic Macrophages Reveals a Strain-Dependent Host-Pathogen Response to Infection. doi:10.3390/ijms23031803 Int J Mol Sci 2022
In Vitro and In Vivo Inhibition of the Mycobacterium tuberculosis Phosphopantetheinyl Transferase PptT by Amidinoureas. doi:10.1021/acs.jmedchem.1c01565 J Med Chem 2022
Type 2 leprosy reaction presenting as a monoarthritis post multidrug therapy. doi:10.1016/j.idcr.2022.e01386 IDCases 2022
Persistent dysglycemia is associated with unfavorable treatment outcomes in patients with pulmonary tuberculosis from Peru. doi:10.1016/j.ijid.2022.01.012 Int J Infect Dis 2022
A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis. doi:10.1186/s12864-022-08291-4 BMC Genomics 2022
Cutaneous tuberculosis: epidemiological, clinical, diagnostic and therapeutic update. doi:10.1016/j.abd.2021.07.004 An Bras Dermatol 2022
Antibiotic resistance and potential bacterial pathogens identified in red deer's faecal DNA. doi:10.1111/tbed.14448 Transbound Emerg Dis 2022
Catecholamine-induced cardiomyopathy improvement after para-aortic paraganglioma resection: a case report. doi:10.1002/ehf2.13783 names it ESC Heart Fail 2022
Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study. doi:10.1136/thoraxjnl-2021-217592 Thorax 2022
Pyogenic and Non-pyogenic Spinal Infections: Diagnosis and Treatment. doi:10.2174/1573405617666211117143203 Curr Med Imaging 2022
Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to para-Aminosalicylic Acid in Mycobacterium tuberculosis. doi:10.1128/AAC.01465-21 names it Antimicrob Agents Chemother 2022
[Recommendations to develop Care Models for patients with Heart Failure (MAIC Project) from macromanagement]. doi:10.1016/j.jhqr.2021.09.003 J Healthc Qual Res 2022
The Effect of Diabetes and Prediabetes on Antituberculosis Treatment Outcomes: A Multicenter Prospective Cohort Study. doi:10.1093/infdis/jiab427 J Infect Dis 2022
COVID-19 Related Hospital Re-organization and Trends in Tuberculosis Diagnosis and Admissions: Reflections From Portugal. doi:10.1016/j.arbres.2021.09.005 Arch Bronconeumol 2022
Para-aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research. doi:10.1111/bcp.15056 names it Br J Clin Pharmacol 2022
Cyclosporin A as an Alternative Neuroimmune Strategy to Control Neurites and Recover Neuronal Tissues in Leprosy. doi:10.1159/000517993 Neuroimmunomodulation 2022
A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes. doi:10.1093/cid/ciab598 Clin Infect Dis 2022
New Perspectives in Drug Delivery Systems for the Treatment of Tuberculosis. doi:10.2174/0929867328666210629154908 Curr Med Chem 2022
Cardiac Tuberculosis on (18) F-FDG PET Imaging-A Great Masquerader of Cardiac Sarcoidosis. doi:10.1055/s-0041-1739379 Indian J Radiol Imaging 2021
Prevalence and Clinical Profiling of Dysglycemia and HIV Infection in Persons With Pulmonary Tuberculosis in Brazil. doi:10.3389/fmed.2021.804173 Front Med (Lausanne) 2021
Identification of Unique Key miRNAs, TFs, and mRNAs in Virulent MTB Infection Macrophages by Network Analysis. doi:10.3390/ijms23010382 Int J Mol Sci 2021
Evolution of Antibacterial Drug Screening Methods: Current Prospects for Mycobacteria. doi:10.3390/microorganisms9122562 Microorganisms 2021
Whole genome sequencing reveals large deletions and other loss of function mutations in Mycobacterium tuberculosis drug resistance genes. doi:10.1099/mgen.0.000724 Microb Genom 2021
Policy transfer of the directly observed treatment of tuberculosis: speeches of health managers. doi:10.1590/1983-1447.2021.20200427 Rev Gaucha Enferm 2021
Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil. doi:10.1128/Spectrum.01163-21 Microbiol Spectr 2021
Therapeutic Deep Eutectic Systems towards the Treatment of Tuberculosis and Colorectal Cancer: Opportunities and Challenges. doi:10.3390/molecules26227022 Molecules 2021
Scrapie at Abattoir: Monitoring, Control, and Differential Diagnosis of Wasting Conditions during Meat Inspection. doi:10.3390/ani11113028 Animals (Basel) 2021
[Combined use of serologic markers and spatial analysis for epidemiological surveillance of leprosyUso conjunto de los marcadores serológicos y del análisis espacial en la vigilancia epidemiológica de la lepra]. doi:10.26633/RPSP.2021.129 Rev Panam Salud Publica 2021
Small RNA Profiling in Mycobacterium Provides Insights Into Stress Adaptability. doi:10.3389/fmicb.2021.752537 Front Microbiol 2021
Diagnostic performance of whole-genome sequencing for identifying drug-resistant TB in Thailand. doi:10.5588/ijtld.21.0096 Int J Tuberc Lung Dis 2021
Nursing care for the Amazon population: knowledge production and human resource development. doi:10.1590/0034-7167-2020-1084 Rev Bras Enferm 2021
Spatial analysis studies of endemic diseases for health surveillance: Application of scan statistics for surveillance of tuberculosis among residents of a metropolitan municipality aged 60 years and above. doi:10.1590/1413-812320212611.3.09132020 Cien Saude Colet 2021
DiHS/DRESS syndrome induced by second-line treatment for tuberculosis and Epstein-Barr virus. doi:10.5114/ceji.2021.109670 Cent Eur J Immunol 2021
The expression of FOXP3 in lesions of several forms of leprosy in patients co-infected with HIV. doi:10.1371/journal.pntd.0009887 PLoS Negl Trop Dis 2021
Oral Kaposi sarcoma development is associated with HIV viral load, CD4+ count and CD4+/CD8+ ratio. doi:10.4317/medoral.24708 Med Oral Patol Oral Cir Bucal 2021
A Novel Para-Amino Salicylic Acid Magnesium Layered Hydroxide Nanocomposite Anti-Tuberculosis Drug Delivery System with Enhanced in vitro Therapeutic and Anti-Inflammatory Properties. doi:10.2147/IJN.S297040 names it Int J Nanomedicine 2021
Bayesian accuracy estimates of environmental sampling for determining herd paratuberculosis infection status and its association with the within-herd individual fecal culture prevalence in Québec dairies. doi:10.1016/j.prevetmed.2021.105510 Prev Vet Med 2021
In Silico Identification of Possible Inhibitors for Protein Kinase B (PknB) of Mycobacterium tuberculosis. doi:10.3390/molecules26206162 Molecules 2021
Imported Malaria in Portugal: Prevalence of Polymorphisms in the Anti-Malarial Drug Resistance Genes pfmdr1 and pfk13. doi:10.3390/microorganisms9102045 Microorganisms 2021
The latest developments in the area of therapeutic delivery excluding some diseases, such as COVID-19 and the big three (HIV/AID, malaria and tuberculosis). doi:10.4155/tde-2021-0066 Ther Deliv 2021
RD(Rio)Mycobacterium tuberculosis strains associated with isoniazid resistance in Northern Mexico. doi:10.1016/j.eimce.2020.07.010 Enferm Infecc Microbiol Clin (Engl Ed) 2021
Serological detection of Mycobacterium Tuberculosis complex infection in multiple hosts by One Universal ELISA. doi:10.1371/journal.pone.0257920 PLoS One 2021
Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB. doi:10.5588/ijtld.21.0428 Int J Tuberc Lung Dis 2021
Whole-Genome Sequencing of Alcaligenes faecalis HZ01, with Potential to Inhibit Nontuberculous Mycobacterial Growth. doi:10.1128/MRA.00521-21 Microbiol Resour Announc 2021
Inhibition of Mycobacterium tuberculosis Dethiobiotin Synthase (MtDTBS): Toward Next-Generation Antituberculosis Agents. doi:10.1021/acschembio.1c00491 ACS Chem Biol 2021
Determinants of losses in the latent tuberculosis infection cascade of care in Brazil. doi:10.1136/bmjgh-2021-005969 BMJ Glob Health 2021
National multi-stakeholder meetings: a tool to support development of integrated policies and practices for testing and prevention of HIV, viral hepatitis, TB and STIs. doi:10.1186/s12879-021-06492-y BMC Infect Dis 2021
Tuberculosis amongst foreign-born and nationals: different delays, different risk factors. doi:10.1186/s12879-021-06635-1 BMC Infect Dis 2021
An abattoir-based study on the prevalence of bovine tuberculosis from culled adult dairy cows in Wuhan, China. doi:10.1016/j.prevetmed.2021.105477 Prev Vet Med 2021
Feasibility of an mobile application as a tool for multidrug-resistant tuberculosis contact monitoring in Peru. doi:10.17843/rpmesp.2021.382.6236 Rev Peru Med Exp Salud Publica 2021
Co-existent abdominoperitoneal tuberculosis with endometrial cancer: A diagnostic and surgical challenge. doi:10.1016/j.gore.2021.100848 Gynecol Oncol Rep 2021
Whole Genome Sequencing Refines Knowledge on the Population Structure of Mycobacterium bovis from a Multi-Host Tuberculosis System. doi:10.3390/microorganisms9081585 Microorganisms 2021
GIS as an Epidemiological Tool to Monitor the Spatial-Temporal Distribution of Tuberculosis in Large Game in a High-Risk Area in Portugal. doi:10.3390/ani11082374 Animals (Basel) 2021
Novel C-3-(N-alkyl-aryl)-aminomethyl rifamycin SV derivatives exhibit activity against rifampicin-resistant Mycobacterium tuberculosis RpoB(S522L) strain and display a different binding mode at the RNAP β-subunit site compared to rifampicin. doi:10.1016/j.ejmech.2021.113734 Eur J Med Chem 2021
Interferon gamma release assays for detection of latent Mycobacterium tuberculosis in older Hispanic people. doi:10.1016/j.ijid.2021.08.014 Int J Infect Dis 2021
Tuberculosis Burden and Determinants of Treatment Outcomes According to Age in Brazil: A Nationwide Study of 896,314 Cases Reported Between 2010 and 2019. doi:10.3389/fmed.2021.706689 Front Med (Lausanne) 2021
The quality of alternative models of primary health care and morbidity and mortality in Brazil: a national longitudinal analysis. doi:10.1016/j.lana.2021.100034 Lancet Reg Health Am 2021
Reducing costs and infections related to hospitalisation for TB. doi:10.5588/ijtld.21.0311 Int J Tuberc Lung Dis 2021
QuantiFERON-TB Gold Plus Assay Specificity in Children and Adolescents With Suspected Tuberculosis-A Multicenter Cross-sectional Study in Spain. doi:10.1097/INF.0000000000003173 Pediatr Infect Dis J 2021
Intragenic Distribution of IS6110 in Clinical Mycobacterium tuberculosis Strains: Bioinformatic Evidence for Gene Disruption Leading to Underdiagnosed Antibiotic Resistance. doi:10.1128/Spectrum.00019-21 Microbiol Spectr 2021
Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study. doi:10.3389/fimmu.2021.661934 Front Immunol 2021
Use of Rv0222-Rv2657c-Rv1509 Fusion Protein to Improve the Accuracy of an Antibody ELISA for Extra-Pulmonary Tuberculosis in Humans. doi:10.3390/pathogens10070828 Pathogens 2021
Screening People with Tuberculosis for High Risk of Severe Illness at Notification: Programmatic Experience from Karnataka, India. doi:10.3390/tropicalmed6020102 Trop Med Infect Dis 2021
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries. doi:10.3390/life11060528 Life (Basel) 2021
Dehydroabietic Acid Microencapsulation Potential as Biofilm-Mediated Infections Treatment. doi:10.3390/pharmaceutics13060825 Pharmaceutics 2021
Spatiotemporal distribution and temporal trends of brucellosis and tuberculosis in water buffalo (Bubalus bubalis) in Brazil. doi:10.1016/j.prevetmed.2021.105417 Prev Vet Med 2021
The effect of first-line antituberculosis drugs on the methemoglobin level among patients in treatment for pulmonary tuberculosis: A prospective study. doi:10.1111/bcpt.13628 Basic Clin Pharmacol Toxicol 2021
New and rapid strategies for the diagnosis of bovine paratuberculosis "in situ" using latex particles. doi:10.1016/j.jim.2021.113085 J Immunol Methods 2021
Association of the polymorphism of the vitamin D receptor gene (VDR) with the risk of leprosy in the Brazilian Amazon. doi:10.1042/BSR20204102 Biosci Rep 2021
Active search strategies, clinicoimmunobiological determinants and training for implementation research confirm hidden endemic leprosy in inner São Paulo, Brazil. doi:10.1371/journal.pntd.0009495 PLoS Negl Trop Dis 2021
Bovine tuberculosis due to Mycobacterium bovis and other mycobacteria among water buffalo (Bubalus bubalis) from the Brazilian Amazon. doi:10.3855/jidc.13558 J Infect Dev Ctries 2021
The use of information and communication technology in continuing education in tuberculosis. doi:10.1080/21614083.2021.1930962 J Eur CME 2021
An updated systematic review and meta-analysis on Mycobacterium tuberculosis antibiotic resistance in Iran (2013-2020). doi:10.22038/IJBMS.2021.48628.11161 Iran J Basic Med Sci 2021
Culture of Mycobacterium smegmatis in Different Carbon Sources to Induce In Vitro Cholesterol Consumption Leads to Alterations in the Host Cells after Infection: A Macrophage Proteomics Analysis. doi:10.3390/pathogens10060662 Pathogens 2021
In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis. doi:10.1080/14756366.2021.1900162 J Enzyme Inhib Med Chem 2021
Comparación de cuatro técnicas quirúrgicas para el manejo de la espondilitis tuberculosa de la columna torácica en adultos. doi:10.24875/CIRU.20000907 names it Cir Cir 2021
Caspase-1 inhibits IFN-β production via cleavage of cGAS during M. bovis infection. doi:10.1016/j.vetmic.2021.109126 Vet Microbiol 2021
On the Identification of Clinically Relevant Bacterial Amino Acid Changes at the Whole Genome Level Using Auto-PSS-Genome. doi:10.1007/s12539-021-00439-2 Interdiscip Sci 2021
The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts. doi:10.1093/infdis/jiab264 J Infect Dis 2021
Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children. doi:10.1016/j.jpeds.2021.05.008 J Pediatr 2021
Latent leprosy infection identified by dual RLEP and anti-PGL-I positivity: Implications for new control strategies. doi:10.1371/journal.pone.0251631 PLoS One 2021
Mycobacterium abscessus complex: A Review of Recent Developments in an Emerging Pathogen. doi:10.3389/fcimb.2021.659997 Front Cell Infect Microbiol 2021
Engineering Synthetic Lipopeptide Antigen for Specific Detection of Mycobacterium avium subsp. paratuberculosis Infection. doi:10.3389/fvets.2021.637841 Front Vet Sci 2021
Five-year microevolution of a multidrug-resistant Mycobacterium tuberculosis strain within a patient with inadequate compliance to treatment. doi:10.1186/s12879-021-06069-9 BMC Infect Dis 2021
Antimicrobial Peptides as Potential Anti-Tubercular Leads: A Concise Review. doi:10.3390/ph14040323 Pharmaceuticals (Basel) 2021
Can miRNA Indicate Risk of Illness after Continuous Exposure to M. tuberculosis? doi:10.3390/ijms22073674 Int J Mol Sci 2021
Microevolution of Mycobacterium tuberculosis Subpopulations and Heteroresistance in a Patient Receiving 27 Years of Tuberculosis Treatment in Germany. doi:10.1128/AAC.02520-20 Antimicrob Agents Chemother 2021
Statistical models for analyzing count data: predictors of length of stay among HIV patients in Portugal using a multilevel model. doi:10.1186/s12913-021-06389-1 BMC Health Serv Res 2021
hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis. doi:10.3892/mmr.2021.12109 Mol Med Rep 2021
Global projections of the soil microbiome in the Anthropocene. doi:10.1111/geb.13273 Glob Ecol Biogeogr 2021
[Evaluation of spoligotyping-smear sputum as an alternative and culture-independent methodology for Mycobacterium tuberculosis genotyping]. doi:10.4067/S0716-10182021000100061 Rev Chilena Infectol 2021
Local adaptation in populations of Mycobacterium tuberculosis endemic to the Indian Ocean Rim. doi:10.12688/f1000research.28318.2 F1000Res 2021
A solitary pulmonary nodule caused by Mycobacterium tuberculosis var. BCG after intravesical BCG treatment: a case report. doi:10.1186/s12890-021-01475-w BMC Pulm Med 2021
Antimicrobial Activity of Pyrazinamide Coordination Frameworks Synthesized by Mechanochemistry. doi:10.3390/molecules26071904 Molecules 2021
Study on supplemental test to improve the detection of bovine tuberculosis in individual animals and herds. doi:10.1186/s12917-021-02839-4 BMC Vet Res 2021
Hemoptysis as a warning sign of thoracic aorta pseudoaneurysm: A case report. doi:10.5867/medwave.2021.01.8112 Medwave 2021
Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety. doi:10.1186/s40249-021-00819-2 Infect Dis Poverty 2021
Molecular epidemiology of Mycobacterium tuberculosis in Brazil before the whole genome sequencing era: a literature review. doi:10.1590/0074-02760200517 Mem Inst Oswaldo Cruz 2021
Validation of a novel medium for drug susceptibility testing of Mycobacterium Tuberculosis against First- and Second-Line drugs: AYC.2.2 Agar and AYC.2.1 Broth. doi:10.4103/ijmy.ijmy_194_20 Int J Mycobacteriol 2021
MicroRNA-18b-5p Downregulation Favors Mycobacterium tuberculosis Clearance in Macrophages via HIF-1α by Promoting an Inflammatory Response. doi:10.1021/acsinfecdis.0c00650 ACS Infect Dis 2021
Whole-genome sequencing for TB source investigations: principles of ethical precision public health. doi:10.5588/ijtld.20.0886 Int J Tuberc Lung Dis 2021
Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis. doi:10.1016/j.tiv.2021.105137 Toxicol In Vitro 2021
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019. doi:10.1093/infdis/jiab113 J Infect Dis 2021
Study of TNF-α, IFN-γ, TGF-β, IL-6, and IL-10 Gene Polymorphism in Individuals from the Leprosy-Endemic Area in the Brazilian Amazon. doi:10.1089/jir.2018.0162 J Interferon Cytokine Res 2021
Evaluating the health effect of a Social Housing programme, Minha Casa Minha Vida, using the 100 million Brazilian Cohort: a natural experiment study protocol. doi:10.1136/bmjopen-2020-041722 BMJ Open 2021
Consumption of spine by tuberculosis in the era of directly observed treatment, short-course and genomic diagnosis. doi:10.1016/j.ijtb.2020.08.017 Indian J Tuberc 2021
High exposure to pathogenic leptospires by the population residing in dairy farms in Hidalgo, Mexico. doi:10.1007/s42770-021-00453-y Braz J Microbiol 2021
Phenotypic and Genotypic Drug Susceptibility Assessment of Mycobacterium bovis Bacillus Calmette-Guérin Clinical Strains. doi:10.2147/IDR.S248096 Infect Drug Resist 2021
A Clinical-Epidemiological and Geospatial Study of Tuberculosis in a Neglected Area in the Amazonian Region Highlights the Urgent Need for Control Measures. doi:10.3390/ijerph18031335 Int J Environ Res Public Health 2021
Evaluation of drug susceptibility profile of Mycobacterium tuberculosis Lineage 1 from Brazil based on whole genome sequencing and phenotypic methods. doi:10.1590/0074-02760200520 Mem Inst Oswaldo Cruz 2021
Dysglycemia is associated with Mycobacterium tuberculosis lineages in tuberculosis patients of North Lima-Peru. doi:10.1371/journal.pone.0243184 PLoS One 2021
A rare case of synchronous bilateral epididymal and testicular metastases of urothelial carcinoma of the bladder after intravesical bacillus Calmette-Guérin. doi:10.1007/s13691-020-00448-w Int Cancer Conf J 2021
Mutations of folC cause increased susceptibility to sulfamethoxazole in Mycobacterium tuberculosis. doi:10.1038/s41598-020-80213-4 Sci Rep 2021
Isolation and whole protein characterization of species A and B bovine rotaviruses from Chinese calves. doi:10.1016/j.meegid.2021.104715 Infect Genet Evol 2021
Mycobacterium tuberculosis Infection Up-Regulates Sialyl Lewis X Expression in the Lung Epithelium. doi:10.3390/microorganisms9010099 Microorganisms 2021
Antimicrobial and antitumor activity of S-methyl dithiocarbazate Schiff base zinc(II) complexes. doi:10.1016/j.jinorgbio.2020.111331 J Inorg Biochem 2021
How to reduce household costs for people with tuberculosis: a longitudinal costing survey in Nepal. doi:10.1093/heapol/czaa156 Health Policy Plan 2021
The hard numbers of tuberculosis epidemiology in wildlife: A meta-regression and systematic review. doi:10.1111/tbed.13948 Transbound Emerg Dis 2021
Frequency and patterns of first- and second-line drug resistance-conferring mutations in Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients in a cross-sectional study in Tigray Region, Ethiopia. doi:10.1016/j.jgar.2020.11.017 J Glob Antimicrob Resist 2021
Novel stepwise approach to assess representativeness of a large multicenter observational cohort of tuberculosis patients: The example of RePORT Brazil. doi:10.1016/j.ijid.2020.11.140 Int J Infect Dis 2021
Management of patients with myocardial tuberculosis: A case series. doi:10.1016/j.ijcard.2020.11.001 Int J Cardiol 2021
4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study. doi:10.2174/1568026620666201102121606 Curr Top Med Chem 2021
Juxtaposed Homonymous Hemianopsia Due to Neurotuberculosis. doi:10.1097/WNO.0000000000001085 J Neuroophthalmol 2021
Magnetic resonance imaging evaluation of posterior spinal tuberculosis: a cross-sectional study. doi:10.1177/0284185120948496 Acta Radiol 2021
Global trends of epidemiological research in livestock tuberculosis for the last four decades. doi:10.1111/tbed.13763 Transbound Emerg Dis 2021
FluoroType® MTB in pleural fluid for diagnosing tuberculosis. doi:10.1016/j.rce.2020.04.010 Rev Clin Esp 2021
[Access to complementary tests for the diagnosis of infectious diseases in primary care paediatric clinics]. doi:10.1016/j.anpedi.2020.03.015 An Pediatr (Engl Ed) 2021
Clinical features and para-clinical findings of cryptococcal meningitis in the North of Iran during 2011-19. doi:10.18502/cmm.6.4.5330 names it Curr Med Mycol 2020
[Extrapulmonary tuberculosis in children under the age of 15 hospitalized at the Pereira Rossell Hospital Center, Uruguay]. doi:10.4067/S0716-10182020000500577 Rev Chilena Infectol 2020
[Social determinants and the Sustainable Development Goals' tuberculosis target in the AmericasDeterminantes sociais e a meta para a tuberculose dos Objetivos de Desenvolvimento Sustentável nas Américas]. doi:10.26633/RPSP.2020.153 names it Rev Panam Salud Publica 2020
Quantifying the Economic Impact of Bovine Tuberculosis on Livestock Farms in South-Western Spain. doi:10.3390/ani10122433 Animals (Basel) 2020
[Evaluation of the first level of care for tuberculosis control in Buenos Aires, ArgentinaAvaliação da atenção primária à saúde no controle da tuberculose em Buenos Aires, Argentina]. doi:10.26633/RPSP.2020.156 Rev Panam Salud Publica 2020
[Tuberculosis care cascade for the indigenous population in Colombia: an operational research studyCascata de atenção da tuberculose para os povos indígenas na Colômbia: pesquisa operacional]. doi:10.26633/RPSP.2020.150 names it Rev Panam Salud Publica 2020
Drug Delivery Systems on Leprosy Therapy: Moving Towards Eradication? doi:10.3390/pharmaceutics12121202 Pharmaceutics 2020
Family Health Strategy and determinants of directly observed treatment for tuberculosis in Brazil: a cross-sectional study with surveillance system data, 2014-2016. doi:10.1590/S1679-49742020000500010 Epidemiol Serv Saude 2020
[Artificial intelligence and innovation to optimize the tuberculosis diagnostic process]. doi:10.17843/rpmesp.2020.373.5585 Rev Peru Med Exp Salud Publica 2020
Adverse treatment outcomes in multidrug resistant tuberculosis go beyond the microbe-drug interaction: Results of a multiple correspondence analysis. doi:10.7705/biomedica.5072 Biomedica 2020
BCG Vaccination Status, Age, and Gender as Risk Factors for Leprosy in Endemic Areas in the Brazilian Amazon. doi:10.3390/idr12030019 Infect Dis Rep 2020
Addressing Latent Tuberculosis: New Advances in Mimicking the Disease, Discovering Key Targets, and Designing Hit Compounds. doi:10.3390/ijms21228854 Int J Mol Sci 2020
Tuberculosis in wild South American sea lions Otaria flavescens stranded in Chubut, Argentina. doi:10.3354/dao03520 Dis Aquat Organ 2020
Identification of nontuberculous mycobacteria species by multiplex real-time PCR with high-resolution melting. doi:10.1590/0037-8682-0211-2020 Rev Soc Bras Med Trop 2020
Investigating extradomiciliary transmission of tuberculosis: An exploratory approach using social network patterns of TB cases and controls and the genotyping of Mycobacterium tuberculosis. doi:10.1016/j.tube.2020.102010 Tuberculosis (Edinb) 2020
Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis. doi:10.1038/s41467-020-19412-6 Nat Commun 2020
Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients. doi:10.3390/antibiotics9110771 Antibiotics (Basel) 2020
Amerindian genetic ancestry as a risk factor for tuberculosis? Critical perspectives and implications for public policies in indigenous peoples's health. doi:10.1590/0102-311X00245420 Cad Saude Publica 2020
Rifabutin-Loaded Nanostructured Lipid Carriers as a Tool in Oral Anti-Mycobacterial Treatment of Crohn's Disease. doi:10.3390/nano10112138 Nanomaterials (Basel) 2020
Spatial patterns of multidrug-resistant tuberculosis: correlation with sociodemographic variables and type of notification. doi:10.1590/0034-7167-2019-0845 Rev Bras Enferm 2020
Facile Synthesis and Metabolic Incorporation of m-DAP Bioisosteres Into Cell Walls of Live Bacteria. doi:10.1021/acschembio.0c00618 ACS Chem Biol 2020
Video-Assisted Ligation of Intersphincteric Fistula Tract for Complex Anal Fistula: Technique and Preliminary Outcomes. doi:10.1097/DCR.0000000000001691 Dis Colon Rectum 2020
Trend of tuberculosis in Brazilian indigenous people in the 2011-2017 period. doi:10.1590/1413-812320202510.28482018 Cien Saude Colet 2020
In Silico Identification of Novel Immunogenic Secreted Proteins of Mycoplasma bovis from Secretome Data and Experimental Verification. doi:10.3390/pathogens9090770 Pathogens 2020
Characterization of Mycobacterium tuberculosis var. africanum isolated from a patient with pulmonary tuberculosis in Brazil. doi:10.1016/j.meegid.2020.104550 Infect Genet Evol 2020
Case report demonstrating abdominal tuberculosis presenting as an irreducible para-umbilical hernia. doi:10.1016/j.ijscr.2020.09.004 names it Int J Surg Case Rep 2020
Non-Tuberculous Mycobacteria: Molecular and Physiological Bases of Virulence and Adaptation to Ecological Niches. doi:10.3390/microorganisms8091380 Microorganisms 2020
Modification of PapA5 acyltransferase substrate selectivity for optimization of short-chain alcohol-derived multimethyl-branched ester production in Escherichia coli. doi:10.1007/s00253-020-10872-w Appl Microbiol Biotechnol 2020
Tuberculosis: evaluation of the time between identification of symptoms and beginning of treatment. doi:10.1590/0034-7167-2018-0902 Rev Bras Enferm 2020
Tuberculosis associated with the living conditions in an endemic municipality in the North of Brazil. doi:10.1590/1518-8345.3223.3343 Rev Lat Am Enfermagem 2020
Mycobacterium vaccae Adaptation to Disinfectants and Hand Sanitisers, and Evaluation of Cross-Tolerance with Antimicrobials. doi:10.3390/antibiotics9090544 Antibiotics (Basel) 2020
RD(Rio)Mycobacterium tuberculosis strains associated with isoniazid resistance in Northern Mexico. doi:10.1016/j.eimc.2020.07.003 Enferm Infecc Microbiol Clin (Engl Ed) 2020
Irreversible neuropathy in extremely-drug resistant tuberculosis: An unfortunate clinical conundrum. doi:10.1016/j.ijtb.2019.11.012 Indian J Tuberc 2020
Multiple tuberculomas in an immunocompetent patient and their diagnostic challenge in a high prevalence country: Case report and literature review. doi:10.1016/j.ijtb.2020.05.007 Indian J Tuberc 2020
Meanings and senses of being a health professional with tuberculosis: an interpretative phenomenological study. doi:10.1136/bmjopen-2019-035873 BMJ Open 2020
TRIM25 upregulation by Mycobacterium tuberculosis infection promotes intracellular survival of M.tb in RAW264.7 cells. doi:10.1016/j.micpath.2020.104456 Microb Pathog 2020
Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study. doi:10.1371/journal.pone.0236362 PLoS One 2020
Mycobacterial para-Hydroxybenzoic Acid-Derivatives (pHBADs) and Related Structures Induce Macrophage Innate Memory. doi:10.1021/acschembio.0c00378 names it ACS Chem Biol 2020
Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis. doi:10.5588/ijtld.19.0809 Int J Tuberc Lung Dis 2020
Peripheral nerve biopsy: a tool still needed in the early diagnosis of neural leprosy? doi:10.1093/trstmh/traa053 Trans R Soc Trop Med Hyg 2020
Amerindian genetic ancestry as a risk factor for tuberculosis in an amazonian population. doi:10.1371/journal.pone.0236033 PLoS One 2020
Investigation of genetic susceptibility to Mycobacterium tuberculosis (VDR and IL10 genes) in a population with a high level of substructure in the Brazilian Amazon region. doi:10.1016/j.ijid.2020.06.090 Int J Infect Dis 2020
Probability of mycobactericidal activity of para-aminosalicylic acid with novel dosing regimens. doi:10.1007/s00228-020-02943-8 names it Eur J Clin Pharmacol 2020
Role of Whole-Genome Sequencing in Characterizing the Mechanism of Action of para-Aminosalicylic Acid and Its Resistance. doi:10.1128/AAC.00675-20 names it Antimicrob Agents Chemother 2020
Carrageenan from red algae: an application in the development of inhalable tuberculosis therapy targeting the macrophages. doi:10.1007/s13346-020-00799-0 Drug Deliv Transl Res 2020
1-(1-Arylethylpiperidin-4-yl)thymine Analogs as Antimycobacterial TMPK Inhibitors. doi:10.3390/molecules25122805 Molecules 2020
[New medicines and regimes for resistant tuberculosis.]. Rev Esp Salud Publica 2020
Can diabetes mellitus modify the plasma concentrations of rifampicin in patients under treatment for tuberculosis? doi:10.1016/j.bjid.2020.05.007 Braz J Infect Dis 2020
Use Chou's 5-steps rule to evaluate protective efficacy induced by antigenic proteins of Mycobacterium tuberculosis encapsulated in chitosan nanoparticles. doi:10.1016/j.lfs.2020.117961 Life Sci 2020
[Natural Killer/T cell primary extranasal ileum lymphoma]. doi:10.17843/rpmesp.2020.371.4331 Rev Peru Med Exp Salud Publica 2020
Quantification of the Animal Tuberculosis Multi-Host Community Offers Insights for Control. doi:10.3390/pathogens9060421 Pathogens 2020
Population Genomics of Mycobacterium leprae Reveals a New Genotype in Madagascar and the Comoros. doi:10.3389/fmicb.2020.00711 Front Microbiol 2020
The pharmacokinetics of para-aminosalicylic acid and its relationship to efficacy and intolerance. doi:10.1111/bcp.14395 names it Br J Clin Pharmacol 2020
Risk factors associated with pulmonary tuberculosis relapses in Cali, Colombia. doi:10.7705/biomedica.5061 Biomedica 2020
A biochemically-interpretable machine learning classifier for microbial GWAS. doi:10.1038/s41467-020-16310-9 Nat Commun 2020
No significant influence of diabetic mellitus on isoniazid plasma levels in patients under treatment for tuberculosis. doi:10.1080/23744235.2020.1761561 Infect Dis (Lond) 2020
Exploring the Enzymatic and Antibacterial Activities of Novel Mycobacteriophage Lysin B Enzymes. doi:10.3390/ijms21093176 Int J Mol Sci 2020
Mycobacterium tuberculosis YrbE3A Promotes Host Innate Immune Response by Targeting NF-κB/JNK Signaling. doi:10.3390/microorganisms8040584 Microorganisms 2020
[Study on the prevalence of Beijing genotype Mycobacterium tuberculosis and its relationship with second-line anti-tuberculosis drug resistance]. doi:10.3760/cma.j.cn112147-20191215-00827 Zhonghua Jie He He Hu Xi Za Zhi 2020
Population structure and genetic diversity of Mycobacterium tuberculosis in Ecuador. doi:10.1038/s41598-020-62824-z Sci Rep 2020
Monomeric NADH-Oxidizing Methylenetetrahydrofolate Reductases from Mycobacterium smegmatis Lack Flavin Coenzyme. doi:10.1128/JB.00709-19 J Bacteriol 2020
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings. doi:10.1080/09273948.2020.1716025 Ocul Immunol Inflamm 2020
Detection and Quantification of HspX Antigen in Sputum Samples Using Plasmonic Biosensing: Toward a Real Point-of-Care (POC) for Tuberculosis Diagnosis. doi:10.1021/acsinfecdis.9b00502 ACS Infect Dis 2020
Model-based integration of genomics and metabolomics reveals SNP functionality in Mycobacterium tuberculosis. doi:10.1073/pnas.1915551117 Proc Natl Acad Sci U S A 2020
Acetylene containing cyclo(L-Tyr-L-Tyr)-analogs as mechanism-based inhibitors of CYP121A1 from Mycobacterium tuberculosis. doi:10.1016/j.bcp.2020.113938 Biochem Pharmacol 2020
Whole Genome Sequencing for the Analysis of Drug Resistant Strains of Mycobacterium tuberculosis: A Systematic Review for Bedaquiline and Delamanid. doi:10.3390/antibiotics9030133 Antibiotics (Basel) 2020
Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis. doi:10.1038/s41590-020-0610-z Nat Immunol 2020
Deficiency in the glycosyltransferase Gcnt1 increases susceptibility to tuberculosis through a mechanism involving neutrophils. doi:10.1038/s41385-020-0277-7 Mucosal Immunol 2020
Are We Ready for the New Coronavirus? doi:10.1016/j.arbres.2020.02.009 Arch Bronconeumol (Engl Ed) 2020
Animal tuberculosis: Impact of disease heterogeneity in transmission, diagnosis and control. doi:10.1111/tbed.13539 Transbound Emerg Dis 2020
Spirometry results after treatment for pulmonary tuberculosis: comparison between patients with and without previous lung disease: a multicenter study. doi:10.36416/1806-3756/e20180198 J Bras Pneumol 2020
Treatment outcomes in multidrug-resistant tuberculosis according to pyrazinamide susceptibility. doi:10.5588/ijtld.19.0314 Int J Tuberc Lung Dis 2020
Integrative proteomic and glycoproteomic profiling of Mycobacterium tuberculosis culture filtrate. doi:10.1371/journal.pone.0221837 PLoS One 2020
Evolutionary analysis of Mycobacterium bovis genotypes across Africa suggests co-evolution with livestock and humans. doi:10.1371/journal.pntd.0008081 PLoS Negl Trop Dis 2020
The Dual-Targeting Activity of the Metabolite Substrate of Para-amino Salicyclic Acid in the Mycobacterial Folate Pathway: Atomistic and Structural Perspectives. doi:10.1007/s10930-020-09885-1 names it Protein J 2020
Determinants of losses in the latent tuberculosis cascade of care in Brazil: A retrospective cohort study. doi:10.1016/j.ijid.2020.02.015 Int J Infect Dis 2020
Severe pulmonary radiological manifestations are associated with a distinct biochemical profile in blood of tuberculosis patients with dysglycemia. doi:10.1186/s12879-020-4843-0 BMC Infect Dis 2020
Inhalable Spray-Dried Chondroitin Sulphate Microparticles: Effect of Different Solvents on Particle Properties and Drug Activity. doi:10.3390/polym12020425 Polymers (Basel) 2020
Tuberculin skin test and predictive host factors for false-negative results in patients with pulmonary and extrapulmonary tuberculosis. doi:10.1111/crj.13166 Clin Respir J 2020
[Infectious and parasitic diseases in Brazil, 2010 to 2017: considerations for surveillanceEnfermedades infecciosas y parasitarias en Brasil de 2010 a 2017: aspectos para la vigilancia sanitaria]. doi:10.26633/RPSP.2020.10 names it Rev Panam Salud Publica 2020
Molecular characterization of pre-extensive drug resistant Mycobacterium tuberculosis in Northeast Brazil. doi:10.1590/S1678-9946202062004 Rev Inst Med Trop Sao Paulo 2020
Genetic, Immunological, and Clinical Features of the First Mexican Cohort of Patients with Chronic Granulomatous Disease. doi:10.1007/s10875-020-00750-5 J Clin Immunol 2020
Phylogenomic Perspective on a Unique Mycobacterium bovis Clade Dominating Bovine Tuberculosis Infections among Cattle and Buffalos in Northern Brazil. doi:10.1038/s41598-020-58398-5 Sci Rep 2020
Cinnamic Derivatives as Antitubercular Agents: Characterization by Quantitative Structure-Activity Relationship Studies. doi:10.3390/molecules25030456 Molecules 2020
Looking beyond Typical Treatments for Atypical Mycobacteria. doi:10.3390/antibiotics9010018 Antibiotics (Basel) 2020
Ferrier Carbocyclization-Mediated Synthesis of Enantiopure Azido Inositol Analogues. doi:10.1021/acs.joc.9b03064 J Org Chem 2020
7-oxo-DHEA enhances impaired M. tuberculosis-specific T cell responses during HIV-TB coinfection. doi:10.1186/s12929-019-0604-z J Biomed Sci 2020
Serological and molecular detection of infection with Mycobacterium leprae in Brazilian six banded armadillos (Euphractus sexcinctus). doi:10.1016/j.cimid.2019.101397 Comp Immunol Microbiol Infect Dis 2020
Lack of Weight Gain During the First 2 Months of Treatment and Human Immunodeficiency Virus Independently Predict Unsuccessful Treatment Outcomes in Tuberculosis. doi:10.1093/infdis/jiz595 J Infect Dis 2020
Pharmacokinetics of Para-Aminosalicylic Acid and Its 2 Major Metabolites: A Potential Relationship to the Development of Gastrointestinal Intolerance. doi:10.1002/jcph.1542 names it J Clin Pharmacol 2020
Molecular epidemiology of mycobacteria among herds in Marajó Island, Brazil, reveals strains genetically related and potential zoonotic risk of clinical relevance. doi:10.1016/j.meegid.2019.104044 Infect Genet Evol 2020
Molecular characterization of Mycobacterium bovis infection in cattle and buffalo in Amazon Region, Brazil. doi:10.1002/vms3.203 Vet Med Sci 2020
Genome-wide DNA methylation and transcriptome and proteome changes in Mycobacterium tuberculosis with para-aminosalicylic acid resistance. doi:10.1111/cbdd.13625 names it Chem Biol Drug Des 2020
Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China. doi:10.1016/j.jgar.2019.08.005 names it J Glob Antimicrob Resist 2020
A rare case of multi-focal human TB after BCG instillation for non-muscle-invasive bladder cancer. doi:10.1177/0391560319860396 Urologia 2020
Emergence and Transmission of Drug-/Multidrug-resistant Mycobacterium leprae in a Former Leprosy Colony in the Brazilian Amazon. doi:10.1093/cid/ciz570 Clin Infect Dis 2020
[Recommendations for the screening for infectious diseases, mental health, and female genital mutilation in immigrant patients seen in Primary Care]. doi:10.1016/j.aprim.2019.02.005 Aten Primaria 2020
Prevalence and Mechanisms of Carbapenem Resistance in Acinetobacter baumannii: A Comprehensive Systematic Review of Cross-Sectional Studies from Iran. doi:10.1089/mdr.2018.0435 Microb Drug Resist 2020
Benzoylthioureas: Design, Synthesis and Antimycobacterial Evaluation. doi:10.2174/1573406415666181208110753 Med Chem 2020
Risk of infection and disease progression in children exposed to tuberculosis at home, Colombia. doi:10.25100/cm.v50i4.4185 Colomb Med (Cali) 2019
Primary tonsillar tuberculosis: a forgotten clinical identity. Iran J Microbiol 2019
NSC 18725, a Pyrazole Derivative Inhibits Growth of Intracellular Mycobacterium tuberculosis by Induction of Autophagy. doi:10.3389/fmicb.2019.03051 Front Microbiol 2019
[Low detection rate and therapeutic success of tuberculosis in a prison in EcuadorBaixo recrutamento de pacientes e sucesso no tratamento da tuberculose em uma prisão do Equador]. doi:10.26633/RPSP.2019.106 Rev Panam Salud Publica 2019
[Loss to follow-up in patients treated for multidrug-resistant tuberculosis in EcuadorA Perda de seguimento de pacientes tratados para tuberculose multirresistente a medicamentos no Equador]. doi:10.26633/RPSP.2019.91 names it Rev Panam Salud Publica 2019
Extensively resistant tuberculosis, Colombia, 2006-2016. doi:10.7705/biomedica.4842 Biomedica 2019
Temporal pattern of tuberculosis cure, mortality, and treatment abandonment in Brazilian capitals. doi:10.1590/1518-8345.3019.3218 Rev Lat Am Enfermagem 2019
Association of Leukotriene A4 Hydrolase with Tuberculosis Susceptibility Using Genomic Data in Portugal. doi:10.3390/microorganisms7120650 Microorganisms 2019
Leprosy Reactions In Childhood: A Prospective Cohort Study In The Brazilian Amazon. doi:10.2147/IDR.S217181 Infect Drug Resist 2019
[Use of database linkage and scripting rules to upgrade variables in the Sinan-TB database]. doi:10.1590/0102-311X00074318 Cad Saude Publica 2019
Country-wide rapid screening for the Mycobacterium tuberculosis Beijing sublineage in Ecuador using a single-nucleotide polymorphism-polymerase chain reaction method. doi:10.4103/ijmy.ijmy_132_19 Int J Mycobacteriol 2019
Nonparametric Population Pharmacokinetic Modeling of Isoniazid in Colombian Patients With Tuberculosis. doi:10.1097/FTD.0000000000000661 Ther Drug Monit 2019
Antituberculosis Drug Interactions with Membranes: A Biophysical Approach Applied to Bedaquiline. doi:10.3390/membranes9110141 Membranes (Basel) 2019
[Clofazimine suspension formulation for treating extremely resistant tuberculosis in a nursing patient]. Rev Esp Quimioter 2019
Machine Learning Predicts Accurately Mycobacterium tuberculosis Drug Resistance From Whole Genome Sequencing Data. doi:10.3389/fgene.2019.00922 Front Genet 2019
The First Case of Para-Bombay Blood Type Encountered in a Korean Tertiary Hospital. doi:10.3346/jkms.2019.34.e258 names it J Korean Med Sci 2019
[Control de la tuberculosis multirresistente a fármacos: un objetivo posible]. doi:10.7705/biomedica.5216 Biomedica 2019
Factors associated with directly observed treatment in tuberculosis/HIV coinfection cases in Porto Alegre, 2009-2013: A retrospective cohort. doi:10.1371/journal.pone.0222786 PLoS One 2019
Rhodoccoccus erythropolis Is Different from Other Members of Actinobacteria: Monoploidy, Overlapping Replication Cycle, and Unique Segregation Pattern. doi:10.1128/JB.00320-19 J Bacteriol 2019
Experimental Evidence for Limited in vivo Virulence of Mycobacterium africanum. doi:10.3389/fmicb.2019.02102 Front Microbiol 2019
Analysis of mutations leading to para-aminosalicylic acid resistance in Mycobacterium tuberculosis. doi:10.1038/s41598-019-48940-5 names it Sci Rep 2019
The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin. doi:10.3390/antibiotics8030153 Antibiotics (Basel) 2019
Spatial analysis on tuberculosis and the network of primary health care. doi:10.1590/0034-7167-2017-0897 Rev Bras Enferm 2019
The impact of the diagnosis of tuberculosis through its social representations. doi:10.1590/0034-7167-2017-0881 Rev Bras Enferm 2019
High prevalence and heterogeneity of Dysglycemia in patients with tuberculosis from Peru: a prospective cohort study. doi:10.1186/s12879-019-4416-2 BMC Infect Dis 2019
Health service access for tuberculosis diagnosis and treatment among indigenous peoples in Rondônia state, Brazilian Amazon, 2009-2011: a cross-sectional study. doi:10.5123/S1679-49742019000300002 Epidemiol Serv Saude 2019
Widespread cutaneous nontuberculous mycobacterial infection in the absence of bacteremia mimicking leukemia cutis. doi:10.1016/j.jdcr.2019.05.024 JAAD Case Rep 2019
Molecular characterization of para-aminosalicylic acid resistant Mycobacterium tuberculosis clinical isolates in southwestern China. doi:10.2147/IDR.S207259 names it Infect Drug Resist 2019
Evaluation of Whole-Genome Sequence Method to Diagnose Resistance of 13 Anti-tuberculosis Drugs and Characterize Resistance Genes in Clinical Multi-Drug Resistance Mycobacterium tuberculosis Isolates From China. doi:10.3389/fmicb.2019.01741 Front Microbiol 2019
NGSReadsTreatment - A Cuckoo Filter-based Tool for Removing Duplicate Reads in NGS Data. doi:10.1038/s41598-019-48242-w Sci Rep 2019
Are Opportunities Being Missed? Burden of HIV, STI and TB, and Unawareness of HIV among African Migrants. doi:10.3390/ijerph16152710 Int J Environ Res Public Health 2019
A case report of tuberculous chylothorax. doi:10.5867/medwave.2019.05.7655 Medwave 2019
Short communication: Mycolicibacterium smegmatis, basonym Mycobacterium smegmatis, causing pyogranulomatous mastitis and its cross-reactivity in bovine (para)tuberculosis testing. doi:10.3168/jds.2019-16610 names it J Dairy Sci 2019
Organization of health services for tuberculosis case diagnosis and treatment in Manaus, Amazonas, Brazil, 2014. doi:10.5123/S1679-49742019000200007 Epidemiol Serv Saude 2019
A nationwide study of multidrug-resistant tuberculosis in Portugal 2014-2017 using epidemiological and molecular clustering analyses. doi:10.1186/s12879-019-4189-7 BMC Infect Dis 2019
[The road from the "antituberculosis armory" to the Huipulco Tuberculosis Sanatorium in Mexico City, 1920-1940]. doi:10.1590/S0104-59702019000200009 Hist Cienc Saude Manguinhos 2019
The Fight against HIV-Associated Disseminated Histoplasmosis in the Americas: Unfolding the Different Stories of Four Centers. doi:10.3390/jof5020051 J Fungi (Basel) 2019
Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis. doi:10.1371/journal.pone.0218487 PLoS One 2019
Evaluation of thin-layered agar for Mycobacterium tuberculosis isolation and drug susceptibility testing. doi:10.4103/ijmy.ijmy_45_19 Int J Mycobacteriol 2019
Diagnostic accuracy of whole spine magnetic resonance imaging in spinal tuberculosis validated through tissue studies. doi:10.1007/s00586-019-06031-z Eur Spine J 2019
Respiratory Complications in Patients with Hyper IgM Syndrome. doi:10.1007/s10875-019-00650-3 J Clin Immunol 2019
Mycobacterium tuberculosis lineage 1 genetic diversity in Pará, Brazil, suggests common ancestry with east-African isolates potentially linked to historical slave trade. doi:10.1016/j.meegid.2019.06.001 Infect Genet Evol 2019
Right main bronchus para-occluder fistula closure with a septal defect occluder. doi:10.1177/0218492319854240 names it Asian Cardiovasc Thorac Ann 2019
Isolated gastric varices secondary to abdominal tuberculosis mimicking lymphoma: a case report. doi:10.1186/s12876-019-0998-9 BMC Gastroenterol 2019
Traditional detoxification of Jatropha curcas L. seeds. doi:10.1016/j.jep.2019.111970 J Ethnopharmacol 2019
Concentrations of rifampicin in pre-dose samples in patients with pulmonary tuberculosis. doi:10.1016/j.bjid.2019.05.001 Braz J Infect Dis 2019
Microenvironment of Mycobacterium smegmatis Culture to Induce Cholesterol Consumption Does Cell Wall Remodeling and Enables the Formation of Granuloma-Like Structures. doi:10.1155/2019/1871239 Biomed Res Int 2019
Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis. doi:10.2147/IDR.S200697 names it Infect Drug Resist 2019
Preventive impacts of PAS-Na on the slow growth and activated inflammatory responses in Mn-exposed rats. doi:10.1016/j.jtemb.2019.04.013 J Trace Elem Med Biol 2019
Synthesis and biological evaluation of 2-chloro-3-[(thiazol-2-yl)amino]-1,4-naphthoquinones. doi:10.1016/j.bmcl.2019.05.001 Bioorg Med Chem Lett 2019
Actions for tuberculosis controlin Brazil: evaluation of primary care. doi:10.1590/1980-549720190031 Rev Bras Epidemiol 2019
Design, synthesis, and antimycobacterial activity of novel ciprofloxacin derivatives. doi:10.1111/cbdd.13534 Chem Biol Drug Des 2019
[Prevalencia y factores asociados a la tuberculosis y las micobacteriosis en pacientes positivos para HIV en Bogotá]. names it Biomedica 2019
Serum pyrazinamide concentrations in patients with pulmonary tuberculosis. doi:10.1590/1806-3713/e20180254 J Bras Pneumol 2019
Tuberculosis care for migrant patients in Portugal: a mixed methods study with primary healthcare providers. doi:10.1186/s12913-019-4050-0 BMC Health Serv Res 2019
Smear-Positive Tuberculosis Prevalence and Associated Factors among Pregnant Women Attending Antinatal Care in North Gondar Zone Hospitals, Ethiopia. doi:10.1155/2019/9432469 Int J Microbiol 2019
Acmella oleracea (L) R. K. Jansen Reproductive Toxicity in Zebrafish: An In Vivo and In Silico Assessment. doi:10.1155/2019/1237301 Evid Based Complement Alternat Med 2019
Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents. doi:10.1016/j.chembiol.2019.02.013 Cell Chem Biol 2019
Thymoma Recurrence and its Predisposing Factors in Iranian Population: a Single Center Study. Tanaffos 2019
Genome-wide analysis of Mycobacterium tuberculosis polymorphisms reveals lineage-specific associations with drug resistance. doi:10.1186/s12864-019-5615-3 BMC Genomics 2019
Prevalence, Drug Resistance, and Genotypic Diversity of the Mycobacterium tuberculosis Beijing Family in Ecuador. doi:10.1089/mdr.2018.0429 Microb Drug Resist 2019
Cryptic Resistance Mutations Associated With Misdiagnoses of Multidrug-Resistant Tuberculosis. doi:10.1093/infdis/jiz104 J Infect Dis 2019
In Silico Study to Identify New Antituberculosis Molecules from Natural Sources by Hierarchical Virtual Screening and Molecular Dynamics Simulations. doi:10.3390/ph12010036 Pharmaceuticals (Basel) 2019
Data Collection And Microbiological Monitoring In Global Tuberculosis Intervention. doi:10.1016/j.arbres.2019.01.018 Arch Bronconeumol (Engl Ed) 2019
Mycobacterial Aminoglycoside Acetyltransferases: A Little of Drug Resistance, and a Lot of Other Roles. doi:10.3389/fmicb.2019.00046 Front Microbiol 2019
The impact of a cash transfer programme on tuberculosis treatment success rate: a quasi-experimental study in Brazil. doi:10.1136/bmjgh-2018-001029 BMJ Glob Health 2019
The macroscopic and histomorphological properties of periosteal rib lesions and its relation with disease duration: evidence from the Luis Lopes Skeletal Collection (Lisbon, Portugal). doi:10.1111/joa.12936 J Anat 2019
Characteristics of the First Protein Tyrosine Phosphatase with Phytase Activity from a Soil Metagenome. doi:10.3390/genes10020101 Genes (Basel) 2019
Fingerstick test quantifying humoral and cellular biomarkers indicative for M. leprae infection. doi:10.1016/j.clinbiochem.2019.01.007 Clin Biochem 2019
TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB - a study protocol. doi:10.1186/s12890-018-0777-3 BMC Pulm Med 2019
Diagnostic Accuracy of Pleural Fluid Adenosine Deaminase for Diagnosing Tuberculosis. Meta-analysis of Spanish Studies. doi:10.1016/j.arbres.2018.05.007 Arch Bronconeumol (Engl Ed) 2019
Synthesis, biological evaluation and molecular docking study of 1,2,3-1H-triazoles having 4H-pyrano[2,3-d]pyrimidine as potential Mycobacterium tuberculosis protein tyrosine phosphatase B inhibitors. doi:10.1016/j.bmcl.2018.12.009 Bioorg Med Chem Lett 2019
An interferon gamma release assay specific for Histoplasma capsulatum to detect asymptomatic infected individuals: A proof of concept study. doi:10.1093/mmy/myy131 Med Mycol 2019
Toxin-antitoxin systems shows variability among Mycobacterium tuberculosis lineages. doi:10.1093/femsle/fny276 FEMS Microbiol Lett 2019
Competition between DivIVA and the nucleoid for ParA binding promotes segrosome separation and modulates mycobacterial cell elongation. doi:10.1111/mmi.14149 names it Mol Microbiol 2019
Drug resistance in Mycobacterium tuberculosis and targeting the l,d-transpeptidase enzyme. doi:10.1002/ddr.21455 Drug Dev Res 2019
Hypothyroidism associated with therapy for multi-drug-resistant tuberculosis in Australia. doi:10.1111/imj.14085 Intern Med J 2019
Use of adenosine deaminase as a marker for selecting pleural fluids for culture and/or molecular techniques for detection of mycobacteria. doi:10.1016/j.eimc.2018.03.013 Enferm Infecc Microbiol Clin (Engl Ed) 2019
Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13. doi:10.1080/07391102.2018.1462734 J Biomol Struct Dyn 2019
Inhalable Fucoidan Microparticles Combining Two Antitubercular Drugs with Potential Application in Pulmonary Tuberculosis Therapy. doi:10.3390/polym10060636 Polymers (Basel) 2018
Chondroid and osseous metaplasia in an incidental type II papillary renal cell carcinoma with extensive solid areas: an unraveled molecular character. doi:10.11604/pamj.2018.31.26.16137 Pan Afr Med J 2018
Rapid tests reduce the burden of tuberculosis in Azerbaijan prisons: special emphasis on rifampicin-resistance. Rev Esp Sanid Penit 2018
[Drug resistance in Mycobacterium tuberculosis: contribution of constituent and acquired mechanisms]. doi:10.15446/rsap.V20n4.50575 Rev Salud Publica (Bogota) 2018
Endoplasmic Reticulum Stress Markers and Their Possible Implications in Leprosy's Pathogenesis. doi:10.1155/2018/7067961 Dis Markers 2018
[Brazilian National Registry of Healthcare Establishments as a tool for the analysis of decentralization of tuberculosis treatment to basic care services]. doi:10.1590/0102-311X00173917 Cad Saude Publica 2018
Evaluation of Immunodiagnostic Tests for Leprosy in Brazil, China and Ethiopia. doi:10.1038/s41598-018-36323-1 Sci Rep 2018
The inflammasome in leprosy skin lesions: an immunohistochemical evaluation. doi:10.2147/IDR.S172806 Infect Drug Resist 2018
Analysis of potential household transmission events of tuberculosis in the city of Belem, Brazil. doi:10.1016/j.tube.2018.09.011 Tuberculosis (Edinb) 2018
Methionine Antagonizes para-Aminosalicylic Acid Activity via Affecting Folate Precursor Biosynthesis in Mycobacterium tuberculosis. doi:10.3389/fcimb.2018.00399 names it Front Cell Infect Microbiol 2018
Isolated ovarian tuberculosis in an Immuno- competent woman in the post partum period: case report. doi:10.1186/s13048-018-0472-2 J Ovarian Res 2018
Immunohistochemical characterization of the M4 macrophage population in leprosy skin lesions. doi:10.1186/s12879-018-3478-x BMC Infect Dis 2018
[Inicio del tratamiento farmacológico de la tuberculosis]. doi:10.24875/GMM.17003616 Gac Med Mex 2018
Estimating diagnostic accuracy of fecal culture in liquid media for the detection of Mycobacterium avium subsp. paratuberculosis infections in Québec dairy cows: A latent class model. doi:10.1016/j.prevetmed.2018.09.025 Prev Vet Med 2018
Low sensitivity of the MPT64 identification test to detect lineage 5 of the Mycobacterium tuberculosis complex. doi:10.1099/jmm.0.000846 J Med Microbiol 2018
Utility of para-aminosalicylic acid in drug-resistant tuberculosis: Should it be classified as Group D3 or Group C? doi:10.4103/lungindia.lungindia_141_18 names it Lung India 2018
Tuning the Anti(myco)bacterial Activity of 3-Hydroxy-4-pyridinone Chelators through Fluorophores. doi:10.3390/ph11040110 Pharmaceuticals (Basel) 2018
Most Reliable Time in Predicting Residual Kyphosis and Stability: Pediatric Spinal Tuberculosis. doi:10.31616/asj.2018.12.6.1069 Asian Spine J 2018
Early stage ovarian carcinoma with symptoms mimicking tuberculous peritonitis in a postmenopausal woman: A case report. doi:10.1097/MD.0000000000012669 Medicine (Baltimore) 2018
Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study. doi:10.1136/bmjopen-2018-023899 BMJ Open 2018
[Causal association of antibiotic use and resistant tuberculosis infection: Casecontrol meta-analysis]. Rev Esp Salud Publica 2018
Human T Lymphotropic Virus and Pulmonary Diseases. doi:10.3389/fmicb.2018.01879 Front Microbiol 2018
Langerin (CD207)-positive cells in leprosy: Possible implications for pathogenesis of the disease with special emphasis on dermal immunoreactivity. doi:10.1016/j.micpath.2018.08.020 Microb Pathog 2018
Boldine-Derived Alkaloids Inhibit the Activity of DNA Topoisomerase I and Growth of Mycobacterium tuberculosis. doi:10.3389/fmicb.2018.01659 Front Microbiol 2018
The Historical Need for a National Tuberculosis Program for Spain. doi:10.1016/j.arbres.2018.06.013 Arch Bronconeumol (Engl Ed) 2018
Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosis. doi:10.1128/AAC.00359-18 Antimicrob Agents Chemother 2018
Can Brazil achieve the new World Health Organization global targets for tuberculosis control? doi:10.5123/S1679-49742018000200007 Epidemiol Serv Saude 2018
Evidence of zoonotic leprosy in Pará, Brazilian Amazon, and risks associated with human contact or consumption of armadillos. doi:10.1371/journal.pntd.0006532 PLoS Negl Trop Dis 2018
Whole genome sequence of Mycobacterium kansasii isolates of the genotype 1 from Brazilian patients with pulmonary disease demonstrates considerable heterogeneity. doi:10.1590/0074-02760180085 Mem Inst Oswaldo Cruz 2018
Primary peritoneal tuberculosis, a forgotten localization. Case report. doi:10.1016/j.ijtb.2016.10.004 Indian J Tuberc 2018
[Comparison of two methods for the detection of antituberculous drug susceptibility in Mycobacterium tuberculosis complex isolates: sensititre MycoTB MIC plate and the indirect agar proportion methods]. doi:10.5578/mb.66683 Mikrobiyol Bul 2018
[Pott's Disease in Upper Thoracic Vertebrae in a Two-Year-Old Boy: Case Report]. doi:10.17843/rpmesp.2018.351.3564 Rev Peru Med Exp Salud Publica 2018
Analysis of ParAB dynamics in mycobacteria shows active movement of ParB and differential inheritance of ParA. doi:10.1371/journal.pone.0199316 names it PLoS One 2018
[MGIT and other methods for diagnosing tuberculosis in a private hospital system with low incidence]. Rev Med Inst Mex Seguro Soc 2018
Nerve Growth Factor and Pathogenesis of Leprosy: Review and Update. doi:10.3389/fimmu.2018.00939 Front Immunol 2018
Genetic Diversity and Drug Susceptibility of Mycobacterium tuberculosis Isolates in a Remote Mountain Area of China. doi:10.3967/bes2018.046 Biomed Environ Sci 2018
Pelvic Tuberculosis Diagnosed during Operative Laparoscopy for Suspected Ovarian Cancer. doi:10.1155/2018/6452721 Case Rep Obstet Gynecol 2018
Clinical aspects in patients with pulmonary infection caused by mycobacteria of the Mycobacterium abscessus complex, in the Brazilian Amazon. doi:10.1590/s1806-37562016000000378 J Bras Pneumol 2018
Interferon-gamma release assay performance in northeastern Brazil: influence of the IFNG+874 A>T polymorphism. doi:10.1016/j.bjid.2018.04.004 Braz J Infect Dis 2018
Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico. doi:10.1186/s12954-018-0225-y Harm Reduct J 2018
The role of the Xpert MTB/RIF assay among adolescents suspected of pulmonary tuberculosis in Rio de Janeiro, Brazil. doi:10.1590/0037-8682-0298-2017 Rev Soc Bras Med Trop 2018
[Recommendations to prevent the transmission of Mycobacterium abscessus in dental procedures]. doi:10.21149/8400 Salud Publica Mex 2018
Author Correction: Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis. doi:10.1038/s41588-018-0074-3 Nat Genet 2018
[Management and treatment difficulties of multi-drug resistant pulmonary tuberculosis in a pediatric case]. doi:10.5578/mb.61937 Mikrobiyol Bul 2018
Epigenetic alterations are associated with monocyte immune dysfunctions in HIV-1 infection. doi:10.1038/s41598-018-23841-1 Sci Rep 2018
Localized hepatic tuberculosis presenting as severe hypercalcemia. doi:10.1016/j.ijtb.2017.08.012 Indian J Tuberc 2018
Uptake of governmental social protection and financial hardship during drug-resistant tuberculosis treatment in Rio de Janeiro, Brazil. doi:10.1183/13993003.00274-2018 Eur Respir J 2018
B3LYP Study of 3-hydroxynaphthalene-2-carboxanilide para-derivatives. names it Acta Chim Slov 2018
Total Synthesis of Ripostatin B and Structure-Activity Relationship Studies on Ripostatin Analogs. doi:10.1021/acs.joc.8b00193 J Org Chem 2018
Impaired TNF, IL-1β, and IL-17 production and increased susceptibility to Mycobacterium tuberculosis infection in HTLV-1 infected individuals. doi:10.1016/j.tube.2017.10.004 Tuberculosis (Edinb) 2018
Microbial etiology in hospitalized North Indian adults with community-acquired pneumonia. doi:10.4103/lungindia.lungindia_288_17 Lung India 2018
Endobronchial Tuberculosis Simulating Carcinoid Tumor. doi:10.29271/jcpsp.2018.03.S39 J Coll Physicians Surg Pak 2018
Antituberculosis drug prescribing for inpatients in a national tuberculosis hospital in China, 2011-2015. doi:10.1016/j.jgar.2018.02.008 J Glob Antimicrob Resist 2018
Prognostic factors for treatment success in patients with multidrug-resistant tuberculosis in China. doi:10.5588/ijtld.17.0183 Int J Tuberc Lung Dis 2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors). doi:10.1016/j.cmi.2018.02.009 Clin Microbiol Infect 2018
The challenges to eliminating tuberculosis in Brazil. doi:10.5123/s1679-49742018000100009 Epidemiol Serv Saude 2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors). doi:10.1016/j.cmi.2018.02.002 Clin Microbiol Infect 2018
Proteasome substrate capture and gate opening by the accessory factor PafE from Mycobacterium tuberculosis. doi:10.1074/jbc.RA117.001471 J Biol Chem 2018
The important role of co-infections in patients with AIDS and progressive disseminated histoplasmosis (PDH): A cohort from Colombia. doi:10.1016/j.mmcr.2017.07.004 Med Mycol Case Rep 2018
A complex scenario of tuberculosis transmission is revealed through genetic and epidemiological surveys in Porto. doi:10.1186/s12879-018-2968-1 BMC Infect Dis 2018
Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae. doi:10.1038/s41467-017-02576-z Nat Commun 2018
Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis. doi:10.1038/s41588-017-0029-0 Nat Genet 2018
Effects of Bhramari Pranayama on health - A systematic review. doi:10.1016/j.jtcme.2017.02.003 J Tradit Complement Med 2018
Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia. doi:10.1186/s12879-017-2929-0 BMC Infect Dis 2018
[Results of the implementation of a protocol for outpatient management of the paediatric patient with tuberculosis]. doi:10.1016/j.jhqr.2018.03.007 J Healthc Qual Res 2018
Sequential strategy for the LTBI screening of newly-arrived immigrants in vulnerable social situations. doi:10.1016/j.eimc.2017.10.010 Enferm Infecc Microbiol Clin (Engl Ed) 2018
Primaquine hybrids as promising antimycobacterial and antimalarial agents. doi:10.1016/j.ejmech.2017.11.083 Eur J Med Chem 2018
Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis. doi:10.1128/AAC.01784-17 Antimicrob Agents Chemother 2018
The role of T helper 25 cells in the immune response to Mycobacterium leprae. doi:10.1016/j.jaad.2017.11.025 J Am Acad Dermatol 2018
Infectious and Non-Infectious Diseases Causing the Air Crescent Sign: A State-of-the-Art Review. doi:10.1007/s00408-017-0069-3 Lung 2018
IL-37 and leprosy: A novel cytokine involved in the host response to Mycobacterium leprae infection. doi:10.1016/j.cyto.2017.10.016 Cytokine 2018
Microbial sensor for drug susceptibility testing of Mycobacterium tuberculosis. doi:10.1111/jam.13617 J Appl Microbiol 2018
Roadmap for Tuberculosis Elimination in Latin America and the Caribbean. doi:10.1016/j.arbres.2017.07.004 Arch Bronconeumol (Engl Ed) 2018
Tuberculoma Cavitation: A Rare Aspect of a Common Disease Clinical Image. doi:10.1016/j.arbres.2017.07.014 Arch Bronconeumol (Engl Ed) 2018
CXCR3 ligands in pleural fluid as markers for the diagnosis of tuberculous pleural effusion. doi:10.5588/ijtld.17.0232 Int J Tuberc Lung Dis 2017
Standardization and validation of real time PCR assays for the diagnosis of histoplasmosis using three molecular targets in an animal model. doi:10.1371/journal.pone.0190311 PLoS One 2017
Abdominopelvic Tuberculosis Secondary to a Nontuberculous Mycobacterium in an Immunocompetent Patient. doi:10.1155/2017/9016782 Case Rep Med 2017
Bilateral Mycobacterium chelonae Keratitis after Phacoemulsification Cataract Surgery. doi:10.1155/2017/6413160 Case Rep Ophthalmol Med 2017
Leprosy As a Complex Infection: Breakdown of the Th1 and Th2 Immune Paradigm in the Immunopathogenesis of the Disease. doi:10.3389/fimmu.2017.01635 Front Immunol 2017
Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies. doi:10.1186/s12890-017-0537-9 BMC Pulm Med 2017
Evidence of hidden leprosy in a supposedly low endemic area of Brazil. doi:10.1590/0074-02760170173 Mem Inst Oswaldo Cruz 2017
Comparative Genomic Analysis of Two Clonally Related Multidrug Resistant Mycobacterium tuberculosis by Single Molecule Real Time Sequencing. doi:10.3389/fcimb.2017.00478 Front Cell Infect Microbiol 2017
[Tuberculosis in Peru: epidemiological situation, progress and challenges for its control]. doi:10.17843/rpmesp.2017.342.2384 Rev Peru Med Exp Salud Publica 2017
NFκB transcription factor (p65) immunohistochemistry in leprosy dermal microvasculature. doi:10.1016/j.micpath.2017.11.027 Microb Pathog 2017
[Evaluation of Xpert® MTB/RIF technique for Mycobacterium tuberculosis complex detection in extra-respiratory specimens]. doi:10.4067/s0716-10182017000400333 Rev Chilena Infectol 2017
High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks. doi:10.1128/mBio.01390-17 mBio 2017
Tuberculosis in children and adolescents: Strategies for social workers' interventions. doi:10.5546/aap.2017.eng.e391 Arch Argent Pediatr 2017
Genetic diversity of Mycobacterium tuberculosis from Pará, Brazil, reveals a higher frequency of ancestral strains than previously reported in South America. doi:10.1016/j.meegid.2017.10.021 Infect Genet Evol 2017
Genital Tuberculosis Mimicking Carcinoma Ovary: Can Ultrasound Guided Biopsy Be A Resolution! J Ayub Med Coll Abbottabad 2017
Antimycobacterial activity of nitrogen heterocycles derivatives: 7-(pyridine-4-yl)-indolizine derivatives. Part VII(8-12). doi:10.1080/14756366.2017.1375483 J Enzyme Inhib Med Chem 2017
Intrathoracic tuberculous lymphadenopathy in children: a guide to chest radiography. doi:10.1007/s00247-017-3890-1 Pediatr Radiol 2017
Leprosy Associated with Atypical Cutaneous Leishmaniasis in Nicaragua and Honduras. doi:10.4269/ajtmh.16-0622 Am J Trop Med Hyg 2017
[Budget impact of the incorporation of GeneXpert MTB/RIF for diagnosis of pulmonary tuberculosis from the perspective of the Brazilian Unified National Health System, Brazil, 2013-2017]. doi:10.1590/0102-311X00214515 Cad Saude Publica 2017
[Identification of risk areas for the transmission of tuberculosis in the municipality of São Carlos, São Paulo State, Brazil, 2008 to 2013]. doi:10.5123/S1679-49742017000300010 Epidemiol Serv Saude 2017
Synthesis and Analysis of Bacterial Folate Metabolism Intermediates and Antifolates. doi:10.1021/acs.orglett.7b02487 Org Lett 2017
Pulmonary alveolar proteinosis: a case report. doi:10.5867/medwave.2017.08.7040 Medwave 2017
[Multidrug-resistant tuberculosis: a barrier to achieving the Sustainable Development Goals]. doi:10.21149/8042 Salud Publica Mex 2017
Genomic epidemiology of a national outbreak of post-surgical Mycobacterium abscessus wound infections in Brazil. doi:10.1099/mgen.0.000111 Microb Genom 2017
Evaluation of the SD Bioline TB Ag MPT64 test for identification of Mycobacterium tuberculosis complex from liquid cultures in Southwestern Uganda. doi:10.4102/ajlm.v6i2.383 Afr J Lab Med 2017
Production, crystallization and structure determination of a mycobacterial glucosylglycerate hydrolase. doi:10.1107/S2053230X17012419 Acta Crystallogr F Struct Biol Commun 2017
[Latent tuberculosis infection in persons with HIV/AIDS, associated factors, and progression to active disease in a city in southern Brazil]. doi:10.1590/0102-311X00050916 Cad Saude Publica 2017
Field-friendly serological tests for determination of M. leprae-specific antibodies. doi:10.1038/s41598-017-07803-7 Sci Rep 2017
Poncet's disease after the intravesical instillation of Bacillus Calmette-Guérin (BCG): a case report. doi:10.1186/s13104-017-2606-9 BMC Res Notes 2017
Extensively Drug-resistant Tuberculosis of the Lumbar Spine in a Six-year-old Child: A Case Report. doi:10.13107/jocr.2250-0685.742 J Orthop Case Rep 2017
Environmental aspects related to tuberculosis and intestinal parasites in a low-income community of the Brazilian Amazon. doi:10.1590/S1678-9946201759057 Rev Inst Med Trop Sao Paulo 2017
A case of pulmonary infection due to Mycobacterium paraffinicum from the Amazon Region. doi:10.1016/j.idcr.2017.07.001 IDCases 2017
Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins. doi:10.1128/AAC.00866-17 Antimicrob Agents Chemother 2017
Frequency of indeterminate results from an interferon-gamma release assay among HIV-infected individuals. doi:10.1590/S1806-37562016000000125 J Bras Pneumol 2017
Hearing thresholds in patients with drug-resistant tuberculosis: baseline audiogram configurations and associations. doi:10.1590/S1806-37562016000000165 J Bras Pneumol 2017
Recombinant Invasive Lactococcus lactis Carrying a DNA Vaccine Coding the Ag85A Antigen Increases INF-γ, IL-6, and TNF-α Cytokines after Intranasal Immunization. doi:10.3389/fmicb.2017.01263 Front Microbiol 2017
Structural analysis of the regulatory mechanism of MarR protein Rv2887 in M. tuberculosis. doi:10.1038/s41598-017-01705-4 Sci Rep 2017
Incidence of tuberculosis among patients with rheumatoid arthritis using TNF blockers in Brazil: data from the Brazilian Registry of Biological Therapies in Rheumatic Diseases (Registro Brasileiro de Monitoração de Terapias Biológicas - BiobadaBrasil). doi:10.1016/j.rbre.2017.05.005 Rev Bras Reumatol Engl Ed 2017
High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala. doi:10.4269/ajtmh.16-0009 Am J Trop Med Hyg 2017
Deletion of sigB Causes Increased Sensitivity to para-Aminosalicylic Acid and Sulfamethoxazole in Mycobacterium tuberculosis. doi:10.1128/AAC.00551-17 names it Antimicrob Agents Chemother 2017
The Emergence of Phenolic Glycans as Virulence Factors in Mycobacterium tuberculosis. doi:10.1021/acschembio.7b00394 ACS Chem Biol 2017
[Cervical pain radiating to the upper limb]. Rev Med Brux 2017
Anti-Mycobacterial Evaluation of 7-Chloro-4-Aminoquinolines and Hologram Quantitative Structure-Activity Relationship (HQSAR) Modeling of Amino-Imino Tautomers. doi:10.3390/ph10020052 Pharmaceuticals (Basel) 2017
Towards leprosy elimination by 2020: forecasts of epidemiological indicators of leprosy in Corrientes, a province of northeastern Argentina that is a pioneer in leprosy elimination. doi:10.1590/0074-02760160490 Mem Inst Oswaldo Cruz 2017
[Access barriers to comprehensive care for people affected by tuberculosis and human immunodeficiency virus coinfection in Peru, 2010-2015]. doi:10.26633/RPSP.2017.23 Rev Panam Salud Publica 2017
Spatial distribution of tuberculosis in a municipality in the interior of São Paulo, 2008-2013. doi:10.1590/1518-8345.1064.2888 Rev Lat Am Enfermagem 2017
Drug-resistant tuberculosis in Zhejiang Province, China: an updated analysis of time trends, 1999-2013. doi:10.1080/16549716.2017.1293925 Glob Health Action 2017
The studies of ParA and ParB dynamics reveal asymmetry of chromosome segregation in mycobacteria. doi:10.1111/mmi.13712 names it Mol Microbiol 2017
Systems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications. doi:10.1038/s41598-017-01767-4 Sci Rep 2017
Tuberculosis and diabetes: probabilistic linkage of databases to study the association between both diseases. doi:10.5123/S1679-49742017000200013 Epidemiol Serv Saude 2017
Risk factors associated with multidrug-resistant tuberculosis in Espírito Santo, Brazil. doi:10.1590/S1518-8787.2017051006688 Rev Saude Publica 2017
Identification of Mycobacterial Genes Involved in Antibiotic Sensitivity: Implications for the Treatment of Tuberculosis with β-Lactam-Containing Regimens. doi:10.1128/AAC.00425-17 Antimicrob Agents Chemother 2017
The case against performing pleural biopsies for the aetiological diagnosis of exudates. doi:10.1016/j.rce.2017.02.016 Rev Clin Esp (Barc) 2017
The case for performing pleural biopsies for the aetiological diagnosis of exudates. Yes. doi:10.1016/j.rce.2017.02.015 Rev Clin Esp (Barc) 2017
Discourses of healthcare professionals about health surveillance actions for Tuberculosis control. doi:10.1590/S1980-220X2016018203213 Rev Esc Enferm USP 2017
Isolation and identification of multiple drug resistant nontuberculous mycobacteria from organs of cattle produced typical granuloma lesions. doi:10.1016/j.micpath.2017.03.047 Microb Pathog 2017
Primary Tuberculosis of Nose Causing Bilateral Nasal Obstruction and Halitosis in a 25-Year-Old Woman. doi:10.7860/JCDR/2017/22506.9455 J Clin Diagn Res 2017
Tuberculosis control program in the municipal context: performance evaluation. doi:10.1590/S1518-8787.2017051006553 Rev Saude Publica 2017
Impaired pulmonary function after treatment for tuberculosis: the end of the disease? doi:10.1590/S1806-37562016000000053 J Bras Pneumol 2017
Miliary tuberculosis in a patient with tuberculous mycotic aneurysm of the abdominal aorta: Case report and review of the literature. doi:10.1016/j.rmcr.2017.03.010 Respir Med Case Rep 2017
Influence of socio-economic inequality measured by the Gini coefficient on meningitis incidence caused by Mycobacterium tuberculosis and Haemophilus influenzae in Colombia, 2008-2011. Infez Med 2017
An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis. doi:10.1183/13993003.00803-2016 Eur Respir J 2017
Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application. doi:10.1128/mBio.01586-16 mBio 2017
[Composite Index of health Inequity for a Middle Income Country]. doi:10.15446/rsap.v19n2.63850 Rev Salud Publica (Bogota) 2017
Discourses on short-coursetherapy for tuberculosis control. doi:10.1590/0034-7167-2016-0463 Rev Bras Enferm 2017
Evaluation of para-Aminosalicylic Acid as a Substrate of Multiple Solute Carrier Uptake Transporters and Possible Drug Interactions with Nonsteroidal Anti-inflammatory Drugs In Vitro. doi:10.1128/AAC.02392-16 names it Antimicrob Agents Chemother 2017
Antimycobacterial, antimicrobial activity, experimental (FT-IR, FT-Raman, NMR, UV-Vis, DSC) and DFT (transition state, chemical reactivity, NBO, NLO) studies on pyrrole-isonicotinyl hydrazine. doi:10.1016/j.saa.2017.02.021 Spectrochim Acta A Mol Biomol Spectrosc 2017
Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDRsl Assays. doi:10.1128/AAC.02169-16 Antimicrob Agents Chemother 2017
Association of tuberculosis with multimorbidity and social networks. doi:10.1590/S1806-37562016000000075 J Bras Pneumol 2017
Childhood Vaccine Acceptance and Refusal among Warao Amerindian Caregivers in Venezuela; A Qualitative Approach. doi:10.1371/journal.pone.0170227 PLoS One 2017
Antituberculosis drugs: reducing efflux=increasing activity. doi:10.1016/j.drudis.2017.01.002 Drug Discov Today 2017
Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China. doi:10.1371/journal.pone.0169413 PLoS One 2017
Anti-folates potentiate bactericidal effects of other antimicrobial agents. doi:10.1038/ja.2016.159 J Antibiot (Tokyo) 2017
Synthesis and anti-mycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicylhydrazones: revitalizing an old drug. doi:10.1007/s12272-016-0882-x Arch Pharm Res 2017
Multi drug resistant female genital tuberculosis: A preliminary report. doi:10.1016/j.ejogrb.2016.12.009 Eur J Obstet Gynecol Reprod Biol 2017
Th9 cytokines response and its possible implications in the immunopathogenesis of leprosy. doi:10.1136/jclinpath-2016-204110 J Clin Pathol 2017
Preliminary SAR and biological evaluation of antitubercular triazolothiadiazine derivatives against drug-susceptible and drug-resistant Mtb strains. doi:10.1016/j.bmc.2016.10.027 Bioorg Med Chem 2017
Response to: Is the nasal airway the main mode of transmission for pharyngeal tuberculosis? doi:10.1016/j.otorri.2016.07.004 Acta Otorrinolaringol Esp 2017
Is the nasal airway the main mode of transmission for pharyngeal tuberculosis? doi:10.1016/j.otorri.2016.07.003 Acta Otorrinolaringol Esp 2017
WHO strategies for the management of drug-resistant tuberculosis. doi:10.1016/j.arbres.2016.07.015 Arch Bronconeumol 2017
A Systematic Approach for Developing Bacteria-Specific Imaging Tracers. doi:10.2967/jnumed.116.181792 J Nucl Med 2017
[Introduction of rapid syphilis and HIV testing in prenatal care in Colombia: qualitative analysis]. Rev Panam Salud Publica 2016
Clinicoradiologic Profile of Involvement and Healing in Tuberculosis of the Spine. doi:10.4103/amhsr.amhsr_188_15 Ann Med Health Sci Res 2016
[Tuberculosis caused by Mycobacterium bovis in workers of bovine tuberculosis sanitation farms in Antioquia, Boyacá and Cundinamarca]. doi:10.15446/rsap.v18n5.51187 Rev Salud Publica (Bogota) 2016
Loss to follow-up in tuberculosis treatment and its relationship with patients' knowledge of the disease and other associated factors. doi:10.15446/rsap.v18n5.54842 Rev Salud Publica (Bogota) 2016
Propuestas para reducir el contagio de tuberculosis en el transporte público. doi:10.21149/spm.v58i6.7767 names it Salud Publica Mex 2016
Association between diabetes and tuberculosis: case-control study. doi:10.1590/S1518-8787.2016050006374 Rev Saude Publica 2016
Tuberculous Lymphadenitis and Parotitis. doi:10.1128/microbiolspec.TNMI7-0008-2016 Microbiol Spectr 2016
Primary Liver Abscess with Anterior Abdominal Wall Extension Caused by Mycobacteriumtuberculosis Complex. doi:10.7860/JCDR/2016/21845.8795 J Clin Diagn Res 2016
The variability and reproducibility of whole genome sequencing technology for detecting resistance to anti-tuberculous drugs. doi:10.1186/s13073-016-0385-x Genome Med 2016
Chylous Ascites in Advanced Gallbladder Cancer. doi:10.1007/s12262-016-1528-4 Indian J Surg 2016
Experience of health professionals in care of the homeless population with tuberculosis. doi:10.1590/S0080-623420160000600014 Rev Esc Enferm USP 2016
Neuropathic organophosphates: from Scrugham, Heim and Lorot to Jake leg paralysis. doi:10.1691/ph.2016.6080 Pharmazie 2016
Additional synthesis on thiophene-containing trisubstituted methanes (TRSMs) as inhibitors of M. tuberculosis and 3D-QSAR studies. doi:10.1080/1062936X.2016.1243575 SAR QSAR Environ Res 2016
Post-2015 agenda strategies for tuberculosis control in Brazil: challenges and opportunities. doi:10.5123/S1679-49742016000200021 Epidemiol Serv Saude 2016
Population-Based Drug Resistance Surveillance of Multidrug-Resistant Tuberculosis in Taiwan, 2007-2014. doi:10.1371/journal.pone.0165222 PLoS One 2016
[Tuberculosis in children. Challenges and opportunities]. doi:10.1016/j.anpedi.2016.09.012 An Pediatr (Barc) 2016
Retraction Note to: Diagnostic procedures for improving of the KIT (CD117) expressed allele burden for the liver metastases from uterus mast cell tumors: prognostic value of the metastatic pattern and tumor biology. doi:10.1007/s13277-016-5474-3 Tumour Biol 2016
Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis? doi:10.1590/S1806-37562016000000226 J Bras Pneumol 2016
Prevalence of latent Mycobacterium tuberculosis infection in prisoners. doi:10.1590/S1806-37562016000000001 J Bras Pneumol 2016
Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo. doi:10.1016/j.ijid.2016.08.027 Int J Infect Dis 2016
Miliary tuberculosis in an immunocompetent male with a fatal outcome. doi:10.1136/bcr-2016-216720 BMJ Case Rep 2016
[Risk Factors for the Development of multidrug-resistant tuberculosis in Colombia 2008 A 2011]. doi:10.15446/rsap.v18n6.38871 Rev Salud Publica (Bogota) 2016
Pharmacological Inhibition of Host Heme Oxygenase-1 Suppresses Mycobacterium tuberculosis Infection In Vivo by a Mechanism Dependent on T Lymphocytes. doi:10.1128/mBio.01675-16 mBio 2016
Precursor-directed biosynthesis of new sansanmycin analogs bearing para-substituted-phenylalanines with high yields. doi:10.1038/ja.2016.2 names it J Antibiot (Tokyo) 2016
Role of the Neutrophil-Lymphocyte Ratio in the Differential Diagnosis of Exudative Pleural Effusion. doi:10.6061/clinics/2016(10)10 Clinics (Sao Paulo) 2016
A single capsule formulation of RHB-104 demonstrates higher anti-microbial growth potency for effective treatment of Crohn's disease associated with Mycobacterium avium subspecies paratuberculosis. doi:10.1186/s13099-016-0127-z Gut Pathog 2016
[South-South cooperation to strengthen the medicines control laboratories of the Caribbean community (CARICOM)]. Rev Panam Salud Publica 2016
The antifibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosis. doi:10.1172/jci.insight.86017 JCI Insight 2016
The experience of bedaquiline implementation at a decentralised clinic in South Africa. doi:10.5588/pha.16.0037 Public Health Action 2016
Mycobacterium tuberculosis Arylamine N-Acetyltransferase Acetylates and Thus Inactivates para-Aminosalicylic Acid. doi:10.1128/AAC.01312-16 names it Antimicrob Agents Chemother 2016
Tuberculosis control in people living with HIV/AIDS. doi:10.1590/1518-8345.1187.2798 Rev Lat Am Enfermagem 2016
[Support groups for patients with tuberculosis in Facebook]. doi:10.4067/S0034-98872016000600021 Rev Med Chil 2016
Drug-Induced Hypothyroidism during Anti-Tuberculosis Treatment of Multidrug-Resistant Tuberculosis: Notes from the Field. doi:10.4236/jtr.2016.43013 J Tuberc Res 2016
Accuracy of probabilistic and deterministic record linkage: the case of tuberculosis. doi:10.1590/S1518-8787.2016050006327 Rev Saude Publica 2016
Epidemiology and patterns of drug resistance among tuberculosis patients in Northwestern Iran. doi:10.4103/0255-0857.188352 Indian J Med Microbiol 2016
[Recommendations for the preparation and administration of antituberculosis drugs in children. Second phase of the Magistral Project of the Spanish Network for the Study of Paediatric Tuberculosis (pTBred)]. doi:10.1016/j.anpedi.2016.06.012 An Pediatr (Barc) 2016
Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital. doi:10.4269/ajtmh.15-0837 Am J Trop Med Hyg 2016
[Next generation sequencing for the diagnostics and epidemiology of tuberculosis]. doi:10.1016/S0213-005X(16)30217-8 Enferm Infecc Microbiol Clin 2016
Spatial and temporal epidemiology of Mycobacterium leprae infection among leprosy patients and household contacts of an endemic region in Southeast Brazil. doi:10.1016/j.actatropica.2016.07.019 Acta Trop 2016
Multicomponent Petasis-borono Mannich Preparation of Alkylaminophenols and Antimicrobial Activity Studies. doi:10.1002/cmdc.201600244 ChemMedChem 2016
[Disease in the cloisters: requests to leave Convento da Ajuda, Rio de Janeiro, for the treatment of contagious diseases, c.1750-1780]. doi:10.1590/S0104-59702016005000013 Hist Cienc Saude Manguinhos 2016
Hilar and para-aortic necrotizing lymphadenopathy associated with antineutrophil cytoplasmic antibody-negative pauci-immune crescentic glomerulonephritis. doi:10.4103/1319-2442.185264 names it Saudi J Kidney Dis Transpl 2016
Executive Summary of the Guidelines for the Use of interferon-gamma Release Assays in the Diagnosis of Tuberculosis Infection. doi:10.1016/j.arbres.2016.02.020 Arch Bronconeumol 2016
Detection of Mycobacterium avium subspecies paratuberculosis in tie-stall dairy herds using a standardized environmental sampling technique and targeted pooled samples. Can J Vet Res 2016
Evaluation of the implementation of the directly observed treatment strategy for tuberculosis in a large city. doi:10.1590/S0080-623420160000200010 Rev Esc Enferm USP 2016
Care production for tuberculosis cases:analysis according to the elements of the Chronic Care Model. doi:10.1590/S0080-623420160000200009 Rev Esc Enferm USP 2016
Bronchoscopic diagnostic procedures and microbiological examinations in proving endobronchial tuberculosis. doi:10.1590/S1806-37562015000000134 J Bras Pneumol 2016
Cultural adaptation of the Tuberculosis-related stigma scale to Brazil. doi:10.1590/1413-81232015217.10582015 Cien Saude Colet 2016
A solid state NMR study of layered double hydroxides intercalated with para-amino salicylate, a tuberculosis drug. doi:10.1016/j.ssnmr.2016.06.001 names it Solid State Nucl Magn Reson 2016
Multiplex Assay of Second-Line Anti-Tuberculosis Drugs in Dried Blood Spots Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry. doi:10.3343/alm.2016.36.5.489 Ann Lab Med 2016
An old enemy not to be forgotten during PET CT scanning of cancer patients: tuberculosis. doi:10.5114/wo.2014.43985 Contemp Oncol (Pozn) 2016
Social representations of nurses on tuberculosis. doi:10.1590/0034-7167.2016690316i Rev Bras Enferm 2016
Paratuberculosis in buffaloes in Northeast Brazil. doi:10.1007/s11250-016-1100-z Trop Anim Health Prod 2016
Whole-Genome Sequencing of a Haarlem Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolate from Medellín, Colombia. doi:10.1128/genomeA.00566-16 Genome Announc 2016
RHB-104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn's disease associated with Mycobacterium paratuberculosis. doi:10.1186/s13099-016-0115-3 Gut Pathog 2016
Draft Genome Sequence of a Mycobacterium africanum Clinical Isolate from Antioquia, Colombia. doi:10.1128/genomeA.00486-16 Genome Announc 2016
Utility of MPT64 antigen test for differentiating mycobacteria: Can correlation with liquid culture smear morphology add further value? doi:10.4103/0377-4929.182009 Indian J Pathol Microbiol 2016
Function, expression, specificity, diversity and incompatibility of actinobacteriophage parABS systems. doi:10.1111/mmi.13414 Mol Microbiol 2016
Primary Paranasal Tuberculosis in a Diabetic Mimicking Odontogenic Infection: A Rare Case; A Unique Presentation. doi:10.7860/JCDR/2016/17195.7501 J Clin Diagn Res 2016
A fatal case of pulmonary infection by Mycobacterium colombiense in Para State, Amazon Region, Brazil. doi:10.1016/j.diagmicrobio.2016.02.011 names it Diagn Microbiol Infect Dis 2016
Draft Genome Sequence of Mycobacterium brumae ATCC 51384. doi:10.1128/genomeA.00237-16 Genome Announc 2016
Atypical mycobacteriosis involving parotid and para-retropharyngeal spaces. doi:10.1007/s00405-016-4053-y names it Eur Arch Otorhinolaryngol 2016
[Erythema nodosum: Analysis of 91 hospitalized patients]. doi:10.4067/S0034-98872016000200003 Rev Med Chil 2016
Phylogenetic and Structural Significance of Dihydrofolate Synthase (folC) Mutations in Drug-Resistant Mycobacterium tuberculosis. doi:10.1089/mdr.2015.0193 Microb Drug Resist 2016
Glucose Metabolism Disorder Is Associated with Pulmonary Tuberculosis in Individuals with Respiratory Symptoms from Brazil. doi:10.1371/journal.pone.0153590 PLoS One 2016
Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates. doi:10.5588/ijtld.15.0573 Int J Tuberc Lung Dis 2016
Whole-Genome Sequencing of Two Latin American-Mediterranean Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates from Medellín, Colombia. doi:10.1128/genomeA.00192-16 Genome Announc 2016
dfrA thyA Double Deletion in para-Aminosalicylic Acid-Resistant Mycobacterium tuberculosis Beijing Strains. doi:10.1128/AAC.00253-16 names it Antimicrob Agents Chemother 2016
Structural Insights into Mycobacterium tuberculosis Rv2671 Protein as a Dihydrofolate Reductase Functional Analogue Contributing to para-Aminosalicylic Acid Resistance. doi:10.1021/acs.biochem.5b00993 names it Biochemistry 2016
Whole-Genome Sequence of a Beijing Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolate from Buenaventura, Colombia. doi:10.1128/genomeA.01549-15 Genome Announc 2016
Diabetes Is Associated with Worse Clinical Presentation in Tuberculosis Patients from Brazil: A Retrospective Cohort Study. doi:10.1371/journal.pone.0146876 PLoS One 2016
Simultaneous occurrence of Hodgkin's disease and tubercular lymphadenitis in the same cervical lymph node: a rare presentation. doi:10.1136/bcr-2015-213355 BMJ Case Rep 2016
Langerhans cells (CD1a and CD207), dermal dendrocytes (FXIIIa) and plasmacytoid dendritic cells (CD123) in skin lesions of leprosy patients. doi:10.1016/j.micpath.2015.11.013 Microb Pathog 2016
Peripheral neuropathy in persons with tuberculosis. doi:10.1016/j.jctube.2015.11.002 J Clin Tuberc Other Mycobact Dis 2016
Correlation between nerve growth factor and tissue expression of IL-17 in leprosy. doi:10.1016/j.micpath.2015.11.019 Microb Pathog 2016
A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis. doi:10.1080/07391102.2015.1117397 J Biomol Struct Dyn 2016
[A para-aortic opacity]. doi:10.1016/j.revmed.2015.09.006 names it Rev Med Interne 2016
Pneumothorax following bronchoalveolar lavage for the diagnosis of non-tuberculous mycobacterial infection. An «atypical» complication of bronchoscopy? doi:10.1016/j.arbres.2015.07.009 Arch Bronconeumol 2016
Coinfection of Trypanosoma cruzi and Mycobacterium tuberculosis in a patient from Colombia. doi:10.1016/j.jiph.2015.09.004 J Infect Public Health 2016
Targeting the cell wall of Mycobacterium tuberculosis: a molecular modeling investigation of the interaction of imipenem and meropenem with L,D-transpeptidase 2. doi:10.1080/07391102.2015.1029000 J Biomol Struct Dyn 2016
Clinical features and treatment of drug fever caused by anti-tuberculosis drugs. doi:10.1111/crj.12242 Clin Respir J 2016
Disseminated tuberculosis in a patient with recurrent transitional cell carcinoma of renal pelvis and bladder following intravesical BCG therapy: A report of a rare case. doi:10.4103/0973-1482.151860 J Cancer Res Ther 2015
Contralateral contiguous tuberculous lymphadenitis in a case of right breast carcinoma--Diagnostic dilemma. doi:10.4103/0973-1482.150410 J Cancer Res Ther 2015
[GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis]. doi:10.7705/biomedica.v35i4.2813 Biomedica 2015
Therapeutic itineraries and explanations for tuberculosis: an indigenous perspective. doi:10.1590/S0034-8910.2015049005904 Rev Saude Publica 2015
Pulmonary and extra-pulmonary manifestations of sarcoidosis. doi:10.4103/0300-1652.169702 Niger Med J 2015
Various Spectrum of MRI Findings in Articular and Para-articular Tuberculosis: Pictorial Assay. doi:10.1007/s12262-013-0979-0 names it Indian J Surg 2015
Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America. doi:10.1371/journal.pone.0145380 PLoS One 2015
Treatment of Tuberculosis. A Historical Perspective. doi:10.1513/AnnalsATS.201509-632PS Ann Am Thorac Soc 2015
Comparison of the predictive ability of two scoring systems for the diagnosis of tuberculosis in children. doi:10.5546/aap.2015.eng.491 Arch Argent Pediatr 2015
Associations between Mycobacterium paratuberculosis sero-status, milk quality parameters, and reproduction in dairy cows. Berl Munch Tierarztl Wochenschr 2015
Primary gastric tuberculosis presenting as gastric outlet obstruction: a case report and review of the literature. doi:10.1186/s13256-015-0748-8 J Med Case Rep 2015
Spatial epidemiology and serologic cohorts increase the early detection of leprosy. doi:10.1186/s12879-015-1254-8 BMC Infect Dis 2015
Correlates of perceived risk of HIV infection among persons who inject drugs in Tijuana, Baja California, Mexico. doi:10.21149/spm.v57s2.7597 Salud Publica Mex 2015
[Guidelines for the prevention and control of tuberculosis in health care workers]. doi:10.1016/j.medcli.2015.06.018 Med Clin (Barc) 2015
Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents. doi:10.1016/j.ejmech.2015.10.024 Eur J Med Chem 2015
Early culture conversion and cure for extensively drug-resistant tuberculosis is possible with appropriate treatment: lessons learnt from a case study in South Africa. doi:10.1016/j.ijid.2015.09.020 Int J Infect Dis 2015
Multiple osteolytic lesions in a 14-year-old boy with HIV disease. doi:10.4103/0253-7184.156747 Indian J Sex Transm Dis AIDS 2015
Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates. doi:10.1128/AAC.01028-15 Antimicrob Agents Chemother 2015
Influence of Genetic Ancestry on INDEL Markers of NFKβ1, CASP8, PAR1, IL4 and CYP19A1 Genes in Leprosy Patients. doi:10.1371/journal.pntd.0004050 PLoS Negl Trop Dis 2015
New Players in the Same Old Game: Disturbance of Group 2 Innate Lymphoid Cells in HIV-1 and Mycobacterium leprae Co-infected Patients. doi:10.1371/journal.pntd.0004030 PLoS Negl Trop Dis 2015
[Polymorphism of the bphA genes in bacteria destructing biphenyl/chlorinated biphenils]. doi:10.7868/S0026898415040151 Mol Biol (Mosk) 2015
Para-aminosalicylic acid: the return of an old friend. doi:10.1016/S1473-3099(15)00263-7 names it Lancet Infect Dis 2015
Antifolate Activity of Plant Polyphenols against Mycobacterium tuberculosis. doi:10.1002/ptr.5437 Phytother Res 2015
Chronic symptoms and pulmonary dysfunction in post-tuberculosis Brazilian patients. doi:10.1016/j.bjid.2015.06.005 Braz J Infect Dis 2015
An intervention of active TB case finding among smokers attending routine primary care facilities in China: an exploratory study. doi:10.1093/trstmh/trv063 Trans R Soc Trop Med Hyg 2015
Epiglottic masses identified on CT imaging: A case report and review of the broad differential diagnosis. doi:10.1177/1971400915594517 Neuroradiol J 2015
[Preliminary guidelines of the Brazilian Society of Rheumatology for evaluation and treatment of tuberculosis latent infection in patients with rheumatoid arthritis, in face of unavailability of the tuberculin skin test]. doi:10.1016/j.rbr.2015.01.006 Rev Bras Reumatol 2015
Simulating the inhibition reaction of Mycobacterium tuberculosis L,D-transpeptidase 2 by carbapenems. doi:10.1039/c5cc03202d Chem Commun (Camb) 2015
[Phenotypic and genotypic diagnosis of bone and miliary tuberculosis in an HIV+ patient in Bogotá, Colombia]. doi:10.1590/S0120-41572015000100002 Biomedica 2015
Prevalence and evolution of Mycobacterium tuberculosis infection in tuberculosis case contacts. doi:10.1590/0037-8682-0014-2015 Rev Soc Bras Med Trop 2015
CMRegNet-An interspecies reference database for corynebacterial and mycobacterial regulatory networks. doi:10.1186/s12864-015-1631-0 BMC Genomics 2015
[Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides]. doi:10.1016/j.rbr.2014.06.006 Rev Bras Reumatol 2015
Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance. doi:10.1128/AAC.00647-15 names it Antimicrob Agents Chemother 2015
Leprosy Reactions in Patients Coinfected with HIV: Clinical Aspects and Outcomes in Two Comparative Cohorts in the Amazon Region, Brazil. doi:10.1371/journal.pntd.0003818 PLoS Negl Trop Dis 2015
Differentiation between tuberculosis and leukemia in abdominal and pelvic lymph nodes: evaluation with contrast-enhanced multidetector computed tomography. doi:10.6061/clinics/2015(03)02 Clinics (Sao Paulo) 2015
[Transport of dinitrosyl iron complexes into animal lungs]. Biofizika 2015
An unusual case of pseudochylothorax. doi:10.4103/0975-7406.155814 J Pharm Bioallied Sci 2015
Opportunistic infections among individuals with HIV-1/AIDS in the highly active antiretroviral therapy era at a Quaternary Level Care Teaching Hospital. doi:10.1590/0037-8682-0299-2014 Rev Soc Bras Med Trop 2015
Genome sequencing reveals novel deletions associated with secondary resistance to pyrazinamide in MDR Mycobacterium tuberculosis. doi:10.1093/jac/dkv128 J Antimicrob Chemother 2015
N-acetyltransferase genotypes and the pharmacokinetics and tolerability of para-aminosalicylic acid in patients with drug-resistant pulmonary tuberculosis. doi:10.1128/AAC.04049-14 names it Antimicrob Agents Chemother 2015
Comparison of the tuberculin test, histopathological examination, and bacterial culture for the diagnosis of tuberculosis (Mycobacterium bovis) in buffaloes (Bubalus bubalis) in Brazil. doi:10.1007/s11250-015-0842-3 Trop Anim Health Prod 2015
Multidrug-resistant tuberculosis in the Amazonas State, Brazil, 2000-2011. doi:10.5588/ijtld.14.0291 Int J Tuberc Lung Dis 2015
Outcomes and use of therapeutic drug monitoring in multidrug-resistant tuberculosis patients treated in virginia, 2009-2014. doi:10.4046/trd.2015.78.2.78 Tuberc Respir Dis (Seoul) 2015
Oral and systemic manifestations in HIV-1 patients. doi:10.1590/0037-8682-0179-2014 Rev Soc Bras Med Trop 2015
[Risk groups for tuberculosis in Chile]. doi:10.4067/S0716-10182015000200003 Rev Chilena Infectol 2015
[Wrong thinking in theory resulted in potent drug in practice]. Lakartidningen 2015
A stepwise approach to the etiologic diagnosis of pleural effusion in respiratory intensive care unit and short-term evaluation of treatment. doi:10.4103/0970-2113.152615 Lung India 2015
Phosphorylation of Mycobacterium tuberculosis ParB participates in regulating the ParABS chromosome segregation system. doi:10.1371/journal.pone.0119907 PLoS One 2015
New immunologic pathways in the pathogenesis of leprosy: role for Th22 cytokines in the polar forms of the disease. doi:10.1016/j.jaad.2014.11.023 J Am Acad Dermatol 2015
Immunohistochemical analysis of the expression of cellular transcription NFκB (p65), AP-1 (c-Fos and c-Jun), and JAK/STAT in leprosy. doi:10.1016/j.humpath.2015.01.015 Hum Pathol 2015
Pulmonary tuberculosis caused by Mycobacterium bovis in China. doi:10.1038/srep08538 Sci Rep 2015
Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development. doi:10.1016/j.tube.2015.01.006 Tuberculosis (Edinb) 2015
Safety and tolerability profile of second-line anti-tuberculosis medications. doi:10.1007/s40264-015-0267-y Drug Saf 2015
Antibiotic Susceptibility Patterns of Mycobacterium tuberculosis Isolates from Guizhou Province of China Against 13 Antituberculosis Drugs. doi:10.1089/mdr.2014.0094 Microb Drug Resist 2015
Non-stabilized nucleophiles in Cu-catalysed dynamic kinetic asymmetric allylic alkylation. doi:10.1038/nature14089 Nature 2015
Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study. doi:10.1093/jac/dku438 J Antimicrob Chemother 2015
Finer characterization of Mycobacterium tuberculosis using spoligotyping and 15-loci MIRU-VNTRs reveals phylogeographical specificities of isolates circulating in Guyana and Suriname. doi:10.1016/j.meegid.2014.12.015 Infect Genet Evol 2015
[Proposal of a five MIRU-VNTR panel to screen clinical isolates of Mycobacterium tuberculosis in Mexico]. doi:10.1016/j.eimc.2014.10.010 Enferm Infecc Microbiol Clin 2015
Characterization of 17 strains belonging to the Mycobacterium simiae complex and description of Mycobacterium paraense sp. nov. doi:10.1099/ijs.0.068395-0 Int J Syst Evol Microbiol 2015
Global tuberculosis elimination: the relevance of trend surveillance in Mexico and beyond. doi:10.1016/j.arbres.2014.07.015 Arch Bronconeumol 2015
Association of the CYP2B6 gene with anti-tuberculosis drug-induced hepatotoxicity in a Brazilian Amazon population. doi:10.1016/j.ijid.2014.04.011 Int J Infect Dis 2015
3-benzylidene-4-chromanones: a novel cluster of anti-tubercular agents. doi:10.3109/14756366.2014.913036 J Enzyme Inhib Med Chem 2015
[Evaluation of the BD MGITTM technique for identifying the Mycobacterium tuberculosis complex]. Rev Salud Publica (Bogota) 2014
Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids. doi:10.1128/microbiolspec.MGM2-0021-2013 Microbiol Spectr 2014
French Nationwide Cohort Temporary Utilization Authorization Survey of GranuPAS(®) in MDR-TB patients. doi:10.1159/000371869 Chemotherapy 2014
[Clinical-radiological case for diagnosis]. doi:10.4067/S0370-41062014000500014 Rev Chil Pediatr 2014
Successful management of highly drug resistant tuberculosis with individualised drug susceptibility testing. J Assoc Physicians India 2014
[Performance evaluation of primary care services for the treatment of tuberculosis]. doi:10.1590/S0080-623420140000700012 Rev Esc Enferm USP 2014
[Geography, health and urban development in São Paulo state at the turn of the twentieth century: Domingos Jaguaribe and the construction of the Climate Resort of Campos do Jordão]. doi:10.1590/S0104-59702014005000019 Hist Cienc Saude Manguinhos 2014
Malignant mesothelioma trends in Chihuahua, Mexico. Salud Publica Mex 2014
[Coinfection of Mycobacterium malmoense and Mycobacterium tuberculosis in a patient with acquired inmune deficiency syndrome]. Rev Peru Med Exp Salud Publica 2014
[Analysis of the policy for tuberculosis control in Colombia]. Rev Peru Med Exp Salud Publica 2014
Bacteriological methods as add on tests to fine-needle aspiration cytology in diagnosis of tuberculous lymphadenitis: can they reduce the diagnostic dilemma? doi:10.1186/s12879-014-0720-z BMC Infect Dis 2014
Total knee arthroplasty treatment of active tuberculosis of the knee: a review of 10 cases. Eur Rev Med Pharmacol Sci 2014
Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids. doi:10.1128/microbiolspec.MGM2-0021-2013 Microbiol Spectr 2014
Comparison of epidemiological, clinical, laboratory and radiological features of hospitalized diabetic and non-diabetic patients with pulmonary tuberculosis at razi hospital in ahvaz. doi:10.5812/jjm.12447 Jundishapur J Microbiol 2014
[Factors related to the place of first choice for the diagnosis of tuberculosis]. doi:10.1590/1983-1447.2014.03.44767 Rev Gaucha Enferm 2014
[Colonic perforation due to invasive amebic colitis during anti-TNF therapy for spondyloarthritis]. doi:10.1016/j.rbr.2013.09.004 Rev Bras Reumatol 2014
Relationship between growth factors and its implication in the pathogenesis of leprosy. doi:10.1016/j.micpath.2014.10.005 Microb Pathog 2014
Synthesis, anticancer and antibacterial activity of salinomycin N-benzyl amides. doi:10.3390/molecules191219435 Molecules 2014
Rapid diagnosis of pulmonary tuberculosis. doi:10.11604/pamj.2014.18.141.2295 Pan Afr Med J 2014
Design and synthesis of quinazoline carboxylates against Gram-positive, Gram-negative, fungal pathogenic strains, and Mycobacterium tuberculosis. doi:10.4103/0975-7406.142960 J Pharm Bioallied Sci 2014
Strain classification of Mycobacterium tuberculosis isolates in Brazil based on genotypes obtained by spoligotyping, mycobacterial interspersed repetitive unit typing and the presence of large sequence and single nucleotide polymorphism. doi:10.1371/journal.pone.0107747 PLoS One 2014
Isolated tubercular hepatic abscess with diffuse pattern mimicking hepatocellular carcinoma in HIV positive patient: a case report. doi:10.4314/thrb.v16i4.11 Tanzan J Health Res 2014
Direct detection of Mycobacterium tuberculosis complex in bovine and bubaline tissues through nested-PCR. doi:10.1590/s1517-83822014000200035 Braz J Microbiol 2014
Respiratory tract clinical sample selection for microbiota analysis in patients with pulmonary tuberculosis. doi:10.1186/2049-2618-2-29 Microbiome 2014
Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update. doi:10.5588/ijtld.13.0197 Int J Tuberc Lung Dis 2014
Synthesis and antimycobacterial and photosynthesis-inhibiting evaluation of 2-[(E)-2-substituted-ethenyl]-1,3-benzoxazoles. doi:10.1155/2014/705973 ScientificWorldJournal 2014
Anti tuberculosis drug resistance in west of iran. doi:10.4103/0974-777X.138506 J Glob Infect Dis 2014
[Thin layer agar represents a cost-effective alternative for the rapid diagnosis of multi-drug resistant tuberculosis]. Rev Salud Publica (Bogota) 2014
Concentration of lymph node aspirate improves the sensitivity of acid fast smear microscopy for the diagnosis of tuberculous lymphadenitis in Jimma, southwest Ethiopia. doi:10.1371/journal.pone.0106726 PLoS One 2014
[International financial cooperation in the fight against AIDS in Latin America and the Caribbean]. doi:10.1590/0102-311x00106113 Cad Saude Publica 2014
[The families and directly observed treatment of tuberculosis: senses and prospects to the production of care]. doi:10.1590/1983-1447.2014.02.42741 Rev Gaucha Enferm 2014
Catalytic mechanism of L,D-transpeptidase 2 from Mycobacterium tuberculosis described by a computational approach: insights for the design of new antibiotics drugs. doi:10.1021/ci5003069 J Chem Inf Model 2014
Patch-testing for the management of hypersensitivity reactions to second-line anti-tuberculosis drugs: a case report. doi:10.1186/1756-0500-7-537 BMC Res Notes 2014
Apoptotic activity and Treg cells in tissue lesions of patients with leprosy. doi:10.1016/j.micpath.2014.07.005 Microb Pathog 2014
Antimycobacterial, antimicrobial, and biocompatibility properties of para-aminosalicylic acid with zinc layered hydroxide and Zn/Al layered double hydroxide nanocomposites. doi:10.2147/DDDT.S63753 names it Drug Des Devel Ther 2014
Pharmacokinetics of para-aminosalicylic acid in HIV-uninfected and HIV-coinfected tuberculosis patients receiving antiretroviral therapy, managed for multidrug-resistant and extensively drug-resistant tuberculosis. doi:10.1128/AAC.03073-14 names it Antimicrob Agents Chemother 2014
A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic setting. doi:10.1186/1756-0500-7-512 BMC Res Notes 2014
From milk to rifampicin and back again: history of failures and successes in the treatment for tuberculosis. doi:10.1038/ja.2014.108 J Antibiot (Tokyo) 2014
Synthesis, biological evaluation and 3D-QSAR study of hydrazide, semicarbazide and thiosemicarbazide derivatives of 4-(adamantan-1-yl)quinoline as anti-tuberculosis agents. doi:10.1016/j.ejmech.2014.07.100 Eur J Med Chem 2014
Evaluation of MODS assay for rapid detection of Mycobacterium tuberculosis resistance to second-line drugs in a tertiary care tuberculosis hospital in China. doi:10.1016/j.tube.2014.06.005 Tuberculosis (Edinb) 2014
Reactive dirty fragments: implications for tuberculosis drug discovery. doi:10.1016/j.mib.2014.06.015 Curr Opin Microbiol 2014
Clinical disease and stage of lactation influence shedding of Mycobacterium avium subspecies paratuberculosis into milk and colostrum of naturally infected dairy cows. doi:10.3168/jds.2014-8204 J Dairy Sci 2014
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. doi:10.1016/S0140-6736(14)60844-8 Lancet 2014
Development of a highly biocompatible antituberculosis nanodelivery formulation based on para-aminosalicylic acid-zinc layered hydroxide nanocomposites. doi:10.1155/2014/401460 names it ScientificWorldJournal 2014
Liver abscess in the tropics: an experience from Jammu. doi:10.1177/0036933014543049 Scott Med J 2014
Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis. doi:10.1371/journal.ppat.1004188 PLoS Pathog 2014
[The usefulness of the nitrate reductase assay for detecting drug-resistant Mycobacterium tuberculosis]. doi:10.1590/S0120-41572014000500026 Biomedica 2014
σ(ECF) factors of gram-positive bacteria: a focus on Bacillus subtilis and the CMNR group. doi:10.4161/viru.29514 Virulence 2014
Survey of tuberculosis drug resistance among Tibetan refugees in India. doi:10.5588/ijtld.13.0516 Int J Tuberc Lung Dis 2014
Multilocus sequence typing scheme versus pulsed-field gel electrophoresis for typing Mycobacterium abscessus isolates. doi:10.1128/JCM.00688-14 J Clin Microbiol 2014
Diffusion tensor imaging study of white matter damage in chronic meningitis. doi:10.1371/journal.pone.0098210 PLoS One 2014
The structural modeling of the interaction between levofloxacin and the Mycobacterium tuberculosis gyrase catalytic site sheds light on the mechanisms of fluoroquinolones resistant tuberculosis in Colombian clinical isolates. doi:10.1155/2014/367268 Biomed Res Int 2014
Complete genome sequences of nine mycobacteriophages. doi:10.1128/genomeA.00181-14 Genome Announc 2014
Adenosine deaminase activity in pleural effusions of lymphoma patients. doi:10.1093/qjmed/hcu106 QJM 2014
A first assessment of Mycobacterium tuberculosis genetic diversity and drug-resistance patterns in twelve Caribbean territories. doi:10.1155/2014/718496 Biomed Res Int 2014
A late presentation of isolated lymph node tuberculosis postintravesical BCG therapy for superficial bladder cancer: a novel case. doi:10.1136/bcr-2014-204037 BMJ Case Rep 2014
Diagnostic utility of adenosine deaminase in exudative pleural effusions. doi:10.4103/0970-2113.129842 Lung India 2014
Population structure among mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Colombia. doi:10.1371/journal.pone.0093848 PLoS One 2014
Examining ERBB2 as a candidate gene for susceptibility to leprosy (Hansen's disease) in Brazil. doi:10.1590/0074-0276130344 Mem Inst Oswaldo Cruz 2014
Short communication: Application of an N-acetyl-L-cysteine-NaOH decontamination method for the recovery of viable Mycobacterium avium subspecies paratuberculosis from milk of naturally infected cows. doi:10.3168/jds.2013-7730 J Dairy Sci 2014
Magnetic Resonance Image findings of Spinal Tuberclosis at first presentation. doi:10.1186/1755-7682-7-12 Int Arch Med 2014
[Little snow ball]. doi:10.1016/j.medcli.2014.01.017 Med Clin (Barc) 2014
Prevalence of oral lesions in hospitalized patients with infectious diseases in northern Brazil. doi:10.1155/2014/586075 ScientificWorldJournal 2014
Dose regimen of para-aminosalicylic acid gastro-resistant formulation (PAS-GR) in multidrug-resistant tuberculosis. doi:10.1007/s40261-014-0172-7 names it Clin Drug Investig 2014
Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery. doi:10.1111/bph.12598 Br J Pharmacol 2014
Phylogenetic polymorphisms in antibiotic resistance genes of the Mycobacterium tuberculosis complex. doi:10.1093/jac/dkt535 J Antimicrob Chemother 2014
Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis. doi:10.1128/AAC.01775-13 names it Antimicrob Agents Chemother 2014
Tuberculosis prevalence and risk factors for water buffalo in Pará, Brazil. doi:10.1007/s11250-013-0521-1 Trop Anim Health Prod 2014
Direct observation therapy with appropriate treatment regimens was associated with a decline in second-line drug-resistant tuberculosis in Taiwan. doi:10.1007/s10096-013-2030-6 Eur J Clin Microbiol Infect Dis 2014
Tuberculosis and TNFα antagonists--what are we missing? doi:10.1016/j.rppneu.2013.09.002 Rev Port Pneumol 2014
Activity of linezolid-containing regimens against multidrug-resistant tuberculosis in mice. doi:10.1016/j.ijantimicag.2013.10.010 Int J Antimicrob Agents 2014
Prevalence of asthma and associated factors in adolescents living in Belem (Amazon region), Para, Brazil. doi:10.1016/j.aller.2013.02.014 names it Allergol Immunopathol (Madr) 2014
Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory. doi:10.1128/JCM.02378-13 J Clin Microbiol 2014
Treatment of advanced ovarian carcinoma coexistent with peritoneal tuberculosis. doi:10.3892/mco.2013.183 Mol Clin Oncol 2013
Medical treatment of pulmonary multidrug-resistant tuberculosis. doi:10.3947/ic.2013.45.4.367 Infect Chemother 2013
[Clinical analysis of protionamide and para-aminosalicylic acid induced hepatotoxicity in 129 cases]. names it Zhonghua Jie He He Hu Xi Za Zhi 2013
Clinico-pathological correlates of cervical lymphadenopathy: a hospital based study. doi:10.1007/s12070-011-0443-z Indian J Otolaryngol Head Neck Surg 2013
Clinical features of laryngeal tuberculosis in Iran. Acta Med Iran 2013
Synthesis, SAR Study and Evaluation of Mannich and Schiff Bases of Pyrazol-5(4H)-one Moiety Containing 3-(Hydrazinyl)-2-phenylquinazolin-4(3H)-one. doi:10.4103/0250-474X.119832 Indian J Pharm Sci 2013
[Eliminating tuberculosis one neighborhood at a time]. Rev Panam Salud Publica 2013
Antioxidant factors, nitric oxide levels, and cellular damage in leprosy patients. doi:10.1590/0037-8682-1506-2013 Rev Soc Bras Med Trop 2013
Antituberculosis nanodelivery system with controlled-release properties based on para-amino salicylate-zinc aluminum-layered double-hydroxide nanocomposites. doi:10.2147/DDDT.S50665 names it Drug Des Devel Ther 2013
A rare case of ethambutol induced pulmonary eosinophilia. doi:10.4103/0976-500X.119724 J Pharmacol Pharmacother 2013
Differentiating between abdominal tuberculous lymphadenopathy and lymphoma using multidetector computed tomography (MDCT). J Med Assoc Thai 2013
Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania. doi:10.1186/1471-2334-13-432 BMC Infect Dis 2013
Antimycobacterial and photosynthetic electron transport inhibiting activity of ring-substituted 4-arylamino-7-chloroquinolinium chlorides. doi:10.3390/molecules180910648 Molecules 2013
Haplotypes of the IL10 gene as potential protection factors in leprosy patients. doi:10.1128/CVI.00334-13 Clin Vaccine Immunol 2013
A Rare Case of Cervical Tuberculosis which Simulated Carcinoma of the Cervix. doi:10.7860/JCDR/2013/5460.3077 J Clin Diagn Res 2013
[Extensively drug-resistant tuberculosis (XDR-TB): successful therapies used in the clinic to the disease]. Rev Invest Clin 2013
[Cost-effectiveness of screening for latent tuberculosis in healthcare workers]. doi:10.4067/S0716-10182013000300012 Rev Chilena Infectol 2013
Occurrence of nontuberculous mycobacterial pulmonary infection in an endemic area of tuberculosis. doi:10.1371/journal.pntd.0002340 PLoS Negl Trop Dis 2013
Antibacterial activity of head-to-head bis-benzimidazoles. doi:10.1016/j.ijantimicag.2013.04.033 Int J Antimicrob Agents 2013
Novel pediatric delivery systems for second-line anti-tuberculosis medications: a case study. doi:10.5588/ijtld.13.0196 Int J Tuberc Lung Dis 2013
Evolution of substrate specificity in a recipient's enzyme following horizontal gene transfer. doi:10.1093/molbev/mst115 Mol Biol Evol 2013
[Analysis of clinical characteristics of elderly patients with spinal tuberculosis and its clinical effects with conservative treatment]. Zhongguo Gu Shang 2013
para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis. doi:10.1074/jbc.M113.475798 names it J Biol Chem 2013
[Delay in seeking initial care for tuberculosis diagnosis]. doi:10.1590/s0080-62342013000200024 Rev Esc Enferm USP 2013
[Health Index applied to the city of Araraquara, SP: an instrument to accompaniment the primary care]. Rev Bras Epidemiol 2013
Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania. doi:10.1371/journal.pone.0062034 PLoS One 2013
Pancreatic tuberculosis diagnosed by EUS: one disease, many faces. doi:10.6092/1590-8577/1355 JOP 2013
Use of colorimetric culture methods for detection of Mycobacterium tuberculosis complex isolates from sputum samples in resource-limited settings. doi:10.1128/JCM.00749-13 J Clin Microbiol 2013
Method for simultaneous analysis of nine second-line anti-tuberculosis drugs using UPLC-MS/MS. doi:10.1093/jac/dkt154 J Antimicrob Chemother 2013
Chemical decontamination with N-acetyl-L-cysteine-sodium hydroxide improves recovery of viable Mycobacterium avium subsp. paratuberculosis organisms from cultured milk. doi:10.1128/JCM.00508-13 J Clin Microbiol 2013
Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. doi:10.3201//EID1903.120246 Emerg Infect Dis 2013
A large tuberculosis abscess causing spinal cord compression of the cervico-thoracic region in a young child. doi:10.1007/s00586-013-2729-1 Eur Spine J 2013
Sustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocomposite. doi:10.1186/1752-153X-7-72 names it Chem Cent J 2013
Factors associated with length of hospital stay among HIV positive and HIV negative patients with tuberculosis in Brazil. doi:10.1371/journal.pone.0060487 PLoS One 2013
Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan. doi:10.1093/jac/dkt103 J Antimicrob Chemother 2013
[The Spanish AIDS Study Group and Spanish National AIDS Plan (GESIDA/Secretaría del Plan Nacional sobre el Sida) recommendations for the treatment of tuberculosis in HIV-infected individuals (Updated January 2013)]. doi:10.1016/j.eimc.2013.02.001 Enferm Infecc Microbiol Clin 2013
Cellular and humoral immunogenicity of Mycobacterium avium subsp. paratuberculosis specific lipopentapeptide antigens. doi:10.1016/j.rvsc.2013.03.002 Res Vet Sci 2013
Postexposure subunit vaccination against chronic enteric mycobacterial infection in a natural host. doi:10.1128/IAI.01121-12 Infect Immun 2013
Systemic lymph node tuberculosis presenting with an aseptic psoas abscess caused by a paradoxical reaction after nine months of antituberculosis treatment: a case report. doi:10.1186/1752-1947-7-72 J Med Case Rep 2013
Analysis of novel mycobacteriophages indicates the existence of different strategies for phage inheritance in mycobacteria. doi:10.1371/journal.pone.0056384 PLoS One 2013
N-acetyl transferase 2 and cytochrome P450 2E1 genes and isoniazid-induced hepatotoxicity in Brazilian patients. doi:10.5588/ijtld.12.0645 Int J Tuberc Lung Dis 2013
Antimycobacterial activity evaluation, time-kill kinetic and 3D-QSAR study of C-(3-aminomethyl-cyclohexyl)-methylamine derivatives. doi:10.1016/j.bmcl.2012.12.083 Bioorg Med Chem Lett 2013
A case of DRESS syndrome induced by the antituberculosis drugs, prothionamide, and para-aminosalycilic acid. doi:10.1016/j.anai.2012.11.008 names it Ann Allergy Asthma Immunol 2013
ParA of Mycobacterium smegmatis co-ordinates chromosome segregation with the cell cycle and interacts with the polar growth determinant DivIVA. doi:10.1111/mmi.12146 names it Mol Microbiol 2013
Tuberculosis in the abdominal lymph nodes: evaluation with contrast-enhanced magnetic resonance imaging. doi:10.5588/ijtld.12.0115 Int J Tuberc Lung Dis 2013
MRI in patients with tuberculous spondylitis presenting as vertebra plana: a retrospective analysis and review of literature. doi:10.1016/j.crad.2012.09.004 Clin Radiol 2013
Para-aminosalicylic acid plasma concentrations in children in comparison with adults after receiving a granular slow-release preparation. doi:10.1093/tropej/fms053 names it J Trop Pediatr 2013
Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis. doi:10.1126/science.1228980 names it Science 2013
Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. doi:10.1183/09031936.00136312 Eur Respir J 2013
No evidence of association between MBL2A/O polymorphisms and Mycobacterium tuberculosis infection in populations from the Brazilian Amazon region. doi:10.1016/j.humimm.2012.09.001 Hum Immunol 2013
[Estimate of the real incidence of tuberculosis in the Leon Health Area: application of the capture-recapture method to compare two information sources]. doi:10.1016/j.eimc.2012.06.009 Enferm Infecc Microbiol Clin 2013
Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay. doi:10.1183/09031936.00059812 Eur Respir J 2013
Tuberculosis in indigenous communities of Antioquia, Colombia: epidemiology and beliefs. doi:10.1007/s10903-012-9688-1 J Immigr Minor Health 2013
Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids. doi:10.3109/14756366.2011.650168 J Enzyme Inhib Med Chem 2013
[Detection of S315T mutation in the katg gene as a strategy for identification of isoniazid-resistant Mycobacterium tuberculosis in a reference laboratory]. doi:10.4067/S0716-10182012000700004 Rev Chilena Infectol 2012
Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil. doi:10.1590/s0074-02762012000900017 Mem Inst Oswaldo Cruz 2012
High rates of undiagnosed leprosy and subclinical infection amongst school children in the Amazon Region. doi:10.1590/s0074-02762012000900011 Mem Inst Oswaldo Cruz 2012
Unveiling healthy carriers and subclinical infections among household contacts of leprosy patients who play potential roles in the disease chain of transmission. doi:10.1590/s0074-02762012000900010 Mem Inst Oswaldo Cruz 2012
The internal organization of mycobacterial partition assembly: does the DNA wrap a protein core? doi:10.1371/journal.pone.0052690 PLoS One 2012
[A comparative study for adenosine deaminase and anti-antigen A-60 antibodies detection for the diagnosis of tuberculous meningitis]. doi:10.4067/S0716-10182012000600007 Rev Chilena Infectol 2012
[Delay in the search for health services for the diagnosis of tuberculosis in Ribeirao Preto, Sao Paulo]. doi:10.1590/s1413-81232012001100024 Cien Saude Colet 2012
Tuberculosis and histoplasmosis co-infection in AIDS patients. doi:10.4269/ajtmh.2012.12-0292 Am J Trop Med Hyg 2012
Gynecomastia caused by ethionamide. doi:10.4103/0253-7613.100408 Indian J Pharmacol 2012
Effect of anti-tuberculosis therapy on polymorphic drug metabolizing enzyme CYP2C9 using phenytoin as a probe drug. doi:10.4103/0253-7613.99314 Indian J Pharmacol 2012
Effectiveness of tuberculosis treatment. doi:10.1590/s1806-37132012000400013 J Bras Pneumol 2012
Bilateral suspected tuberculous empyema thoracis. APSP J Case Rep 2012
Identification of Mycobacterium tuberculosis complex by polymerase chain reaction of Exact Tandem Repeat-D fragment from mycobacterial cultures. doi:10.1016/j.ijmyco.2012.07.002 Int J Mycobacteriol 2012
Prevalence of non-tuberculous mycobacterium in a tertiary care hospital from South India. J Commun Dis 2012
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings. doi:10.1371/journal.pmed.1001290 PLoS Med 2012
From magic mountain to table mountain. doi:10.4414/smw.2012.13665 Swiss Med Wkly 2012
[Tuberculosis among healthcare workers and health students: an outstanding issue for healthcare services and the university]. doi:10.1590/s1726-46342012000200002 Rev Peru Med Exp Salud Publica 2012
[Using treatment compliance to determine the under-notification of tuberculosis in a health region for the years 2007-2009]. doi:10.1016/j.aprim.2012.06.001 Aten Primaria 2012
Rapid identification of Mycobacterium tuberculosis in BACTEC MGIT960 cultures by in-house loop-medicated isothermal amplification. doi:10.7883/yoken.65.306 Jpn J Infect Dis 2012
Characterization of three propane-inducible oxygenases in Mycobacterium sp. strain ENV421. doi:10.1111/j.1472-765X.2012.03290.x Lett Appl Microbiol 2012
Characterization of a conserved interaction between DNA glycosylase and ParA in Mycobacterium smegmatis and M. tuberculosis. doi:10.1371/journal.pone.0038276 names it PLoS One 2012
[Beyond bars and punishments: a systematic review of prison health]. doi:10.1590/s1413-81232012000500017 Cien Saude Colet 2012
Pharmacotherapy for multidrug resistant tuberculosis. doi:10.4103/0976-500X.95502 J Pharmacol Pharmacother 2012
Nested PCR-positive tubercular ampiginous choroiditis: a case report. doi:10.3109/09273948.2012.685684 Ocul Immunol Inflamm 2012
Tubercular endometritis detected through Pap smear campaign in Enugu, Nigeria. Pan Afr Med J 2012
Frequency of adverse reactions to first- and second-line anti-tuberculosis chemotherapy in a Korean cohort. doi:10.5588/ijtld.11.0574 Int J Tuberc Lung Dis 2012
[Cholera in Haiti: it never rains but it pours]. doi:10.1016/j.medcli.2012.03.010 Med Clin (Barc) 2012
Neonate human remains: a window of opportunity to the molecular study of ancient syphilis. doi:10.1371/journal.pone.0036371 PLoS One 2012
Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability. doi:10.1016/j.bmc.2012.03.058 Bioorg Med Chem 2012
[Molecular test Genotype® MTBDRplus, an alternative to rapid detection of multidrug resistance tuberculosis]. doi:10.1590/s1726-46342012000100014 Rev Peru Med Exp Salud Publica 2012
Images in clinical medicine. Leonine facies: lepromatous leprosy. doi:10.1056/NEJMicm1106238 N Engl J Med 2012
The promoter of Rv0560c is induced by salicylate and structurally-related compounds in Mycobacterium tuberculosis. doi:10.1371/journal.pone.0034471 PLoS One 2012
Tuberculosis of the elbow: A clinicoradiological analysis. doi:10.4103/0019-5413.93684 Indian J Orthop 2012
Transforming growth factor β and apoptosis in leprosy skin lesions: possible relationship with the control of the tissue immune response in the Mycobacterium leprae infection. doi:10.1016/j.micinf.2012.02.010 Microbes Infect 2012
Risk factors associated with kanamycin-resistant tuberculosis in a Beijing tuberculosis referral hospital. doi:10.1099/jmm.0.042655-0 J Med Microbiol 2012
Nuevas pautas para la prevención de tuberculosis en adultos con infección VIH. doi:10.1016/j.rce.2011.09.006 names it Rev Clin Esp 2012
Evaluation of small molecule tuberculostats for targeting tuberculosis infections of the central nervous system. doi:10.2174/187152412800229170 Cent Nerv Syst Agents Med Chem 2012
Aortic endograft infection with aortoduodenal fistula associated with adjacent vertebral body mycobacterial osteomyelitis (Pott's disease). doi:10.1016/j.avsg.2011.05.043 Ann Vasc Surg 2012
Cojedes: a leprosy hyperendemic state. doi:10.1111/j.1365-4632.2011.05080.x Int J Dermatol 2012
Clusters of leprosy transmission and of late diagnosis in a highly endemic area in Brazil: focus on different spatial analysis approaches. doi:10.1111/j.1365-3156.2011.02945.x Trop Med Int Health 2012
The TDR Tuberculosis Strain Bank: a resource for basic science, tool development and diagnostic services. doi:10.5588/ijtld.11.0223 Int J Tuberc Lung Dis 2012
Medicinal plants and formulations used by the Soren clan of the Santal tribe in Rajshahi district, Bangladesh for treatment of various ailments. doi:10.4314/ajtcam.v9i3.8 Afr J Tradit Complement Altern Med 2012
Real-time PCR using mycobacteriophage DNA for rapid phenotypic drug susceptibility results for Mycobacterium tuberculosis. doi:10.1128/JCM.01315-11 J Clin Microbiol 2012
Diagnosis of tuberculosis by trained African giant pouched rats and confounding impact of pathogens and microflora of the respiratory tract. doi:10.1128/JCM.01199-11 J Clin Microbiol 2012
[Gastric juice versus induced sputum for the diagnosis of pulmonary tuberculosis in children]. doi:10.1016/j.eimc.2011.10.001 Enferm Infecc Microbiol Clin 2012
Spoligotypes of Mycobacterium tuberculosis complex isolates from patients residents of 11 states of Brazil. doi:10.1016/j.meegid.2011.08.027 Infect Genet Evol 2012
Successful oral desensitization to i.v. para-aminosalicylic acid (PAS) using encapsulated PAS dry substance. doi:10.1007/s15010-011-0172-y names it Infection 2012
Homology modeling, molecular dynamics and QM/MM study of the regulatory protein PhoP from Corynebacterium pseudotuberculosis. doi:10.1007/s00894-011-1145-x J Mol Model 2012
Breast tuberculosis: rare but still present in Italy--a case of mycobacterium breast infection. doi:10.3233/BD-2012-000338 Breast Dis 2011
[Reliability and agreement of two smear reading scales for classification and monitoring of multidrug therapy in leprosy patients]. doi:10.1590/S0120-41572011000300012 Biomedica 2011
Anti-PGL-I seroepidemiology in leprosy cases: household contacts and school children from a hyperendemic municipality of the Brazilian Amazon. Lepr Rev 2011
Endoscopic ultrasound-guided biopsies for mediastinal lesions and lymph node diagnosis and staging. doi:10.1590/s1807-59322011000900013 Clinics (Sao Paulo) 2011
[Cost analysis of rapid methods for diagnosis of multidrug resistant tuberculosis in different epidemiologic groups in Perú]. doi:10.1590/s1726-46342011000300004 Rev Peru Med Exp Salud Publica 2011
Tuberculosis arthritis and tenosynovitis. doi:10.1055/s-0031-1293492 Semin Musculoskelet Radiol 2011
[Tuberculosis: steady dynamics between past and present to imagine the future]. Rev Med Chil 2011
Abnormal thyroid function tests in children on ethionamide treatment. doi:10.5588/ijtld.10.0707 Int J Tuberc Lung Dis 2011
[Tuberculous meningitis: tips for diagnosis and proposals for treatment]. Rev Chilena Infectol 2011
[The front door of the Ribeirão Preto health system for diagnosing tuberculosis]. doi:10.1590/s0080-62342011000400015 Rev Esc Enferm USP 2011
[A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China]. Zhonghua Jie He He Hu Xi Za Zhi 2011
Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex for first and second line drugs by broth dilution in a microtiter plate format. doi:10.3791/3094 J Vis Exp 2011
[Development of subcutaneous nodules after mesotherapy]. doi:10.1016/j.eimc.2011.05.008 Enferm Infecc Microbiol Clin 2011
Specific detection of Mycobacterium sp. genomic DNA using dual labeled gold nanoparticle based electrochemical biosensor. doi:10.1016/j.ab.2011.05.034 Anal Biochem 2011
Pharmacophore modeling and density functional theory analysis for a series of nitroimidazole compounds with antitubercular activity. doi:10.1111/j.1747-0285.2011.01161.x Chem Biol Drug Des 2011
The chemotherapy of osteo-articular tuberculosis with recommendations for treatment of children. doi:10.1016/j.jinf.2011.04.239 J Infect 2011
[Comparative performance of QuantiFERON(®)-TB Gold IT versus tuberculin skin test among contact investigations for latent tuberculosis infection]. doi:10.1016/j.medcli.2010.11.036 Med Clin (Barc) 2011
[In countries with few resources]. doi:10.1016/j.rce.2010.11.004 Rev Clin Esp 2011
Identification of mannich base as a novel inhibitor of Mycobacterium tuberculosis isocitrate by high-throughput screening. doi:10.7150/ijbs.7.376 Int J Biol Sci 2011
New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. doi:10.1097/MCP.0b013e3283452346 Curr Opin Pulm Med 2011
Physiological role and potential clinical interest of mycobacterial pigments. doi:10.1002/iub.424 IUBMB Life 2011
[Haiti, before and after]. doi:10.1016/j.medcli.2010.11.015 Med Clin (Barc) 2011
[The validity of Mycobacterium tuberculosis complex species identification. Comments on the article: "Differentiation of species within the Mycobacterium tuberculosis complex by molecular techniques"]. doi:10.1016/j.eimc.2010.10.008 Enferm Infecc Microbiol Clin 2011
Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005. doi:10.1016/j.ijid.2011.01.001 Int J Infect Dis 2011
Involving community partners in the management of tuberculosis among drug users. doi:10.1016/j.puhe.2010.09.002 Public Health 2011
Molecular cloning, expression, and functional analysis of a predicted sulfotransferase STF9 from Mycobacterium avium. doi:10.1007/s11010-010-0693-1 Mol Cell Biochem 2011
Identification of the monooxygenase gene clusters responsible for the regioselective oxidation of phenol to hydroquinone in mycobacteria. doi:10.1128/AEM.02316-10 Appl Environ Microbiol 2011
HPLC analysis of para-aminosalicylic acid and its metabolite in plasma, cerebrospinal fluid and brain tissues. doi:10.1016/j.jpba.2010.11.031 names it J Pharm Biomed Anal 2011
A combined global and local approach to elucidate spatial organization of the Mycobacterial ParB-parS partition assembly. doi:10.1021/bi1016759 Biochemistry 2011
Rapid first- and second-line drug susceptibility assay for Mycobacterium tuberculosis isolates by use of quantitative PCR. doi:10.1128/JCM.01500-10 J Clin Microbiol 2011
Diagnostic value of procalcitonin in pleural effusions. doi:10.1007/s10096-010-1082-0 Eur J Clin Microbiol Infect Dis 2011
[Mantoux versus immunoferon-gamma test for diagnosis of latent tuberculosis infection in TB patient contacts]. doi:10.1016/j.aprim.2009.12.014 Aten Primaria 2011
Evaluation of a Rapid Differentiation Test for Mycobacterium Tuberculosis from other Mycobacteria by Selective Inhibition with p-nitrobenzoic Acid using MGIT 960. doi:10.4103/0974-2727.72157 J Lab Physicians 2010
[Serological and cellular reactivity to mycobacterial proteins in Hansen's disease]. Invest Clin 2010
[Development of capacities for tobacco control in Latin America]. doi:10.1590/s0036-36342010000800027 Salud Publica Mex 2010
[How to implement the airborne infection isolation room in health-care settings with occupational risk for Mycobacterium tuberculosis transmission?]. doi:10.1590/s0037-86822010000600036 Rev Soc Bras Med Trop 2010
Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 2: second line drugs. doi:10.1590/s1806-37132010000500017 J Bras Pneumol 2010
Synthesis and structure-activity relationships of aza- and diazabiphenyl analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). doi:10.1021/jm101288t J Med Chem 2010
Molecular identification of nontuberculous mycobacteria isolates in a Brazilian mycobacteria reference laboratory. doi:10.1016/j.diagmicrobio.2010.07.019 Diagn Microbiol Infect Dis 2010
In vivo and in vitro evaluation of highly specific thiolate carrier group copper(II) and zinc(II) complexes on Ehrlich ascites carcinoma tumor model. doi:10.1016/j.ejmech.2010.09.004 Eur J Med Chem 2010
Comparison of the QuantiFERON®-TB Gold assay and tuberculin skin test to detect latent tuberculosis infection among target groups in Trinidad & Tobago. doi:10.1590/s1020-49892010000700006 Rev Panam Salud Publica 2010
Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugs. doi:10.1111/j.1365-2672.2010.04840.x J Appl Microbiol 2010
Evaluation of nitrate reductase assay for rapid detection of resistance to second-line drugs in Mycobacterium tuberculosis in a tertiary care hospital. doi:10.1016/j.diagmicrobio.2010.06.017 Diagn Microbiol Infect Dis 2010
[A case of multidrug-resistant tuberculosis who acquired additional resistance to ethambutol before the result of the initial drug sensitivity test was reported]. Kekkaku 2010
Targeting the chromosome partitioning protein ParA in tuberculosis drug discovery. doi:10.1093/jac/dkq311 names it J Antimicrob Chemother 2010
The chemotherapy of tuberculous meningitis in children and adults. doi:10.1016/j.tube.2010.07.003 Tuberculosis (Edinb) 2010
Growth rate retardation and inhibitory effect of para-JEM(R) BLUE on Mycobacterium avium subspecies paratuberculosis. doi:10.1177/104063871002200511 names it J Vet Diagn Invest 2010
Thr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistance. doi:10.1128/AAC.00738-10 names it Antimicrob Agents Chemother 2010
[Enabling intervention for active screening of respiratory symptomatic patients in two municipalities located in the City of Havana province]. Rev Cubana Med Trop 2010
[Three-month course of rifampicin and isoniazid for the treatment of latent tuberculous infection]. doi:10.1016/j.medcli.2010.02.038 Med Clin (Barc) 2010
Assessment of mycobacteremia detection as a complementary method for the diagnosis of tuberculosis in HIV-infected patients. doi:10.1007/s10096-010-1023-y Eur J Clin Microbiol Infect Dis 2010
Antituberculosis agents and an inhibitor of the para-aminobenzoic acid biosynthetic pathway from Hydnocarpus anthelminthica seeds. doi:10.1002/cbdv.201000072 names it Chem Biodivers 2010
Clinic-epidemiological evaluation of ulcers in patients with leprosy sequelae and the effect of low level laser therapy on wound healing: a randomized clinical trial. doi:10.1186/1471-2334-10-237 BMC Infect Dis 2010
Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity. doi:10.1016/j.ejmech.2010.07.003 Eur J Med Chem 2010
[Contagion - some notes on the epistemology and the ethics of public health]. Acta Med Port 2010
[Abandonment of tuberculosis treatment among patients co-infected with TB/HIV]. doi:10.1590/s0080-62342010000200020 Rev Esc Enferm USP 2010
Performance of the Ogawa-Kudoh method for isolation of mycobacteria in a laboratory with large-scale workload. doi:10.1590/S0325-75412010000200003 Rev Argent Microbiol 2010
[A case of fatal disseminated infection caused by Mycobacterium bovis BCG strain and the identification of the isolate by spoligotyping]. Mikrobiyol Bul 2010
Tuberculosis at vulva and vagina. J Med Assoc Thai 2010
[Competence of senior medical students in diagnosing tuberculosis based on chest X-rays]. doi:10.1590/s1806-37132010000200006 J Bras Pneumol 2010
Tuberculosis of the central nervous system. Mymensingh Med J 2010
Novel 1,3,5-triphenyl-2-pyrazolines as anti-infective agents. doi:10.1016/j.bmcl.2010.03.083 Bioorg Med Chem Lett 2010
[Evaluation of a strategy for the control of tuberculosis in a health district of andalusia, Spain]. doi:10.1590/s1135-57272010000100008 Rev Esp Salud Publica 2010
IFNG +874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis. doi:10.1016/j.humimm.2010.03.008 Hum Immunol 2010
Outbreak of mesotherapy-associated cutaneous infections caused by Mycobacterium chelonae in Colombia. Jpn J Infect Dis 2010
[HIV infection in different age groups: Potential implications for prevention. CoRIS Cohort, Spain, 2004-2008]. doi:10.1016/j.medcli.2009.09.053 Med Clin (Barc) 2010
Atypical mycobacterium keratitis associated with penetrating keratoplasty: case report of successful therapy with topical gatifloxacin 0.3%. doi:10.1097/ICO.0b013e3181b532c7 Cornea 2010
[Consensus document for the control of tuberculosos in Spanish prisons]. doi:10.4321/S1575-06202010000300002 Rev Esp Sanid Penit 2010
New, easy-to-use tools for standardised and quality-controlled genotyping of Mycobacterium tuberculosis complex strains. doi:10.1016/S0873-2159(15)30098-2 Rev Port Pneumol 2010
Building tuberculosis laboratory capacity: Needs and strategies. doi:10.1016/S0873-2159(15)30094-5 Rev Port Pneumol 2010
Symposium: Point-of-care tests for tuberculosis. doi:10.1016/S0873-2159(15)30093-3 Rev Port Pneumol 2010
[The outlook of patients with respect to the quality of sputum smears for bacilloscopy in tuberculosis]. Rev Cubana Med Trop 2010
Prefilled certolizumab pegol (Cimzia(®)) syringes for self-use in the treatment of rheumatoid arthritis. doi:10.2147/mder.s7504 Med Devices (Auckl) 2010
[The Boletim Médico: the tuberculosis specialists' prescription for curing the city of São José dos Campos (1930-1935)]. doi:10.1590/s0104-59702010000300009 Hist Cienc Saude Manguinhos 2010
[On the way to shortening tuberculosis treatments: clinical trials of the Unitat d' Investagació en Tuberculosi de Barcelona supported by the Centers for Disease Control and Prevention]. doi:10.1016/j.gaceta.2009.08.008 Gac Sanit 2010
[Fifí and Ismael: alive until when?]. doi:10.1016/j.medcli.2009.10.005 Med Clin (Barc) 2010
Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). doi:10.1021/jm901207n J Med Chem 2010
[Treatment of tuberculosis according to the different pattern of resistance]. doi:10.1016/j.medcli.2008.12.024 Med Clin (Barc) 2010
[Assessment of the Amplicor PCR for the detection of Mycobacterium tuberculosis in smear negative respiratory and non respiratory specimens: a retrospective analysis]. Rev Chilena Infectol 2009
Overproduction and localization of Mycobacterium tuberculosis ParA and ParB proteins. doi:10.1016/S1472-9792(09)70015-0 names it Tuberculosis (Edinb) 2009
Protective effects of sodium para-amino salicylate on manganese-induced neuronal death: the involvement of reactive oxygen species. doi:10.1211/jpp/61.11.0017 names it J Pharm Pharmacol 2009
Early documentation of therapeutic response at 6 weeks following corticosteroid therapy in extensive sarcoidosis: promise of FDG-PET. doi:10.1097/RLU.0b013e3181b53155 Clin Nucl Med 2009
Imaging features of extraaxial musculoskeletal tuberculosis. doi:10.4103/0971-3026.54873 Indian J Radiol Imaging 2009
Molecular identification of rapidly growing mycobacteria isolates from pulmonary specimens of patients in the State of Pará, Amazon region, Brazil. doi:10.1016/j.diagmicrobio.2009.08.003 Diagn Microbiol Infect Dis 2009
Prevalence of extensively drug-resistant tuberculosis in Vladimir and Orel regions, Russia. Int J Tuberc Lung Dis 2009
Expression and functional analysis of a predicted AtsG arylsulphatase identified from Mycobacterium tuberculosis genomic data. doi:10.1093/jb/mvp141 J Biochem 2009
Pharmacokinetics of prothionamide in patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2009
[Genotyping Colombian Mycobacterium leprae for determining disease transmission patterns]. doi:10.1590/s0124-00642009000100002 Rev Salud Publica (Bogota) 2009
[Is the tuberculin skin test still suitable to diagnose tuberculosis infection ?]. Medicina (B Aires) 2009
[The importance of rest in sanatoria for tuberculous patients]. Rev Chilena Infectol 2009
CD1a and factor XIIIa immunohistochemistry in leprosy: a possible role of dendritic cells in the pathogenesis of Mycobacterium leprae infection. doi:10.1097/DAD.0b013e31819f1997 Am J Dermatopathol 2009
[Health education in schools in Argentina: an art contest as a motivating activity]. doi:10.1590/s1020-49892009000200013 Rev Panam Salud Publica 2009
[Consensus document for the management of tuberculosis in solid organ transplant recipients]. doi:10.1016/j.eimc.2008.10.008 Enferm Infecc Microbiol Clin 2009
Comparison of three methods for susceptibility testing of Mycobacterium avium subsp. paratuberculosis to 11 antimicrobial drugs. doi:10.1093/jac/dkp184 J Antimicrob Chemother 2009
Analysis of the CYP51 gene and encoded protein in propiconazole-resistant isolates of Mycosphaerella fijiensis. doi:10.1002/ps.1770 Pest Manag Sci 2009
[Differentiation of species within the Mycobacterium tuberculosis complex by molecular techniques]. doi:10.1016/j.eimc.2009.01.008 Enferm Infecc Microbiol Clin 2009
First insight into Mycobacterium tuberculosis epidemiology and genetic diversity in Trinidad and Tobago. doi:10.1128/JCM.00535-09 J Clin Microbiol 2009
Impairment of D-alanine biosynthesis in Mycobacterium smegmatis determines decreased intracellular survival in human macrophages. doi:10.1099/mic.0.024901-0 Microbiology (Reading) 2009
[Portuguese recommendations for the use of methotrexate in the treatment of rheumatoid arthritis]. Acta Reumatol Port 2009
Clinical and ultrasonographic features of abdominal tuberculosis in HIV positive adults in Zambia. doi:10.1186/1471-2334-9-44 BMC Infect Dis 2009
Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. doi:10.1378/chest.08-2427 Chest 2009
Theoretical basis for reducing time-lines to the determination of positive Mycobacterium tuberculosis cultures using thymidylate kinase (TMK) assays. doi:10.1186/1742-4682-6-4 Theor Biol Med Model 2009
Development of leprosy in a patient with ankylosing spondylitis during the infliximab treatment: reactivation of a latent infection? doi:10.1007/s10067-009-1140-0 Clin Rheumatol 2009
[National plan for the prevention and control of tuberculosis in Spain]. doi:10.1016/j.arbres.2009.01.001 Arch Bronconeumol 2009
Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis. doi:10.1128/AAC.01197-08 names it Antimicrob Agents Chemother 2009
[New diagnostic solutions to rule out tuberculous meningitis]. Rev Neurol 2009
Recurrent metastatic tuberculous gummata with a unique para-spinal tuberculous abscess. doi:10.1684/ejd.2008.0546 names it Eur J Dermatol 2009
Chelation therapy of manganese intoxication with para-aminosalicylic acid (PAS) in Sprague-Dawley rats. doi:10.1016/j.neuro.2008.12.007 names it Neurotoxicology 2009
Variations in quality of carbol fuchsin stains collected from routine tuberculosis laboratories. Int J Tuberc Lung Dis 2009
Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides. doi:10.1016/j.bmc.2008.10.086 Bioorg Med Chem 2009
[Discourses and practices in the sanatoriums for tuberculosis sufferers in the province of Cordoba. 1910-1947]. doi:10.3989/asclepio.2008.v60.i2.262 Asclepio 2008
[Dona Amélia Queen Reformatory: a sanatorium for weak children]. doi:10.3989/asclepio.2008.v60.i2.261 Asclepio 2008
[Spondilodyscitis: five years of experience in a department of rehabilitation]. Acta Med Port 2008
[The performance of health services in providing DOTs in households to control tuberculosis]. doi:10.1590/s0080-62342008000400003 Rev Esc Enferm USP 2008
[Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study]. Zhonghua Yi Xue Za Zhi 2008
[Multiple tuberculous aortic aneurysms in a child. A case report]. doi:10.1016/j.jmv.2008.09.006 J Mal Vasc 2008
Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method. Int J Tuberc Lung Dis 2008
Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. Int J Tuberc Lung Dis 2008
[Bayesian model for the risk of tuberculosis infection for studies with individuals lost to follow-up]. doi:10.1590/s0034-89102008000600004 Rev Saude Publica 2008
[Detection of Mycobacterium leprae DNA in nasal swab]. doi:10.1590/s0034-71672008000700013 Rev Bras Enferm 2008
[Evaluation of training programs in Hansen's Disease: opinion of physicians and nurses of family health teams]. doi:10.1590/s0034-71672008000700003 Rev Bras Enferm 2008
[An alternative for improving the diagnosis of smear-negative tuberculosis and other bronchopulmonary disorders in Cuba]. Arch Bronconeumol 2008
Second-line drug resistance in multidrug-resistant tuberculosis cases of various origins in the Netherlands. Int J Tuberc Lung Dis 2008
Novel hypertonic saline-sodium hydroxide (HS-SH) method for decontamination and concentration of sputum samples for Mycobacterium tuberculosis microscopy and culture. doi:10.1099/jmm.0.2008/001339-0 J Med Microbiol 2008
Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. doi:10.1086/591702 Clin Infect Dis 2008
Perspectives on advancing preventative medicine through vaccinology at the comparative veterinary, human and conservation medicine interface: not missing the opportunities. doi:10.1016/j.vaccine.2008.07.094 Vaccine 2008
Auxiliary tools in tuberculosis. The hemolysis in pleural fluids underestimate the values of adenosine deaminase activity determined by the method of Giusti. Rev Argent Microbiol 2008
Evaluation of methods for rapid detection of resistance to isoniazid and rifampin in Mycobacterium tuberculosis isolates collected in the Caribbean. doi:10.1128/JCM.01455-08 J Clin Microbiol 2008
Biochemical and structural characterization of the putative dihydropteroate synthase ortholog Rv1207 of Mycobacterium tuberculosis. doi:10.1111/j.1574-6968.2008.01302.x FEMS Microbiol Lett 2008
Pott's disease in a young child. Mymensingh Med J 2008
Development and in vitro Evaluation of Enteric Coated Multiparticulate System for Resistant Tuberculosis. doi:10.4103/0250-474X.44597 Indian J Pharm Sci 2008
[Cytochrome P450 and NAT2 polymorphisms and drug metabolism in DOTS]. Rev Invest Clin 2008
[Clinical performance of antigen-specific interferon-gamma assay for the diagnosis of latent tuberculosis in risky hospital-based populations]. doi:10.1157/13121100 Med Clin (Barc) 2008
Para-aminosalicylic acid. doi:10.1016/S1472-9792(08)70019-2 names it Tuberculosis (Edinb) 2008
[Destombes Rosaï Dorfman syndrome: description of one case and diagnostic challenges in the tropical setting]. Med Trop (Mars) 2008
Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity. doi:10.1016/j.bmc.2008.04.045 Bioorg Med Chem 2008
[Cavited pneumonia with Mycobacterium gastri positive culture smear]. Rev Clin Esp 2008
Factors predictive of adherence to tuberculosis treatment, Valle del Cauca, Colombia. Int J Tuberc Lung Dis 2008
Interpretation of mycobacterial antibodies in the cerebrospinal fluid of adults with tuberculous meningitis. doi:10.1111/j.1365-3156.2008.02053.x Trop Med Int Health 2008
TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. doi:10.1016/j.meegid.2008.03.001 Infect Genet Evol 2008
[Utility of an information system for primary care]. doi:10.1157/13118058 Aten Primaria 2008
par genes in Mycobacterium bovis and Mycobacterium smegmatis are arranged in an operon transcribed from "SigGC" promoters. doi:10.1186/1471-2180-8-51 BMC Microbiol 2008
[Evaluation and monitoring of requirements for sputum microscopic study in tuberculosis surveillance]. doi:10.1157/13116178 Med Clin (Barc) 2008
Emil Zuckerkandl (1849-1910): anatomist and pathologist. doi:10.1016/j.aanat.2007.09.001 Ann Anat 2008
Recommendations for the diagnosis and treatment of latent and active tuberculosis in inflammatory joint diseases candidates for therapy with tumor necrosis factor alpha inhibitors - March 2008 update. doi:10.1016/S0873-2159(15)30235-X Rev Port Pneumol 2008
[A case of multi-drug resistant tuberculosis showing psychiatric adverse effect by cycloserine]. Kekkaku 2008
[Evaluation of a scoring system recommended by the Brazilian Ministry of Health for the diagnosis of childhood tuberculosis]. doi:10.1590/s0102-311x2008000200019 Cad Saude Publica 2008
[Evaluation of two commercial tests for the serodiagnosis of pulmonary tuberculosis]. Rev Chilena Infectol 2008
Human immunodeficiency virus and tuberculosis in Argentina: prevalence, genotypes and risk factors. doi:10.1099/jmm.0.47492-0 J Med Microbiol 2008
Bilateral Mammary Tuberculosis Associated with a Borderline Ovarian Tumor. doi:10.1159/000136105 Breast Care (Basel) 2008
Genomic interrogation of ancestral Mycobacterium tuberculosis from south India. doi:10.1016/j.meegid.2007.09.007 Infect Genet Evol 2008
Analyzing the catalytic mechanism of MPtpA: a low molecular weight protein tyrosine phosphatase from Mycobacterium tuberculosis through site-directed mutagenesis. doi:10.1002/prot.21816 Proteins 2008
Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda. doi:10.1016/j.ijid.2007.05.003 Int J Infect Dis 2008
[Approach to diagnosing tuberculosis of intrathoracic lymph nodes of a paraaortic group in children]. Probl Tuberk Bolezn Legk 2007
[Effectiveness of prophylaxis against tuberculosis in patients infected with HIV]. Biomedica 2007
[Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis]. names it Zhonghua Jie He He Hu Xi Za Zhi 2007
[Recent contribution of the World Health Organization to control childhood tuberculosis]. doi:10.1590/s0034-89102007000800016 Rev Saude Publica 2007
[Tuberculosis and HIV infection in Brazil: magnitude of the problem and strategies for control]. doi:10.1590/s0034-89102007000800014 Rev Saude Publica 2007
[Tuberculosis surveillance and health information system in Brazil, 2001-2003]. doi:10.1590/s0034-89102007000800011 Rev Saude Publica 2007
[Retrospect of tuberculosis control in Brazil]. doi:10.1590/s0034-89102007000800008 Rev Saude Publica 2007
Characterization of the mycobacterial chromosome segregation protein ParB and identification of its target in Mycobacterium smegmatis. doi:10.1099/mic.0.2007/011619-0 Microbiology (Reading) 2007
Overview of anti-tuberculosis (TB) drugs and their resistance mechanisms. doi:10.2174/138955707782331740 Mini Rev Med Chem 2007
[Living groups: contributions for an educational proposal for tuberculosis]. doi:10.1590/s0034-71672007000500020 Rev Bras Enferm 2007
[Endoscopic ultrasound-guided biopsy for the evaluation of pancreatic tumors]. doi:10.1157/13112588 Gastroenterol Hepatol 2007
[Anti-tuberculosis chemotherapy]. Kekkaku 2007
HTLV-1/2 among high-risk groups in Argentina: molecular diagnosis and prevalence of different sexual transmitted infections. doi:10.1002/jmv.21036 J Med Virol 2007
Clinical Presentation, treatment outcome and survival among the HIV infected children with culture confirmed tuberculosis. doi:10.2174/157016207781662434 Curr HIV Res 2007
Synthesis and biological evaluation of a C5-biphenyl thiolactomycin library. doi:10.1016/j.bmcl.2007.07.082 Bioorg Med Chem Lett 2007
Study on enhancement of fibronectin-mediated bacillus Calmette-Guérin attachment to urinary bladder wall in rabbits. doi:10.1007/s00345-007-0198-z World J Urol 2007
Macrophage migration inhibitory factor gene influences the risk of developing tuberculosis in northwestern Colombian population. doi:10.1111/j.1399-0039.2007.00843.x Tissue Antigens 2007
Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion. doi:10.1111/j.1440-1843.2007.01056.x Respirology 2007
[Randomized clinical trial investigating three chemoprophylaxis regimens for latent tuberculosis infection in HIV-infected patients]. doi:10.1157/13102265 Enferm Infecc Microbiol Clin 2007
[Short-course isoniazid and rifampin compared with isoniazid for latent tuberculosis infection: a randomized clinical trial]. doi:10.1157/13102264 Enferm Infecc Microbiol Clin 2007
A polymorphism in the inducible nitric oxide synthase gene is associated with tuberculosis. doi:10.1016/j.tube.2007.03.002 Tuberculosis (Edinb) 2007
[Evaluation of a multiplex PCR assay to differentiate mycobacteria of the Mycobacterium tuberculosis complex in a reference laboratory]. doi:10.4067/s0716-10182007000200002 Rev Chilena Infectol 2007
[Guidelines for prescribing and monitoring biologic therapies in juvenile idiopathic arthritis]. Acta Reumatol Port 2007
Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis 2007
[Innovative strategies to diagnose and monitor tuberculosis patients]. doi:10.1016/s1579-2129(07)60055-x Arch Bronconeumol 2007
Lymph node paradoxical enlargement during treatment for tuberculous spondylodiscitis (Pott's disease). doi:10.1016/j.jbspin.2006.06.010 Joint Bone Spine 2007
[Last Ugandan stories or Mamadis triumph]. doi:10.1016/s0025-7753(07)72544-7 Med Clin (Barc) 2007
Nanomolar competitive inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor type II dehydroquinase. doi:10.1002/cmdc.200600208 ChemMedChem 2007
Laparoscopic biopsy in patients with abdominal lymphadenopathy. doi:10.4103/0972-9941.30681 J Minim Access Surg 2007
[Endovascular repair of a tuberculous aortic false aneurysm]. doi:10.1016/j.revmed.2006.11.017 Rev Med Interne 2007
Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients. Indian J Chest Dis Allied Sci 2006
Establishing of a minimal set of tests (minimal standards) to identify species included in the genus Mycobacterium. Roum Arch Microbiol Immunol 2006
[Human and bovine tuberculosis in Latin America: from the studies about virulence to some tools for its control]. Rev Latinoam Microbiol 2006
[Septic arthritis in tropical environment. 176 cases report in Brazzaville]. Mali Med 2006
[Use of polymerase chain reaction for the diagnosis of central nervous system infections]. Invest Clin 2006
[Evaluation of a colorimetric micromethod for determining the minimal inhibitory concentration of antibiotics against Mycobacterium tuberculosis]. Rev Argent Microbiol 2006
[Analysis of drug resistance to antituberculosis drugs of the first time retreated pulmonary tuberculosis patients in Shanghai]. Zhonghua Jie He He Hu Xi Za Zhi 2006
A testing scheme for the detection of Mycobacterium avium subsp. paratuberculosis in bovine feces utilizing the ESP para-JEM liquid culture system. doi:10.1177/104063870601800602 names it J Vet Diagn Invest 2006
[Guidelines for the diagnosis and treatment of latent tuberculosis infection and active tuberculosis in patients with inflammatory joint diseases proposed for treatment with tumour necrosis factor alpha antagonist drugs]. Rev Port Pneumol 2006
[Recommendations for the diagnosis and treatment of latent and active tuberculosis in patients with inflammatory joint diseases treated with tumour necrosis factor alpha inhibitors]. Acta Reumatol Port 2006
[Risk factors for drug-resistant tuberculosis in San Luis Potosí, Mexico 2003-2004]. Salud Publica Mex 2006
[Validation of the PCR-based universal heteroduplex generator assay for identification of rifampicin-resistant and multiresistant Mycobacterium tuberculosis in Lima, Peru]. doi:10.1157/13092465 Enferm Infecc Microbiol Clin 2006
[Inequity in infant vaccination coverage in Colombia 2000 and 2003]. Rev Salud Publica (Bogota) 2006
Clinical and radiological presentation of tuberculosis of the elbow. Acta Orthop Belg 2006
Case report of lymph nodal, hepatic and splenic tuberculosis in an HIV-positive patient. doi:10.1590/s1413-86702006000200014 Braz J Infect Dis 2006
[Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy]. Kekkaku 2006
HIV seroincidence estimates among at-risk populations in Buenos Aires and Montevideo: use of the serologic testing algorithm for recent HIV seroconversion. doi:10.1097/01.qai.0000221678.06822.8b J Acquir Immune Defic Syndr 2006
API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. J Assoc Physicians India 2006
[Roses stamps]. doi:10.1157/13089867 Med Clin (Barc) 2006
Evaluation of a rapid culture method for tuberculosis diagnosis: a Latin American multi-center study. Int J Tuberc Lung Dis 2006
[Dystrophic calcinosis cutis after subcutaneous administration of para-aminosalicylic acid for treatment of pulmonary tuberculosis]. doi:10.1111/j.1610-0387.2006.05948.x names it J Dtsch Dermatol Ges 2006
[A case of severe intestinal tuberculosis, treated with ciprofloxacin, kanamycin and prednisolone]. Kekkaku 2006
Spinal cord compression from spinal tuberculosis in a child. doi:10.1159/000091864 Pediatr Neurosurg 2006
Analysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosis. doi:10.1111/j.1399-0039.2006.00566.x Tissue Antigens 2006
Multidrug-resistant tuberculosis without HIV infection: success with individualised therapy. Int J Tuberc Lung Dis 2006
[Control and elimination of tuberculosis in Spain: recommendations for the twenty-first century]. doi:10.1016/s1695-4033(06)70011-x An Pediatr (Barc) 2006
A community-based TB drug susceptibility study in Mimika District, Papua Province, Indonesia. Int J Tuberc Lung Dis 2006
A major cell wall lipopeptide of Mycobacterium avium subspecies paratuberculosis. doi:10.1074/jbc.M512465200 J Biol Chem 2006
Imaging of extraspinal musculoskeletal tuberculosis. doi:10.1016/j.ejrad.2005.07.005 Eur J Radiol 2006
[Disseminated mycobacterial infections in patients with HIV/AIDS. Evaluation of blood cultures]. Rev Argent Microbiol 2005
An unusual presentation of extrapulmonary tuberculosis. J Indian Med Assoc 2005
[Evaluation of the MTD-2 test for the direct detection of Mycobacterium tuberculosis in specimens]. doi:10.4321/s1137-66272005000500006 An Sist Sanit Navar 2005
[Recommendations for the medical treatment of rheumatoid arthritis]. Rev Invest Clin 2005
Synthesis and evaluation of cyclic secondary amine substituted phenyl and benzyl nitrofuranyl amides as novel antituberculosis agents. doi:10.1021/jm050765n J Med Chem 2005
[Frequent return as a novel strategy for tuberculosis treatment adherence]. doi:10.1590/s0034-89102005000600005 Rev Saude Publica 2005
[From farm to fork--Mycobacterium avium ssp. paratuberculosis (MAP) as zoonotic agent?]. Berl Munch Tierarztl Wochenschr 2005
[Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective]. Rev Invest Clin 2005
[Epidemiological survey of a suspected nosocomial case of tuberculosis by spoligotyping]. doi:10.1016/j.patbio.2005.07.001 Pathol Biol (Paris) 2005
[Phenotypic and genotypic methods for detecting multidrug resistance in Mycobacterium tuberculosis]. Biomedica 2005
[Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)]. doi:10.1157/13074594 Arch Bronconeumol 2005
Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis 2005
Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 2005
[Guidelines for the management of community pneumonia in adult who needs hospitalization]. doi:10.1016/S0210-5691(05)74199-1 Med Intensiva 2005
Analysis of Mycobacterium tuberculosis isolates from treatment failure patients living in East Timor. Int J Tuberc Lung Dis 2005
Mycobacterium gastri causing disseminated infection in children of same family. doi:10.1002/ppul.20186 Pediatr Pulmonol 2005
[Tuberculosis in Salvador, Brazil: costs to health system and families]. doi:10.1590/s0034-89102005000100016 Rev Saude Publica 2005
[Organization of tuberculosis surveillance in France]. Med Mal Infect 2004
What is the probability of a patient presenting a pleural effusion due to tuberculosis? doi:10.1590/s1413-86702004000400007 Braz J Infect Dis 2004
Diagnosis of abdominal tuberculosis: experience from 11 cases and review of the literature. doi:10.3748/wjg.v10.i24.3647 World J Gastroenterol 2004
[Recommendations for the treatment of severe nosocomial pneumonia]. doi:10.1016/s0300-2896(04)75583-0 Arch Bronconeumol 2004
Pharmacokinetics and relative bioavailability of clofazimine in relation to food, orange juice and antacid. doi:10.1016/j.tube.2004.04.001 Tuberculosis (Edinb) 2004
[Perspectives for new anti-tuberculous vaccines in the post-genomic era]. Biomedica 2004
[New tools for detection of latent tuberculosis]. Biomedica 2004
[Gene inactivation in Mycobacterium tuberculosis and its use in tuberculosis control and prevention]. Biomedica 2004
[Five year experience with thin layer agar medium for rapid diagnosis of tuberculosis]. Biomedica 2004
[Polymorphism of TNF-alpha in autoimmunity and tuberculosis]. Biomedica 2004
[Recommendations for the treatment of severe in-hospital pneumonia. Spanish Society of Critical, Coronary, and Intensive Medicine. Spanish Society for Respiratory Tract Pathology. Spanish Society of Infectious Diseases and Clinical Microbiology]. doi:10.1157/13066855 Enferm Infecc Microbiol Clin 2004
Uncontrolled trial of sparfloxacin in retreatment of pulmonary tuberculosis. doi:10.1111/j.1440-1843.2004.00596.x Respirology 2004
[Intestinal tuberculosis and pulmonary tuberculosis. Ileal resection and PCR for the diagnosis]. doi:10.4321/s0212-71992004000700013 An Med Interna 2004
[Multiple drug resistance: a threat for tuberculosis control]. doi:10.1590/s1020-49892004000700013 Rev Panam Salud Publica 2004
A new group of potential antituberculotics: hydrochlorides of piperidinylalkyl esters of alkoxy-substituted phenylcarbamic acids. doi:10.1007/BF02931041 Folia Microbiol (Praha) 2004
The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. doi:10.1111/j.1365-2958.2004.04120.x names it Mol Microbiol 2004
Characterization of the replicon of a 51-kb native plasmid from the gram-positive bacterium Leifsonia xyli subsp. cynodontis. doi:10.1016/j.femsle.2004.05.014 FEMS Microbiol Lett 2004
Antituberculosis agents X. Synthesis and evaluation of in vitro antituberculosis activity of 2-(5-nitro-2-furyl)- and 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,3,4-thiadiazole derivatives. doi:10.1007/BF02980122 Arch Pharm Res 2004
A microplate indicator-based method for determining the susceptibility of multidrug-resistant Mycobacterium tuberculosis to antimicrobial agents. Int J Tuberc Lung Dis 2004
Pulmonary sarcoidosis: atypical HRTC features and differential diagnostic problems. Radiol Med 2004
New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity. doi:10.1021/jm030438k J Med Chem 2004
[Social risk factors for noncompliance with tuberculosis treatment in Pontevedra [Spain]]. doi:10.1016/s0213-9111(04)71997-4 Gac Sanit 2004
[Difficulties to enroll patients in non-remunerated clinical trials. Apropos of a clinical trial comparing two treatment options for latent tuberculosis infection]. doi:10.1016/s0025-7753(04)74160-3 Med Clin (Barc) 2004
[Educational strategy for improving patient compliance with the tuberculosis treatment regimen in Chiapas, Mexico]. doi:10.1590/s1020-49892003001100005 Rev Panam Salud Publica 2003
[Isoniazid and rifampicin resistance and prior treatment for tuberculosis]. doi:10.1590/s0102-311x2003000500006 Cad Saude Publica 2003
Direct lung delivery of para-aminosalicylic acid by aerosol particles. doi:10.1016/j.tube.2003.08.016 names it Tuberculosis (Edinb) 2003
[Risk factors for tuberculous disease in AIDS cases reported in Brazil, from 1980 to 2000]. Rev Esp Salud Publica 2003
Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. doi:10.1128/AAC.47.11.3616-3619.2003 Antimicrob Agents Chemother 2003
[Effectiveness of Spanish tuberculosis control programmes]. doi:10.1016/s0025-7753(03)73954-2 Med Clin (Barc) 2003
[Prognosis of mono- and polydrug resistant pulmonary tuberculosis in the city of Santa Cruz, Bolivia]. doi:10.1016/s0300-2896(03)75412-x Arch Bronconeumol 2003
Factors influencing the chlorine susceptibility of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum. doi:10.1128/AEM.69.9.5685-5689.2003 Appl Environ Microbiol 2003
[Measures for prevention of some infections in those who are HIV-positive]. Sidahora 2003
Epidemiological, clinical, and prognostic differences between the diseases caused by Mycobacterium kansasii and Mycobacterium tuberculosis in patients infected with human immunodeficiency virus: a multicenter study. doi:10.1086/376987 Clin Infect Dis 2003
A multicentre comparison of a novel surrogate marker for determining the specific potency of anti-tuberculosis drugs. doi:10.1093/jac/dkg345 J Antimicrob Chemother 2003
[Randomized trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy]. doi:10.1016/s0213-005x(03)72942-5 Enferm Infecc Microbiol Clin 2003
Para-aminosalicylic acid (PAS) desensitization review in a case of multidrug-resistant pulmonary tuberculosis. names it Int J Tuberc Lung Dis 2003
Nested polymerase chain reaction for Mycobacterium tuberculosis DNA detection in aqueous and vitreous of patients with uveitis. doi:10.1016/S0188-4409(02)00467-8 Arch Med Res 2003
[Sumaya's feet are burning]. Med Clin (Barc) 2003
Primary MDR-TB of the breast. Indian J Chest Dis Allied Sci 2003
[Muscle weakness, skin manifestations and para-hilar space-occupying lesions in a 59-year-old patient. Cushing disease and pulmonary lymph node tuberculosis]. names it Internist (Berl) 2003
Multidrug-resistant tuberculosis in pregnancy: case report and review of the literature. doi:10.1378/chest.123.3.953 Chest 2003
Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice. doi:10.1128/AAC.47.1.360-362.2003 Antimicrob Agents Chemother 2003
PepN, the major Suc-LLVY-AMC-hydrolyzing enzyme in Escherichia coli, displays functional similarity with downstream processing enzymes in Archaea and eukarya. Implications in cytosolic protein degradation. doi:10.1074/jbc.M207926200 J Biol Chem 2003
[Tuberculosis in Puerto Rico. What has been done to combat it; what is being done, what remains to be done: modern approaches. 1926]. Bol Asoc Med P R 2002
[Tuberculosis and milk: elements of a polemic]. doi:10.1590/s0104-59702002000300007 Hist Cienc Saude Manguinhos 2002
[The validity of the proteins concentrations in the ascitic liquid and serum for the differential diagnosis of the ascitis]. Rev Gastroenterol Peru 2002
Comparative study on the use of solid media: Löwenstein-Jensen and Ogawa in the determination of anti-tuberculosis drug susceptibility. doi:10.1054/tube.2002.0323 Tuberculosis (Edinb) 2002
[Criteria for definition of environmental contamination indicators related to solid waste from health care facilities: a proposal for evaluation]. doi:10.1590/s0102-311x2002000500033 Cad Saude Publica 2002
[Immigrations from the perspective of demography. Impact on health]. An R Acad Nac Med (Madr) 2002
Tuberculosis therapy: past, present and future. doi:10.1183/09031936.02.00309102 Eur Respir J Suppl 2002
[Developing and using a PCR test to detect subclinical Mycobacterium leprae infection]. doi:10.1590/s1020-49892002000400004 Rev Panam Salud Publica 2002
[Territorial priorities for tuberculosis in Cuba: alternatives for stratification with a single indicator]. Rev Esp Salud Publica 2002
[Indications for thoracic radiography in the preoperative evaluation for elective surgery]. Rev Esp Anestesiol Reanim 2002
Mediastinal transthoracic needle and core lymph node biopsy: should it replace mediastinoscopy? doi:10.1378/chest.121.4.1165 Chest 2002
Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents. doi:10.1016/s0014-827x(01)01187-9 Farmaco 2002
[New technologies in the surgical treatment of tuberculous spondylitis]. Probl Tuberk 2002
Use of recombinant proteins in antibody tests for bovine tuberculosis. doi:10.1016/s0378-1135(02)00005-6 Vet Microbiol 2002
[Back to home]. doi:10.1016/s0025-7753(02)72327-0 Med Clin (Barc) 2002
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis. doi:10.1093/jac/49.2.275 names it J Antimicrob Chemother 2002
Pharmacokinetics of antituberculosis medications delivered via percutaneous gastrojejunostomy tube. doi:10.1378/chest.121.1.281 Chest 2002
[Enhancement of bacillus Calmette-Guerin attachment to the bladder wall: experimental study]. Zhonghua Wai Ke Za Zhi 2001
[New recommendations and perspectives for the control of tuberculosis]. doi:10.23938/ASSN.0521 An Sist Sanit Navar 2001
[The 50-year history of PAS production at Tanabe Seiyaku]. Yakushigaku Zasshi 2001
[Non conventional diagnostic methods for tuberculosis]. Acta Cient Venez 2001
[Bacteriological techniques for the design and identification of Mycobacterium tuberculosis]. Acta Cient Venez 2001
Synthesis and in vitro tuberculostatic activity of Co (II), Cu (II) and Ni (II) complexes of dialdehyde starch dithiosemicarbazone. Acta Pol Pharm 2001
[Reccomendations for the diagnosis of pneumonia associated with mechanical ventilation]. doi:10.1016/s0213-005x(01)72706-1 Enferm Infecc Microbiol Clin 2001
[The Mycobacteria Growth Indicator Tube (MGIT) is useful for anticipating the resistance of Mycobacterium tuberculosis to rifampicin but not to isoniazid]. Rev Argent Microbiol 2001
[Clinical utility of a commercial ligase chain-reaction kit for the diagnosis of pulmonary and extrapulmonary tuberculosis in the adult]. Rev Argent Microbiol 2001
[Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases]. Kekkaku 2001
[Mycobacterium avium complex in water buffaloes slaughtered for consumption]. doi:10.1590/s0034-89102001000300016 Rev Saude Publica 2001
[Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism]. names it Kekkaku 2001
[Drug resistance of Mycobacterium tuberculosis in Orizaba, Veracruz. Implications for the tuberculosis prevention and control program]. Rev Invest Clin 2001
[Determination of antibodies against A-60 antigen for diagnosis of M. tuberculosis infection. A useful tool for rationalization of chemoprophylaxis in HIV patients]. An Med Interna 2001
Salicylate uniquely induces a 27-kDa protein in tubercle bacillus. doi:10.1111/j.1574-6968.2001.tb10843.x FEMS Microbiol Lett 2001
[Recommendations for diagnosing ventilator-associated pneumonia]. doi:10.1016/s0300-2896(01)75102-2 Arch Bronconeumol 2001
[Prognostic factors for pulmonary tuberculosis outcome in Recife, Pernambuco, Brazil]. doi:10.1590/s1020-49892001000600003 Rev Panam Salud Publica 2001
[A case of tuberculous endometritis detected by cytology of mass screening for gynecologic cancer]. Kekkaku 2001
[Seeking tuberculosis care in Chiapas, Mexico]. doi:10.1590/s1020-49892001000500001 Rev Panam Salud Publica 2001
Antimicrobial activity of starch dialdehyde dithiosemicarbazone against Mycobacterium tuberculosis. Acta Pol Pharm 2001
Mycobacterium fortuitum-chelonae complex infection in a child with complete interleukin-12 receptor beta 1 deficiency. doi:10.1097/00006454-200105000-00021 Pediatr Infect Dis J 2001
[Secondary prevention of opportunistic infections in HIV-infected patients]. doi:10.1016/s0014-2565(01)70757-6 Rev Clin Esp 2001
[Is chemoprophylaxis a good strategy for tuberculosis control?]. doi:10.1016/s0025-7753(01)71777-0 Med Clin (Barc) 2001
[The elimination of leprosy in the year 2000: what will be the fate of Antonio and Bajamut]. doi:10.1016/s0213-005x(01)72598-0 Enferm Infecc Microbiol Clin 2001
[Causes of para-allergy to tuberculin]. names it Zh Mikrobiol Epidemiol Immunobiol 2001
[Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients]. Kekkaku 2001
Transverse myelopathy and radiculomyelopathy associated with pulmonary atypical Mycobacterium infections. doi:10.1136/thorax.56.2.158 Thorax 2001
[Fibrin net in the cerebrospinal fluid of children with tuberculous meningitis: an old, forgotten and effective method of early diagnosis]. An Esp Pediatr 2000
[Basic package of services based on evidence for primary level of attention: a proposal]. Rev Med Chil 2000
[Cavitated pulmonary condensation by Rhodococcus equi, in an HIV seropositive individual]. Acta Med Port 2000
[Effectiveness of smears and cultures in gastric aspirate samples in the diagnosis of tuberculosis]. An Esp Pediatr 2000
[Diagnostic errors related with tuberculosis in hospitalized patients]. Arch Bronconeumol 2000
[Delayed-type hypersensitivity and caseous necrosis in tuberculous granuloma. New ideas for the design of a new vaccine against human tuberculosis]. doi:10.1016/s0025-7753(00)71606-x Med Clin (Barc) 2000
[Diagnostic efficacy of the study of contacts of tuberculosis patients in a high prevalence urban area]. doi:10.1016/s0014-2565(00)70678-3 Rev Clin Esp 2000
Multidrug-resistant tuberculosis: long term follow-up of 40 non-HIV-infected patients. doi:10.1155/2000/457905 Can Respir J 2000
Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action. doi:10.1006/jmbi.2000.4094 J Mol Biol 2000
[Usefulness of the IUATLD respiratory symptoms questionnaire for the differential diagnosis of bronchial asthma and chronic bronchitis]. Arch Bronconeumol 2000
Mycobacterium chelonae sepsis associated with long-term use of an intravenous catheter for treatment of hyperemesis gravidarum. A case report. J Reprod Med 2000
[Tuberculosis in health personnel. Difficult diagnosis in Spain]. doi:10.1016/s0025-7753(00)71422-9 Med Clin (Barc) 2000
[Intracranial tuberculomas developing during treatment of pulmonary tuberculosis: case report]. doi:10.1590/s0004-282x2000000300028 Arq Neuropsiquiatr 2000
[Simplified method for the processing of sputum in the diagnosis of tuberculosis]. Enferm Infecc Microbiol Clin 2000
Pleural effusions in patients with AIDS. doi:10.1136/sti.76.2.122 Sex Transm Infect 2000
[Effect of antiretroviral treatment and prophylaxis for opportunistic infections on survival of patients with AIDS]. doi:10.1016/s0014-2565(00)70603-5 Rev Clin Esp 2000
Dengue epidemic in Belém, Pará, Brazil, 1996-97. doi:10.3201/eid0603.000311 Emerg Infect Dis 2000
Supra-sternal notch tuberculous abscess: a report of three cases. doi:10.1016/s0035-9203(00)90440-1 Trans R Soc Trop Med Hyg 2000
[Evaluation of the pyrazinamidase test for the detection of susceptibility of Mycobacterium tuberculosis to pyrazinamide]. Rev Cubana Med Trop 1999
Association of tuberculosis with malignancy at KIMIO--an oncology centre. Indian J Pathol Microbiol 1999
Serum pharmacokinetics of antimycobacterial drugs in patients with multidrug-resistant tuberculosis during therapy. Int J Clin Pharmacol Res 1999
[Utility of gas chromatography for the identification of mycobacterial species]. Medicina (B Aires) 1999
Antimycobacterial activity of new ortho-, meta- and para-toluidine derivatives. doi:10.1016/s0014-827x(99)00084-1 names it Farmaco 1999
Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis. doi:10.1089/mdr.1999.5.265 Microb Drug Resist 1999
Early results from indirect drug susceptibility test for tubercle bacilli. Indian J Med Res 1999
Value of radiologically guided fine needle aspiration cytology (FNAC) in the diagnosis of spinal tuberculosis: a study of 29 cases. doi:10.1046/j.1365-2303.1999.00206.x Cytopathology 1999
[Extensive mycotic coronary aneurysm detected by echocardiography. Apropos of a case]. Arch Mal Coeur Vaiss 1999
[Molecular markers in the epidemiology of bovine tuberculosis]. Rev Argent Microbiol 1999
[Prevalence of tuberculosis and HIV infections among participants in an intravenous drug user risk-control program]. Rev Esp Salud Publica 1999
[The mechanisms of Mycobacterium tuberculosis disease and the implications for its prevention in patients with HIV infection]. Med Clin (Barc) 1999
[Problems in the standardization of the polymerase chain reaction for the diagnosis of pulmonary tuberculosis]. doi:10.1590/s0034-89101999000300009 Rev Saude Publica 1999
Quinolones and multidrug-resistant tuberculosis. doi:10.1159/000048477 Chemotherapy 1999
Tuberculosis presenting as deep vein thrombosis. doi:10.1136/pgmj.75.880.104 Postgrad Med J 1999
[Rules for declaring tuberculosis as an occupational disease]. Arch Bronconeumol 1999
Tuberculous abdominal aortic aneurysm in a 14-year-old child. doi:10.1007/s002470050639 Pediatr Radiol 1999
[Evaluation of an automatic system (MB/BacT) for the isolation of Mycobacterium spp]. Enferm Infecc Microbiol Clin 1999
[Usefulness of a gene amplification technique (LCx MTB) in the diagnosis of tuberculosis: preliminary results with different sputum samples]. doi:10.1016/s0300-2896(15)30303-3 Arch Bronconeumol 1999
Microcolony detection in 7H11 thin layer culture is an alternative for rapid diagnosis of Mycobacterium tuberculosis infection. Int J Tuberc Lung Dis 1999
Tuberculous mycotic aneurysm of the aorta: review of published medical and surgical experience. doi:10.1378/chest.115.2.522 Chest 1999
[Rapid diagnosis and susceptibility of Mycobacterium tuberculosis to antibiotics using MGIT system]. Rev Argent Microbiol 1998
[Health service coverage in Latin America and the Caribbean]. doi:10.1590/s1020-49891998001100003 Rev Panam Salud Publica 1998
[On "The national tuberculosis control program for Spain"]. Med Clin (Barc) 1998
[Clinical evaluation of a new non-radiometric automatic system for the rapid diagnosis of tuberculosis]. Rev Clin Esp 1998
[Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis]. Med Clin (Barc) 1998
[Bovine paratuberuclosis: history and resulrs of new efforts to control an old disease]. Berl Munch Tierarztl Wochenschr 1998
F-18-FDG uptake in tuberculosis. doi:10.1097/00003072-199811000-00003 Clin Nucl Med 1998
Use of the 27-kilodalton recombinant protein from Paracoccidioides brasiliensis in serodiagnosis of paracoccidioidomycosis. doi:10.1128/CDLI.5.6.826-830.1998 Clin Diagn Lab Immunol 1998
[Shortened directly observed treatment of pulmonary tuberculosis]. Salud Publica Mex 1998
Splenic para-amyloid material: a possible vasculopathy of the acquired immunodeficiency syndrome. doi:10.1016/s0046-8177(98)90118-6 names it Hum Pathol 1998
[The project of a national control program for tuberculosis in Spain]. Med Clin (Barc) 1998
Lipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes. Role of the Src homology 2 containing tyrosine phosphatase 1. doi:10.1074/jbc.273.1.645 J Biol Chem 1998
[Usefulness of computerized tomography in the study of pleural effusion with no presumed diagnosis]. doi:10.1016/s0300-2896(15)30532-9 Arch Bronconeumol 1997
Unusual miliary tuberculosis presenting with generalized lymphadenopathy and abdominal involvement. Int J Tuberc Lung Dis 1997
Structural analysis of the 6 kb cryptic plasmid pFAJ2600 from Rhodococcus erythropolis NI86/21 and construction of Escherichia coli-Rhodococcus shuttle vectors. doi:10.1099/00221287-143-10-3137 Microbiology (Reading) 1997
Multidrug-resistant tuberculosis in Denmark 1993-1995. Int J Tuberc Lung Dis 1997
A para-site-specific hydroxylation of aromatic compounds by Mycobacterium sp. strain 12523: stabilization of the hydroxylation activity. doi:10.1007/s002530051047 names it Appl Microbiol Biotechnol 1997
[Lost opportunities for preventing tuberculosis and derived costs; comment]. Med Clin (Barc) 1997
[The 50th anniversary of para-amino-salicylic acid--a historical retrospect. Again and important agent in tuberculosis]. names it Lakartidningen 1997
Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients. doi:10.1128/jcm.35.6.1390-1393.1997 J Clin Microbiol 1997
[Clinical interest of a new simple system for isolating Mycobacterium tuberculosis]. Rev Clin Esp 1997
Tuberculosis then and now: a personal perspective on the last 50 years. doi:10.7326/0003-4819-126-3-199702010-00011 Ann Intern Med 1997
Gynaecological tuberculosis since 1951. doi:10.1080/01443619750113618 J Obstet Gynaecol 1997
Chorioretinitis secondary to mycobacterium tuberculosis in acquired immune deficiency syndrome. doi:10.1097/00006982-199709000-00013 Retina 1997
[Histopathologic findings for the research of acid-fast bacilli in erythema nodosum]. doi:10.1590/s0034-89101996000600007 Rev Saude Publica 1996
[Usefulness of polymerase chain reaction for the diagnosis of Bazin erythema induratum]. Med Clin (Barc) 1996
Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. doi:10.1007/BF01691956 names it Eur J Clin Microbiol Infect Dis 1996
Duration of antituberculosis chemotherapy in conjunction with radical surgery in the management of spinal tuberculosis. doi:10.1097/00007632-199608150-00014 Spine (Phila Pa 1976) 1996
[Youth mortality: analysis of the period from 1930 to 1991 (the epidemiological transition to violence)]. doi:10.1590/s0034-89101996000400005 Rev Saude Publica 1996
[HIV infection: recommendations for the management of asymptomatic adults and of various clinical syndromes]. Rev Med Chil 1996
Disseminated mycobacterium avium complex. Review of Ga-67 and TI-201 scans and autopsy findings. doi:10.1097/00003072-199607000-00009 Clin Nucl Med 1996
Impact on USAF tuberculosis detection and control program given a low facility tuberculosis prevalence rate. Mil Med 1996
DEC treatment of non-nematodal infections. doi:10.1177/004947559602600204 Trop Doct 1996
[Usefulness of adenosine deaminase determination in cerebrospinal fluid for the diagnosis of meningeal tuberculosis: 4 years experience at a public hospital]. Rev Med Chil 1996
Immunological characterization of a recombinant 27-kilodalton antigenic protein from Paracoccidioides brasiliensis. doi:10.1128/cdli.3.2.239-241.1996 Clin Diagn Lab Immunol 1996
[Resistance of Mycobacterium tuberculosis in the province of Castellón]. doi:10.1016/s0300-2896(15)30796-1 Arch Bronconeumol 1996
A pathological study of a mycobacterial infection in a cat caused by a variant with cultural characteristics between Mycobacterium tuberculosis and M bovis. doi:10.1136/vr.138.4.87 Vet Rec 1996
[Jenner's cowpox vaccine in light of current vaccinology]. Verh K Acad Geneeskd Belg 1996
[Evaluation of 3 culture media for isolating mycobacteria from extrapulmonary samples]. Enferm Infecc Microbiol Clin 1995
[Risk factors for antitubercular drug resistance in Chiapas, Mexico]. Salud Publica Mex 1995
[HIV infection and its effects on tuberculosis endemic in Chile]. Bol Oficina Sanit Panam 1995
[Resistance of Mycobacterium tuberculosis in Mexican patients. I. Clinical features and risk factors]. Rev Invest Clin 1995
Cervical tuberculous lymphadenitis: mimicking recurrence of gestational trophoblastic disease. J Med Assoc Thai 1995
Asherman syndrome caused by schistosomiasis. doi:10.1016/0029-7844(94)00371-j Obstet Gynecol 1995
Tuberculosis of the hip in children. J Bone Joint Surg Br 1995
Disinfection of trucks and trailers. Rev Sci Tech 1995
[Tuberculous pseudochylothorax. Presentation of a case with positive Mycobacterium tuberculosis culture and review of the literature]. Arch Bronconeumol 1995
[The use of UIT-A culture medium to produce a biomass for mycobacterial biochemical identification]. Rev Cubana Med Trop 1995
[The identification of Mycobacterium tuberculosis strains using paper strips for the niacin technic]. Rev Cubana Med Trop 1995
Antimycobacterial drugs. Semin Respir Infect 1994
[Utility of the direct culture examination (Ziehl-Neelsen) using the Bactec system for the presumptive identification of Mycobacterium tuberculosis complex, Mycobacterium avium complex, Mycobacterium xenopi, and Mycobacterium kansasii]. Enferm Infecc Microbiol Clin 1994
Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. doi:10.1128/AAC.38.4.773 Antimicrob Agents Chemother 1994
[Ultramicro ELISA to the detection of IgM antibodies in Mycobacterium leprae using dry blood samples]. Rev Inst Med Trop Sao Paulo 1994
[Basic steps for the control of tuberculosis in a community]. Med Clin (Barc) 1994
[Evaluation of an ELISA for the serologic diagnosis of tuberculosis]. Rev Cubana Med Trop 1994
Pharmacokinetic evaluation of para-aminosalicylic acid granules. doi:10.1002/j.1875-9114.1994.tb02787.x names it Pharmacotherapy 1994
Is BCG vaccination against tuberculosis still indicated? doi:10.1080/17843286.1994.11718380 Acta Clin Belg 1994
Computed tomographic findings of abdominal tuberculosis--report of five cases. Ann Acad Med Singap 1993
[Diagnosis and treatment of esophageal ulcers in patients seropositive for the human immunodeficiency virus (HIV-positive)]. Rev Esp Enferm Dig 1993
[Pulmonary tuberculosis: differences between patients seropositive and seronegative for the acquired immunodeficiency virus]. An Med Interna 1993
[Usefulness of IgG and IgM detection against antigen 60 in the diagnosis of thoracic tuberculosis]. An Med Interna 1993
[Risk of tuberculosis in parenteral drug addicts with human immunodeficiency virus seropositivity. A cohort study in detoxication communities]. Med Clin (Barc) 1993
[Efficiency of an ELISA using complete and delipidated protein extract from Mycobacterium tuberculosis H37Rv strain as a serological test for ruling out pulmonary tuberculosis]. Rev Latinoam Microbiol 1993
[The cut-off points used in chemiluminescent probes for the identification of mycobacteria]. Rev Clin Esp 1993
Disseminated histoplasmosis in a patient with acquired immunodeficiency syndrome (AIDS): a case report. East Afr Med J 1993
Stability of antimycobacterial drugs in susceptibility testing. doi:10.1128/AAC.36.11.2398 Antimicrob Agents Chemother 1992
[The National Consensus for the Control of Tuberculosis in Spain]. Med Clin (Barc) 1992
Characterization of aromatic dehalogenases of Mycobacterium fortuitum CG-2. doi:10.1128/jb.174.17.5669-5675.1992 J Bacteriol 1992
Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis. doi:10.1136/gut.33.7.947 Gut 1992
Differential diagnosis of idiopathic fibrosis from malignant lymphadenopathy with PET and F-18 fluorodeoxyglucose. doi:10.1097/00003072-199205000-00002 Clin Nucl Med 1992
[Tuberculosis in 7 general hospitals in Andalusia. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas]. names it Enferm Infecc Microbiol Clin 1992
[Isolated splenic tuberculosis]. doi:10.3143/geriatrics.29.305 Nihon Ronen Igakkai Zasshi 1992
[Difficulties in carrying out the treatment as seen by the tuberculous patient]. Aten Primaria 1992
[Comparison of the Bacter system and Löwenstein-Jensen medium for cultivation of Mycobacterium tuberculosis in clinical samples]. Enferm Infecc Microbiol Clin 1992
[A suspected case of perforation of a lymph node into the bronchus during the treatment of adult hilar lymph node tuberculosis]. Kekkaku 1992
[National consensus on the control of tuberculosis in Spain. Task Group on Tuberculosis]. Med Clin (Barc) 1992
[Effectiveness of BCG vaccination in children in relation to genetic and social factors]. Probl Tuberk 1992
[Analysis of 98 cases of thoracic empyema]. doi:10.11150/kansenshogakuzasshi1970.65.1583 Kansenshogaku Zasshi 1991
[Ultramicro-ELISA for the detection of IgM antibodies anti M. leprae]. Rev Inst Med Trop Sao Paulo 1991
Emergency laparoscopy in patients submitted previously to abdominal surgery: a study of 20 cases. Rev Hosp Clin Fac Med Sao Paulo 1991
A modified broth dilution assay for antibiotic sensitivity testing of Mycobacterium avium-intracellulare using paraffin slide cultures. doi:10.1016/0041-3879(91)90008-g Tubercle 1991
Correspondence with a pioneer, Jürgen Lehmann (1898-1989), producer of the first effective antituberculosis specific. S Afr Med J 1991
[The importance of the protein antigens of Mycobacterium leprae. Their potential use for the development of a vaccine against leprosy]. Gac Med Mex 1991
[Immunotherapy: new strategies to enhance the immune response in tuberculosis]. Medicina (B Aires) 1991
Bovine Nodular Thelitis: a Clinicopathological Study of 20 Cases. doi:10.1111/j.1365-3164.1990.tb00095.x Vet Dermatol 1990
[Health in Chile: reflections for the future]. Rev Med Chil 1990
[Comparative study of 2 rapid techniques (DNA hybridization and chromatography) for the identification of Mycobacterium tuberculosis complex isolated from clinical specimens]. Enferm Infecc Microbiol Clin 1990
[Peripheral arthritis, cavitated nodule initially thought to be of tuberculosis origin, and denial of drug dependence. Important difficulties to diagnose infective endocarditis in a drug addict]. An Med Interna 1990
[A case of spontaneous regression of malignant lymphoma, complicated with miliary tuberculosis, liver dysfunction and pancytopenia]. Nihon Kyobu Shikkan Gakkai Zasshi 1990
[Evaluation in our milieu of an ELISA method (ANDA-Tb) for the serological diagnosis of tuberculosis]. Enferm Infecc Microbiol Clin 1990
[Avoidable years of life lost ratio: an indicator to identify excess mortality in health areas. Mortality workshop of the Valencia region]. doi:10.1016/s0213-9111(90)70987-9 Gac Sanit 1990
[A 42-year-old woman, admitted for the study of fever syndrome and anemia]. Rev Clin Esp 1989
Structure-activity relationships of tetramethylpiperidine-substituted phenazines against Mycobacterium leprae in vitro. doi:10.1128/AAC.33.11.2004 Antimicrob Agents Chemother 1989
Diagnostic significance of pleural fluid eosinophilia during initial thoracocentesis. Indian J Chest Dis Allied Sci 1989
[Tuberculosis of the breast misdiagnosed as breast cancer]. Zhonghua Jie He He Hu Xi Za Zhi 1989
[Paid blood donors: a new risk group for the development of AIDS in Mexico]. Salud Publica Mex 1989
Crohn's disease, sulfasalazine, and mycobacteria. J Lab Clin Med 1989
[Development of molecular probes for the diagnosis of mycobacteria]. Rev Argent Microbiol 1989
[Identification of 219 mycobacterial strains: with a report of 3 cases of pulmonary mycobacterial intracellular diseases]. Zhonghua Jie He He Hu Xi Za Zhi 1989
[New drugs for tuberculosis: are they necessary in Brazil?]. Rev Paul Med 1989
[Therapeutic efficacy of the principal antitubercular drugs: an evaluation by antibiogram]. Minerva Med 1989
[Evaluation of an enzyme immunoassay for the rapid diagnosis of paucibacillary tuberculosis in adults]. Medicina (B Aires) 1989
Degradation and O-methylation of chlorinated phenolic compounds by Rhodococcus and Mycobacterium strains. doi:10.1128/aem.54.12.3043-3052.1988 Appl Environ Microbiol 1988
Structure-activity relationships of selected phenazines against Mycobacterium leprae in vitro. doi:10.1128/AAC.32.10.1583 Antimicrob Agents Chemother 1988
The history of para-aminosalicylic acid (pas), the first tuberculosis anti-microbial agent, and streptomycin (sm): a comparative study. names it Adler Mus Bull 1988
[Adenosine deaminase: biochemical characteristics and clinical significance of an enzyme key to cellular immunity]. Med Clin (Barc) 1988
[Evaluation of four antigens for the detection of anti-Mycobacterium bovis antibodies by enzyme immunoassay]. Rev Argent Microbiol 1988
[Use of UAP culture medium in isolating mycobacteria from expectorations]. Rev Latinoam Microbiol 1988
[A new medium for the isolation, culture and identification of Mycobacterium]. Rev Latinoam Microbiol 1987
Molding of the uterus following intrauterine contraceptive device removal: documentation by hysterosalpingography. doi:10.1007/BF02932660 Urol Radiol 1987
[A case of giant hydronephrosis caused by renal fibrosarcoma]. Hinyokika Kiyo 1986
[Testing of the footpad technic for the cultivation of Mycobacterium leprae in different lines of mice populations in Cuba]. Rev Cubana Med Trop 1986
Primary drug-resistant tuberculosis in children. Emergence of primary drug-resistant strains of M. tuberculosis to rifampin. doi:10.1164/arrd.1986.134.3.446 Am Rev Respir Dis 1986
[The control of paratuberculosis]. Tijdschr Diergeneeskd 1986
Papulonecrotic tuberculid: a neglected disease in Western countries. doi:10.1016/s0190-9622(86)70099-6 J Am Acad Dermatol 1986
[Acquired immune deficiency syndrome in poor countries: disseminated tuberculosis as opportunistic infection in drug addicts?]. Med Clin (Barc) 1986
[Comparative study of various culture media for mycobacteria, including the new UIT-A modification]. Rev Cubana Med Trop 1986
[Towards a vaccine against leprosy]. Servir 1985
[Production and standardization of Paracoccidioides brasiliensis, Histoplasma capsulatum and Aspergillus fumigatus antigens to be used in immunodiagnosis. Comparison between immunodiffusion and immunoelectrophoresis]. doi:10.1590/s0074-02761985000300005 Mem Inst Oswaldo Cruz 1985
[Immunological study of the Easter Island population to detect Hansen's infection]. Rev Med Chil 1985
[Resistance of Mycobacterium tuberculosis. An 8-year survey in the Poitiers area]. Rev Pneumol Clin 1985
[Efficacy of specific chemotherapy combined with amben in newly diagnosed cases of destructive pulmonary tuberculosis]. Probl Tuberk 1985
[Comparison of 4 methods for the isolation of Mycobacterium tuberculosis from sputum]. Rev Cubana Med Trop 1984
[Multivariate analysis technics for the evaluation of health conditions of the municipalities of Rio Grande do Sul, Brazil]. doi:10.1590/s0034-89101984000400004 Rev Saude Publica 1984
[Histopathological investigation of the central nervous system in leprosy. I. Distribution of para-rosanilin positive materials in leprosy with special relation to tissue injury]. names it Nihon Rai Gakkai Zasshi 1984
[Bases for the diagnosis of pulmonary tuberculosis in children]. Bol Med Hosp Infant Mex 1984
Genetic effects of drug interaction in tuberculosis patients and their fate. doi:10.1002/tcm.1770040302 Teratog Carcinog Mutagen 1984
[Value of measuring central renin for the etiologic study of hypertension with unilateral nephro-uropathy]. Med Clin (Barc) 1983
[The Mitsuda reaction and its antigen, good subjects for a bibliography]. Hansenol Int 1983
[Indirect immunofluorescence for detecting antibodies against M. leprae. Application to a group of patients and persons living with them]. Rev Cubana Med Trop 1983
Hepatic complications of antituberculosis therapy revisited. S Afr Med J 1983
[The tuberculin index and the annual risk of infection as data for studying tuberculosis epidemiology]. An R Acad Nac Med (Madr) 1983
Further study on the cytogenetic effects of combined chemotherapy with isoniazid and para-aminosalicylic acid on human lymphocytes in vivo: sister chromatid exchanges, chromosome aberrations in first-division metaphases, cell growth kinetics, and mitotic index. doi:10.1002/em.2860050609 names it Environ Mutagen 1983
Wild animal mycobacterial isolates. Characterization by cellular fatty acid composition and polar lipid patterns. doi:10.1186/BF03546749 Acta Vet Scand 1983
[The Rubino reaction. Criterion for inactivation in lepromatous patients]. Med Cutan Ibero Lat Am 1983
Cytogenetic effects of chemotherapy with three combinations of anti-tubercular drugs involving isoniazid, thiacetazone, para-aminosalicylic acid and streptomycin on human lymphocytes: chromosome aberrations, sister chromatid exchanges and mitotic index. doi:10.1007/BF00289477 names it Hum Genet 1983
Adenosine deaminase estimations in the differentiation of pleural effusions. S Afr Med J 1982
Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka. names it Ceylon Med J 1982
[Relapses in pulmonary tuberculosis. Value of the case history for the selection of the best retreatment regimen]. Medicina (B Aires) 1982
A 10-year assessment of a controlled trial comparing debridement and anterior spinal fusion in the management of tuberculosis of the spine in patients on standard chemotherapy in Hong Kong. Eighth Report of the Medical Research Council Working Party on Tuberculosis of the Spine. doi:10.1302/0301-620X.64B4.7047536 J Bone Joint Surg Br 1982
[Influence of culture conditions (oxygenation) on the residual virulence of Brazil-BCG and Glaxo-BCG vaccines in mice]. An Microbiol (Rio J) 1982
Tuberculosis in association with pregnancy. doi:10.1016/0002-9378(81)90222-2 Am J Obstet Gynecol 1981
Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazonensis. doi:10.1016/s0140-6736(81)92296-0 Lancet 1981
Rapid drug-susceptibility testing of Mycobacterium tuberculosis. doi:10.1164/arrd.1981.123.4.402 Am Rev Respir Dis 1981
Transmission of multiple drug-resistant tuberculosis: report of a school and community outbreak. doi:10.1093/oxfordjournals.aje.a113110 Am J Epidemiol 1981
Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi. doi:10.1164/arrd.1981.123.1.104 Am Rev Respir Dis 1981
Combined action of isoniazid and para-aminosalicylic acid in vivo on human chromosomes in lymphocyte cultures. doi:10.1007/BF00274696 names it Hum Genet 1981
[Tuberculous trochanteritis : radiological diagnosis (author's transl)]. J Radiol 1981
[Renal tuberculosis with a fistulous tract to the skin in the coxofemoral joint region]. AMB Rev Assoc Med Bras 1980
[Post-vaccinal tuberculin sensitivity and its irrelevance to BCG revaccination]. doi:10.1590/s0034-89101980000200011 Rev Saude Publica 1980
Para-aminosalicylic acid-induced hypoglycaemia in a patient with diabetic nephropathy. doi:10.1136/pgmj.56.652.135 names it Postgrad Med J 1980
Pelvic actinomycosis following insertion of an intrauterine contraceptive device. doi:10.1111/j.1479-828x.1980.tb00900.x Aust N Z J Obstet Gynaecol 1980
[Seminary on tuberculosis: regional forum for the interchange of ideas and experiences]. Bol Oficina Sanit Panam 1980
Vascular lesions in tuberculosis. Diagn Imaging 1980
Structure-activity relationships for the inhibition of formation of acid-fastness im mycobacterial organisms by coumarins and cinnamates. doi:10.1248/bpb1978.3.41 J Pharmacobiodyn 1980
[Influence of the inoculation route on residual virulence of different substrains of BCG for albino mice]. Rev Inst Med Trop Sao Paulo 1980
[Variants of the Del Río Hortega ammoniacal silver carbonate metallic impregnation technic with special application to I: melanin and amastigotes of Trypanosoma cruzi; II: basal membranes; III: fungi and Hansen's bacilli]. Rev Fac Cien Med Univ Nac Cordoba 1980
Tuberculosis of the male urethra. doi:10.1016/s0022-5347(17)56440-x J Urol 1979
[Program of detection, treatment and control of tuberculosis, latrine construction, and health education]. Prensa Med Mex 1979
Canadian survey to determine the rate of drug resistance to isoniazid, PAS and streptomycin in newly detected untreated tuberculosis patients and retreatment cases. Int J Clin Pharmacol Biopharm 1979
[Patient difficulties to explain to the physician the symptoms that he suffers: the "susto" disease, as an example]. Bol Oficina Sanit Panam 1979
Primary drug resistance in children. Drug susceptibility of strains of Mycobacterium tuberculosis isolated from children during the years 1973 through 1977 at the Kings County Hospital Center of Brooklyn. doi:10.1164/arrd.1979.119.4.680 Am Rev Respir Dis 1979
[Residual virulence of lyophilized commercial BCG-Brazil vaccine, and of the one cultured in Dubos media for mice]. An Microbiol (Rio J) 1979
[Application of a mathematical model for choosing the best combination of instruments for the detection and treatment of pulmonary tuberculosis]. doi:10.1590/s0034-89101978000400006 Rev Saude Publica 1978
Primary antituberculous drug resistance in Hawaii, 1957 to 1977. doi:10.1164/arrd.1978.118.4.701 Am Rev Respir Dis 1978
[Value of cholinesterase in pleural fluid for its etiological diagnosis]. Rev Clin Esp 1978
Poncet's disease: para-infective tuberculous polyarthropathy. doi:10.1136/bmj.1.6127.1590 names it Br Med J 1978
Antibacterial activity of N-(beta-styryl) formamides related to tuberin. doi:10.1021/jm00204a017 J Med Chem 1978
[Important metabolic disorders due to the administration of para aminosalicylic acid]. names it Rev Clin Esp 1978
[Resources for the prevention of tuberculosis in Londrina, P.R., Brazil]. doi:10.1590/s0034-89101978000100005 Rev Saude Publica 1978
[Resistance to antitubercular drugs of atypical Mycobacterium pathogenic to man]. Rev Clin Esp 1978
The lymphogram in abdominal tuberculosis. doi:10.1016/s0009-9260(77)80051-2 Clin Radiol 1977
Drug resistant tuberculosis in a large southern California hospital. doi:10.1164/arrd.1977.116.5.821 Am Rev Respir Dis 1977
Radiological features of tuberculosis of the spine in Ibadan, Nigeria. Afr J Med Med Sci 1977
[Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli]. names it Pneumonol Pol 1977
[Antibodies against respiratory virus in human sera]. Bol Oficina Sanit Panam 1977
[Homogenization of samples for the culture of mycobacteria. A comparative study of samples with and without centrifugation]. Rev Cubana Med Trop 1977
Tuberculosis due to Mycobacterium kansasii. doi:10.1111/j.1445-5994.1977.tb03347.x Aust N Z J Med 1977
Tuberculosis in Indonesia: recent studies on detection and drug susceptibility of mycobacteria in Jakarta. Southeast Asian J Trop Med Public Health 1976
[New method for the identification of slow-growing mycobacteria. Use of a numerical code]. Rev Sanid Hig Publica (Madr) 1976
[Bacteriological antituberculosis survey: preliminary study for its application in a community of São Paulo (Brazil)]. doi:10.1590/s0034-89101976000200004 Rev Saude Publica 1976
Genitourinary tuberculosis: a study of short course regimens. doi:10.1016/s0022-5347(17)59342-8 J Urol 1976
Chemoprophylaxis in inactive tuberculosis: long-term evaluation of a Canadian trial. Can Med Assoc J 1976
A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968. A U.S. Public Health Service cooperative study. doi:10.1164/arrd.1976.113.4.419 Am Rev Respir Dis 1976
[Approaches for the control of tuberculosis in the Americas]. Bol Oficina Sanit Panam 1976
[Mature intraligamentary pregnancy with florid salpingitis tuberculosa (author's transl)]. Geburtshilfe Frauenheilkd 1976
[Forms and instructions to register tuberculosis data in 1976]. Front Gastrointest Res 1976
Some bacteriologic aspects of the epidemiology of pulmonary and extrapulmonary tuberculosis. doi:10.1093/oxfordjournals.aje.a112198 Am J Epidemiol 1976
[Counter-immunoelectrophoresis in the diagnosis of meningoencephalitis by Diplococcus pneumoniae and Hemophilus influenzae]. Arch Invest Med (Mex) 1976
[Measures for the control of tuberculosis in Brazil, using BCG vaccination]. AMB Rev Assoc Med Bras 1975
Tuberculosis of the wrist: a report of ten cases. doi:10.1097/00007611-197511000-00006 South Med J 1975
Comparison of specificities of humoral and cellular immune response to haptens. doi:10.1002/eji.1830051107 Eur J Immunol 1975
[Bacteriological investigations and animal experiments with Mycobacterium ulcerans (Tübingen 1971) (author's transl)]. Zentralbl Bakteriol Orig A 1975
[Comparative studies on 2 methods employed in the search for alcohol-resistant bacilli in pulmonary secretions]. Rev Saude Publica 1975
[Acute renal failure following para-aminosalicylic-acid therapy]. names it Acta Chir Acad Sci Hung 1975
[Experimental studies on allergenic effect of Mycobacterium intracellulare in cattle]. Arch Exp Veterinarmed 1975
[Methods for the bacteriological diagnosis of bovine tuberculosis]. Bol Oficina Sanit Panam 1974
[A program for the control of adult tuberculosis in general out-patient clinics (author's transl)]. Rev Med Chil 1974
[Current concepts in the diagnosis and treatment of pulmonary tuberculosis. VI. Results of medical treatment and perspectives for the future]. Gac Med Mex 1974
[Tropism of Mycobacterium leprae for the nevis cells]. Med Cutan Ibero Lat Am 1974
[Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis]. names it Probl Tuberk 1974
[Role of paramedical personnel in tuberculosis control. Supervision of personnel in West Nigeria]. Bull Int Union Tuberc 1973
Thrombocytopenia following administration of para-aminosalicylic acid. doi:10.1016/s0022-3476(73)80289-6 names it J Pediatr 1973
[Synthesis of a cord factor analogs. I. Study of the selective esterification of trehalose by p-toluene sulfonyl chloride. Demonstration of a nonsymetrical ester:trehalose 2,6-ditosylate]. doi:10.1016/s0300-9084(73)80417-1 Biochimie 1973
Controlled comparison of oral twice-weekly and oral daily isoniazid plus PAS in newly diagnosed pulmonary tuberculosis. Br Med J 1973
[Concentration in the blood and excretion of para-aminosalicylic acid and its metabolites after intake of BEPAS preparation]. names it Probl Tuberk 1973
[Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test]. names it Acta Biol Med Ger 1973
[BCG vaccine and the vaccine prepared with BRC for the prevention of tuberculosis in adolescents and young adults. 4th report to the Medical Research Council by its Tuberculosis Vaccines Clinical Trials Committee]. Bol Oficina Sanit Panam 1972
Para-aminosalicylic acid-induced malabsorption. doi:10.1007/BF02231645 names it Am J Dig Dis 1972
[Para-aminosalicylic acid metabolism in the body. VII. Resorption and tolerance of calcium-PAS compound and early results of treatment of pulmonary tuberculosis]. names it Gruzlica 1972
[Articular and para-articular localizations of calcified Dracunculi medinensis (apropos of 4 cases)]. names it Med Trop (Mars) 1972
[Surgical indications of paratracheobronchial tuberculous adenopathies]. Bronches 1972
[Allergic, immunohemolytic anemia due to para-aminosalicylic acid (PAS). Immunohematologic studies of three cases]. doi:10.1055/s-0028-1107332 names it Dtsch Med Wochenschr 1972
Drug-induced malabsorption of vitamin B 12 . V. Intestinal pH and absorption of vitamin B 12 during treatment with para-aminosalicylic acid. doi:10.1111/j.1600-0609.1972.tb00907.x names it Scand J Haematol 1972
[Hepatotoxic effect of ethionamide and para-amino-salicylic acid in initial chemotherapy of patients with pulmonary tuberculosis in the light of liver function tests]. names it Gruzlica 1971
[Studies on the metabolism of para-aminosalicylic acid in the body. VI. Absorption, tolerance and therapeutic effect of Napashin in double gastro-enteric coating]. names it Gruzlica 1971
[Study of the utilization of the hospitals for tuberculosis patients in Mexico]. Salud Publica Mex 1971
[Coordination of chest clinics and hospitals for tuberculosis patients]. Salud Publica Mex 1971
[Instructions for the treatment of pulmonary tuberculosis in chest clinics]. Salud Publica Mex 1971
[Instructions for pulmonary tuberculosis patient finding by means of microscopy]. Salud Publica Mex 1971
Acute hepatitis due to para-aminosalicylic acid. names it Br J Clin Pract 1971
Para-hydroxyphenylacetic and homovanillic acid excretion: variation during growth and in cystic fibrosis and other pulmonary diseases. doi:10.1093/ajcp/55.3.318 names it Am J Clin Pathol 1971
The effect of some antituberculous drugs upon the upper gastrointestinal tract: an experiment with para-aminosalicylic acid, isoniazid, and streptomycin. doi:10.3109/00365527109181139 names it Scand J Gastroenterol 1971
[Economical test for evaluation of the sensitivity and resistance of Koch's bacillus to reserve drugs (preliminary report)]. Rev Bras Med 1970
Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS). names it Scand J Respir Dis 1970
[Isofetil in personal clinical practice. N,N-di-(para-isopentyloxyphenyl) thiocarbamide]. names it God Zb Med Fak Skopje 1970
[Aspergillus fumigatus antigens for serologic reactions]. Prensa Med Argent 1969
Hypersensitivity, misdiagnosis, and death in tuberculosis treated with para-aminosalicylic acid. names it N Y State J Med 1969
Course of cases of pulmonary tubercurosis with bacilli resistant to streptmycin, para-aminosalicylic acid and isoniazid and with multiple drug-resistance. names it Sci Rep Res Inst Tohoku Univ Med 1969
[Standard technic for the isolation and identification of the etiological agent of tuberculosis of the olive tree]. Microbiol Esp 1969
Miliary tuberculosis in adults. doi:10.1136/bmj.2.5652.273 Br Med J 1969
Malabsorption induced by para-aminosalicylate. doi:10.1136/bmj.1.5647.825 names it Br Med J 1969
The sensitivity to thiacetazone and para-aminosalicylic acid and the virulence in the guinea pig of East African strains of Mycobacterium tuberculosis. doi:10.1016/0041-3879(69)90002-6 names it Tubercle 1969
Intermittent chemotherapy for tuberculosis in an urban community. doi:10.1136/bmj.1.5636.82 Br Med J 1969
[Effect of sodium para-aminosalicylate on the concentration of isoniazid (tubazid) in the blood of patients with tuberculosis]. names it Ter Arkh 1969
[Allergic purpura with active antibodies in the presence of P.A.S. (para-aminosalicylic acid)]. names it Rev Fr Transfus 1969
Introduction of para-amino-salicylic acid and streptomycin in the treatment of tuberculosis. Recollections of the last 25 years. names it Scand J Respir Dis 1969
[A study of para-allergic reactions to tuberculin in fowl]. names it Veterinariia 1968
Para-aminosalicylic acid as a cause of intestinal malabsorption. doi:10.1016/0041-3879(68)90055-x names it Tubercle 1968
[On a case of simple goiter in a tuberculous subject treated with para-aminosalicylic acid]. names it Atti Accad Fisiocrit Siena Med Fis 1968
[Tuberculin index (prevalence of infection) in medical students and those in paramedical specialties]. Acta Tuberc Pneumol Belg 1968
[Mononucleosis during treatment of tuberculosis with para-aminosalicylic acid]. names it Bratisl Lek Listy 1968
Disturbances in the thyroid function during the treatment with the para-aminosalicylic acid derivatives. names it Pol Med J 1968
Treatment of unclassified mycobacterial infection of the lungs. doi:10.1136/thx.23.1.94 Thorax 1968
[Atypical mycobacteria as a factor provoking para-allergy to human, bovine and avian tuberculin in guinea pigs]. names it C R Acad Bulg Sci 1968
[On the pathologic morphology of para-rectal fistulas]. names it Vestn Khir Im I I Grek 1967
[Serological diagnosis of tuberculosis. Evaluation of the specificity and sensitivity of the complement fixation reaction for the diagnosis of tuberculosis]. Rev Invest Salud Publica 1967
[Retino-choroidal pigmented paravenous degeneration]. Bull Soc Ophtalmol Fr 1967
[Comparative study of the possibillities Löwentein-Jensen medium and reconstituted lyophilized Sula medium for isolation of Mycobacterium tuberculosis]. Bol Oficina Sanit Panam 1967
Comparative studies with isoniazid alone, isoniazid with thiacetazone and isoniazid with para-aminosalicylic acid in ambulatory treatment of pulmonary tuberculosis. names it J Indian Med Assoc 1967
[Utilization in the treatment of tuberculosis in children of a single daily oral dose of isoniazid and para-aminosalicylic acid]. names it Ann Pediatr (Paris) 1967
[Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug]. names it G Ital Mal Torace 1967
Use of thiosemicarbazone and para-nitrobenzoic acid in screening tests for anonymous mycobacteria. doi:10.1136/jcp.20.1.86 names it J Clin Pathol 1967
[Atypical mycobacteria in drinking water--the cause of para-allergies against tuberculin in animals]. names it Z Tuberk Erkr Thoraxorg 1967
A simple biological method for determination of small amounts of tuberculostatic agents in fluids. Bull World Health Organ 1967
[Methemoglobinemia and hemolytic anemia caused by para-aminosalicylic acid (PAS) infusion therapy]. names it Fracastoro 1966
Para-aminobenzoic acid medium as an aid in differentiating mammalian tubercle bacilli, M. fortuitum and M. balnei from other mycobacteria. doi:10.1164/arrd.1966.94.4.620 names it Am Rev Respir Dis 1966
[Need for social psychology in the ambulatory treatment of the tuberculosis patient]. Salud Publica Mex 1966
Treatment of original cavitary pulmonary tuberculosis with capreomycin (CM) and para-aminosalicylic acid (PAS). doi:10.1111/j.1749-6632.1966.tb45542.x names it Ann N Y Acad Sci 1966
Ethambutol: a substitute for para-aminosalicylic acid in regimens for pulmonary tuberculosis. doi:10.1111/j.1749-6632.1966.tb45533.x names it Ann N Y Acad Sci 1966
[Isolation and description of a mycobacterium species, the cause of a para-allergy against tuberculin in poultry]. names it Zentralbl Bakteriol Orig 1966
The prevalence in Canada of drug-resistant tubercle bacilli in newly discovered untreated patients with tuberculosis. Can Med Assoc J 1966
Toleration and absorption of sodium para-aminosalicylate and para-aminosalicylic acid (neopasalate). Comparison with other forms of para-aminosalicylic acid. doi:10.1378/chest.49.2.165 names it Dis Chest 1966
[Resistance effect to the para-amino-salicylic acid and the isoniazid phenyl-para-amino-salicylate]. names it Prensa Med Argent 1966
[Importance, for human tuberculosis, of strains of mycobacteria with attenuated or lessened virulence for the cuy]. Rev Chil Pediatr 1966
The influence of para-aminosalicylic acid on isonicotinic acid hydrazide blood levels after oral and intravenous administration. names it Scand J Respir Dis 1966
[Resistance of the tuberculosis bacillus to ethionamide, cycloserine, and viomycin noting coexistant resistance to streptomycin, isonicotinic acid, and para-aminosalicylic acid]. names it Med Dosw 1966
[Preliminary report on pulmonary myosis. Sanatorio Nacional for tuberculous patients]. Rev Med Hondur 1965
[The para-aminosalicylic acid (PAS) level of the venous blood in patients after the administration of various PAS preparations for pulmonary tuberculosis]. names it Ned Tijdschr Geneeskd 1965
[Venous thrombosis and thrombotic embolism in a patient under 20 years of age, with Hodgkin's disease evolving typically from the granulomatous to the sarcomatous form]. Rev Bras Cir 1965
Influence of corticosteroids on the blood-brain barrier permeability to isoniazid. Preliminary note] (Por. Rev Port Pediatr Pueric 1965
[CONTRIBUTION TO THE STUDY OF THE GENERAL AND LOCAL THERAPY OF PULMONARY AND PLEURAL TUBERCULOSIS WITH RIFAMYCIN SV (RIFOCINE)]. J Med (Oporto) 1965
[Programming of activities in the control of tuberculosis]. Torax 1965
[CONSIDERATIONS ON LYOPHILIZED BCG. NEW PROSPECTS FOR INDISCRIMINATE VACCINATION IN PUBLIC HEALTH PROGRAMS]. Hospital (Rio J) 1965
HYPERSENSITIVITY TO PARA-AMINOSALICYLIC ACID: A HAZARD IN THE TREATMENT OF ORTHOPAEDIC TUBERCULOSIS. names it J Bone Joint Surg Br 1965
RESISTANCE OF TUBERCLE BACILLI TO STREPTOMYCIN, PARA-AMINOSALICYLIC ACID AND ISONIAZID. names it Acta Tuberc Pneumol Scand 1965
THE EFFECT OF ISONIAZID AND PARA-AMINOSALICYLIC ACID ON INFECTION IN MICE PRODUCED BY MYCOBACTERIUM KANSASII. doi:10.1164/arrd.1965.91.1.21 names it Am Rev Respir Dis 1965
[COMMENTS ON 2 CASES OF SEVERE ALLERGIC REACTION TO SODIUM PARA-AMINOSALICYLATE (PAS)]. names it Med Interna (Bucur) 1964
[CLINICAL TOLERANCE OF RIFAMYCIN SV ADMINISTERED BY VENOUS PERFUSION. (RESEARCH ON THE USE OF SOLUTIONS CONTAINING OR WITHOUT POLYVINYLPYRROLIDONE AND ON THE ASSOCIATION WITH PARA-AMINOSALYCILIC ACID)]. names it Arch Tisiol Mal Appar Respir 1964
[ARTERIOGRAPHIC PRINCIPLES IN THE TREATMENT OF RENAL TUBERCULOSIS]. Arch Esp Urol 1964
[USE OF BCG ANTIGEN IN THE COMPLEMENT FIXATION TEST FOR THE DIAGNOSIS OF VISCERAL LEISHMANIASIS. (PRELIMINARY NOTE)]. Rev Inst Med Trop Sao Paulo 1964
ALTERNATING REGIMENS OF STREPTOMYCIN-PYAZINAMIDE, ISONIAZID-PARA-AMINOSALICYLIC ACID AT BATTEY STATE HOSPITAL. doi:10.1164/arrd.1964.90.2.262 names it Am Rev Respir Dis 1964
[STUDIES ON THE DOSAGE OF P-AMINOSALICYLIC ACID IN THE TREATMENT OF TUBERCULOSIS]. Gruzlica (1926) 1964
[ACTION ON MYCOBACTERIUM TUBERCULOSIS OF CAPREOMYCIN IN VITRO, ALONE OR COMBINED WITH STREPTOMYCIN, INH (ISONICOTINIC HYDRAZIDE) OR PAS (PARA-AMINOSALICYLIC ACID)]. names it C R Hebd Seances Acad Sci 1964
SKIN RASH, HEPATITIS, AND HEMOLYTIC ANEMIA CAUSED BY PARA-AMINOSALICYLIC ACID. doi:10.1164/arrd.1964.89.3.440 names it Am Rev Respir Dis 1964
[BASIC CONCEPTS FOR THE DIAGNOSIS, PROPHYLAXIS AND TREATMENT OF T.B.C]. Sem Med 1964
[HEALTH INDICATORS FOR THE STATE OF ISRAEL]. Sem Med 1964
[INTRA-PULMONARY INOCCULATION: AN EASY AND EFFECTIVE METHOD FOR INDUCING EXPERIMENTAL PULMONARY TUBERCULOSIS IN WHITE MICE]. Rev Inst Salubr Enferm Trop 1964
[ANALYTICAL STUDY AND IMMEDIATE RESULTS OF THE TREATMENT OF 163 PATIENTS IN THE THORACIC DEPARTMENT OF THE PARA CIN GENERAL HOSPITAL OBSERVED IN 1961 AND 1962]. names it Tuberkuloza 1964
[COMBINATION OF ETHIONAMIDE AND P-AMINOSALICYLIC ACID IN THE TREATMENT OF PULMONARY TUBERCULOSIS WITH GERMS RESISTANT TO ISONIAZID AND STREPTOMYCIN]. Prensa Med Argent 1963
[REHABILITATION TREATMENT OF TUBERCULOSIS. (EXPERIENCES OF THE HONORARY COMISSION FOR TUBERCULOSIS CONTROL)]. Rev Esp Tuberc 1963
[THE ROLE OF ACETYLATION IN THE EFFECTIVENESS OF TREATMENT WITH COMBINED ISONIAZID AND PARA-AMINOSALICYLIC ACID, AND ISONIAZID WITH PARA-AMINOBENZOIC ACID, IN PULMONARY TUBERCULOSIS]. names it Bull Sci Med (Bologna) 1963
[THE EFFECTIVENESS OF TREATMENT WITH COMBINED ISONIAZID AND PARA-AMINOSALICYLIC ACID (PAS) AND WITH ISONIAZID AND PARA-AMINOBENZOIC ACID (PABA) IN EXPERIMENTAL TUBERCULOSIS IN GUINEA PIGS]. names it Riv Patol Clin 1963
[SHOCK WITH ANTI-ERYTHROCYTE ALLERGIC ANTIBODIES APPEARING DURING SODIUM P-AMINOSALICYLATE PERFUSIONS. CLINICAL AND IMMUNOLOGICAL STUDY; THERAPEUTIC INTEREST]. J Med Nantes 1963
Antifibrosis therapy in the management of pulmonary tuberculosis. S Afr Med J 1963
[EFFECT OF STREPTOMYCIN, PARA-AMINOSALICYLIC ACID AND ISONICOTINIC ACID HYDRAZIDE ON THE ABSORPTION OF GLUCOSE BY THE ISOLATED SMALL INTESTINE OF THE RAT]. names it Gruzlica (1926) 1963
[THE TUBERCULOSIS PROBLEM IN CHILE. EPIDEMIOLOGY OF TUBERCULOSIS AND THE PLANS FOR ITS PREVENTION]. Rev Chil Pediatr 1963
An evaluation of surveillance methods for self-medication with isoniazid and para-aminosalicylic acid in tuberculous patients. doi:10.1164/arrd.1963.87.6.844 names it Am Rev Respir Dis 1963
[MODIFICATION OF THE FITE-FARACO TECHNIQUE FOR THE STAINING OF ACID-ALCOHOL FAST BACILLI IN HISTOLOGIC SECTIONS]. Rev Latinoam Anat Patol 1963
[MINIMUM VACCINATION SCHEDULE FOR CHILDREN IN BRAZIL]. Bol Inst Pueric 1963
[Hypersensitivity to para-amino salysilic acid (P.A.S.). Report of a fatal case]. names it Arch Med Panamenos 1963
[PREVALENCE OF DIFFERENT GROUPS OF MYCOBACTERIA IN A TUBERCULOSIS HOSPITAL IN MONTEVIDEO]. Hoja Tisiol 1963
Unclassified mycobacteria isolated from human suspect tuberculosis cases in New-foundland: preliminary studies on fifteen strains. Can Med Assoc J 1963
[RESISTANCE OF TUBERCLE BACILLI TO STREPTOMYCIN, ISONICOTINIC ACID HYDRAZIDE AND P-AMINOSALICYLIC ACID IN VITRO AND IN VIVO]. Med Dosw 1963
[CRITERIA OF BED UTILIZATION IN TUBERCULOSIS HOSPITALS]. Arch Argent Tisiol Neumonol 1963
[On the problem of the synthesis of paraaminobenzoic acid by Mycobacterium tuberculosis and Staphylococcus albus]. Zh Mikrobiol Epidemiol Immunobiol 1963
[Present place of para-aminosalicylic acid in therapy]. names it Beitr Klin Tuberk Spezif Tuberkuloseforsch 1963
[Effect of para-aminosalicylic acid therapy on serum lipid fractions in tuberculosis]. names it Tuberkulozis 1963
The clinical significance of initial resistance to para-aminosalicylic acid in Mycobacteria tuberculosis sensitive to isoniazid and to streptomycin. names it East Afr Med J 1962
Initial resistance to isoniazid para-aminosal-icylic acid and streptomycin in two areas in Kenya. names it East Afr Med J 1962
Toleration and absorption of phenyl para-aminosalicylate. A comparison with other PAS preparations. names it Geriatrics 1962
Tolerance of phenyl para-aminosalicylate, a comparative study. doi:10.1378/chest.42.4.379 names it Dis Chest 1962
The chemotherapy and epidemiology of tuberculosis. Some findings of general applicability from the tuberculosis Chemotherapy Centre, Madras. doi:10.1016/s0140-6736(62)90279-9 Lancet 1962
[Chemotherapy in lung tuberculosis with Neotebamine]. Nord Med 1962
[Occurrence and significance of resistant tubercle bacilli in Denmark today]. Nord Med 1962
[On ambulant therapy of pulmonary tuberculosis in the aged]. Chiryo 1962
[Incidence of wild strains of Mycobacterium tuberculosis in variants resistant to minor antibiotics (p-aminosalicylic acid, ethionamide, cycloserine, viomycin, kanamycin)]. Ann Inst Pasteur (Paris) 1962
Observations on intravenous P.A.S. therapy in pulmonary tuberculosis. J Indian Med Assoc 1962
[Instituto Brasileiro para Investigaco da Tubercolose (IBIT) in Bahia. Its 25 years of existence]. names it Dia Med 1962
Study of eosinophilia in pulmonary tuberculosis during antibiotic and chemotherapy. Indian J Med Sci 1962
[Study on infection with drug resistant tubercle bacilli from patients among the already tuberculin-positive persons without tuberculous lesions in a workshop]. Kekkaku 1962
Effect of several anti-leprosy drugs on multiplication of human leprosy bacilli in footpads of mice. doi:10.3181/00379727-109-27293 Proc Soc Exp Biol Med 1962
[Effect of p-aminosalicylic acid on the capillary resistance and on the number of thrombocytes in genital tuberculosis]. Tuberkulozis 1962
[Qualitative laboratory control of PAS self-administration]. Gruzlica (1926) 1962
[Qualitative control of the presence of PAS in urine in patients treated in ambulatory conditions]. Gruzlica (1926) 1962
The course of pulmonary tuberculosis in patients excreting organisms which have acquired resistance. Response to continued treatment for a second year with isoniazid alone or with isoniazid plus PAS. Bull World Health Organ 1962
[Content of p-aminobenzoic acid in the cerebrospinal fluid of children with tuberculous meningitis]. Probl Tuberk 1962
[Modern chemotherapy of pulmonary tuberculosis (a summary of WHO & NTA statements)]. Hanguk Uiyak 1962
[Comparison of the level of free isonicotinic acid hydrazine in the blood serum determined with a vertical method after the oral administration of INH alone, INH with PAS or Napashin]. Gruzlica (1926) 1962
[Results in the treatment of chronic pulmonary tuberculosis in adults with pyrazinamide in association with PAS]. Gruzlica (1926) 1962
[Reparative processes in the lungs in primary tuberculosis in children treated with antibacterial preparations]. Pediatriia 1961
Formation of a red color product from PAS by certain mycobacteria. Jpn J Tuberc 1961
Certain saprophytic mycobacteria from soil sources forming a red color product from PAS. doi:10.1164/arrd.1961.84.6.916 Am Rev Respir Dis 1961
The treatment of chronic cavitating pulmonary tuberculosis by long-term chemotherapy. doi:10.1016/s0041-3879(61)80133-5 Tubercle 1961
Tuberculous meningitis. J Assoc Physicians India 1961
A controlled trial of calcium B-PAS. doi:10.1016/s0007-0971(61)80063-6 Br J Dis Chest 1961
[Result of sensitivity evaluation of human, bovine and avian tuberculosis bacteria]. Tuberkulosearzt 1961
[Spontaneous development of primary tuberculosis and its changes under the influence of chemotherapy]. Monatsschr Kinderheilkd (1902) 1961
[Resistance to PAS according to material of the pulmonary tuberculosis clinic of the Academy of Medicine in Bialystok]. Gruzlica (1926) 1961
[On the metabolism of PAS. IV. With special reference to the different forms of glucuronic acid in PAS-glycosuria]. Yokohama Med Bull 1961
[On the metabolism of PAS. III. With special reference to the relation between the PAS-Ca concentration in the blood and PAS glycosuria]. Yokohama Med Bull 1961
[On the metabolism of PAS. II. With special reference to PAS-Ca-glycosuria]. Yokohama Med Bull 1961
[Clinical studies of INH-on the role of INH in combination with SM, PAS, and INH with special reference to the role of INH]. Kekkaku 1961
A case of hypersensitivity to para-amino-sallicylic acid in a child. doi:10.1016/s0022-3476(61)80215-1 names it J Pediatr 1961
[Controlled trial of 3 types of oral treatment of pulmonary tuberculosis conducted at Morocco in Tangiers. (I.N.H. and Ethionamide, I.N.H. and P.A.S., I.N.H. only). Preliminary results after 1 year of observation]. Maroc Med 1961
[Effects of working conditions on chemotherapy of pulmonary tuberculosis]. doi:10.1265/jjh.16.105 Nihon Eiseigaku Zasshi 1961
[On the current status of PAS in the treatment of pulmonary tuberculosis]. Wien Med Wochenschr 1961
[Apropos of resistance of Koch's bacillus to streptomycin, para-aminosalicylic acid, isonicotinoyl hydrazide and viomycin. Resistance of the organisms at the time of admission of the patient to the sanatorium]. names it Acta Tuberc Pneumol Belg 1961
[A case of severe sensitivity to PAS, SM and INH with manifestations of the involvement of various organs]. Gruzlica (1926) 1961
A short-term clinical trial with a combination of INH and PAS in the treatment of tuberculosis in infants and children. J Indian Med Assoc 1961
Isoniazid and 4-aminobenzoic acid in the treatment of murine tuberculosis. doi:10.1007/BF02171438 Experientia 1961
Drugs other than streptomycin, para-aminosalicylic acid, and isoniazid in the surgical treatment of pulmonary tuberculosis. names it J Thorac Cardiovasc Surg 1961
[Studies on inactivation of antituberculous agents in media. II. Influence of p-aminobenzoic acid on inactivating effect of activated carbon]. Kekkaku 1961
[Clinical experiences with Iso-Benzacyl in childhood tuberculosis]. Praxis 1961
[Treatment of genital tuberculosis]. Rev Obstet Ginecol Venez 1961
Studies on some factors affecting the acetylation of para-aminosalicylic acid in the organism. names it Sci Rep Res Inst Tohoku Univ Med 1961
Prevalence and early attack rate of tuberculosis among close family contacts of tuberculous patients in South India under domiciliary treatment with isoniazid plus PAS or isoniazid alone. Bull World Health Organ 1961
Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of domiciliary chemotherapy, and influence of further chemotherapy on the relapse rate. Bull World Health Organ 1961
[Is resistance break-through possible after INH and PAS long-term therapy in pulmonary tuberculosis by the use of INHA-PAS?]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1961
Chemotherpy of pulmonary tuberculosis with neotebanyl. Acta Tuberc Scand 1961
[Iontophoresis treatment with sodium-aminosalicylate in tuberculosis in children]. Probl Tuberk 1961
Further mutational studies on the PAS resistance of Mycobacterium tuberculosis var. hominis. doi:10.1099/00221287-23-2-203 J Gen Microbiol 1960
[Experimental contribution to the study of the para-specific defense induced by antitubercular diffusing vaccine (V.D.S.) in mice infected with Singapore influenza A2 virus]. names it Clin Pediatr (Bologna) 1960
[Kanamycin in association with PAS-perfusion in the treatment of pulmonary tuberculosis]. Minerva Med 1960
[Histomorphological study of the gastric mucosa obtained by transoral biopsy in patients with pulmonary tuberculosis treated with unique dose of p-aminosalicylic acid]. Lotta Tuberc 1960
Bacterial resistance to streptomycin, PAS and isoniazid in untreated patients with symptomatic pulmonary tuberculosis in Ashanti. doi:10.1016/s0041-3879(60)80060-8 Tubercle 1960
[Treatment of tuberculous meningitis with the p-amino-salicylate of isoniazid (Dipasic)]. Med Esp 1960
[Studies on double or triple resistance of Mycobacterium tuberculosis. 1. The rate of appearance of double or triple resistance, and the effect of drugs on the appearance of this resistance]. Kekkaku 1960
New stick test for P.A.S. in urine. Report on use of "phenistix" and problems of long-term chemotherapy for tuberculosis. doi:10.1136/bmj.1.5187.1679 Br Med J 1960
[Determination of para-aminosalicylic acid in undiluted urine. A simple method]. names it Nord Med 1960
An evaluation of chemotherapy in pulmonary tuberculosis. High doses of isoniazid and PAS versus daily streptomycin with high doses of isoniazid and PAS. doi:10.1164/arrd.1960.81.3.407 Am Rev Respir Dis 1960
The prevalence of bacterial resistance to isoniazid and to PAS in patients with acute pulmonary tuberculosis presenting for treatment in East Africa. doi:10.1016/s0041-3879(60)80021-9 Tubercle 1960
[Concentrations of PAS and INH in sputa of patients receiving them orally and the method for their inactivation. Report 1. Free PAS concentrations in sputum]. Kekkaku 1960
[PAS concentration in the pulmonary tuberculosis lesion. Part III. The residual condition of PAS-Na after its oral administration]. Kekkaku 1960
[Studies on the biological properties of the laboratory strains of Mycobacterium avium. 3rd Report. Susceptibility to para-aminosalicylic acid, isoniazid and neotetrazolium]. names it Kekkaku 1960
[Results of 58 titrations of sensitivity to streptomycin, PAS and isoniazid of Mycobacterium tuberculosis]. Rev Med Nancy 1960
A concurrent comparison of isoniazid plus PAS with three regimens of isoniazid alone in the domiciliary treatment of pulmonary tuberculosis in South India. Bull World Health Organ 1960
[Contribution to the current status of chemotherapy of pulmonary tuberculosis]. Acta Tuberc Scand 1960
The influence of growth-stimulating factors on the bacteriotropic potencies of isoniazid. J Hyg Epidemiol Microbiol Immunol 1960
[Results of treatment of abdominal tuberculosis with antibiotics]. Probl Tuberk 1960
[PAS concentration in the pulmonary tuberculosis lesion. Part II. Periodical change of PAS-Na concentration intravenously injected. II]. Kekkaku 1960
Results of the PAS urine test (phenistix) study done in May and June, 1959. doi:10.1164/arrd.1960.81.1P1.111 Am Rev Respir Dis 1960
Progress in the second year of patients with quiescent pulmonary tuberculosis after a year of chemotherapy at home or in sanatorium, and influence of further chemotherapy on the relapse rate. Bull World Health Organ 1960
A comparison of the sensitivity to p-aminosalicylic acid of tubercle bacilli from South Indian and British patients. Bull World Health Organ 1960
Serum isoniazid concentrations in Japanese tuberculosis patients and the effect of the simultaneous administration of PAS. doi:10.1111/j.1348-0421.1960.tb00146.x Jpn J Microbiol 1960
[Combined treatment of pulmonary tuberculosis with DSM pantothenate, INH and PAS in continuous infusion]. Schweiz Z Tuberc Pneumonol 1960
Can we rely upon the fact that the different PAS-preparations really will be resorbed in the gastrointestinal tract after oral dosage? Some observations during PAS treatment in pulmonary tuberculosis. Acta Tuberc Scand 1960
Drug resistance in out-patients treated with sodium PAS and isoniazid cachets. doi:10.1016/s0041-3879(59)80100-8 Tubercle 1959
[Para-aminosalicylic acid (PAS). Review]. names it Gruzlica (1926) 1959
[PAS concentration in the pulmonary tuberculosis lesion. Part I. Punctual movement of PAS-Na concentration intravenously injected. I]. Kekkaku 1959
[Our therapeutic results in genital tuberculosis]. Tokoginecol Pract 1959
[Treatment of tuberculosis on a combined regimen of x-ray and anti-tuberculous drugs. Report 2. An animal experiment as to the effectiveness of a combined regimen of x-ray, streptomycin (SM), isonicotinic acid hydrazide (INH) and/or para-aminosalicylic acid (PAS)]. names it Kekkaku 1959
Comparison of isoniazid alone with isoniazid--PAS in the original chemotherapy of noncavitary pulmonary tuberculosis. Results from the Veterans Administration-Armed Forces co-operative study on the chemotherapy of tuberculosis. doi:10.1164/arrd.1959.80.5.641 Am Rev Respir Dis 1959
[The treatment of tuberculosis with PAS-streptomycin pantothenate in venous perfusion]. G Ital Tuberc Mal Torace 1959
SEQUENTIAL use of paired combinations of isoniazid, streptomycin, para-aminosalicylic acid, and pyrazinamide. A United States Public Health Service tuberculosis therapy trial. doi:10.1164/arrd.1959.80.5.627 names it Am Rev Respir Dis 1959
[Treatment of tuberculosis on a combined regimen of x-ray and anti-tuberculous drugs. Report 1: An animal experiment as to the effectiveness of a combined regimen of x-ray, streptomycin (SM) and para-aminosalicylic acid (PAS)]. names it Kekkaku 1959
Follow-up investigation of eleven cases of miliary tuberculosis and tuberculous meningitis. Med J Aust 1959
[Potassium p-aminosalicylate in the treatment of pulmonary tuberculosis]. Gac Med Mex 1959
Usefulness of a combined isoniazid, para-aminosalicylic acid and pyridoxine preparation. names it Am Pract Dig Treat 1959
[On elimination of side-effects arising in patients with tuberculosis during treatment with PAS]. Sov Med 1959
[Further considerations on antituberculosis chemotherapeutic action of p-aminosalicylic hydrazide: in vitro activity on Koch's bacillus resistant to streptomycin and isoniazid]. Arch Ital Sci Farmacol 1959
[Results of the treatment of pulmonary tuberculosis with the preparation napashin with regard to the preservation of isonicotinic acid hydrazide resistance in bacilli]. Gruzlica (1926) 1959
[Experimental tuberculous meningitis in guinea pigs. 3. The effect of the administration of SM or INH alone and of SM. INH and PAS in combination]. Kekkaku 1959
Isoniazid and para-aminosalicylic acid toxicity in 513 cases: a study including high doses of INH and gastrointestinal intolerance to PAS. doi:10.1378/chest.36.2.146 names it Dis Chest 1959
Comparative study of concentrations in the blood of para-aminosalicylic acid in tuberculous patients. doi:10.1378/chest.36.1.41 names it Dis Chest 1959
[Analogies in the morphological behavior of some tuberculous lesions in respect to treatment with PAS and cycloserine]. Lotta Tuberc 1959
[Use of isoniazid para-aminosalicylate in treatment of urogenital tuberculosis]. names it Presse Med (1893) 1959
[Hepatonephritis during PAS therapy]. Alger Medicale 1959
Genetic considerations of the mechanisms involved in PAS-resistant tubercle bacilli. doi:10.1164/artpd.1959.79.3.371 Am Rev Tuberc 1959
The tolerability of calcium benzoyl-PAS and calcium PAS; a double blind study. doi:10.1164/artpd.1959.79.3.351 Am Rev Tuberc 1959
[Beneficiary funds for tuberculosis]. Sem Med 1959
Association between carcinoma of the bladder and pulmonary tuberculosis: evaluation of PAS and INH as carcinogenic agents. doi:10.1016/S0022-5347(17)66007-5 J Urol 1959
Diagnosis and treatment of joint tuberculosis. Calif Med 1959
Psychological side-effects during long-term ambulatory chemotherapy with isoniazid and PAS. Acta Tuberc Scand 1959
[Course of tuberculosis in children and adolescents treated with streptomycin and PAS]. Probl Tuberk 1959
[Results of clinical study of the therapy of tuberculosis with intravenous PAS-streptomycin-pantothenate infusions and their combination possibilities]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1959
The development of mycobacterial resistance to PAS in pulmonary tuberculosis. Acta Tuberc Scand 1959
[Effect of streptomycin, PAS and rimifon on ocular adaptation in pulmonary tuberculosis]. Suvr Med (Sofiia) 1959
A five-year assessment of patients in a controlled trial of streptomycin with different doses of para-aminosalicylic acid in pulmonary tuberculosis. names it Q J Med 1959
[BCG: pathogenicity for humans and the hamster, allergy and resistance]. Rev Bras Tuberc Doencas Torac 1958
On the mechanism of increasing the bacteriotropic potencies of isoniazid in the presence of para-aminobenzoic acid (PABA). doi:10.1164/artpd.1958.78.6.949 names it Am Rev Tuberc 1958
Comparison of toleration, absorption, and clinical efficacy of several para-aminosalicylic acid preparations in three hundred tuberculous patients. doi:10.1164/artpd.1958.78.6.899 names it Am Rev Tuberc 1958
[Resistance of tubercle bacilli to streptomycin, PAS & isoniazid]. Ned Tijdschr Geneeskd 1958
[Mechanism of action of paraaminosalicylic acid on Mycobacterium]. Farmakol Toksikol 1958
Effect of single and of double daily doses of para-aminosalicylic acid in tuberculosis of guinea pigs. doi:10.1164/artpd.1958.78.5.753 names it Am Rev Tuberc 1958
Clinical use of a single daily dose of para-aminosalicylic acid in association with isoniazid. doi:10.1164/artpd.1958.78.5.749 names it Am Rev Tuberc 1958
[Treatment of pulmonary tuberculosis by isoniazid-para-aminosalicylate]. names it Ann Soc Belg Med Trop (1920) 1958
[Effects of antituberculous drugs on the secretory capacity of a tuberculous kidney]. Acta Urol Belg 1958
[Personal experience with hydracid para-aminosalicylate of isonicotinic acid (dipasic) as basic treatment in 104 cases of pulmonary tuberculosis]. names it Med Esp 1958
Severe hypersensitivity reaction to para-aminosalicylic acid; report of two cases and review of the literature. doi:10.1164/artpd.1958.78.3.462 names it Am Rev Tuberc 1958
[Experimental studies on the effect of certain anti-tuberculous drugs on carboxylase activity in vitro]. Boll Soc Ital Biol Sper 1958
[New method of qualitative & quantitative analysis with para-aminosalicylic acid (PAS) & its calcium, potassium & sodium salts]. names it Sem Med 1958
[Sensitivity of tuberculous bacillus to streptomycin, isoniazid & para-aminosalicylic acid in 1,879 patients]. names it Acta Tuberc Belg 1958
[BCG: pathogenicity in man & the hamster: allergy & resistance]. Med Cir Farm 1958
Drug resistance in pulmonary tuberculosis treated with calcium B-PAS. doi:10.1016/s0041-3879(58)80077-x Tubercle 1958
The use of corticotrophin in rapid desensitization to PAS. doi:10.1016/s0041-3879(58)80074-4 Tubercle 1958
[A new service organization of the Sanatório-Escola Azevedo Lima; bases for a dynamic anti-tuberculous & pneumonological center]. Arq Bras Med Nav 1958
[Plan for the creation of an Instituto Internacional de Radiofotografía de Abreu]. Rev Esp Tuberc 1958
[Epidemiological value of the cases discovered at mobile dispensaries of the Comisión Honoraria para la Lucha Antituberculosa]. names it Hoja Tisiol 1958
[Recent knowledge concerning the biochemistry of Mycobacterium tuberculosis]. Arch Tisiol Mal Appar Respir 1958
On omitting PAS. doi:10.1016/s0041-3879(58)80040-9 Tubercle 1958
[Blood levels of paraaminosalicylic acid (PAS) in patients with pulmonary tuberculosis. II. Production and clinical use of the potassium salt of paraaminosalicylic acid (K-PAS)]. Gruzlica (1926) 1958
[Differences in morphological reactions caused by the major antituberculosis agents]. Rev Tuberc 1958
[The effects of antituberculous drugs on the morphology of tubercle bacilli studied by the slide culture method]. Kekkaku 1958
Streptovaricin: therapeutic effect on guinea pigs infected with tubercle bacilli resistant to streptomycin and to para-aminosalicylic acid. names it Proc Staff Meet Mayo Clin 1958
[Urease activity in Mycobacterium. I. Trials for the choice of a quantitative method]. Rev Bras Tuberc Doencas Torac 1958
Metal chelates and antitubercular activity. III. p-Aminosalicylic acid: chelate vs. complex. doi:10.1002/jps.3030470418 J Am Pharm Assoc Am Pharm Assoc 1958
[Development of sensitivity to three antituberculous antibiotics of strains of Mycobacterium tuberculosis isolated between 1953 & 1957 from human pathological materials]. Ann Inst Pasteur (Paris) 1958
Antagonism of methionine in aminosalicylate-inhibition of Mycobacterium tuberculosis. doi:10.1128/jb.75.4.417-421.1958 J Bacteriol 1958
[Simplified process for identification of catalase and dehydrogenase in Mycobacteria]. Rev Bras Tuberc Doencas Torac 1958
Mechanisms involved in the resistance of Mycobacterium tuberculosis to para-aminosalicylic acid. doi:10.1128/jb.75.3.345-350.1958 names it J Bacteriol 1958
[Suppurative adenitis resulting from BCG vaccination; study of 3,000 vaccinated subjects]. Rev Tuberc 1958
[New trocar for cavern drainage]. Rev Bras Tuberc Doencas Torac 1958
[The attitude of tubercle bacilli in sputum, especially on the smear-positive & culture-negative cases. III. The influence of anti-tuberculous agents contained in sputum on culture for tubercle bacilli]. Kekkaku 1958
[Acute hemolytic anemia with methemoglobinemia, methemoglobinuria & lower nephron syndrome after rectal administration of PAS solution]. Gruzlica (1926) 1958
[Blood levels of para-aminosalicylic acid in pulmonary tuberculosis patients treated with various preparations & by various routes of administration. I]. names it Gruzlica (1926) 1958
Drug-susceptibility testing in tuberculosis; a method using diluted bacterial suspensions for the indirect test. doi:10.1164/artpd.1958.77.2.350 Am Rev Tuberc 1958
Some observations on the composition of bacterial population of PAS-resistant Mycobacterium tuberculosis. doi:10.1164/artpd.1958.77.2.346 Am Rev Tuberc 1958
[The concept of para-tuberculosis of meta-tuberculosis in the light of some recent pharmacological data]. names it Therapie 1958
[Paraosteoarthropathy of the hip during the development of tuberculous meningoencephalitis]. Pediatrie 1958
[Variability of the polyresistance of the tubercle bacillus. I. Sensitivity to the paminosalicylic salt of isoniazid]. C R Seances Soc Biol Fil 1958
[Toxic side-effects of antibacterial therapy of tuberculosis and methods of their prevention]. Suvr Med (Sofiia) 1958
[Intolerance to anti-tuberculosis preparations PAS, isonicotinic acid hydrazide and streptomycin]. Suvr Med (Sofiia) 1958
[Comparative study of the tolerance of orally administered PAS-calcium and benzoyl-PAS-calcium in therapy of pulmonary tuberculosis]. Schweiz Z Tuberc Pneumonol 1958
[Utilization of p-aminosalicylic acid hydrazide in pulmonary tuberculosis; results of 15 observations]. Ann Soc Belg Med Trop (1920) 1957
[Recent work on the para-aminosalicylic salt of isoniazid]. names it Sem Hop 1957
[Development of acute liver dystrophy in a patient with tuberculosis treated with PAS]. Klin Med (Mosk) 1957
The intravenous administration of a high concentration of para-aminosalicylic acid (PAS). names it Acta Tuberc Jpn 1957
[Suggestions for administrative cooperation of the official antituberculous campaign with other organizations]. Rev Esp Tuberc 1957
[Plan for a tuberculosis campaign with special reference to ages from 0 to 15 years]. Dia Med 1957
Eczematous complications in treatment of tuberculosis; eruptions resulting from combined aminosalicylic acid, dihydrostreptomycin, and isoniazid therapy. doi:10.1001/jama.1957.02980300006002 J Am Med Assoc 1957
[Para-pneumothoracic pleurisy detected or controlled by thoracoscopy before or after the advent of the anti-tuberculosis drugs]. names it Lotta Tuberc 1957
Mutations to triple-drug-resistance in double-drug-resistant Mycobacterium tuberculosis. J Antibiot (Tokyo) 1957
[Agar-plate method of study of the action of antibiotics (streptomycin, fungi and bacteria) on the human type of Mycobacterium tuberculosis]. Rev Bras Tuberc Doencas Torac 1957
Studies of conjugated PAS and ascorbic acid and other forms of para-aminosalicylic acid. I. Patient tolerance. doi:10.1164/artpd.1957.76.5.877 names it Am Rev Tuberc 1957
A study of amino acid metabolism with urine from tuberculous patients. doi:10.1164/artpd.1957.76.5.867 Am Rev Tuberc 1957
[A new trocar for drainage of pulmonary caverns]. Rev Bras Tuberc Doencas Torac 1957
Treatment of tuberculous meningitis with a combination of isonicotinic acid hydrazides, streptomycin and para-aminosalicylic acid. doi:10.7326/0003-4819-47-4-782 names it Ann Intern Med 1957
Sensitivity of Mycobacterium tuberculosis to para-aminosalicylic acid, isoniazid, and the P.A.S. salt of isoniazid. doi:10.1016/s0140-6736(57)91943-8 names it Lancet 1957
[Studies on the response of PAS-resistant tubercle bacilli to para-aminobenzoic acid]. names it Nord Med 1957
[Cyanacetic acid hydrazide associated with dihydrostreptomycin in the treatment of pulmonary tuberculosis]. Minerva Med 1957
[Changes in heart function caused by hypopotassemia during PAS therapy]. Lotta Tuberc 1957
The quantitative analysis of the drug resistance of Mycobacterium tuberculosis in patients. II. The analysis of streptomycin resistance, especially its correlation with the therapeutic effect of isoniazid-PAS therapy. J Antibiot (Tokyo) 1957
[Experimental data on the mechanism of therapeutic action of PAS]. Biull Eksp Biol Med 1957
The treatment of pulmonary tuberculosis with dipasic. doi:10.1016/s0041-3879(57)80179-2 Tubercle 1957
Diagnosis and antimicrobial therapy of primary tuberculosis in children. doi:10.1001/jama.1957.02980110030006 J Am Med Assoc 1957
[Benzacyl & PAS in therapy of pulmonary tuberculosis; a comparison]. Sven Lakartidn 1957
[A new organization in the Azevedo Lima Teaching Sanatorium; bases for a dynamic tuberculosis & pneumonology center]. Rev Bras Tuberc Doencas Torac 1957
Discussion on the modern outlook in the management of pulmonary tuberculosis: chemotherapy. Proc R Soc Med 1957
[Tuberculous bacilli in bone tuberculosis subjected to antibiotics; therapeutic considerations]. Sem Hop 1957
[On the tuberculostatic activity of para-substituted N-arylglycines]. doi:10.1007/BF02157429 names it Experientia 1957
Streptomycin twice a week with daily PAS in the treatment of pulmonary tuberculosis. doi:10.1016/s0041-3879(57)80084-1 Tubercle 1957
[Chemotherapy of pulmonary tuberculosis with special reference to new results of resistance & virulence research]. Med Monatsschr 1957
The treatment of endometrial tuberculosis with streptomycin and PAS; a supplementary report on an investigation carried out on behalf of the Research Committee of the British Tuberculosis Association and of the Royal College of Obstetricians and Gynaecologists; the report has been prepared on behalf of the joint sub-committee representing the two bodies. doi:10.1111/j.1471-0528.1957.tb02666.x J Obstet Gynaecol Br Emp 1957
[High-dosage isoniazid therapy of pulmonary tuberculosis with alternating treatment with antibacterial drugs]. Gazz Med Ital 1957
[Catamnesis of tuberculous meningitis from 1946 to 1954 with special reference to the follow-up examination of survivors]. Ann Paediatr 1957
[Future of one hundred cavitary tuberculosis case declared cured by exclusive and prolonged antibiotic therapy]. Sem Hop 1957
[Treatment of pulmonary tuberculosis with benzacyl]. Schweiz Med Wochenschr 1957
Observations with cyanocetyl hydrazide PAS compound in pulmonary tuberculosis. J Indian Med Assoc 1957
[Resistance of Mycobacterium tuberculosis to antituberculotics in synthetic culture media]. Tuberkulozis 1957
[Studies of 30 case histories of pulmonary tuberculosis patients treated with dipasic (GEWO 339)]. Med Cir Guerra 1957
[Use of streptopas in the treatment of tuberculous fistulas]. Scalpel (Brux) 1957
RESISTANT tubercle bacilli. Lancet 1957
The in vitro effect of Na-PAS and NA-B-PAS on Mycobacterium tuberculosis and a comparison of Dubos and ATS media for the study. Antibiot Chemother (Northfield) 1957
[Preliminary studies for the construction of a pavilion for the aid of tuberculous patients in the Hospital Militar de Campo de Mayo Cirujano Primero Dr. Juan Madera]. Rev Sanid Milit Argent 1957
[Chemotherapy of pulmonary tuberculosis]. Med Monatsschr 1957
[Treatment of primary tuberculosis in children]. Maroc Med 1957
[INHA-PAS in the screening test]. Arzneimittelforschung 1957
[Report on the use of the Gewo preparation dipasic in various forms of pulmonary tuberculosis]. Ther Ggw 1957
Response of tuberculosis to intensive combined four drug therapy. J La State Med Soc 1957
Pyrazinamide together with oxytetracycline in patients with tubercle bacilli resistant to streptomycin, PAS and isoniazid. doi:10.1016/s0366-0869(57)80031-8 Br J Tuberc Dis Chest 1957
The properties of para-aminosalicylic acid-resistant Mycobacterium tuberculosis var. hominis. doi:10.1164/artpd.1957.75.4.608 names it Am Rev Tuberc 1957
[Treatment of destructive forms of pulmonary tuberculosis with isoniazid in combination with PAS and streptomycin]. Cas Lek Cesk 1957
[Comparison of five culture media for the primary isolation of Mycobacterium tuberculosis]. Rev Mex Tuberc Enferm Apar Respir 1957
[Culture media for the production of BCG vaccine; modification of the Sauton medium]. Hoja Tisiol 1957
[Bases for a program of rehabilitation of the tuberculous patients of the Armed Forces]. Rev Bras Tuberc Doencas Torac 1957
[Subcutaneous PAS infusion in therapy of pulmonary tuberculosis]. Tuberkulosearzt 1957
[Outcome of tuberculous pneumonia treated by antibiotics]. Presse Med (1893) 1957
[One step resistance development to streptomycin, isoniazid and para-aminosalcylic acid]. names it Kekkaku 1957
[Fundamental experiments on combined effects of three antituberculous agents, streptomycin, PAS and isoniazid. IIl. Studies on the one step mutants isolated from the parent strain transferred serially in the cultural environment of three drugs used concomitantly]. Kekkaku 1957
The treatment of endometrial tuberculosis with streptomycin and PAS; a report to a joint sub-committee of the British Tuberculosis Association and the Royal College of Obstetricians and Gynaecologists. doi:10.1016/s0041-3879(57)80071-3 Tubercle 1957
A trial of tuberculin with chemotherapy in the treatment of pulmonary tuberculosis. doi:10.1016/s0041-3879(57)80065-8 Tubercle 1957
[New concepts on the resistance to anti-tuberculous drugs]. Rev Prat 1957
[Effect of N-Benzoyl-p-aminosalicylic acid]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1957
Determination of blood levels of para-aminosalicylic acid (PAS) in tuberculous patients treated with various PAS preparations. names it Acta Tuberc Scand 1957
[Acid-release function of the stomach during PAS therapy of tuberculosis]. Probl Tuberk 1957
Investigation of the effect of para-aminobenzoic acid on tubercle bacilli. doi:10.1111/j.1699-0463.1957.tb01011.x names it Acta Pathol Microbiol Scand 1957
[Prognosis for 100 cavitary tuberculosis cases declared cured by prolonged antibiotic therapy alone]. Rev Tuberc 1957
Some in vitro and in vivo observations on the composition of population of Mycobacterium tuberculosis var. hominis with respect to drug resistance. J Antibiot (Tokyo) 1957
[Observations on the use of PAS in venous perfusions in pulmonary tuberculosis]. G Clin Med 1957
[Functional issues of antibiotic therapy in osteoarticular tuberculosis in children]. Probl Tuberk 1957
[Efficiency according to experimental and clinical data of therapy in tuberculous meningitis with isonicotinic acid hydrazide]. Probl Tuberk 1957
[Experimental study of the use of isoniazid combined with other antibacterial preparations]. Probl Tuberk 1957
[Comparative appreciation of morphological reactions during tuberculosis therapy with antibiotics and chemical preparations in man and in experience]. Probl Tuberk 1957
[Streptomycin and PAS in treatment of pulmonary tuberculosis]. Probl Tuberk 1957
[Systematic treatment of tuberculous invasions]. Mars Med 1957
[Anti-tuberculosis action of calcium salt of N-benzoyl-paraaminosalicylic acid]. G Ital Della Tuberc 1957
[Treatment of conjunctival tuberculosis]. Vestn Oftalmol 1957
Antagonism between p-aminosalicylic acid and procaine penicillin on the growth of tubercle bacilli. Acta Pathol Microbiol Scand 1957
[Preliminary report on the use of isoniazid and PAS in tuberculosis]. Med Panam 1957
The determination of the sensitivity of Mycobacterium tuberculosis to para-aminosalicylic acid. names it J Med Lab Technol 1957
[New treatment of renal tuberculosis]. Acta Urol Belg 1957
[Ambulant chemotherapy of pulmonary tuberculosis]. Tuberkulosearzt 1957
Anti-tuberculous drugs. Practitioner 1957
The results of combined drug therapy and early fusion in bone tuberculosis. J Bone Joint Surg Am 1957
Isoniazid salt of calcium para-aminosalicylic acid in pulmonary tuberculosis. names it J Indian Med Assoc 1956
Isoniazid salt of para-aminosalicylic acid in the treatment of tuberculosis; a preliminary report. names it J Indian Med Assoc 1956
On the role of isoniazid in the treatment of tuberculosis. J Indian Med Assoc 1956
[Role of acetylation in the efficiency of para-aminosalicylic acidisoniazid therapy in pulmonary tuberculosis]. names it Schweiz Med Wochenschr 1956
Studies on action mechanisms of antituberculous drugs. II. Effect of streptomycin, para-aminosalicylic acid and isonicotinic acid hydrazide for BCG asparaginase. names it Sci Rep Res Inst Tohoku Univ Med 1956
Studies on action mechanisms of antituberculous drugs. I. Studies on inhibitory action of SM, PAS, INH against BCG dehydrogenase. Sci Rep Res Inst Tohoku Univ Med 1956
[Incidence of tuberculosis in underdeveloped countries & methods assessment]. Hoja Tisiol 1956
[The biologists and the so-called paratuberculous alcohol-acid resistant bacillus]. Tunis Med 1956
[Diagnosis of blastomycosis by direct sputum examination in a tuberculosis sanatorium]. Rev Bras Tuberc Doencas Torac 1956
[Comparative study of the results of tuberculostatic agents with and without prednisolone in therapy of common phthisis]. Acta Tuberc Belg 1956
[Reticuloendothelial system and renewal of antibiotic therapy in chronic tuberculosis]. Minerva Med 1956
Antagonism of the inhibitory action of aminosalicylic acid on Mycobacterium tuberculosis by methionine, biotin and certain fatty acids, amino acids, and purines. doi:10.1128/jb.72.6.839-846.1956 J Bacteriol 1956
[Comparative examinations in the treatment of pulmonary tuberculosis with combined PAS-INH therapy and an isoniazid-PAS compound]. Praxis 1956
[Para-aminosalicylic acid & coagulation factors]. names it Lotta Tuberc 1956
[Our research and experiments with a new product (para-amino salicylate hydrazide cianacetina) in the treatment of human tuberculosis]. names it Rev Esp Tuberc 1956
[Mode of action of the PAS-isoniazid molecular compounds (dipasic) in the body]. Tuberkulosearzt 1956
[PAS-hydrazide in therapy of female genital tuberculosis]. Quad Clin Ostet Ginecol 1956
[Behavior of various serological tests in tuberculotics treated with PAS and PAS plus isoniazid by intravenous perfusions]. Gazz Med Ital 1956
Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. doi:10.1084/jem.104.5.737 J Exp Med 1956
Ambulatory treatment of tuberculous intrathoracic lymphadenitis. doi:10.1378/chest.30.5.508 Dis Chest 1956
[Sensitivity to antituberculous drugs of bacillary strains from initial tuberculosis in children]. Presse Med (1893) 1956
[Combined therapy in tuberculous meningitis]. Nord Med 1956
Tuberculous meningitis: combined corticosteroid and antimicrobial therapy. Can Med Assoc J 1956
[Attenuation of virulence, for the guinea pig, of Koch bacillus isolated from patients undergoing chemotherapy; clinical & experimental aspects of the problem]. Rev Bras Tuberc Doencas Torac 1956
[Para-aminosalicylic acid hydrazide in the treatment of female genital tuberculosis]. names it Riv Patol Clin 1956
[Giant, pseudocystic cells and current treatment of pulmonary tuberculosis]. Rev Esp Tuberc 1956
[Combined ACTH-antibiotic therapy in various forms of chronic tuberculous empyema]. Gazz Med Ital 1956
Sensitivity of Mycobacterium tuberculosis (bovine type) to PAS. doi:10.1016/s0041-3879(56)80082-2 Tubercle 1956
Management of tuberculosis in childhood. Calif Med 1956
[Clinical aspects of various cases of pulmonary tuberculosis treated with apacizine]. Minerva Med 1956
[Results of rotation therapy in chronic pulmonary tuberculosis]. Turk Tip Cemiy Mecm 1956
[Experience in treatment of experimental meningeal tuberculosis in rabbits]. Probl Tuberk 1956
Studies on the drug resistance in mycobacteria with genetic reference; on the frequency of appearance of PAS-resistant mutants in Mycobacterium tuberculosis var. hominis simultaneously resistant to streptomycin and isoniazid. J Antibiot (Tokyo) 1956
Studies on the drug resistance in Mycobacterium tuberculosis var. hominis. J Antibiot (Tokyo) 1956
[Prognosis in meningeal tuberculosis in adults in the light of current therapeutic agents]. G Med Mil 1956
Streptomycin in advanced pelvic tuberculosis; evaluation; report of six cases. Obstet Gynecol 1956
Allergic (Löffler's) pneumonitis occurring during antituberculous chemotherapy; report of three cases. doi:10.1164/artpd.1956.74.3.445 Am Rev Tuberc 1956
[Treatment of minimal pulmonary tuberculosis]. Sem Hop 1956
Hyperthyroidism developing during P.A.S. therapy. doi:10.1136/bmj.2.4987.281 Br Med J 1956
[Tuberculous meningitis in children and its treatment]. Arch Pediatr Urug 1956
Present method and results of treatment of tuberculous meningitis. doi:10.1164/artpd.1956.74.2-2.221 Am Rev Tuberc 1956
Prolonged chemotherapy in chronic pulmonary tuberculosis with combinations of isoniazid, para-aminosalicylic acid, and streptomycin. doi:10.1016/s0140-6736(56)91694-4 names it Lancet 1956
[Isoniazid resistance, catalase activity and pathogenicity of Koch's bacillus in guinea pigs]. Prensa Med Argent 1956
[Efficacy of isoniazid-PAS in pulmonary tuberculosis therapy]. Med Klin 1956
[Treatment of a case of acute tuberculosis with antibiotics]. Rev Med Moyen Orient 1956
[New method for the culture of Mycobacterium tuberculosis; trials with a medium of orange juice base; preliminary report]. Rev Ecuat Hig Med Trop 1956
[The attack therapy of pulmonary tuberculosis by the triple combination of PAS, INH and streptomycin in intravenous perfusion]. J Med Bord 1956
[A copper complex of p-aminosalicylic acid]. Arzneimittelforschung 1956
Impressions of chemotherapy in the out-patient treatment of pulmonary tuberculosis in Singapore. doi:10.1016/s0366-0869(56)80031-2 Br J Tuberc Dis Chest 1956
[Indications and results of prolonged bronchoclysis in pulmonary tuberculosis]. Prensa Med Argent 1956
[Focal therapy of tuberculous lymphadenitis]. Rass Int Clin Ter 1956
[Action of the PAS salt of isoniazid in pulmonary tuberculosis]. Sem Hop 1956
[Treatment of peripheral lymph node tuberculosis]. Bull Mens Soc Med Mil Fr 1956
Acute pulmonary tuberculosis in East Africans: a controlled trial of isoniazid in combination with streptomycin or PAS. doi:10.1016/s0041-3879(56)80035-4 Tubercle 1956
[Dermic and hypodermic nodular skin disease with a necrosing tendency, probably tuberculous]. Arch Belg Dermatol Syphiligr 1956
[Study of 45 cases of silicotuberculosis treated by the triple association: Streptomycin-PAS-isoniazid in prolonged and continuous treatment]. Acta Tuberc Belg 1956
Genital tuberculosis; management with antibiotic therapy and surgery. Obstet Gynecol 1956
[Use of PAS aerosols for the treatment of pulmonary tuberculosis]. Lyon Med 1956
[New laboratory accomplishments in thoracic pathology]. Rev Med Cubana 1956
[Results of the treatment of pulmonary tuberculosis with 2 grams of streptomycin weekly associated with PAS]. Gruzlica (1926) 1956
[Paraaminosalicylic acid and isonicotinic acid hydrazide in the treatment of pulmonary tuberculosis]. Gruzlica (1926) 1956
[Current treatment of meningeal tuberculosis]. Poumon Coeur 1956
[Resistance of tuberculosis bacilli to antibiotics]. Ann Biol Clin (Paris) 1956
Pyrazinamide-isoniazid: comparison with isoniazid-para-aminosalicylic acid in active pulmonary tuberculosis with the choice of regimens determined by chance. doi:10.1164/artpd.1956.73.5.704 names it Am Rev Tuberc 1956
[Preliminary trials with pasiniazid (Paraminosalicylate of isonicotylhydrazide) in urinary tuberculosis]. Presse Med (1893) 1956
[Principles of treatment of female genital tuberculosis]. Nord Med 1956
[Hypersensitivity to tuberculostatic drugs in the treatment of pulmonary tuberculosis; in reference to a case]. J Med (Oporto) 1956
[Comparative study of antibiotics as anticontaminants in cultures for the diagnosis of tuberculosis]. Rev Ecuat Hig Med Trop 1956
[Present conception of treatment of primary infection tuberculosis]. Rev Med Moyen Orient 1956
[Phleboclysis of para-aminosalicylic acid in preoperative and postoperative treatment of advanced pulmonary tuberculosis]. names it Gazz Med Ital 1956
Methods for determining the sensitivity of Mycobacterium tuberculosis to isoniazid, streptomycin and PAS. doi:10.1016/s0041-3879(56)80112-8 Tubercle 1956
A five-year assessment of patients in a controlled trial of streptomycin, para-aminosalicylic acid, and streptomycin plus para-aminosalicylic acid, in pulmonary tuberculosis. names it Q J Med 1956
[Studies concerning the intra-aortic injection method (arcus) of anti-tuberculous drugs in pulmonary tuberculosis. II. The therapeutic effect in experimental tuberculosis of rabbits]. Kekkaku 1956
The effect of the major therapies on the hospital tuberculosis mortality rate. doi:10.1016/s0096-0217(15)31938-5 Dis Chest 1956
Jaundice associated with the administration of sodium p-aminosalicylic acid: review of the literature and report of a case. doi:10.7326/0003-4819-44-4-764 Ann Intern Med 1956
[Topical administration of hydrocortisone in the treatment of exudative pleurisy with antitubercular therapy]. Minerva Med 1956
[Various recent works concerning the treatment of meningitis and miliary tuberculosis]. Scalpel (Brux) 1956
[Effect of benemid on PAS excretion; in a case of pulmonary tuberculosis with diabetes insipidus]. Tuberkuloza 1956
[Slow intravenous infusion of PAS in severe pulmonary tuberculosis]. Rass Giuliana Med 1956
[Antibacillosis and cutaneous tuberculosis; Clinical, histological, bacteriological study]. Arch Belg Dermatol Syphiligr 1956
Treatment of pulmonary tuberculosis on a combined regimen of para-amino-salicylic acid, streptomycin and isonicotinic acid hydrazide. names it Sci Rep Res Inst Tohoku Univ Med 1956
Massive doses of INH with PAS and SM for treatment of tuberculous meningitis in adults. Chin Med J 1956
[Effect of para-aminosalicylate of isonicotyl hydrazide on Mycobacterium. II. Experiments in vivo]. names it Ann Inst Pasteur (Paris) 1956
[Treatment in pulmonary tuberculosis with subcutaneous (Para-Aminosalicylic Acid) PAS infusisons]. names it Tuberkulosearzt 1956
[New clinical studies on the treatment of tertiary pulmonary tuberculosis with a new substance of chemical synthesis]. Rev Esp Tuberc 1956
[The arterial blood gas in tuberculous patients. 2. Chemotherapy and gas content in arterial blood]. Kekkaku 1956
[Intravenous Na-PAS in combined treatment of tuberculous meningitis]. Cesk Pediatr 1956
[Treatment of meningeal tuberculosis]. Policlinico Prat 1956
Treatment of renal tuberculosis with triple-drug therapy; use of a combination of streptomycin, isoniazid, and sodium aminosalicylic acid. doi:10.1001/jama.1956.02960420024007 J Am Med Assoc 1956
On the mode of action of synthetic antituberculotica. doi:10.1007/BF02164687 Experientia 1956
[Bacteriology of tuberculosis]. Rev Med Cordoba 1956
[Bone tuberculosis in children]. Bol Asoc Med P R 1956
[Tuberculo-pneumoconiosis of coal miners treated with triple combination of streptomycin isonicotinic hydrazid and PAS]. Acta Tuberc Belg 1956
[Treatment of tuberculosis in children with the p-aminosalicylic acid salt of isonicotinic hydrazide]. Monatsschr Kinderheilkd (1902) 1956
A quantitative analysis of the resistance of Mycobacterium tuberculosis to streptomycin, isoniazid and PAS. Kekkaku 1956
Electronmicroscopic and phase contrast studies of effects of para-aminosalicylic acid, isoniazid, and viomycin on tubercle bacilli. doi:10.1164/artpd.1956.73.2.296 names it Am Rev Tuberc 1956
[Subcutaneous infusion of para-aminosalicylic acid in treatment of tuberculosis]. names it Schweiz Med Wochenschr 1956
[Side effects of para-aminosalicylic acid (PAS)]. names it Praxis 1956
[Our experience in the treatment of tuberculous meningitis with a combination of steroid hormones and specific drugs]. Rev Clin Esp 1956
[Problems raised by the study of the treatment of primary tuberculous infection in child]. Sem Hop 1956
[Rehabilitation in a tuberculosis sanatorium; plan of organization of the department of rehabilitation in a hospital for tuberculosis patients]. Rev Mex Tuberc Enferm Apar Respir 1956
Importance of subcutaneous PAS infusion in therapy of pulmonary tuberculosis. Z Tuberk 1956
[Comparative evaluation of tuberculous colitis treated and not treated with streptomycin and PAS]. Probl Tuberk 1956
[Clinical experiences with pyrazinamide]. Schweiz Z Tuberc Pneumonol 1956
[Potassium balance disorders in intravenous management of pulmonary tuberculosis with the sodium salt of p-aminosalicylic acid (Na-PAS)]. Z Tuberk 1956
[Para-aminosalicylic acid and streptomycin blood level in renal tuberculosis]. doi:10.1159/000277202 names it Urol Int 1956
Results of long-term treatment of renal tuberculosis by antibiotics. doi:10.1159/000277192 Urol Int 1956
[Management of pulmonary tuberculosis with cyanoacetic acid hydrazide]. Schweiz Z Tuberc Pneumonol 1956
[Results of the treatment of peripheral tuberculous adenitis with antibiotics based on 184 case reports]. Pediatrie 1956
[Incidence of resistance of Koch bacillus to antibiotics during primary infection]. Arch Fr Pediatr 1956
[Modern chemotherapy of tuberculosis]. Rev Ecuat Hig Med Trop 1956
[Problem of hormesis induced by synthetic antituberculosis agents]. G Ital Chemioter 1956
Paper electrophoresis and determination of resistance in urogenital tuberculosis. Z Urol 1956
The influence of chemo-antibiotic treatment on the culturability of tubercle bacilli. Acta Tuberc Scand 1956
[Subcutaneous PAS infusion in the treatment of pulmonary tuberculosis]. Z Tuberk 1956
[The picture of blood proteins in intravenous administration of para-aminosalicylic acid in pulmonary tuberculosis]. names it Schweiz Z Tuberc Pneumonol 1956
[Evaluation of a simple blood agar medium for determination of resistance of tubercle bacilli to chemotherapy]. Schweiz Z Tuberc Pneumonol 1956
[Treatment of evolutive pulmonary tuberculosis by short infusions of PAS administered daily and twice daily]. Schweiz Z Tuberc Pneumonol 1956
[Tuberculous meningitis in adults]. Duodecim 1956
[Retarded appearance of resistant Mycobacteria tuberculosis during treatment with the combined preparation dipasic]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1956
[Blood concentration in the treatment of pulmonary tuberculosis with intravenous PAS]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1956
[Evaluation of results after administration of drugs in the presence of Mycobacterium tuberculosis resistant]. Arch Med Panamenos 1956
[Value of implantation of tissue fragments (endometrium, fallopian tubes, etc.) in the guinea-pig for the diagnosis of genital tuberculosis; comparison with histopathological examination]. Acta Gynaecol Obstet Hisp Lusit 1956
[Data on absorption correlations of the thorax in pulmonary tuberculosis]. Z Tuberk 1956
[Clinical experience with dipasic and isoniazid-PAS compounds in therapy of tuberculosis]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1956
[Treatment of tuberculous meningitis in child; results]. Arch Fr Pediatr 1956
[Four cases of goiter after PAS therapy]. J Med Liban 1956
[Use of ACTH and cortisone combined with antibiotics and chemotherapeutic drugs in the treatment of tuberculous meningitis]. Policlinico Med 1956
[Combined INH-PAS therapy in cutaneous tuberculosis]. Borgyogy Venerol Sz 1956
[Action of isonicotyl hydrazide para-amino salicylate on mycobacteria. I. Bacteriostatic action exerted in vitro]. names it Ann Inst Pasteur (Paris) 1956
Tuberculous meningitis in children treated with isoniazid, streptomycin, and PAS. Antibiotic Med Clin Ther (New York) 1956
Streptomycin, isoniazid, and para-aminosalicylic acid in the treatment of pulmonary tuberculosis. doi:10.1164/artpd.1956.73.1.117 names it Am Rev Tuberc 1956
[Treatment of pulmonary tuberculosis in its various clinical forms with streptomycin, para-aminosalicylic acid (PAS), thiosemicarbazone (TB1) and isoniazid]. names it Rev Clin Esp 1955
[Experience with aminosalyl for cutaneous tuberculosis]. Nord Med 1955
Antibiotic therapy of tuberculosis of the female genitalia. doi:10.1016/s0140-6736(55)92897-x Lancet 1955
The inhibitory effect of p-aminosalicylic acid in serum against Mycobacterium tuberculosis. Antibiot Chemother (Northfield) 1955
[Resistance determination in practice in a tuberculosis clinic]. Zentralbl Bakteriol Orig 1955
[Enzymes of the mycobacteria. I. The hydroperoxidases]. Zentralbl Bakteriol Orig 1955
[First trials with a combined preparation of PAS and isoniazid in urinary tuberculosis]. J Urol Medicale Chir 1955
The mechanism of action of para-aminosalicylic acid in preventing the emergence of resistance to streptomycin in mycobacterium tuberculosis. names it J Antibiot (Tokyo) 1955
[Combination of streptomycin, PAS and isoniazid in the treatment of cavitary and bacillary pulmonary tuberculosis; immediate results]. Acta Tuberc Belg 1955
[Pneumothorax and antibiotics in the treatment of tuberculosis with cavitation in children]. Riv Clin Pediatr 1955
[Generalized tuberculosis (Empis' disease) in a 3-month-old infant]. Maandschr Kindergeneeskd 1955
[Treatment of pulmonary tuberculosis with isoniazid combined with PAS]. Klin Med (Mosk) 1955
[Intravenous PAS infusions in the treatment of pulmonary tuberculosis]. Tuberkulosearzt 1955
Isoniazid, Streptomycin, and Para-Aminosalicylic Acid Compared as Two- Drug Regimens in the Treatment of Pulmonary Tuberculosis Among Previously Untreated Patients. III. An Account of the Cooperative Investigation of the Veterans Administration, Army, and Navy, August, 1952, to September, 1954. doi:10.1164/artpd.1955.72.6.756 names it Am Rev Tuberc 1955
[ Comparative Efficacy of Three Streptomycin and Para-Aminosalicylic Acid Regimens of Prolonged Duration in Patients with Previously Untreated Pulmonary Tuberculosis. II. An Account of the Cooperative Investigation of the Veterans Administration, Army, and Navy, February, 1951, to January, 1952. doi:10.1164/artpd.1955.72.6.733 names it Am Rev Tuberc 1955
Allergic reactions to paraaminosalicylic acid; report of six cases. doi:10.1001/archinte.1955.00250170074011 AMA Arch Intern Med 1955
[Three years of experience with combined isoniazid and PAS therapy of pulmonary tuberculosis; caustic study]. Minerva Med 1955
[Therapeutic trends in very grave and evolutive forms of pulmonary tuberculosis]. Minerva Med 1955
[Early clinical results of cocarboxylase in grave human tuberculosis]. Minerva Med 1955
[Results of endobronchial antibiotic therapy of caverns and tuberculous bronchitis]. Minerva Med 1955
[The Regional Hospital for Tuberculosis of Tampico and its planning in the antituberculous campaign of Northeast Mexico]. Rev Mex Tuberc Enferm Apar Respir 1955
[Current status of therapy of tuberculosis of the mucous membranes of the ENT area, a comparative evaluation of new drugs, streptomycin, PAS, TB1 and isonicotinic acid hydrazide]. Gac Med Caracas 1955
[Endometrial implant in guinea pigs for diagnosis of genital tuberculosis]. Rev Esp Obstet Ginecol 1955
[Fundamental experiments on combined effects of three anti-tuberculous agents, streptomycin, PAS and isoniazid. I. Studies mainly on the course of the resistance development of M. tuberculosis serially transferred in the cultural environment of three drugs used concomitantly]. Kekkaku 1955
[A study on PAS-resistance; its relation to clinical symptoms and SM-resistance, the change of resistance in the course of treatment]. Kekkaku 1955
[A new rapid determination method of resistance applying the color reaction of tubercle bacilli]. Kekkaku 1955
[Spontaneous para-articular ankylosis in tuberculous coxitis]. names it Acta Chir Orthop Traumatol Cech 1955
Drug therapy of tuberculosis. Va Med Mon (1918) 1955
Pediatric tuberculosis. Ohio State Med J 1955
Management of tuberculosis in children. J Mich State Med Soc 1955
Conventional therapy versus the continuous and concurrent use of streptomycin, isoniazid, and para-aminosalicylic acid plus early surgery in the treatment of tuberculosis. doi:10.1378/chest.28.5.537 names it Dis Chest 1955
[The modern antituberculotic drugs and their ambulant use]. Wien Med Wochenschr 1955
Clinical trial of P.A.S. salt of isoniazid in treatment of pulmonary tuberculosis. doi:10.1136/bmj.2.4946.1004 Br Med J 1955
[Isoniazid and PAS in the treatment of pulmonary tuberculosis]. Dtsch Med J 1955
[Four-year experience with antibiotic treatment in tuberculous primo infection of children in preventorium]. Sem Hop 1955
The chemotherapeutic agents and their resistance against tubercle bacilli. III. Hemin starch liquid medium for the cultivation of isoniazid-susceptible and resistant tubercle bacilli. Sci Rep Res Inst Tohoku Univ Med 1955
The action of chemotherapeutic agents of intracellular tubercle bacilli. Sci Rep Res Inst Tohoku Univ Med 1955
Influence of various chemicals upon oxygen consumption of the mycobacterium tuberculosis. Sci Rep Res Inst Tohoku Univ Med 1955
[Effectivity of combined isoniazid-PAS preparations]. Tuberkulosearzt 1955
Tuberculous osteomyelitis of the malar bone; report of a case. Pediatrics 1955
The influence of chemoantibiotic treatment on tubercle bacilli (culture properties and guinea pig pathogenicity). doi:10.1378/chest.28.4.391 Dis Chest 1955
Blood concentration studies with buffered paraaminosalicylic acid tablets. doi:10.1164/artpd.1955.72.4.543 Am Rev Tuberc 1955
[Antibacterial mechanism of p-aminosalicylic acid from the stand-point of purine biosynthesis in Mycobacterium avium]. Kekkaku 1955
[Treatment of pulmonary tuberculosis with associated intravenous PAS]. Med Trop (Mars) 1955
The problem of bacterial resistance in antimicrobial therapy of tuberculosis. doi:10.1378/chest.28.3.260 Dis Chest 1955
The modern medical treatment of pulmonary tuberculosis. doi:10.7326/0003-4819-43-3-539 Ann Intern Med 1955
The influence of the size of inoculum on susceptibility testing of Mycobacterium tuberculosis. doi:10.1164/artpd.1955.72.3.390 Am Rev Tuberc 1955
[The appearance of diabetes mellitus in a pulmonary tuberculosis patient just beginning treatment with intravenous PAS]. Lyon Med 1955
[Present status of therapy of pulmonary cavities with antituberculotics]. Prakt Lek 1955
[Intravenous infusion of PAS, in therapy of exudative tuberculosis]. Ned Tijdschr Geneeskd 1955
Agranulocytosis complicating PAS and streptomycin therapy. U S Armed Forces Med J 1955
Prolonged combined chemotherapy in the treatment of pulmonary tuberculosis, using streptomycin, para-aminosalicylic acid and iso-nicotinic acid hydrazide. names it Mil Med 1955
[Effects of hyaluronidase on the sedimentation rate]. Rev Esp Tuberc 1955
[Associated diseases and antibiotic combinations]. J Med Bord 1955
[Progress in therapy of tuberculous meningitis]. J Pediatr (Rio J) 1955
[Clinical contribution to the treatment of pulmonary tuberculosis with p-aminosalicylic acid hydrazide]. Gazz Med Ital 1955
The bactericidal activities of combinations of streptomycin, isoniazid, p-aminosalicylic acid (PAS), oxytetracycline (terramycin) and viomycin against Mycobacterium tuberculosis. doi:10.1099/00221287-13-1-176 J Gen Microbiol 1955
Comparison of solid and liquid medium sensitivity tests of tubercle bacilli to para-aminosalicylic acid. doi:10.1136/jcp.8.3.229 names it J Clin Pathol 1955
Streptomycin and para-aminosalicylic acid in pulmonary tuberculosis. I. Results during treatment: 528 patients. doi:10.1164/artpd.1955.72.2.242 names it Am Rev Tuberc 1955
[The treatment of tuberculous meningitis with tuberculostatics in combination with cortisone]. Schweiz Med Wochenschr 1955
[Recurrences of tuberculous meningitis in adults; frequency and prognosis in connection with therapy]. doi:10.1055/s-0028-1116130 Dtsch Med Wochenschr 1955
[Prolonged antibiotic therapy of pulmonary tuberculosis with isoniazid combined with streptomycin or PAS; indications for pneumothorax]. Sem Hop 1955
[Combined isoniazid and PAS therapy in experimental tuberculosis]. Schweiz Med Wochenschr 1955
[Antibacterial rotation therapy in pulmonary tuberculosis]. G Ital Chemioter 1955
[Testing of twofold resisting Koch's bacilli]. Tuberkuloza 1955
[Tuberculous meningitis in pregnancy treated with combined therapy of streptomycin isoniazid and PAS]. Srp Arh Celok Lek 1955
[Mechanism of chemotherapeutic action of PAS hydrazide in tuberculosis; in vitro effects on PAS-resistant tubercle bacillus]. Arch Ital Sci Farmacol 1955
[Combined PAS and streptomycin therapy of osteoarticular tuberculosis in children]. Probl Tuberk 1955
[Effectiveness of streptomycin and PAS in therapy of pulmonary tuberculosis]. Probl Tuberk 1955
[The results of the treatment of pulmonary tuberculosis with tebethion and PAS; examination of 600 cases in an advisory clinic]. Z Arztl Fortbild (Jena) 1955
["Swing therapy" in pulmonary tuberculosis with a triple combination]. Tuberkulosearzt 1955
Metal chelates and antitubercular activity. II. p-Aminosalicylic acid. doi:10.1002/jps.3030440709 J Am Pharm Assoc Am Pharm Assoc 1955
Routine culture and sensitivity tests of Myco. tuberculosis. doi:10.1007/BF02955276 Ir J Med Sci 1955
The management of hypersensitivity reactions to streptomycin and P.A.S. doi:10.1016/s0366-0869(55)80052-4 Br J Tuberc Dis Chest 1955
Tuberculostatic activity of 2-pyridyl-(4)-I, 3,4-oxdiazolon-(5), its p-amino-salicylate and other related substances. doi:10.1016/s0366-0869(55)80047-0 Br J Tuberc Dis Chest 1955
[First trails of combined isoniazid and PAS in tuberculosis]. Dia Med 1955
[Scientific bases of PAS treatment; route of administration, elimination, toxicity; application in the treatment of tertiary tuberculosis]. Laval Med 1955
Paraaminosalicylic acid in sputum. II. Elimination of its effects on culture for tubercle bacilli. doi:10.1164/artpd.1955.71.6.860 Am Rev Tuberc 1955
Isoniazid in single and multiple drug regimens in the treatment of pulmonary tuberculosis of recent origin. doi:10.1164/artpd.1955.71.6.841 Am Rev Tuberc 1955
[Preliminary bill of statutes for a social welfare association to function in connection with a tuberculosis dispensary]. Rev Bras Tuberc Doencas Torac 1955
[Suggestions for new trend in national campaign against tuberculosis in the light of recent therapeutic progress]. Rev Bras Tuberc Doencas Torac 1955
X-RAY FINDINGS of the chest in patients treated with PAS in combination with streptomycin. J Antibiot (Tokyo) 1955
[New tuberculostatic]. Sem Med 1955
TREATMENT of tuberculous meningitis. Br Med J 1955
[Intravenous perfusions of PAS in combination therapy of pulmonary tuberculosis]. Riforma Med 1955
Results of treatment of meningeal tuberculosis in children since the use of isoniazid. J Med Bord 1955
[Results in the treatment of 40 cases of tuberculosis of the eye]. Ann Ocul (Paris) 1955
Treatment of a patient with lupus erythematosus and pulmonary tuberculosis with ACTH, streptomycin and para-aminosalicylic acid. doi:10.7326/0003-4819-42-5-1109 names it Ann Intern Med 1955
The chemotherapy of eye tuberculosis. doi:10.1016/0002-9394(55)90060-x Am J Ophthalmol 1955
[Combined therapy of tuberculosis]. Rev Bras Tuberc Doencas Torac 1955
[Effect of isonicotinic acid hydrazide associated with para-aminosalicylic acid on experimental tuberculosis in guinea pigs]. names it Gruzlica (1926) 1955
[Clinical study of the effects of p-aminosalicylic acid hydrazide (pasdrazide) in some forms of pulmonary and extra-pulmonary tuberculosis]. Gazz Med Ital 1955
[Koch bacillus resistance to antibiotics in the inoculated and antibiotic-treated guinea pig]. Ann Biol Clin (Paris) 1955
[Para-aminosalicylic acid, streptomycin and tuberculin in therapy of tuberculosis of the lymphatic glands of the neck in adults]. names it Probl Tuberk 1955
[Changes of oxygen metabolism in pulmonary tuberculosis during therapy with PAS alone and in combination with streptomycin]. Probl Tuberk 1955
[Tests of continuous injection of streptomycin with PAS in tuberculous Camerouns]. Med Trop (Mars) 1955
[Rapid development of constrictive pericarditis after antituberculous chemotherapy]. Arch Mal Coeur Vaiss 1955
[Pregnancy and genital tuberculosis: effects of antibiotics therapy]. Presse Med (1893) 1955
Current trends in therapy of meningeal tuberculosis; critical evaluation based on personal experience. Minerva Med 1955
[Difference in the results of bacteriological studies on animals and in vitro, as demonstrated by a new tuberculostatic (INHA-PAS)]. Arzneimittelforschung 1955
[Resistance determination from lung resection preparations]. Tuberkulosearzt 1955
Chemotherapy in pulmonary tuberculosis. J Indian Med Assoc 1955
Two years' experience with isonicotinic acid hydrazide. Can Med Assoc J 1955
Relapse after pulmonary resection during prolonged streptomycin-para-aminosalicylic acid treatment of pulmonary tuberculosis; an analysis of nine relapses in eighty-two cases. doi:10.1016/0002-9343(55)90455-1 names it Am J Med 1955
[IX. Histopathological study of organs from animals infected and treated with substance H-1006 (isonicotinoylhydrazonopyruvic acid), isonicotinic acid hydrazide, streptomycin, TB1 (para-acetylamino-benzaldehyde-thiosemicarbazone) and PAS (paraaminosalicylate of sodium)]. names it Bul Stiint Sect Stiint Medicale Acad Republicii Pop Romane 1955
[VIII. Study of the therapeutic effect of isonicotinoylhydrazonopyruvic acid in experimental tuberculosis as compared with the effect of isonicotinic acid hydrazide, of streptomycin, para-acetyl-amino-benzaldehyde-thiosemicarbazone (TB1) and of paraaminosalicylate of sodium (PAS)]. names it Bul Stiint Sect Stiint Medicale Acad Republicii Pop Romane 1955
The chemotherapy of bone and joint tuberculosis. III. Different courses of symptoms on chemotherapeutic agents. Ann Tuberc 1955
[PAS-isoniazid and PAS-streptomycin combined therapy, a comparison of two case series]. Nord Med 1955
The anti-tuberculous activity of some derivatives of p-aminosalicylic acid, nicotinic acid, and isonicotinic acid. Antibiot Chemother (Northfield) 1955
[Experimental tests of paraaminosalicylate of isonicotinic hydrazide]. Lotta Tuberc 1955
[General aspects of chemoresistance of Mycobacterium tuberculosis and its relation to pathology and therapy]. Arch Tisiol Mal Appar Respir 1955
[Combined streptomycin, PAS and tibone therapy of pulmonary tuberculosis]. Probl Tuberk 1955
[Studies on the inhibition of tuberculosis by drugs. 2]. Kekkaku 1955
[Evolution of laryngo-pulmonary tuberculosis in our days]. J Med Bord 1955
Chemotherapy of miliary and meningeal tuberculosis; progress report on isoniazid. Tex State J Med 1955
Combined action of PAS and chloromycetin on tubercle bacilli. doi:10.1378/chest.27.3.330 Dis Chest 1955
VARIOUS combinations of isoniazid with streptomycin or with P.A.S. in the treatment of pulmonary tuberculosis; seventh report to the Medical Research Council by their Tuberculosis Chemotherapy Trials Committee. Br Med J 1955
THE PATHOLOGICAL response of renal tuberculosis to chemotherapy. doi:10.5694/j.1326-5377.1955.tb88621.x Med J Aust 1955
[Experimental studies on influence of chemotherapeutic agents upon tubercle bacilli in mice]. Kekkaku 1955
[Major chemotherapy in the treatment of tuberculosis]. J Med Bord 1955
[Severe tuberculous lesions of the fundus oculi favorably modified by specific therapy; manifested by exudative chorioretinitis with periphlebitis]. Bull Soc Ophtalmol Fr 1955
The treatment of pulmonary tuberculosis with intravenous PAS-infusions. doi:10.1016/s0041-3879(55)80078-5 Tubercle 1955
Bactericidal activity of streptomycin and isoniazid in combination with p-aminosalicylic acid against Mycobacterium tuberculosis. doi:10.1099/00221287-12-1-76 J Gen Microbiol 1955
Clinical use of potassium para-aminosalicylate (KPAS). doi:10.1164/artpd.1955.71.2.220 names it Am Rev Tuberc 1955
Decline of tuberculosis mortality in Belem (State of Pará); its causes. Rev Bras Tuberc Doencas Torac 1955
[Suggestions for organization of a home visiting service in a tuberculosis dispensary]. Rev Bras Tuberc Doencas Torac 1955
The use of a para-aminosalicylic acid-resin combination in the treatment of tuberculosis. names it Can Med Assoc J 1955
[Results and complications of the treatment of meningeal tuberculosis in adults]. Munch Med Wochenschr 1955
[Present status of chemotherapy and surgical treatment of tuberculosis in U.S.A..]. Medizinische 1955
[Blood agar medium in the culture of Mycobacterium tuberculosis]. Rev Mex Tuberc Enferm Apar Respir 1955
[Experience in therapy of renal tuberculosis]. Rev Argent Urol 1955
[Pathologico-anatomical aspects of leptomeningitis tuberculosa treated by streptomycin, PAS and TB1]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1955
ISONIAZID (INH), PAS and streptomycin in pulmonary tuberculosis; a control study on 443 cases. Acta Tuberc Scand 1955
Comparative results of continuous treatment of ulcero-nodular tuberculosis for 10 months with isoniazid-PAS and with isoniazidstreptomycin. Therapie 1955
[Thyroid tuberculosis: case of cold abscess and antibiotic therapy]. Friuli Med 1955
[PAS in collapsed lung and in other organs in experimental tuberculosis]. Biull Eksp Biol Med 1955
Tuberculous pleural effisons treated with streptomycin, paraaminosalicylic acid, and early aspiration. Q J Med 1955
[Studies on classification of acid-fast bacteria. I. Sensitivity of acid-fast bacteria to various antituberculosis agents]. Kekkaku 1955
[Evaluation of various measuring methods for drug resistance of tubercle bacilli. 1. Results with sputum of positive smear]. Kekkaku 1955
[Effect of combined treatment with streptomycin, PAS and isoniazid on resistance of Mycobacterium tuberculosis to streptomycin and isoniazid]. Hig Cas Hig Mikrobiol Epidemiol Sanit Teh 1955
[Does isoniazid change the prognosis of primary infection in its pulmonary lymph node form?]. Pediatrie 1955
A comparison between different preparations of PAS used in the treatment of urogenital tuberculosis. Acta Tuberc Scand 1955
Active treatment of pulmonary tuberculosis in the Netherlands during the last twenty years. Acta Tuberc Scand 1955
[Treatment of utero-adnexal tuberculosis with a new antituberculotic, Gewo 339]. Acta Gynaecol Obstet Hisp Lusit 1955
[Results of alternating therapy of pulmonary tuberculosis; early clinical results and follow-up]. Schweiz Z Tuberk 1955
[Harmlessness of resumption of PAS therapy after a hemolytic accident; pathogenic considerations]. Pediatrie 1955
[Microbial flora in young tuberculotics treated with para-aminosalicylate of isonicotyl hydrazide]. names it Arch Fr Pediatr 1955
Tuberculostatic properties of p-aminosalol (phenyl-p-aminosalicylate). doi:10.1111/j.1600-0773.1955.tb00231.x Acta Pharmacol Toxicol (Copenh) 1955
A para-aminosalicylic acid-enhanced strain of M. tuberculosis. doi:10.1111/j.1699-0463.1955.tb00956.x names it Acta Pathol Microbiol Scand 1955
[PAS drip infusion free of complications by means of the Erfurt Bottle]. Z Tuberk 1955
[Comparative research on the results of ambulatory treatment of pulmonary tuberculosis with conteben/pasalon, respectively isonicotinic acid hydrazide]. Z Tuberk 1955
[Studies on homologous and heterologic resistence of tubercle bacilli in vitro after reciprocal application of streptomycin, PAS and TB 1]. Z Tuberk 1955
[Combined INH and PAS treatment of pulmonary tuberculosis]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1955
[Intravenous PAS drip infusion with addition of rutin in pulmonary tuberculosis]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1955
The current status of the chemotherapy of renal tuberculosis. Trans Am Assoc Genitourin Surg 1955
[Use of swab for seeding in culture of Mycobacterium tuberculosis]. Rev Ecuat Hig Med Trop 1955
[Comparative study of the antibiogramme of the main three bacteriostatics of Koch's bacilli in expectoration and in the resected lung pieces]. Rev Tuberc 1955
[Tuberculosis and cortisone]. Gaz Med Port 1955
[Thiosemicarbazones and serum concentration of paraaminosalicylic acid]. Gaz Med Port 1955
[Chemotherapy of pulmonary tuberculosis with a ready made combination of INH and PAS (dipasic GEWO 339)]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1955
The influence of antituberculous drugs upon the oxygen consumption of mycobacteria. Sci Rep Res Inst Tohoku Univ Med 1955
[Thyroid reactions caused by p-aminosalicylic acid]. Rev Tuberc 1955
[Studies and research on Mycobacteria. XIV. PAS metabolism in various PAS-resistant Mycobacteria]. Rend Ist Sup Sanit 1955
[Bacteriological studies on the resistance of Mycobacterium tuberculosis against streptomycin and other tuberculostatic drugs]. Ergeb Hyg Bakteriol Immunitatsforsch Exp Ther 1955
Experience with pyrazinamide. doi:10.1378/chest.27.1.44 Dis Chest 1955
Chemotherapy in a Cairo Chest Clinic; a preliminary report on the methods adopted in assessing the value of izoniazid, streptomycin and paraminosalicylic acid in 122 cases of pulmonary tuberculosis. doi:10.1016/s0366-0869(55)80007-x Br J Tuberc Dis Chest 1955
Allergic pneumonitis during chemotherapy for tuberculosis: report of two cases due to paraaminosalicylic acid. doi:10.7326/0003-4819-42-1-190 Ann Intern Med 1955
Severe paraaminosalicylic acid hypersensitivity; blood and lymph node studies. Blood 1955
[Tuberculostatic INHA-PAS in clinical examination]. Praxis 1954
[Combined tuberculostatic therapy of laryngopulmonary tuberculosis]. Wien Med Wochenschr 1954
[Intravenous infusions of P.A.S]. Concours Med 1954
[PAS intravenous drip administration in tuberculosis]. Dia Med 1954
The single daily dose of sodium para-aminosalicylic acid used in conjunction with streptomycin in tuberculosis. names it Med J Aust 1954
[Antibiotic treatment in tuberculous pericarditis]. Sem Hop 1954
Resistance of M. tuberculosis to the PAS salt of INH. doi:10.1126/science.120.3128.998 Science 1954
[Virulence for the guinea pig of Koch bacilli isolated from tuberculous patients treated with isoniazid]. Medicina (B Aires) 1954
[Results of streptomycin and PAS therapy of meningeal tuberculosis in rural conditions]. Klin Med (Mosk) 1954
[The results of therapy of cavernous pulmonary tuberculosis with antibacterial drugs]. Bull Mem Soc Med Hop Paris 1954
[Successes and failures of therapy of osteoarticular tuberculosis with PAS and streptomycin in children]. Acta Chir Orthop Traumatol Cech 1954
[Effect of antituberculotics on the course and therapy of osteoarticular tuberculosis]. Acta Chir Orthop Traumatol Cech 1954
[Our views on therapy of osteoarticular tuberculosis with streptomycin and PAS]. Acta Chir Orthop Traumatol Cech 1954
Comments on the posttherapeutic course of meningeal tuberculosis in children. Tuberkulosearzt 1954
[Effects of streptomycin, PAS and isoniazid on tuberculin allergy in experimental tuberculosis in guinea pigs]. J Med Bord 1954
Specific drug therapy in the treatment of pulmonary tuberculosis; a note on the management of drug reactions. Va Med Mon (1918) 1954
Chemotherapy in tuberculosis. J S C Med Assoc (Columbia) 1954
Adrenocorticotrophic effect of intravenous PAS and its therapeutic implications. Dis Chest 1954
Oral antimicrobial therapy of nonhospitalized tuberculous patients. doi:10.1164/art.1954.70.6.1042 Am Rev Tuberc 1954
The treatment of tuberculous meningitis without intrathecal therapy. doi:10.1016/s0140-6736(54)90650-9 Lancet 1954
[Active therapy of osteitis tuberculosa; case report]. Geneeskd Gids 1954
[Remote prognosis of tuberculous meningitis in children, with a follow-up of from four to six and a half years]. Bull Mem Soc Med Hop Paris 1954
Progress and current status of therapy of meningeal tuberculosis. Bull Mem Soc Med Hop Paris 1954
[Under what conditions can intraspinal therapy of tuberculous meningitis in children be omitted?]. Bull Mem Soc Med Hop Paris 1954
[Results of therapy of tuberculous meningitis in adults; study of 255 cases]. Bull Mem Soc Med Hop Paris 1954
[Results of isoniazid, PAS and bed rest in therapy of 145 cases of cavitary pulmonary tuberculosis]. Bull Mem Soc Med Hop Paris 1954
The anti-thyroid action of para-aminosalicylic acid. doi:10.1016/s0140-6736(54)92552-0 names it Lancet 1954
[Combined treatment of cavitary pulmonary tuberculosis with isoniazid and intravenous infusions of PAS]. Prensa Med Argent 1954
[Treatment of pulmonary tuberculosis with cyanoacetic acid hydrazide]. Prensa Med Argent 1954
[Combined streptomycin, PAS and head-down position therapy in several forms of recently cavitated pulmonary tuberculosis]. Osp Maggiore 1954
[Therapeutic results in pulmonary tuberculosis patients with PAS perfusion]. Friuli Med 1954
[Effect of chloramphenicol alone or in combination with other tuberculosis antibiotics on Mycobacterium tuberculosis]. C R Seances Soc Biol Fil 1954
[Almost unknown factors in the mechanism of action of chemotherapeutic agents against tuberculosis]. Ann Pharm Fr 1954
[Intra-articular antibiotic treatment of osteoarticular tuberculosis]. Tuberkulosearzt 1954
[Antibiotics and functional recovery of joints affected by tubercular processes]. Minerva Ortop 1954
[Combined antibacterial and tuberculin therapy of pulmonary and extra-pulmonary tuberculosis]. Probl Tuberk 1954
[The effect of antituberculous substances on the autonomic nervous functions. II. Studies on the pharmaco-dynamic functions of para-aminosalicylic acid and isonicotinic acid hydrazide]. names it Kekkaku 1954
[Clinical contribution to the therapy of tubercular meningitis]. Arch Tisiol Mal Appar Respir 1954
Drug treatment of tuberculosis. J Mich State Med Soc 1954
Tuberculous pneumonia due to organisms resistant to streptomycin and isoniazid. doi:10.1164/art.1954.70.5.881 Am Rev Tuberc 1954
Complications of tuberculous enteritis occurring during antimicrobial therapy. doi:10.1001/archsurg.1954.01270050092017 AMA Arch Surg 1954
[Isoniazid and isoniazid combined with PAS in therapy of pulmonary tuberculosis; clinical and bacteriologic studies]. Ugeskr Laeger 1954
Aims and results of associated antibacterial therapy. Minerva Med 1954
Relapses after isoniazid treatment. Dtsch Med J 1954
[Tuberculostatic drugs in the treatment of pulmonary tuberculosis]. Belg Tijdschr Geneesk 1954
[Chemotherapy of pulmonary tuberculosis; intravenous infusions of para-amino-salicylic acid and iso-nicotylhydrazid]. names it Scalpel (Brux) 1954
[Present treatment of common ulcerative and caseous tuberculosis]. Presse Med (1893) 1954
[Antibiotics in the treatment of primary tuberculosis]. Concours Med 1954
Isoniazid and P. A. S. in chronic pulmonary tuberculosis: a warning. doi:10.1016/s0140-6736(54)90447-x Lancet 1954
Studies on the effect of cortisone with chemotherapeutic agents on tuberculous peritonitis in mice. Antibiot Chemother (Northfield) 1954
[Use of intravenous PAS in the treatment of pulmonary tuberculosis]. Lotta Tuberc 1954
[Allergometric variations during antibacterial therapy with isoniazid associated with PAS]. Rass Giuliana Med 1954
Effect of two isoniazid derivatives and PAS hydrazide on isoniazid susceptible and resistant tubercle bacilli. doi:10.3181/00379727-87-21348 Proc Soc Exp Biol Med 1954
[Personal treatment of tuberculous meningitis; principles and results]. Clin Lab (Zaragoza) 1954
[Cavitary cicatrization by rest therapy and antibiotics: anatomopathological study]. Acta Tuberc Belg 1954
[The enzymatic reduction of p-nitrobenzoic acid by Mycobacterium tuberculosis avium]. Kekkaku 1954
The treatment of tuberculous endometritis with streptomycin and PAS. doi:10.1111/j.1471-0528.1954.tb07694.x J Obstet Gynaecol Br Emp 1954
Intravenous P.A.S. in relation to pulmonary tuberculotherapy, with an account of 1,145 transfusions. doi:10.1016/s0366-0869(54)80128-6 Br J Tuberc Dis Chest 1954
[Nitrogen metabolism during therapy of tuberculous meningitis]. Minerva Pediatr 1954
Chemotherapy of pulmonary tuberculosis with dipasic-gewo. Munch Med Wochenschr 1954
Comparison of the effect of streptomycin plus p-aminosalicylic acid and streptomycin plus isoniazid on tuberculous lesions of the kidneys. doi:10.1016/s0140-6736(54)90311-6 Lancet 1954
Study of para-aminosalicylic acid intolerance in tuberculosis of lung. doi:10.1001/jama.1954.02950020030009b names it J Am Med Assoc 1954
[Effect of PAS in tuberculosis]. Probl Tuberk 1954
[The bacteriological picture before, during and after administration of PAS-hydrazide]. G Ital Della Tuberc 1954
[Clinico-radiological changes during PAS-hydrazide therapy]. G Ital Della Tuberc 1954
[Reaction of Koch's bacillus to antibiotics]. Friuli Med 1954
[Pott's quadriplegia treated and cured by antibiotics]. Afr Fr Chir 1954
The treatment of osteoarticular tuberculosis with tuberculostatics. Tuberkulosearzt 1954
[Effects of modern tuberculosis therapy on pregnancy and labor: development of the newborn]. Hoja Tisiol 1954
[Isambert's disease (pharyngeal tuberculosis) cured rapidly by antibiotics]. Tunis Med 1954
[General study of antibiotic and chemical therapy for tuberculosis]. Rev Corps Sante Mil 1954
Antibiotic therapy of urinary tuberculosis: an interval report of six years experience. doi:10.1016/S0022-5347(17)67584-0 J Urol 1954
Primary tuberculosis of the conjunctiva treated with streptomycin and P.A.S. doi:10.1136/bjo.38.9.568 Br J Ophthalmol 1954
United States Public Health service cooperative investigation of antimicrobial therapy of tuberculosis, V. Report on thirty-two-week observations on combinations of isoniazid, streptomycin, and para-aminosalicylic acid. doi:10.1164/art.1954.70.3.521 names it Am Rev Tuberc 1954
Miliary tuberculous meningitis, and chronic myelogenous leukemia; case report with autopsy findings. doi:10.1164/art.1954.70.3.509 Am Rev Tuberc 1954
The chemotherapy of pulmonary tuberculosis with pyrazinamide used alone and in combination with streptomycin, para-aminosalicylic acid, or isoniazid. doi:10.1164/art.1954.70.3.413 names it Am Rev Tuberc 1954
Chemotherapy of renal tuberculosis. Nord Med 1954
Clinical significance of resistant Mycobacterium tuberculosis. Med Klin 1954
[Bacterial resistance in antituberculosis chemotherapy; current status of the problem]. Rev Med Liege 1954
Löffler's syndrome occurring during streptomycin and P.A.S. therapy. doi:10.1136/bmj.2.4884.398 Br Med J 1954
[Antibiotic therapy in phtisiology]. Sem Hop 1954
[Activity in vitro of paraaminosalicylic acid hydrazide on Koch bacillus rendered PAS-resistant]. Boll Soc Ital Biol Sper 1954
[Action of oxytetracycline (terramycin) alone or associated with anti-tuberculous antibiotics on Mycobacterium tuberculosis]. C R Seances Soc Biol Fil 1954
[Synergistic action of isoniazid and PAS in the treatment of pulmonary tuberculosis]. Rev Esp Tuberc 1954
Resistance of Koch's bacillus to chemoantibiotics; detection and its importance in the surgical treatment of pulmonary tuberculosis. Lotta Tuberc 1954
[First results of the use of isoniazid, streptomycin, PAS, with and without association of collapse in therapy in pulmonary tuberculosis in a group of Indian and Eskimo male adults and children]. Union Med Can 1954
Acute perifocal reaction in tuberculosis due to PAS. doi:10.1016/s0041-3879(54)80203-0 Tubercle 1954
Early results of prolonged streptomycin-PAS treatment of pulmonary tuberculosis. doi:10.7326/0003-4819-41-2-282 Ann Intern Med 1954
Indefinitely prolonged chemotherapy for tuberculosis; preliminary report. doi:10.1164/art.1954.70.2.219 Am Rev Tuberc 1954
Polykaryotic hepatitis in a patient treated with paraaminosalicylic acid. AMA Arch Pathol 1954
Indications and results of treatment of serous membrane tuberculosis and certain pulmonary tuberculoses by ACTH associated with antibiotics. Sem Hop 1954
[Preliminary observations of pulmonary tuberculosis therapy with the combination drug INHA-PAS]. Wien Klin Wochenschr 1954
[Administration and dosage of PAS in combination therapy of pulmonary tuberculosis]. Munch Med Wochenschr 1954
[Side effects in combined therapy of tuberculosis]. Sven Lakartidn 1954
p-Aminosalicylic acid hydrazide in vitro activity against Mycobacterium tuberculosis. Antibiot Chemother (Northfield) 1954
[First clinical experience during therapy with hydrazide of paraaminosalicylic acid apacizine]. G Ital Chemioter 1954
[Bacteriologic changes in the course of Apacizin (4-Amino-2-hydroxybenzoic acid hydrazide) therapy]. G Ital Chemioter 1954
[Clinical report on several cases of pulmonary tuberculosis treated with PAS hydrazide]. G Ital Chemioter 1954
[Virulence of antibiotic-resistant strains of Mycobacterium tuberculosis; preliminary report]. G Ital Chemioter 1954
[Antibiotic therapy of open pulmonary tuberculosis; results 4 to 24 months after termination of streptomycin-PAS-isoniazid therapy in 153 cases]. G Ital Chemioter 1954
[16 Case reports on tuberculous meningitis treated with streptomycin and other drugs administered intramuscularly, orally or rectally together with dia-cerebrospinal therapy (Boschi, Speransky and Madon technics)]. G Ital Chemioter 1954
[Pathology of tubercular meningitis treated with antibacterial therapy]. G Ital Chemioter 1954
[Immunological changes in relation to antimycobacterial therapy]. G Ital Chemioter 1954
[Chemoresistance of Mycobacterium tuberculosis; general aspects and relation to clinical manifestations and therapy; immunity and allergy in antibacterial-treated tuberculosis]. G Ital Chemioter 1954
[Combined chemo- and antibiotic therapy in pulmonary tuberculosis]. G Ital Chemioter 1954
[Effect of chemotherapy on pulmonary tuberculosis in children and adolescents]. G Ital Chemioter 1954
[Determination of p-aminosalicylic acid hydrazide in cerebrospinal fluid in normal subjects and in tuberculous meningitis]. Arch Ital Sci Farmacol 1954
[PAS therapy of pulmonary tuberculosis in a dispensary]. Probl Tuberk 1954
[PAS inhalation therapy of respiratory tuberculosis in the sanatorium LIBANI; preliminary communication]. Probl Tuberk 1954
[Clinical and morphological characteristics of laryngeal tuberculosis treated with streptomycin and PAS]. Probl Tuberk 1954
[Secondary effects of antitubercular antibiotic therapy and chemotherapy]. Arch Maragliano Patol Clin 1954
[Pulmonary tuberculosis in adults treated with streptomycin and PAS]. Arch Maragliano Patol Clin 1954
[Chemotherapy in resection treatment of pulmonary tuberculosis]. Tuberkulosearzt 1954
[Comparative results of the treatment of tuberculous meningitis with streptomycin and PAS and with streptomycin and isonicotinic acid hydrazide]. Pediatr Pol 1954
[Clinical report on a new chemo-antibiotic combination in therapy of tuberculosis: streptomycin-PAS-isoniazid]. G Clin Med 1954
[Results obtained in the Clinica Pediatrica di Bologna by use of anti-tuberculosis drugs, singly and in various combinations, in therapy of tuberculous diseases, with special reference to those of childhood]. Clin Pediatr (Bologna) 1954
A study of the effect of para-aminosalicylic acid on blood coagulation and prothrombin concentration on patients with tuberculosis. names it J Thorac Surg 1954
The clinical use of intravenous sodium para-aminosalicylate and polyvinyl pyrrolidone. doi:10.1378/chest.26.1.47 names it Dis Chest 1954
The continuous and concurrent use of streptomycin, para-aminosalicylic acid, isoniazid plus early surgery in the treatment of tuberculosis. doi:10.1378/chest.26.1.41 names it Dis Chest 1954
Löffler's reaction to para-aminosalicylic acid. doi:10.1164/art.1954.70.1.171 names it Am Rev Tuberc 1954
Infection with drug-resistant tubercle bacilli. doi:10.1016/s0140-6736(54)92205-9 Lancet 1954
[Clinical results of a peroral combined therapy of tuberculosis in adults]. Wien Klin Wochenschr 1954
[Follow-up after one year of isoniazid and PAS-dihydrostreptomycin therapy of pulmonary tuberculosis; a brief orientation]. Sven Lakartidn 1954
[The treatment of female genital tuberculosis with p-aminosalicylic acid, streptomycin, thiosemicarbazone and isonicotinic acid hydrazid]. Medizinische 1954
Biological determination of activities of administered antituberculous drugs in the blood of animals. Acta Tuberc Jpn 1954
[Organic field and mechanism of action of certain drugs against tuberculosis]. Boll Soc Ital Biol Sper 1954
[Early results of the second survey of the mobile dispensaries of the Honorary Commission for Prevention of Tuberculosis]. Hoja Tisiol 1954
[Multiple brain cold abscesses during pulmonary tuberculosis treated by antibiotics; proof of their tuberculous origin furnished by the surgical specimens]. Bull Mem Soc Med Hop Paris 1954
[Clinical and therapeutic aspects of a case of miliary tuberculosis]. Med Esp 1954
Clinical observations on the use of isoniazid in tuberculosis. doi:10.1378/chest.25.6.611 Dis Chest 1954
Current treatment of tuberculous meningitis: a preliminary report. doi:10.7326/0003-4819-40-6-1135 Ann Intern Med 1954
The use of pneumoperitoneum as an adjunct to the prolonged streptomycin-para-aminosalicylic acid treatment of pulmonary tuberculosis. doi:10.1164/art.1954.69.6.963 names it Am Rev Tuberc 1954
Tuberculous meningitis in children treated with streptomycin and P.A.S. doi:10.1016/s0140-6736(54)92155-8 Lancet 1954
Radio-iodine measurements of thyroid function during and after P.A.S. treatment of tuberculosis. doi:10.1136/bmj.1.4873.1234 Br Med J 1954
[Patterns to be followed in the present treatment of tuberculous meningitis in children]. Sem Med 1954
[Treatment of cavernous pulmonary tuberculosis with high dosage intravenous PAS]. Praxis 1954
[Current status of maternal and fetal prognosis in tuberculous meningitis in pregnancy]. Minerva Med 1954
Study of the inhibitory power in vitro of paraaminosalicylic acid, streptomycin, isoniazid and cyclotibine against various paratuberculosis bacilli. Rev Asoc Med Argent 1954
[Our experience in the treatment of tuberculous meningitis]. J Med (Oporto) 1954
Management of tuberculous meningitis with isoniazid, streptomycin, and PAS. Proc Inst Med Chic 1954
[The use of antibiotics in the treatment of tuberculosis]. Prog Med (Paris) 1954
[Treatment of tuberculous meningitis]. Dia Med 1954
[Combined isoniazid and PAS in therapy of experimental tuberculosis]. G Ital Della Tuberc 1954
[Antibiotics in the treatment of oral tuberculosis]. Minerva Stomatol 1954
[Vitamin C, tuberculosis and tuberculostatics; visceral and endocrine ascorbic acid in experimental tuberculosis in guinea pigs treated with streptomycin. PAS, p-succinyl-aminobenzaldehyde thiosemicarbozone and isonicotinyl hydrazide]. Arch Maragliano Patol Clin 1954
[The growth-inhibiting effect in vitro of various tuberculostatics and their combinations]. Tuberkulosearzt 1954
[The testing of tubercle bacteria against chemo-therapeutics]. Med Monatsschr 1954
[Tuberculostatic agents]. J Pharm Belg 1954
[Therapy of pulmonary tuberculosis with intravenous infusions of PAS]. Z Gesamte Inn Med 1954
[A case of bilateral hip disease treated with medications associated with phenylbutazone antibacillary]. Rev Rhum Mal Osteoartic 1954
[PAS and streptomycin blood levels in renal tuberculosis]. Helv Chir Acta 1954
[Results in 105 pulmonary tuberculosis cases treated with INH with or without streptomycin and P.A.S]. Alger Medicale 1954
[Relapse in the tuberculosis patients treated with chemotherapeutic preparations]. Kekkaku 1954
[Comparative results in osteoarticular tuberculosis of children treated with or without tuberculostatics]. Wien Med Wochenschr 1954
Tuberculous peritonitis. J Indian Med Assoc 1954
[Antibiotic and chemotherapeutic therapy of pulmonary tuberculosis in various ways of application; results of 397 clinical cases]. Minerva Med 1954
[Combination treatment of pulmonary tuberculosis]. Z Gesamte Inn Med 1954
[Indications for treatment of initial tuberculosis in children and adolescents]. Presse Med (1893) 1954
[Antibiotics and chemotherapy in treatment of pulmonary tuberculosis: standards of application]. Bol Cult Inf Cons Gen Col Med Esp 1954
[Two cases of fatal allergic purpura in pulmonary tuberculosis treated with I.N.H. and PAS]. Echo Med Nord 1954
Current views on genitourinary tuberculosis. Calif Med 1954
Toxic reactions to para-amino-salicylic acid. doi:10.1016/s0366-0869(54)80064-5 names it Br J Tuberc Dis Chest 1954
Toxicity of isonicotinic acid hydrazides in pulmonary tuberculosis; toxicity of isoniazid and iproniazid used alone and in combination with streptomycin or p-aminosalicylic acid. doi:10.1001/archinte.1954.00240280061006 AMA Arch Intern Med 1954
[Analysis of 57 cases of tuberculous meningitis in children treated with combined isoniazid, PAS and streptomycin, with 53 recoveries]. Bull Mem Soc Med Hop Paris 1954
[Clinical testing of the new tuberculostatic INH-PAS]. Praxis 1954
[Clinical observations on the problem of resistance of tubercle bacteria]. Z Gesamte Inn Med 1954
[Streptomycin-PAS-isoniazid combination in treatment of tuberculous meningitis]. Policlinico Prat 1954
[A year's experience with combined antibacterial therapy in the treatment of pulmonary tuberculosis; statistical and clinicoradiological results]. Minerva Med 1954
[Possibilities and limitations of treatment of peripheral tuberculous adenitis with antibiotics; cures, failures and complications]. J Med Lyon 1954
[The resistance of Mycobacterium tuberculosis to PAS]. Tuberkuloza 1954
Schizophreniform psychosis due to para-aminosalicylic acid. names it West Indian Med J 1954
[Para-aminosalicylic acid hydrazide in the treatment of pulmonary tuberculosis and pleuritis]. names it Arch Maragliano Patol Clin 1954
[Liver function in meningeal tuberculosis]. Riv Clin Pediatr 1954
[Synovial tuberculosis of the knee-joint casting para-articular round shadow in roentgenogram]. names it Fortschr Geb Rontgenstr 1954
[Clinical observation of a case of tuberculous pericarditis]. Rev Med Liege 1954
Epididymectomy and antituberculosis drugs in the treatment of tuberculous epididymitis. doi:10.1097/00007611-195403000-00001 South Med J 1954
The goitrogenic effect of para-aminosalicylic acid during the therapy of pulmonary tuberculosis; report of eleven cases. doi:10.1164/art.1954.69.3.458 names it Am Rev Tuberc 1954
Near-fatal shock from PAS followed by Guillain-Barrés syndrome. doi:10.1164/art.1954.69.3.455 Am Rev Tuberc 1954
Fatal allergic reaction to para-aminosalicylic acid. doi:10.1164/art.1954.69.3.451 names it Am Rev Tuberc 1954
The treatment of tuberculous meningitis; a study of forty-six adult patients. doi:10.1164/art.1954.69.3.370 Am Rev Tuberc 1954
Treatment of tuberculous meningitis. doi:10.1001/archpedi.1954.02050090261002 AMA Am J Dis Child 1954
Chemotherapy of tuberculosis. Miss Valley Med J 1954
[Tuberculous meningitis and miliary tuberculosis; case with combined therapy of isoniazid, dihydrostreptomycin and PAS]. Ugeskr Laeger 1954
[Tuberculostatics in pericarditis]. doi:10.1055/s-0028-1115405 Dtsch Med Wochenschr 1954
[Treatment of pulmonary tuberculosis with streptomycin P.A.S. and isoniazid associated]. Maroc Med 1954
Tuberculous meningitis treatment with streptomycin, para-aminosalicylic acid and promizole, isoniazid and streptomycin, and isoniazid. doi:10.1164/art.1954.69.2.192 names it Am Rev Tuberc 1954
[Present use of antibiotics in the treatment of pulmonary tuberculosis in France]. J Med (Oporto) 1954
[Combinations of the most recent specific drugs in therapy of meningeal tuberculosis in adults]. Minerva Med 1954
[Isonicotinic acid hydrazide combined with streptomycin and PAS in therapy of pulmonary tuberculosis]. Minerva Med 1954
[Early clinical results of a new antimycobacterial: paraaminosalicylic acid hydrazide]. Minerva Med 1954
[Treatment of cutaneous tuberculosis with paraaminosalicylic acid]. Pol Tyg Lek (Wars) 1954
The effect of probenecid on the therapeutic efficacy of PAS on experimental tuberculosis in guinea pigs. Proc Staff Meet Mayo Clin 1954
[Parenteral PAS therapy of chronic fistulous tuberculosis with amyloidosis]. Ned Tijdschr Geneeskd 1954
[Comparison of radioclinical and bacteriological results after six months continuous treatment of ulcero-nodular tuberculosis with combinations of I.N.H.-PAS and I.N.H.-streptomycin]. Rev Tuberc 1954
[Experimental studies of the bactericidal effects of antibacillary agents: clinical experiments]. Rev Tuberc 1954
Treatment of tuberculous meningitis. Harofe Haivri Heb Med J 1954
[Synergism of paraaminosalicylic acid with isonicotinic acid hydrazide]. Biologia (Bratisl) 1954
[p-Hydroxy-alpha-(methylaminomethyl)-benzyl alcohol tartrate sympatol, pentedrin) as an additional medications in chemotherapy of pulmonary tuberculosis]. Z Tuberk 1954
[Antibiotic therapy of bilateral renal tuberculosis]. Z Urol 1954
[Results of three months of combined isoniazid and PAS therapy of pulmonary tuberculosis; comparison with isoniazid therapy alone and with combined isoniazid, streptomycin and PAS]. Rev Tuberc 1954
[Meningitis tuberculosa in children]. Osterr Z Kinderheilkd Kinderfuersorge 1954
[Intravenous PAS-infusions in pulmonary tuberculosis]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1954
[Treatment of tuberculous meningitis]. Arch Argent Tisiol 1954
Variations in the PAS concentration in the blood and their influence on treatment of tuberculosis. Acta Tuberc Scand 1954
The effect of PAS on the cholesterol level in the blood. Acta Tuberc Scand 1954
Changes in plasma proconvertin and prothrombin during PAS therapy. Acta Tuberc Scand 1954
Treatment of bone and joint tuberculosis with streptomycin and P.A.S.; a follow-up study. Acta Tuberc Scand 1954
[Surgical treatment of extrapulmonary tuberculosis]. Zentralbl Chir 1954
[Observations on the course of skeletal tuberculosis treated with tuberculostatics]. Z Orthop Ihre Grenzgeb 1954
Treatment of tuberculosis of genito-urinary organs by drugs. Trans Am Assoc Genitourin Surg 1954
[Experimental contribution to the treatment of pulmonary tuberculosis with paraaminobenzoic acid]. Schweiz Z Tuberk 1954
Combination therapy of cavernous pulmonary tuberculosis with INH and intravenous PAS infusions. Schweiz Z Tuberk 1954
[Superinfection in medical injections during treatment of tuberculous meningitis]. Arch Fr Pediatr 1954
[Trial of treatment of tuberculosis in newborn from the preallergic period]. Arch Fr Pediatr 1954
Medical treatment of tuberculosis: antecedents and effects of bacterial resistance; U.S. Public Health Service cooperative clinical investigation. Trans Annu Meet Natl Tuberc Assoc 1954
Medical treatment of tuberculosis: oral antimicrobial therapy of unhospitalized tuberculosis patients. Trans Annu Meet Natl Tuberc Assoc 1954
Medical treatment of tuberculosis: streptomycin, isoniazid, and para-aminosalicylic acid in the treatment of pulmonary tuberculosis. names it Trans Annu Meet Natl Tuberc Assoc 1954
Surgical treatment and nonpulmonary tuberculosis: renal tuberculosis. Trans Annu Meet Natl Tuberc Assoc 1954
[Observed variations of bacillary sensitivity and their causes in chemotherapy of pulmonary tuberculosis]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1954
[PAS glucoside as an infusion solution in the treatment of cavernous pulmonary tuberculosis and tuberculous meningitis]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1954
[Treatment for tuberculous meningo-encephalitis with the combination of streptomycine, INH and PAS (para-aminosalycilic acid)]. names it Acta Paediatr Belg 1954
[Experiences with Volhard's water test in chemotherapy of urogenital tuberculosis]. Z Urol 1954
[Chemotherapy of urogenital tuberculosis]. Z Urol 1954
[Treatment of urogenital tuberculosis]. Z Urol 1954
[The frequency of complications in surgical collapse therapy after intracavitary injection therapy]. Schweiz Z Tuberk 1954
[Collapse therapy, antibiotics and absolute rest]. Rev Tuberc 1954
Indications and results of treatment of serous tuberculosis and pulmonary tuberculosis with ACTH associated with antibiotics. Rev Tuberc 1954
[Closing of tuberculous cavities by antibiotics: anatomical verifications]. Rev Tuberc 1954
[Anatomical study of tuberculous lesions treated by antibiotics]. Rev Tuberc 1954
[Graphic presentation of antibiotic therapy]. Rev Tuberc 1954
[Appearance of goiters in tuberculous treated and cured by PAS; effect of PAS on the thyroid gland of rats]. Rev Tuberc 1954
Results of three months of combined streptomycin, PAS and isoniazid therapy of pulmonary tuberculosis. Rev Tuberc 1954
[Clinical and radiologic development of two cases of caseous bronchopneumonia treated with a combination of streptomycin, isoniazid and paraaminosalicylic acid]. Pediatria (Napoli) 1954
[Diabetes insipidus with infantilism following recovery from tuberculous meningitis]. Arch Fr Pediatr 1954
[Effect of combined PAS and isonicotinic acid hydrazide on increase of the resistance of Mycobacterium tuberculosis in vitro]. doi:10.1007/BF02543734 Antonie Van Leeuwenhoek 1954
Investigation into the tuberculostatic activity of some derivatives of p. amino-benzoic acid. doi:10.1007/BF02543731 Antonie Van Leeuwenhoek 1954
[Therapeutic results in osteoarticular tuberculosis; critical studies on the use of coli-vaccine, conteben, PAS, streptomycin and neoteben in 410 patients, with special reference to the limits of chemotherapy]. Z Orthop Ihre Grenzgeb 1954
[Activity of associated chemotherapeutic agents in experimental tuberculosis of the guinea pig]. G Ital Chemioter 1954
Chemotherapy in tuberculosis. Acta Tuberc Scand 1954
Therapy of fistulas in osteoarticular tuberculosis with continuous irrigation with antituberculotics. Tuberkuloza 1954
[PAS resistance in relation to therapeutic results]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1954
[Remarks on G. W. Lauenstein's and W. Rockstroh's, additional experiences in treatment of tuberculosis with renal block]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1954
[Studies on simultaneous application of isonicotinic acid hydrazide and other useful antituberculotics. I. In vitro studies]. Acta Microbiol Acad Sci Hung 1954
[Osteoarticular tuberculosis and isoniazid alone or in combination; results in 555 cases treated in specialized sanatoriums]. Rev Tuberc 1954
[Results of treatment of ulcerocaseous pulmonary tuberculosis by combination of streptomycin, isoniazid and PAS, administered at least six months]. Rev Tuberc 1954
[Isonicotinic acid hydrazyde in pulmonary tuberculosis]. Acta Med Ital Mal Infett Parassit 1954
[Hostels for tuberculous patients; problem of initiative]. Rev Esp Tuberc 1954
Combination of PAS with INH and streptomycin in slow perfusions, in the treatment of pulmonary tuberculosis. Mars Med 1954
[Results of treating common pulmonary tuberculosis with a combination of the three major antibiotics; based on 70 cases]. Mars Med 1954
Problems of drug resistance. doi:10.1093/oxfordjournals.bmb.a069388 Br Med Bull 1954
[Tuberculous meningitis, anatomically almost cured by chemotherapy]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1954
[Recent studies on antimycobacterial activity of the blood of rabbits treated with paraaminosalicylic acid hydrazide]. Arch Ital Sci Farmacol 1954
[P.A.S. in the treatment of pulmonary tuberculosis]. Rev Med Nancy 1954
Cancer of the larynx and its relations with tuberculosis. Rev Laryngol Otol Rhinol (Bord) 1954
[Combination of various antituberculous drugs with isoniazid and its effects on hydrazide resistance]. Rass Medica 1954
Indications for excisional pulmonary surgery in tuberculosis treated with isoniazides combined with streptomycin and para-aminosalicylic acid; a special study of sputum-negative cases. names it Q Bull Sea View Hosp 1954
[Chaulmoogra oil, paraaminosalicylic acid, and thiosemicarbazones in tuberculous meningitis]. Acta Pediatr Esp 1954
RECIPE: streptomycin, PAS and isoniazid. Med World 1954
The treatment of tuberculous pericarditis. doi:10.1161/01.cir.9.1.17 Circulation 1954
Streptomycin and PAS vs. streptomycin, PAS and isoniazid in the treatment of pulmonary tuberculosis. Can Med Assoc J 1954
PROGRESS report on therapeutic and toxic effects of combinations of isoniazid, streptomycin, and para-aminosalicylic acid; United States Public Health Service cooperative investigation of antimicrobial therapy of tuberculosis. names it Am Rev Tuberc 1954
[Calcium and sodium blood levels during intravenous PAS and sodium therapy]. Schweiz Med Wochenschr 1953
[Therapy of pulmonary tuberculosis with paraaminosalicylic acid: intravenous administration of PAS; a study of 28 clinical cases]. Scalpel (Brux) 1953
[Study on the resistance of Mycobacterium tuberculosis to various drugs on in experimental tuberculosis]. Sperimentale 1953
[PAS and isoniazid therapy of miliary tuberculosis with meningitis; case report]. Tidsskr Nor Laegeforen 1953
[Therapy of pulmonary tuberculosis with paraaminosalicylic acid: intravenous administration of PAS; a study of 28 cases]. Scalpel (Brux) 1953
Therapy of cutaneous tuberculosis. J Med (Oporto) 1953
[Virulence of human strains of Mycobacterium tuberculosis following contact with sub-inhibiting dose of PAS]. Boll Soc Ital Biol Sper 1953
[Virulence of human Mycobacterium tuberculosis resistant to PAS]. Boll Soc Ital Biol Sper 1953
[Combined therapy of the pulmonary tuberculosis with streptomycin, PAS and isoniazid]. Lotta Tuberc 1953
[Practical significance of perfecting of technics of bacteriological investigation for bacteriologic diagnosis of pulmonary tuberculosis]. Hoja Tisiol 1953
[Prolonged therapy of pulmonary tuberculosis with antibiotics, especially with intravenous perfusions (PAS) and aerosols (PAS and isoniazide)]. Gaz Med Fr 1953
[Pulmonary tuberculosis]. Gaz Med Fr 1953
Antagonism of chemotherapeutic activity of p-aminosalicylic acid in experimental tuberculosis by p-aminobenzoic acid. doi:10.3181/00379727-84-20700 Proc Soc Exp Biol Med 1953
[Carbohydrate metabolism and antitoxic function of the liver during streptomycin and PAS therapy of pulmonary tuberculosis]. Klin Med (Mosk) 1953
[Results of application of streptomycin associated with paraaminosalicylic acid in the treatment of pulmonary tuberculosis]. Klin Med (Mosk) 1953
Dramamine (dimenhydrinate) as an adjunct to PAS (para-aminosalicylic acid) in the treatment of pulmonary tuberculosis. doi:10.1378/chest.24.6.601 names it Dis Chest 1953
Clinical observations on viomycin sulphate in the treatment of tuberculosis. doi:10.1378/chest.24.6.591 Dis Chest 1953
Treatment of tuberculous meningitis. doi:10.1136/bmj.2.4846.1130 Br Med J 1953
Tuberculous meningitis: combined therapy with cortisone and antimicrobial agents. doi:10.1056/NEJM195311192492101 N Engl J Med 1953
[Case of bilateral renal tuberculosis with recovery after conservative therapy]. Ned Tijdschr Geneeskd 1953
ISONIAZID in combination with streptomycin or with P.A.S. in the treatment of pulmonary tuberculosis; fifth report to the Medical Research Council by their Tuberculosis Chemotherapy Trials Committee. Br Med J 1953
[Indications of intravenous perfusion of PAS in therapy of pulmonary tuberculosis]. Tuberkuloza 1953
[Behavior of experimental tuberculosis in guinea pig following administration of para-aminosalicylic acid hydrazide]. names it Arch Maragliano Patol Clin 1953
[Combination of PAS with isoniazid and potassium iodide in therapy of experimental tuberculosis in guinea pigs]. Arch Maragliano Patol Clin 1953
[Treatment of common pulmonary tuberculosis at the Libreville Hospital; isonicotinic acid hydrazide in combination]. Med Trop (Mars) 1953
[Principles in the treatment of urogenital tuberculosis]. Med Monatsschr 1953
Treatment of pulmonary tuberculosis with antibiotics in the Sanatorium Averroes in Alep. J Med Liban 1953
[Present results of the treatment of meningeal tuberculosis in the child with streptomycin, PAS and isoniazid at l'Hôpital des Enfants A. Kyriskou, Athènes]. Helv Paediatr Acta 1953
The influence of long-term chemotherapy on the surgery of pulmonary tuberculosis. J Thorac Surg 1953
Control study of combinations of synthetic and antibiotic drugs in the treatment of pulmonary tuberculosis. J Med Assoc Ga 1953
Isonicotinic acid hydrazide and para-aminosalicylic acid in the treatment of pulmonary tuberculosis. doi:10.1007/BF02949929 names it Ir J Med Sci 1953
The use of the iso-nicotinic acid hydrazides in the treatment of tuberculosis. doi:10.1378/chest.24.5.535 Dis Chest 1953
Clinical trial of para-isobutoxybenzaldehyde thiosemicarbazone in eight cases of tuberculosis. doi:10.1164/art.1953.68.5.799 names it Am Rev Tuberc 1953
Para-isobutoxybenzaldehyde thiosemicarbazone in pulmonary tuberculosis. doi:10.1164/art.1953.68.5.796 names it Am Rev Tuberc 1953
Para-isobutoxybenzaldehyde thiosemicarbazone in the treatment of pulmonary tuberculosis. doi:10.1164/art.1953.68.5.794 names it Am Rev Tuberc 1953
Failure of para-isobutoxybenzaldehyde thiosemicarbazone as an antituberculous drug in man. doi:10.1164/art.1953.68.5.791 names it Am Rev Tuberc 1953
Cultural properties of M. tuberculosis in resected pulmonary lesions of patients treated with streptomycin and para-aminosalicylic acid. doi:10.1164/art.1953.68.5.727 names it Am Rev Tuberc 1953
[Epidemic hepatitis or inoculation hepatitis during intravenous PAS treatment]. Presse Med (1893) 1953
[Combined chemical and antibiotic therapy of tuberculosis]. Nord Med 1953
[Treatment and prognosis of tuberculous meningitis]. Nord Med 1953
[The treatment of tuberculous meningitis]. Rev Clin Esp 1953
[Contribution to the study of the mechanism of action of PAS]. Minerva Pediatr 1953
[Combined therapy of meningeal tuberculosis with isonicotinic acid hydrazide and paraaminosalicylic acid]. Dtsch Gesundheitsw 1953
[Treatment of tuberculosis]. Minerva Med 1953
[Therapy and management in the evolution of meningeal tuberculosis]. Concours Med 1953
[Preliminary results in tuberculosis therapy with the isonicotinic acid ester of p-aminosalicylic acid]. Praxis 1953
[Preliminary data on a new antituberculosis drug, the isonicotinic acid hydrazide ester of p-aminosalicylic acid]. Praxis 1953
[Injectable PAS, 8000 intravenous perfusions]. Maroc Med 1953
[Results of the therapy of 70 pulmonary tuberculosis patients with isoniazid alone and with streptomycin and PAS]. Maroc Med 1953
[The activity of the blood of rabbits treated with p-aminosalicylic acid hydrazide against Mycobacterium tuberculosis]. Arch Ital Sci Farmacol 1953
Studies on the resistance of tubercule bacilli to chemotherapeutic agents. II. In vivo. Sci Rep Res Inst Tohoku Univ Med 1953
Studies on the resistance of tubercle bacilli to chemotherapeutic agents. I. In vitro. Sci Rep Res Inst Tohoku Univ Med 1953
[Modern antituberculous chemotherapy]. Med Colon 1953
The effect of streptomycin, with and without para-amino-salicylic acid, on the pathological histology of renal tuberculosis. doi:10.1002/path.1700660205 names it J Pathol Bacteriol 1953
Coexistent pulmonary tuberculosis and systemic blastomycosis. doi:10.1164/art.1953.68.4.615 Am Rev Tuberc 1953
Isoniazid and isoniazid; para-aminosalicylic acid in the treatment of tuberculous sinuses and fistulas. doi:10.1164/art.1953.68.4.535 names it Am Rev Tuberc 1953
Recent trends in the management of tuberculosis of the cervix. J Int Coll Surg 1953
The treatment of female genital tuberculosis with streptomycin and para-aminosalicylic acid. doi:10.1016/s0002-9378(16)38560-x names it Am J Obstet Gynecol 1953
[Organization and funds for systematic mass examinations in prevention of tuberculosis]. Dia Med 1953
[The present state of chemotherapy of tuberculosis]. Dtsch Gesundheitsw 1953
[Our results and their prognostic consequences in therapy of meningeal tuberculosis in children]. J Sci Med Lille 1953
[Results of the combined therapy with rimifon, streptomycin and paraaminosalicylic acid in tuberculosis]. Praxis 1953
[Tuberculosis in Mozambique, ten-year program for control]. An Inst Med Trop (Lisb) 1953
[Data collected by the first survey made in Angola to determine the extent of tuberculous infection]. An Inst Med Trop (Lisb) 1953
[Complications in combined therapy with streptomycin and PAS]. Probl Tuberk 1953
[Result of PAS therapy in ambulatory conditions]. Probl Tuberk 1953
[Serum proteins in the evaluation of the effects of antibacterial drugs in tuberculosis]. G Ital Della Tuberc 1953
[Blood circulation in the pharyngeal mucosa as an index of autonomic regulation in tuberculosis and the reaction mechanism to neoteben, PAS, streptomycin & conteben]. Z Laryngol Rhinol Otol 1953
[Endovenous infusion of PAS in tuberculous meningitis]. Rev Esp Otoneurooftalmol Neurocir 1953
[Clinical experience obtained with isoniazid in hospital practice]. Medicina (Madr) 1953
[Tuberculosis of the lacrimal sac and dacryocystorhinostomy]. doi:10.1159/000301490 Ophthalmologica 1953
[Contribution of tomography to the study of the changes of the volume and site of pulmonary cavities]. Med Contemp 1953
[Treatment of tuberculous eye diseases with streptomycin associated with PAS]. Vestn Oftalmol 1953
[Streptomycin and PAS therapy of tuberculosis in children and adolescents]. Sov Med 1953
The treatment of tuberculosis in the guinea-pig with streptomycin alone or in combination with dapsone, thiosemicarbazones, PAS, or sodium iodide. doi:10.1111/j.1476-5381.1953.tb00791.x Br J Pharmacol Chemother 1953
Lichen planus-like drug eruption due to para-amino salicylic acid; report of 5 cases, two showing mouth lesions. doi:10.1038/jid.1953.83 names it J Invest Dermatol 1953
Aplastic anemia following the use of streptomycin and paraaminosalicylic acid; report of a fatality. doi:10.1164/art.1953.68.3.455 Am Rev Tuberc 1953
[Chemotherapy of tuberculosis]. Ugeskr Laeger 1953
[Alternating therapy of pulmonary tuberculosis; intermittent administration of streptomycin-PAS and periodically alternated with isoniazide-PAS]. Schweiz Med Wochenschr 1953
[Simultaneous use of isoniazide and PAS in tuberculosis therapy]. Orv Hetil 1953
[Antibiotic and chemotherapy of tuberculosis]. Dia Med 1953
[Study of Italian centers for therapy of meningeal and miliary tuberculosis]. Dia Med 1953
[The combined effects of different tuberculocides with isonicotinic acid hydrazide]. Ann Inst Pasteur (Paris) 1953
[Tuberculous meningitis]. doi:10.4067/s0370-41061953000800004 Rev Chil Pediatr 1953
[PAS perfusions and isonicotinic hydrazide in treatment of tuberculous meningitis]. Turk Tip Cemiy Mecm 1953
[Current state of medical therapy of tuberculosis in children]. Prensa Med Mex 1953
[Combined treatment of tuberculous meningitis with prolonged endovenous infusion of PAS]. Acta Pediatr Esp 1953
[Treatment of tuberculous meningitis]. Acta Pediatr Esp 1953
[Rest and antibiotics in the treatment of ulcerative pulmonary tuberculosis]. Acta Tuberc Belg 1953
[The place of antibiotics in the treatment of pulmonary tuberculosis]. Scalpel (Brux) 1953
[Therapy of periphlebitis tuberculosa by means of electrocoagulation with combined streptomycin and PAS]. doi:10.1159/000301477 Ophthalmologica 1953
Allergic reaction to paraaminosalicylic acid; report of case. Minn Med 1953
Infrequent appearance of drug resistant strains of tubercle bacilli in experimental animals treated with streptomycin and p-amino-salicylic acid. doi:10.1128/jb.66.2.229-237.1953 J Bacteriol 1953
[Combined therapy in bacterial meningitis]. J Med (Oporto) 1953
RESISTANT tubercle bacilli. Lancet 1953
EMERGENCE of bacterial resistance in pulmonary tuberculosis under treatment with isoniazid, streptomycin plus P.A.S. and streptomycin plus isoniazid. Lancet 1953
LABORATORY techniques for the determination of sensitivity of tubercle bacilli to isoniazid, streptomycin, and P.A.S. Lancet 1953
Control study of comparative efficacy of isoniazid, streptomycin-isoniazid, and streptomycin; para-aminosalicylic acid in pulmonary tuberculosis therapy. IV. Report on forty-week observations on 583 patients with streptomycin susceptible infections. doi:10.1164/art.1953.68.2.264 names it Am Rev Tuberc 1953
[Chemotherapy of tuberculosis with p-aminosalicylic acid; experimental studies on PAS and sodium-PAS blood level after administration]. Arztl Forsch 1953
Isoniazid and streptomycin in the treatment of pulmonary tuberculosis. doi:10.1001/jama.1953.03690100004002 J Am Med Assoc 1953
[PAS therapy of tuberculosis of the peripheral lymph nodes]. Probl Tuberk 1953
[Possibility of medical cure of renal tuberculosis]. Lille Chir 1953
Modern chemotherapy of genito-urinary tuberculosis. Q Bull Sea View Hosp 1953
[Diffuse resistance to PAS of Mycobacterium tuberculosis isolated from tuberculous patients in Bologna]. Nuovi Ann Ig Microbiol 1953
[Associated isoniazid and PAS in the treatment of pulmonary tuberculosis; clinical note]. G Ital Della Tuberc 1953
[Therapy of male genital bacillosis]. Bord Chir 1953
The effect of antituberculous treatment on sterility due to genital tuberculosis. Acta Med Orient 1953
[On the tolerance of various PAS preparations]. Ther Ggw 1953
[Comparative data on streptomycin and PAS therapy of scrofulous diseases of the eye]. Vestn Oftalmol 1953
Experimental studies on the synergic effect of antituberculous agents. III. Influence of the combined application of antituberculous agents on the resistance of in vivo tubercle bacilli. Kekkaku 1953
Tuberculosis causing leukaemoid reaction and other blood disorders; results of treatment by streptomycin. Arch Middx Hosp 1953
Chemotherapy of pulmonary tuberculosis. Proc R Soc Med 1953
CHEMOTHERAPY of miliary tuberculosis and tuberculous meningitis; a Public Health Service cooperative investigation. Pediatrics 1953
Reaction to PAS. Can Med Assoc J 1953
Dangers of chemotherapy in pulmonary tuberculosis; report of a case of acquired hypersensitivity to streptomycin and para-amino-salicylic-acid. names it Br J Tuberc Dis Chest 1953
Hepatitis and hypokalemia in tuberculosis. doi:10.1164/art.1953.68.1.136 Am Rev Tuberc 1953
[Comparative clinical results of the combination of isonicotinic acid hydrazide and PAS in pulmonary tuberculosis]. Schweiz Med Wochenschr 1953
[Tuberculous cervicitis]. J Med (Oporto) 1953
[Icterus during intravenous PAS therapy]. Bull Mem Soc Med Hop Paris 1953
Experimental study of combined anti-tuberculosis medication. Sem Hop 1953
[Chemotherapy of tuberculosis]. Schweiz Med Wochenschr 1953
[Endovenous administration of PAS in postoperative therapy of pulmonary tuberculosis]. Clin Nuova Rass Prog Med Int 1953
[Chemotherapy of tuberculosis]. Schweiz Med Wochenschr 1953
Treatment of primary pulmonary tuberculosis with P.A.S. doi:10.1136/bmj.1.4822.1247 Br Med J 1953
Streptomycin resistance in patients with pulmonary tuberculosis previously treated with P.A.S. alone. doi:10.1136/bmj.1.4822.1244 Br Med J 1953
[Treatment of meningeal tuberculosis; general aspects]. J Med Lyon 1953
[Study of the sensitivity of the Koch bacillus in vitro to the antibiotics in use]. Rev Chil Pediatr 1953
[Pott's disease in general practice]. Bol Cult Inf Cons Gen Col Med Esp 1953
The influence of various chemicals upon oxygen consumption of the Mycobacterium tuberculosis. Sci Rep Res Inst Tohoku Univ Med 1953
The effects of benzochinon monosemicarbazon, PAS and PAS combined with benemide on experimental tuberculosis in mice. Sci Rep Res Inst Tohoku Univ Med 1953
[Studies on adequate diet in tuberculosis]. Rev Esp Tuberc 1953
[Treatment of experimental tuberculosis in guinea pigs with isoniazide-streptomycin and isoniazide-PAS combinations]. J Med Bord 1953
[Isoniazide-streptomycin and isoniazide-PAS combination in the treatment of tuberculosis]. J Med Bord 1953
[Transformation of tuberculous lesions in antibiotic therapy]. J Med Bord 1953
[Isoniazide injections, alone and in combination with PAS in pulmonary tuberculosis]. J Med Bord 1953
[Combination treatment of tuberculosis; PAS-isoniazid perfusions]. J Med Bord 1953
Experimental studies on the synergic effect of antituberculous agents. II. Chemotherapeutic effect of antituberculous agents on the experimental tuberculosis of guinea-pigs: cepharanthin, PAS, tibione, streptomycin and vitamin K3 applied alone or in combination. Kekkaku 1953
[Studies on chaulmoogra oil, PAS, and thiosemicarbazone in tuberculous meningitis]. Acta Pediatr Esp 1953
Two cases of neutropenia in children possibly due to streptomycin and P.A.S.A. therapy. doi:10.1016/s0041-3879(53)80128-5 Tubercle 1953
The use of benemid to enhance blood-levels of sodium para-aminosalicylate (PAS). doi:10.1016/s0041-3879(53)80126-1 names it Tubercle 1953
Streptomycin, PAS and isoniazid in renal tuberculosis. doi:10.1016/S0022-5347(17)68142-4 J Urol 1953
Complications following the use of streptomycin and para-amino-salicylic acid in advanced renal tuberculosis. doi:10.1111/j.1464-410x.1953.tb09249.x names it Br J Urol 1953
The newer drugs and their indications in childhood. doi:10.1080/00325481.1953.11711397 Postgrad Med 1953
[Experiences with para-hydroxybenzalisonicotinic acid hydrazone flavoteben in the treatment of pulmonary tuberculosis]. names it Arztl Wochensch 1953
[PAS excretion and kidney function after longacid]. Arztl Forsch 1953
Derivative of p-aminosalicylic acid with enhanced antituberculous activity. doi:10.1016/s0140-6736(53)92066-2 Lancet 1953
[Experiences with tizide in treatment of various forms of tuberculosis]. Wien Med Wochenschr 1953
[Epilepsy as a contraindication for isoniazid therapy]. Rev Sanid Asist Soc 1953
Sensitivity of Koch's bacillus to PAS; clinical and bacteriological aspects. Rev Sanid Asist Soc 1953
[Personal experiences in modern therapy of primary infections in infant and child]. Tuberkuloza 1953
[Treatment of tuberculous meningitis in the child]. Prensa Pediatr Rev Am Puericu Pediatr 1953
[Tuberculosis of the iris in a young child; treatment with antibiotics]. Bull Soc Ophtalmol Fr 1953
[Ocular manifestations of tuberculous meningitis; importance of study of them for early diagnosis and effective therapeutic management]. Medicina (Madr) 1953
[On PAS calcium salts]. Tuberkulosearzt 1953
[Paraaminosalicylic acid in complex therapy of osteoarticular tuberculosis in children]. Probl Tuberk 1953
[Result of the treatment of osteoarticular tuberculosis in children with PAS]. Probl Tuberk 1953
[Application of paraaminosalicylic acid in the treatment of osseous tuberculosis]. Probl Tuberk 1953
[Treatment of osteoarticular tuberculosis with streptomycin associated with PAS at a station and by public health nurse]. Probl Tuberk 1953
The future of subjects of surgery of urogenital tuberculosis. Minerva Urol 1953
[The future of subjects of surgery of urogenital tuberculosis]. Minerva Urol 1953
[Remote results of surgical and medical therapy of bilateral renal tuberculosis]. Minerva Urol 1953
[Current problems in new drug therapy of cutaneous tuberculosis, including isonicotinic acid hydrazide]. Minerva Dermatol 1953
[Lysozyme and lipase activity of the blood of subjects of osseous and primary osteoarticular tuberculosis during and after paraaminosalicylic acid therapy]. Minerva Ortop 1953
[Treatment of tuberculous meningitis with intramuscular and intraspinal streptomycin and with intravenous PAS, addition of isonicotinic acid hydrazide]. Med Esp 1953
Acquired hypersensitivity to sodium PAS and streptomycin. doi:10.1016/s0041-3879(53)80064-4 Tubercle 1953
Tuberculosis of the tongue treated with streptomycin and PAS. doi:10.1378/chest.23.5.582 Dis Chest 1953
EFFECT of streptomycin on the emergence of bacterial resistance to isoniazid; a United States Public Health Service cooperative investigation. Am Rev Tuberc 1953
The intravenous use of a combination of sodium para-aminosalicylate and polyvinyl pyrrolidone in the chemotherapy of tuberculosis. doi:10.1097/00000441-195305000-00014 names it Am J Med Sci 1953
[Considerations on a case of tuberculous meningitis treated with thiosemicarbazone (conteben), dihydrostreptomycin and paraaminosalicylic acid (paracipan)]. Dia Med 1953
[Behavior of blood and cerebrospinal fluid levels of para-aminosalicylic acid in children affected with meningeal tuberculosis, with special reference to the blood-spinal fluid quotient]. names it Minerva Pediatr 1953
[Treatment of female genital tuberculosis; combination of local para-aminosalicylic acid and dihydrostreptomycin]. names it Sem Med 1953
[Inhibition of PAS elimination by sulfalkylamides of benzoic acid]. Dtsch Gesundheitsw 1953
[Experience with the treatment of the corneal tuberculosis with PAS]. Cesk Oftalmol 1953
[Clinical test of TB 1 in pulmonary tuberculosis]. Rev Sanid Milit Argent 1953
[Effect of PAS on the sensitivity to isoniazide of some strains of isoniazide resistant Mycobacterium tuberculosis]. C R Seances Soc Biol Fil 1953
[PAS glycosuria and hyperglycemia]. Tuberkulosearzt 1953
[Clinical and bacterial resistance during treatment of tuberculosis with streptomycin, PAS, TB 1 and INH]. Tuberkulosearzt 1953
[Antibiotics in surgical treatment of pulmonary tuberculosis]. Pol Przegl Chir 1953
[Studies on sensitivity of tuberculous patients to paraaminosalicylic acid]. Klin Med (Mosk) 1953
Drug therapy in tuberculosis. N C Med J 1953
Chronic disseminated tuberculosis; a report of two cases. Br J Tuberc Dis Chest 1953
Control study of comparative efficacy of isoniazid, streptomycin-isoniazid, and streptomycin-para-aminosalicylic acid in pulmonary tuberculosis therapy. III. Report on twenty-eight-week observations on 649 patients with streptomycin-susceptible infections. doi:10.1164/art.1953.67.4.539 names it Am Rev Tuberc 1953
[Antithyroid action of paraaminosalicylic acid and isonicotinic acid hydrazide]. Riforma Med 1953
[Modified intravenous PAS medication]. Dtsch Gesundheitsw 1953
[Remote results of streptomycin and PAS therapy of pulmonary caverns; comparison with early results of isonicotinic acid hydrazide]. Minerva Med 1953
[Isoniazid perfusions]. Sem Hop 1953
[Electron microscope research on morphological alterations of bacillus tuberculosis caused by various drugs]. Minerva Med 1953
STREPTOMYCIN and isoniazid. Br Med J 1953
[Minimum plan for the development of antituberculosis campaign in Mexico]. Rev Mex Tuberc Enferm Apar Respir 1953
[Curative action of isonicotinic acid hydrazide (INH) on infection induced in the mouse by strain 607 of Mycobacterium paratuberculosis]. Ann Inst Pasteur (Paris) 1953
[PAS hyrazide in experimental tuberculosis in the guinea pig]. Boll Soc Ital Biol Sper 1953
[Paraaminosalicylic acid and ocular tuberculosis]. Rev Bras Oftalmol 1953
[Effect in vitro of a new drug in the treatment of tuberculosis; para-aminosalicylic acid]. names it Arch Maragliano Patol Clin 1953
Intermittent viomycin therapy in pulmonary tuberculosis, employed singly and in combination with intermittent streptomycin or daily para-aminosalicylic acid. doi:10.1378/chest.23.3.241 names it Dis Chest 1953
[Combined application of nicotinic acid hydrazide and other antituberculotic drugs]. Orv Hetil 1953
The place of chemotherapy in planned treatment regimes for pulmonary tuberculosis. doi:10.1016/s0041-3879(53)80014-0 Tubercle 1953
AMERICAN College of Chest Physicians; report of the committee on chemotherapy and antibiotics. doi:10.1378/chest.23.2.217 Dis Chest 1953
The medical management of tuberculosis. Miss Doct 1953
[Resistance determination in clinical practice]. Ned Tijdschr Geneeskd 1953
[Sensitization to PAS and streptomycin]. Rev Med Liege 1953
Effect of P.A.S. on the thyroid gland. doi:10.1136/bmj.1.4800.29 Br Med J 1953
[Effect of sodium salt of PAS on experimental tuberculosis of the eye in rabbits]. Rad Med Fak Zagrebu 1953
[Study on the effect of isonicotinic acid hydrazide and p-aminosalicylic acid on experimental tuberculosis in guinea pigs]. Acta Pharm Jugosl 1953
[False cavitary images]. Gaz Med Port 1953
[Present orientation in drug therapy of tuberculosis]. Gaz Med Port 1953
[Isonicotinic acid hydrazide in therapy of tuberculosis]. Ann Ist Carlo Forlanini 1953
Tuberculostatic properties of p-aminosalol (phenyl-p-aminosalicylate) derivatives. doi:10.1111/j.1600-0773.1953.tb02958.x Acta Pharmacol Toxicol (Copenh) 1953
[Treatment of tuberculous meningoencephalitis in the child]. Acta Paediatr Belg 1953
[Experimental studies with isoniazid and other hydrazide derivatives]. Z Tuberk 1953
The unhospitalized tuberculosis patient: available data bearing on this problem. Trans Annu Meet Natl Tuberc Assoc 1953
Effect of antibacterial agents on chronic pulmonary tuberculosis in rabbits: a roentgenographic, pathologic, and bacteriologic study. Trans Annu Meet Natl Tuberc Assoc 1953
A controlled study of isoniazid and iproniazid. Trans Annu Meet Natl Tuberc Assoc 1953
Prolonged administration of streptomycin-PAS therapy in pulmonary tuberculosis. Trans Annu Meet Natl Tuberc Assoc 1953
[Clinical and bacteriological resistance to INH and INH + PAS]. Schweiz Z Tuberk 1953
[Some observations on the resistance of tubercle bacilli to isoniazid]. Schweiz Z Tuberk 1953
[Development of resistance of tubercle bacilli to antibiotics and its effect on the course of tuberculosis]. Schweiz Z Tuberk 1953
[The clinical significance of the development of resistance by the tubercle bacillus]. Schweiz Z Tuberk 1953
[Combined therapy: pneumoperitoneum, isoniazid and PAS in cavitary pulmonary tuberculosis]. Rev Tuberc 1953
[Aerosol therapy (PAS and isoniazid) in the treatment of pulmonary tuberculosis]. Rev Tuberc 1953
[Conservative treatment of tuberculous cavitation by absolute bedrest and antibiotics]. Rev Tuberc 1953
[Treatment of tuberculosis of the female genitalia: combination of local paraaminosalicylic acid and dihydrostreptomycin]. Rev Obstet Ginecol Venez 1953
[Results of local roentgenotherapy associated with PAS in the treatment of pulmonary tuberculosis; remote results]. Radioter Radiobiol Fis Medica 1953
[Action of some drugs on the metabolism of lung tissues and the action of some biochemical constituents of lung on the multiplication of Mycobacterium tuberculosis]. Bull Soc Chim Biol (Paris) 1953
[Clinicopathological conference: comments on the study of the first 400 patients]. Arch Argent Tisiol 1953
[Preventive treatment of primary tuberculosis with PAS; comparison with a non-treated group]. Arch Fr Pediatr 1953
PAS allergy; a severe case of oedema of the gastric mucosa. Acta Tuberc Scand 1953
Resistance determination on tubercle bacilli in sputa with special reference to the Pryce method. I. Acta Tuberc Scand 1953
[Antibiotic and surgical therapy of pulmonary tuberculosis in children]. Arch Kinderheilkd 1953
[Effective tuberculostatic minimal concentration of streptomycin, conteben, PAS and neoteben in vitro and resistance phenomenon]. Z Hyg Infektionskr 1953
[The sanatorium and urinary tuberculosis; surveillance of medical treatment, verification of results; first trial of STA-PAS and rimifon mixture]. J Urol Medicale Chir 1953
Local treatment of tuberculous tension cavities. J Egypt Med Assoc 1953
A critical review of cases of pulmonary tuberculosis treated with and without antimicrobial drugs (streptomycin & P.A.S). J Egypt Med Assoc 1953
Normal sensitivity of non-treated tubercle bacilli in slide microculture to streptomycin, dehydrostreptomycin, PAS, TB1 and isoniazid. doi:10.1007/BF02148682 Beitr Klin Tuberk Spezif Tuberkuloseforsch 1953
[Studies on bacteriostatic and bactericidal effect of streptomycin, PAS, TB1 and rimifon during therapy of tuberculosis]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1953
[Rehabilitation of cured tuberculous patients, employment in tuberculosis hospitals]. Arch Argent Tisiol 1953
[Streptomycin combined with PAS or with PAS and TB 1 in pulmonary tuberculosis; bacteriological and clinical results]. Schweiz Z Tuberk 1953
[Resistance determination of tubercle bacteria against streptomycin, PAS, conteben, isoniazid and paratebin]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1953
[Tuberculosis therapy with antidiuretics]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1953
The combined action of p-aminosalicylic acid and streptomycin with isonicotinic acid hydrazide in vitro. doi:10.1007/BF02594849 Antonie Van Leeuwenhoek 1953
[Studies on combined therapy of experimental tuberculosis in guinea pig with isoniazid, streptomycin and PAS; tuberculosis due to streptomycin sensitivity Mycobacterium tuberculosis]. Rev Tuberc 1953
[PAS and Charpy's therapy in tuberculous lupus]. Rev Med Nancy 1953
Chemotherapy of tuberculosis; comparative experimental study. J Egypt Med Assoc 1953
[The clinical value of combined streptomycin and paraaminosalicylic acid therapy in pulmonary tuberculosis]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1953
[Studies on the effects of modern tuberculosis drugs on Mycobacterium tuberculosis, with special reference to natural, unspecific, phagocytosis]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1953
[Verified anatomical cure of renal tuberculosis treated with streptomycin and PAS]. J Urol Medicale Chir 1953
Intermittent and daily injections of streptomycin with PAS in premedication in pulmonary tuberculosis surgery. Poumon 1953
[Antituberculous agents]. Medicamenta (Madr) 1953
[Treatment of pulmonary tuberculosis with isonicotinic acid hydrazide for six months in a sanatorium]. Gaz Med Fr 1953
[The effect of the modern therapy on the late course of experimental tuberculosis]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1953
[Effectiveness of tuberculostatic substances in human organism]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1953
[PAS in cutaneous tuberculosis]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1953
[Results of the treatment of cutaneous tuberculosis with PAS]. Vestn Venerol Dermatol 1953
[Streptomycin and PAS in the treatment of ulcerative enterocolitis in tuberculosis]. Probl Tuberk 1953
[PAS and streptomycin therapy of tuberculosis]. Sov Med 1953
Clinical experience with isoniazid in childhood tuberculous meningitis. Pediatrics 1953
Studies on the virulence of tubercle bacilli; variations in virulence effected by tween 80 and thiosemicarbazone. doi:10.1084/jem.97.1.1 J Exp Med 1953
An unusual case of PAS allergy. doi:10.1016/s0041-3879(53)80043-7 Tubercle 1953
The use of INH in pulmonary tuberculosis. doi:10.1016/s0041-3879(53)80037-1 Tubercle 1953
Control study of comparative efficacy of isoniazid streptomycin-isoniazid, and streptomycin-para-aminosalicylic acid in pulmonary tuberculosis therapy. doi:10.1164/art.1953.67.1.108 names it Am Rev Tuberc 1953
Failure of P-(di-n-propylsulfamyl)-benzoic acid (benemid) to influence p-aminosalicylic acid blood levels. doi:10.1378/chest.23.1.90 Dis Chest 1953
[Importance of PAS in the treatment of microcavitary pulmonary tuberculosis]. Dia Med 1952
[Continuous intravenous infusion of PAS in tuberculous meningitis]. Dia Med 1952
[Therapy of tuberculous meningitis in children]. Sem Med 1952
[A case of tuberculous cervical lymphadenitis cured by local use of combined streptomycin and PAS]. Sem Med 1952
Association of antibiotics and chemotherapy in different forms of pulmonary tuberculosis; personal experience on technic and results. Rev Asoc Med Argent 1952
[Pseudoremissions in bone and joint tuberculosis after use of tuberculotatic drugs]. Med Klin 1952
Streptomycin and para-amino-salicylic acid in the treatment of renal tuberculosis; some clinical experiences. names it Acta Chir Scand 1952
[Value of chemotherapy in light cases of pulmonary tuberculosis]. Nord Med 1952
[Therapy of cavernous lobitis by PAS in intermittent infusion]. Gaz Med Fr 1952
[Early healing of the caverns due to antibiotic therapy]. Tuberk Kerdesei 1952
[Further observations on the antitubercular action in vitro of para-aminothiosalicylic acid]. names it Boll Soc Ital Biol Sper 1952
[Intravenous perfusion of PAS in the treatment of pulmonary tuberculosis. Comparison with the action of isonicotinic hydrazide]. G Clin Med 1952
[Tuberculosis of the female genital]. C R Soc Fr Gyncol 1952
[Two use of verrucose tuberculosis of the left buttock]. Arch Belg Dermatol Syphiligr 1952
Toxic reactions in the use of para amino salicylic acid. names it N Z Med J 1952
Chemotherapy of experimental tuberculosis in embryonated chicken eggs. III. Chemotherapy of lesions caused by BCG bacillus. Ann Tuberc 1952
[PAS in the treatment of tuberculosis]. Acta Tuberc Belg 1952
Protection of guinea pigs infected intradermally with tuberculosis by streptomycin, isonicotinic acid hydrazide and PAS. Ann Inst Pasteur (Paris) 1952
Streptomycin in the treatment of bone and joint tuberculosis. Proc R Soc Med 1952
The chemotherapy of urinary tuberculosis. Edinb Med J 1952
Treatment of tuberculous periphlebitis of the retina with streptomycin, PAS, and electrocoagulation. Cesk Oftalmol 1952
Toxic psychiatric manifestations in the treatment of tuberculosis with sodium para-aminosalicylate. doi:10.1016/s0041-3879(52)80095-9 names it Tubercle 1952
Development of resistance by Mycobacterium tuberculosis to streptomycin, viomycin, and paraaminosalicylic acid. AMA Am J Dis Child 1952
[Preliminary trials of rimifon therapy of tuberculosis]. Praxis 1952
Current status of antimicrobial therapy in tuberculosis. doi:10.1001/jama.1952.03680120006002 J Am Med Assoc 1952
[Organization and results of systematic examination of communities for tuberculosis control]. Rev Mex Tuberc Enferm Apar Respir 1952
[Organization and results of systematic examination of communities for tuberculosis control]. Rev Mex Tuberc Enferm Apar Respir 1952
[Effect of bacteriostatic medication on the evolution of tuberculosis]. Rev Esp Tuberc 1952
[Beds available to tuberculotics in Brazil]. Rev Bras Tuberc Doencas Torac 1952
[Quantitative determination of malic acid as a metabolite of Mycobacterium tuberculosis and effect of streptomycin and PAS on its synthesis]. Gruzlica (1926) 1952
[Antituberculosis vaccination in Brazil]. Bras Med 1952
[Therapy of tuberculosis of the lacrimal sac by dacryocystorhinostomy]. Szemeszet 1952
[Anatomical and pathological picture of experimental tuberculosis in guinea pig; anatomo-pathologic modifications and their relation to PAS therapy]. Arch Sci Med (Torino) 1952
[Treatment of tuberculosis of the respiratory tract of the ear with paraaminosalicylic acid alone and in combination with streptomycin]. Vestn Otorinolaringol 1952
Therapy of pulmonary tuberculosis with isoniazid alone and in combination with streptomycin and with para-amino-salicylic acid. names it Stanford Med Bull 1952
[Intravenous perfusion of PAS]. Med Contemp 1952
[Results obtained with PAS in the treatment of tuberculosis]. Medicina (Madr) 1952
Febrile reactions to paraamino-salicylic acid, PAS. Can Med Assoc J 1952
A case of recurrent jaundice due to PAS. doi:10.1016/s0041-3879(52)80104-7 Tubercle 1952
Some further studies on tuberculostatic compounds. doi:10.1111/j.2042-7158.1952.tb13218.x J Pharm Pharmacol 1952
Patient tolerance for calcium salt of para-aminosalicylic acid: preliminary report. doi:10.1164/art.1952.66.5.619 names it Am Rev Tuberc 1952
Combined corticotropin (ACTH), para-aminosalicylic acid (PAS), and streptomycin in the treatment of pulmonary tuberculosis. doi:10.1164/art.1952.66.5.542 names it Am Rev Tuberc 1952
[Application and tolerance of molecular combination of streptomycin and PAS in tuberculous meningitis]. Sem Med 1952
Extensive healing of renal tuberculosis by streptomycin and PAS. Wien Med Wochenschr 1952
[Treatment of female genital tuberculosis with streptomycin and paraaminosalicylic acid]. Cas Lek Cesk 1952
[Tuberculous meningitis treated with streptomycin and PAS; two observations]. Rev Sanid Milit Argent 1952
[Case of cervical lymph nodes tuberculosis treated with nicotibine per os and with local streptopas]. Rass Medica 1952
[Para-aminosalicylic acid hydrazide. I. Pharmacological action and effects inhibiting the growth of tubercle bacillus in vitro]. names it Arch Ital Sci Farmacol 1952
[Intravenous PAS and pulmonary tuberculosis]. Vie Med 1952
[Para-aminosalicylic acid and resistance]. names it Resen Clin Cient 1952
[Comparative studies on the treatment of pulmonary tuberculosis with streptomycin and paraaminosalicylic acid]. Rass Giuliana Med 1952
[The effect of medical treatment on ureter lesions in urinary tuberculosis]. J Belge Urol 1952
[Treatment of microcavernous pulmonary tuberculosis with streptomycin, PAS and thiosemicarbazone]. Helv Med Acta 1952
[Synergetic action of paraaminosalicylic acid and of isonicotinic derivatives in experimental tuberculosis of the guinea-pig]. C R Seances Soc Biol Fil 1952
[Application of streptomycin and other antibiotics in primary tuberculosis in the child]. Acta Tuberc Belg 1952
[PAS in surgical therapy of female genital tuberculosis]. Riv Patol Clin 1952
[Therapy of cutaneous tuberculosis with paraaminosalicylic acid]. Z Haut Geschlechtskr 1952
Isoniazid in experimental tuberculosis of guinea pigs infected with tubercle bacilli resistant to streptomycin and to para-aminosalicylic acid. doi:10.1164/art.1952.66.4.477 names it Am Rev Tuberc 1952
[Tuberculostatic effectiveness of the heavy metal complex salts of the paraaminosalicylic acid and its derivatives]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1952
[Clinical and experimental study of depot PAS; importance of its association with intravenous PAS]. Presse Med (1893) 1952
[Thyroid dysfunction and PAS]. Nord Med 1952
[Value of streptomycin and aminosalyl in milder cases of pulmonary tuberculosis]. Nord Med 1952
[PAS and streptomycin administration in surgical therapy of internal female genital tuberculosis]. Geneeskd Gids 1952
[Healing of pulmonary cavities with streptomycin and PAS]. Wien Med Wochenschr 1952
[Pfeiffer's glandular fever and PAS allergy]. Ned Tijdschr Geneeskd 1952
[Pulmonary tuberculosis therapy]. Minerva Med 1952
[Tuberculous meningitis treated with streptomycin and PAS]. Prensa Med Argent 1952
[Organization and results of systematic examination of communities for tuberculosis control]. Rev Mex Tuberc Enferm Apar Respir 1952
Hypopotassemia and hyponatremia in pulmonary tuberculosis during treatment with streptomycin and paraaminosalicylic acid. Am Rev Tuberc 1952
[Positivization of the lepromin reaction by BCG administered to lepers under the clinical, bacterioscopic and histopathological conditions of transfer to dispensary]. Rev Bras Leprol 1952
[New therapeutic utilization of PAS in tuberculosis; intravenous and intramuscular administration]. Union Med Can 1952
[Crystallized intravenous p-aminosalicylic acid in the clinical and surgical treatment of pulmonary tuberculosis]. Rev Bras Cir 1952
[Intermittent application of streptomycin with PAS in pulmonary tuberculosis]. Med Arh 1952
[Isonicotinic acid derivatives, with streptomycin and PAS, in the treatment of pulmonary tuberculosis]. J Med Liban 1952
[Organization of results of systematic group surveys for an antituberculosis campaign]. Hoja Tisiol 1952
[PAS in the treatment of empyema in extrapleural pneumothorax]. G Ital Della Tuberc 1952
[Effect of anti-tuberculous antibiotics and drugs in vitro; comparative study on streptomycin, PAS, thiosemicarbazone succinci derivative, and isonicotinic acid hydrazide]. Arch Maragliano Patol Clin 1952
[Liquid medium for BCG vaccine]. Hospital (Rio J) 1952
[Chemotherapy of experimental tuberculosis in guinea pigs with para-aminosalicylic acid]. names it Arzneimittelforschung 1952
Conditioned hemolysis; quantitative technic standardized for tuberculosis and leprosy. An Paul Med Cir 1952
[Case for diagnosis]. Acta Pediatr Esp 1952
[Dosage and duration of home treatment with PAS in tuberculosis]. Ned Tijdschr Geneeskd 1952
[Role of anti-tuberculous drugs in the treatment of tracheobronchial tuberculosis]. Orv Hetil 1952
[Chemotherapy of pulmonary tuberculosis]. Dia Med 1952
[Clinical trials of a basic salt of paraaminosalicylic acid in pulmonary tuberculosis]. Minerva Med 1952
Hypothyroidism and cerebral edema following combined treatment of tuberculosis with conteben (TB I 698) and p-amino-salicylic acid. doi:10.1111/j.0954-6820.1952.tb14267.x Acta Med Scand 1952
[Evolution of streptomycin-resistant tuberculosis]. Lyon Med 1952
[Intravenous PAS and pulmonary tuberculosis]. Entret Bichat Med Entret Bichat 1952
[Studies on the concentration of PAS and TB 1 in the pleural effusion while undergoing respective treatment. II. On TB 1 (conteben)]. Kekkaku 1952
[Practical viewpoints of resistance against streptomycin, PAS, conteben]. Tuberkulosearzt 1952
[Results in application of paraaminosalicylic acid salts in osteoarticular tuberculosis]. Klin Med (Mosk) 1952
[Indications and limits of use of streptomycin and paraaminosalicylic acid in pulmonary tuberculosis]. Acta Tuberc Belg 1952
[The place of paraaminosalicylic acid in tertiary pulmonary tuberculosis]. Acta Tuberc Belg 1952
[Tri-p-aminosalicylate of dihydrostreptomycin in therapy of some forms of cutaneous tuberculosis]. Dia Med 1952
[Antioxygens and tuberculosis: mechanism of the action of PAS, TB 1 and isonicotinic acid hydrazide]. Sem Med 1952
DRUG resistance of tubercle bacilli following antibiotic treatment. S Afr Med J 1952
[Concentration of paraaminosalicylic acid in tuberculous patients]. Dtsch Med J 1952
[Therapeutic value of the addition of sodium benzoate to PAS in the treatment of tuberculosis; preliminary note]. Bull Mem Soc Med Hop Paris 1952
The effect of para-aminosalicylic acid (PAS) on the development of resistance of tubercle bacilli to streptomycin. doi:10.1097/00000441-195207000-00008 names it Am J Med Sci 1952
[Para-aminosalicylic acid, drip method, in the treatment of tuberculosis]. names it Imprensa Medica 1952
[First results of the treatment of serofibrinous pleurisy with PAS]. An Fac Med Univ Repub Montev Urug 1952
[Virulence of colonies of Mycobacterium tuberculosis hominis at different grades of resistence to p-aminosalicylic acid]. Boll Soc Ital Biol Sper 1952
[Effect of para-aminosalicylic acid in cutaneous tuberculosis]. names it Przegl Dermatol 1952
[Indications and limits of streptomycin and PAS in pulmonary tuberculosis]. doi:10.1080/17843286.1952.11717229 Acta Clin Belg 1952
[Streptomycin, PAS and rimifon]. Union Med Can 1952
[Resorption of chemotherapeutics in intracavernous instillation]. Tuberkulosearzt 1952
[Streptomycin and PAS in the treatment of acute tuberculous pneumonia]. Gruzlica (1926) 1952
[Associated effect of T28 and other chemotherapeutic substances on Mycobacterium tuberculosis in vitro]. Gruzlica (1926) 1952
[Antituberculous activity of p-aminosalicylic acid hydrazide]. Sperimentale 1952
[Therapy of tuberculous ascites by intra-abdominal perfusion of PAS; results of two cases]. Rev Med Nancy 1952
[Studies on the concentration of sodium-paraaminosalicylate or TB1 in the pleural effusion of the cases undergoing respective treatment. I. On sodium-paraaminosalicylate]. Kekkaku 1952
[Effect of chemotherapeutic preparations on the protective function of living bodies especially of antituberculosis preparations. IV. Effect on the agglutination for typhoid bacilli]. Kekkaku 1952
[Success and failure of the chemotherapy of the female urogenital tract]. Helv Chir Acta 1952
Chemotherapy of tuberculosis. Antiseptic 1952
[Effects of antibiotics and chemotherapeutics on mycobacterium tuberculosis typus humanus in incubated chicken eggs; effect of PAS on mycobacterium tuberculosis typus humanus]. Arztl Wochensch 1952
[The therapy of tuberculous peritonitis]. Orv Hetil 1952
[Streptomycin and para-aminosalicylic acid in pulmonary tuberculosis]. names it Scalpel (Brux) 1952
[Chemotherapy of tuberculosis]. Ugeskr Laeger 1952
The antibiotic therapy of tuberculous meningitis. doi:10.1056/NEJM195206052462301 N Engl J Med 1952
[Effects of chaulmoogra oil alone and in combination with PAS of TB I on experimental tuberculosis of mice]. Schweiz Med Wochenschr 1952
[Effects of PAS on laryngeal, bronchial and intestinal complications of pulmonary tuberculosis]. Schweiz Med Wochenschr 1952
[Results of streptomycin and paraaminosalicylic acid therapy of tuberculosis in children]. Pediatr Pol 1952
The use of para-aminosalicylic acid (PAS) in the treatment of intestinal tuberculosis. doi:10.7326/0003-4819-36-6-1475 names it Ann Intern Med 1952
[New antituberculous chemotherapeutic; para-aminosalicylic acid hydrazide]. names it Boll Soc Ital Biol Sper 1952
[PAS alone and associated with streptomycin in the treatment of experimental miliary pulmonary tuberculosis in rabbits]. Riv Clin Pediatr 1952
[PAS resistance of Koch's bacilli in tuberculous meningitis]. Riv Clin Pediatr 1952
[A case of oral tuberculosis treated with streptomycin and para-aminosalicylic acid]. names it Minerva Stomatol 1952
[11 Case records of tuberculosis therapy]. Rev Med Aeron 1952
[Paraaminosalicylic acid in the treatment of female genital tuberculosis]. Quad Clin Ostet Ginecol 1952
[Note on the sensitivity of Mycobacterium tuberculosis to p-aminosalicylic acid in the Lower Congo]. Ann Soc Belg Med Trop (1920) 1952
CHEMOTHERAPY of tuberculosis. Br Med J 1952
Chemotherapy of pulmonary tuberculosis in young adults; an analysis of the combined results of three Medical Research Council trials. doi:10.1136/bmj.1.4769.1162 Br Med J 1952
PREVENTION of streptomycin resistance by combined chemotherapy; a Medical Research Council investigation. Br Med J 1952
[The treatment of purulent effusions in extrapleural pneumothorax by local application of PAS]. Presse Med (1893) 1952
[Combined application of PAS and streptomycin in pulmonary tuberculosis in pulmonary surgical interventions]. Probl Tuberk 1952
Benemid and sodium PAS. doi:10.1016/s0041-3879(52)80082-0 Tubercle 1952
Streptomycin and PAS treatment of genito-urinary tuberculosis. doi:10.1016/S0022-5347(17)68415-5 J Urol 1952
Parenteral use of sodium para-amino-salicylic acid in critical tuberculosis: preliminary report. names it Stanford Med Bull 1952
Whither tuberculosis? A statistical review of reports from selected American and European communities. Dis Chest 1952
Experience with high doses of para-aminosalicylic acid in the treatment of pulmonary tuberculosis. doi:10.1378/chest.21.5.521 names it Dis Chest 1952
[Study of an adequate diet in tuberculosis]. Rev Esp Enferm Apar Dig Nutr 1952
[Treatment of experimental tuberculosis in guinea pig by associated streptomycin, PAS, and potassium iodide]. Arch Maragliano Patol Clin 1952
[Histological observations on tuberculous lesions in guinea pig treated with PAS associated with potassium iodide]. Arch Maragliano Patol Clin 1952
Scientific session for evaluation of results obtained with a new drug in the treatment of tuberculosis, 18 April, 1952. Rev Esp Tuberc 1952
[Intravenous PAS therapy of pulmonary tuberculosis]. Rass Medica 1952
[PAS and tuberculous caverns]. Fr Med 1952
[Therapeutic effect of para-amino-salicylate on tuberculosis]. names it Kekkaku 1952
[Ninety percent permanent recovery in tuberculous meningitis by streptomycin combined with intravenous PAS; 36 cases]. doi:10.1055/s-0028-1116018 Dtsch Med Wochenschr 1952
[Clinical experiences with pasmethion]. Praxis 1952
[Sugar metabolism disorders during PAS treatment]. Schweiz Med Wochenschr 1952
[PAS concentration in blood in therapeutic use of PAS and its salts]. Sven Lakartidn 1952
[Intravenous PAS therapy]. Sven Lakartidn 1952
[Rectal PAS therapy]. Praxis 1952
[Subcutaneous injection of PAS in the presence of a factor of diffusion]. Presse Med (1893) 1952
[Instruction for organization and functioning of the anti-tuberculosis campaign in the Mexican army]. Bol Sanid Mil 1952
[Antituberculous action of para-aminothiosalicylic acid]. names it Arch Ital Sci Farmacol 1952
[Streptomycin and PAS resistance of tubercle bacteria isolated from patients with tuberculous meningitis]. Maandschr Kindergeneeskd 1952
Sacro-iliac tuberculosis treated with streptomycin, PAS and surgery. J Indian Med Assoc 1952
[Intravenous PAS therapy of pulmonary tuberculosis]. G Clin Med 1952
The treatment of genital tuberculosis in the female by streptomycin and para-aminosalicylic acid. doi:10.1111/j.1471-0528.1952.tb04122.x names it J Obstet Gynaecol Br Emp 1952
Pulmonary resection in tuberculosis. Calif Med 1952
Antimicrobial treatment of pulmonary tuberculosis. J Lancet 1952
Further experiences with para-aminosalicylic acid. names it Can Med Assoc J 1952
[Case of cervical tuberculous lymphadenitis treated with local streptomycin and paraaminosalicylic acid]. Rass Medica 1952
[Observations on the treatment of certain forms of cutaneous tuberculosis with tri-p-aminosalicylates with dihidrostreptomycin]. Rass Medica 1952
[Results of PAS therapy of colliquative tuberculosis]. Przegl Dermatol 1952
[Intermittent combined therapy of pulmonary tuberculosis with streptomycin and para-aminosalicylic acid; bacteriologic principles and clinical results]. names it Schweiz Med Wochenschr 1952
Principles of treatment of pulmonary tuberculosis. NY Med 1952
[Onset of pulmonary tuberculosis and paraaminosalicylic acid, PAS]. Brux Med 1952
[Carriers of minimal shadows and work capacity]. Rev Bras Tuberc Doencas Torac 1952
[Studies on variation of the mode of reactivity of the organism in tuberculosis in relation to streptomycin and PAS therapy]. G Ital Della Tuberc 1952
[Perfusions of para-aminosalicylic acid solutions in the treatment of pulmonary and meningeal tuberculosis]. names it Lotta Tuberc 1952
[Para-succinylaminobenzaldehyde thiosemicarbazone in the treatment of tuberculous empyema]. names it Gazz Med Ital 1952
Treatment of genito-urinary tuberculosis with streptomycin and synergistic drugs. Calif Med 1952
Studies on the in vitro effects of radioactive I131 labeled 3,5 diiodo PAS on the tubercle bacillus. doi:10.1164/art.1952.65.3.316 Am Rev Tuberc 1952
Allergic reactions to para-aminosalicylic acid; report of seven cases, including one case of Löffler's syndrome. doi:10.1164/art.1952.65.3.235 names it Am Rev Tuberc 1952
[Air force tuberculosis sanatorium]. Rev Med Aeronaut 1952
[Chemotherapy of tuberculosis. I..]. Z Gesamte Inn Med 1952
[Chemical and pharmacological properties of 4-amino-6-hydroxy-isophthalic acid, by-product in PAS preparation]. Pharm Weekbl 1952
[Results of streptomycin and PAS therapy of pulmonary tuberculosis in children]. Imprensa Medica 1952
Chemotherapy of experimental tuberculosis in embryonated chicken eggs. II. Experiment using PAS, TB-1 and streptomycin with PAS. Ann Tuberc 1952
[Treatment of primary tuberculous infection and paraaminosalicylic acid]. Acta Tuberc Belg 1952
[Forty cases of pulmonary tuberculosis treated by intravenous PAS infusion]. Toulouse Med 1952
[Treatment of cavernous pulmonary tuberculosis with PAS in interrupted perfusion]. Ther Umsch 1952
The use of thiosemicarbazone with streptomycin in pulmonary tuberculosis. doi:10.1016/s0041-3879(52)80153-9 Tubercle 1952
The chemotherapy of tuberculous infections of the urinary tract. doi:10.1136/pgmj.28.316.78 Postgrad Med J 1952
[Immediate results of 100 cases of pulmonary tuberculosis treated with streptomycin, PAS, streptomycin with PAS and TB 1/698]. Hospital (Rio J) 1952
[Considerations on the resistance of tubercle bacilli to p-aminosalicylic acid]. Boll Soc Ital Biol Sper 1952
[Effect of cobalt paraaminosalicylic acid on blood picture]. Rass Int Clin Ter 1952
Effect of combined therapy (dihydrostreptomycin and PAS) on the emergence of streptomycin-resistant strains of tubercle bacilli. doi:10.1056/NEJM195201242460404 N Engl J Med 1952
Tuberculous meningitis; treatment with streptomycin and para-aminosalicylic acid. doi:10.1136/bmj.1.4749.83 names it Br Med J 1952
[Local treatment of cold abscess with a PAS sulfamide powder]. Orv Hetil 1952
[Intravenous PAS in the therapy of common pulmonary tuberculosis; discontinuous perfusion]. Presse Med (1893) 1952
RECENT recommendations in treatment of tuberculosis; use of streptomycin plus para-aminosalicylic acid. names it Whats New 1952
[Effects of benemid on the PAS blood level; its therapeutic use in tuberculosis]. Schweiz Z Tuberk 1952
[Additional pathological examinations on meningitis tuberculosis treated with streptomycin and paraaminosalicylic acid]. Schweiz Z Tuberk 1952
[Resistance of the tubercle-bacillus to drugs in general and PAS in particular]. Schweiz Z Tuberk 1952
Anti-tubercular activity of organic (synthetic) compounds related to PAS in vitro. Indian J Med Res 1952
[A study on the antibiotic power of paraaminosalicylic acid on Mycobacterium tuberculosis. The toxicity of paraaminosalicylic acid proper to Koch's bacillus]. C R Seances Soc Biol Fil 1952
[The study of certain enzymatic properties of Mycobacterium tuberculosis and paratuberculosis bacilli]. C R Seances Soc Biol Fil 1952
[The influence of different p-aminosalicylic acid salts on protein and glucose metabolism in tuberculosis]. C R Seances Soc Biol Fil 1952
[Frequency of tuberculosis in personnel of hospitals for tuberculosis]. Arch Argent Tisiol 1952
Results in treating tuberculous empyemata with para-aminosalicylic acid or with combined administration of para-aminosalicylic acid and streptomycin. names it Acta Tuberc Scand 1952
The results of treatment of pulmonary tuberculosis with combined administration of PAS and streptomycin. Acta Tuberc Scand 1952
[Effects of chemotherapy on urogenital tuberculosis]. Z Urol 1952
[Para-aminosalicylic acid in dermatology]. names it Therapie 1952
[PAS therapy of empyema caused by artificial pneumothorax]. Rass Med Sarda 1952
[Jaundice as a possible manifestation of PAS toxicity in tuberculous meningitis]. Acta Paediatr Lat 1952
[Plan for a campaign against tuberculosis among Indians of Brazil]. Rev Bras Tuberc Doencas Torac 1952
[Chemotherapy of ocular tuberculosis]. Cesk Oftalmol 1952
[In vitro activity of various substance on Mycobacterium tuberculosis. II. Streptomycin aureomycin, PAS, caffeic acid, 5-nitro-2-furaldehyde-semicarbazone and salicylic acid; mechanism of action with reference to bacterial resistance]. Boll Ist Sieroter Milan 1952
[Investigation on Mycobacterium tuberculosis resistance to PAS]. Tuberkuloza 1952
[Adaptation of Mycobacterium tuberculosis to therapeutic agents; recent observations]. Rev Tuberc 1952
[Tuberculous meningitis; contribution of the practitioner to its cure]. Rev Med Suisse Romande 1952
[The effect of streptomycin and PAS, separately and combined, in miliary tuberculosis and meningitis]. Belg Tijdschr Geneesk 1952
Indications for streptomycin and para-aminosalicylic acid in primary tuberculosis in children. names it Indian J Pediatr 1952
[Results of PAS therapy in ambulatory conditions]. Probl Tuberk 1952
[Results of combined treatment of pulmonary tuberculosis with paraaminosalicylic acid and streptomycin]. Probl Tuberk 1952
[Streptomycin, PAS and TB 1 in pulmonary tuberculosis]. Med Cir Guerra 1952
Combined intermittent regimens in the treatment of non-miliary pulmonary tuberculosis; a comparison of streptomycin every third day and para aminosalicylic acid daily with streptomycin every third day and para-aminosalicylic acid every third day. doi:10.1378/chest.21.1.1 names it Dis Chest 1952
[Tuberculous meningitis]. Publ B Aires Cent Investig 1952
[Bacteriological results of the 6 months' continuous treatment of pulmonary tuberculosis with the triple antibacterial combination: streptomycin, isoniazid and para-amino-salicylic acid; comparison with univalent or bivalent antibacterial therapy]. names it Ann Inst Pasteur Lille 1952
[Effect of various antibacterial substances used alone or in combination in experimental tuberculosis of guinea pigs; streptomycin, PAS, isonicotinic acid hydrazide and sulfones]. Ann Inst Pasteur Lille 1952
[Abuse of oral PAS therapy]. Therapie 1952
[Coma during PAS therapy]. Therapie 1952
[Intravenous PAS therapy, major treatment of tuberculosis]. Therapie 1952
[Importance of determination of PAS in blood and body fluids of the patient during anti-tuberculosis therapy; causes of error]. Therapie 1952
[Pseudophlegmonous edema after subcutaneous perfusion of PAS; sensitization to the para group]. names it Rev Tuberc 1952
[Antibiotics and collapse therapy of pulmonary tuberculosis]. Gruzlica (1926) 1952
Comparison of two methods for the determination of the resistance of Mycobacterium tuberculosis to p-aminosalicylic acid and streptomycin. doi:10.1007/BF02538619 Antonie Van Leeuwenhoek 1952
Technique, results of and indications for the treatment of pulmonary tuberculosis by short intravenous transfusion of PAS. Acta Tuberc Scand 1952
PARA-AMINOSALICYLIC acid (PAS) and streptomycin in pulmonary tuberculosis; comparison between 84 PAS-treated and 82 streptomycin-treated cases. names it Acta Tuberc Scand 1952
[Antibacterial therapy of tuberculous empyema]. Z Tuberk 1952
[Electron-microscopy of the effect of streptomycin, PAS, conteben, and solvoteben on the development of Mycobacterium avium chester]. Z Hyg Infektionskr 1952
[Resistance of Mycobacterium tuberculosis to paraaminosalicylic acid; increase of resistance following therapy of experimental infection in guinea pig]. Sperimentale 1952
[Resistance of Mycobacterium tuberculosis to paraaminosalicylic acid; virulence in guinea pig of resistant strains]. Sperimentale 1952
[Resistance of Mycobacterium tuberculosis to paraaminosalicylic acid; composition of sensitive and resistant cultures]. Sperimentale 1952
[Clinical aspects of hematogenous tuberculous phases of dissemination]. Schweiz Z Tuberk 1952
[Case of severe intolerance to PAS]. Rev Tuberc 1952
[Purpura during the course of therapy of tuberculosis with PAS]. Rev Tuberc 1952
[Anatomical verification of closure of pulmonary cavities in double artificial pneumothorax and histological cure of a case of renal tuberculosis treated with PAS]. Rev Tuberc 1952
[Treatment of female genital tuberculosis and streptomycin and PAS]. Bratisl Lek Listy 1952
[Behavior of prothrombinemia in tuberculotic children treated with para-aminosalicylic acid]. names it Arch Ital Pediatr Pueric 1952
[Experiences with PAS therapy]. Z Tuberk 1952
[The effect of chemotherapeutic and antibiotics on intermediary phosphate metabolism]. Z Tuberk 1952
[Surgical treatment of pulmonary tuberculosis and antibiotics]. Przegl Lek 1952
[Prolonged administration of paraaminosalicylic acid in the treatment of pulmonary tuberculosis]. Bull Mem Soc Med Hop Paris 1952
[Favorable effects of prolonged cures of perfusions with PAS in common pulmonary tuberculosis]. Bull Mem Soc Med Hop Paris 1952
[Treatment with streptomycin and PAS of endometrial tuberculosis]. Bull Fed Soc Gynecol Obstet Lang Fr 1952
[Histological studies of tuberculous tracheo-bronchitis treated with PAS]. Ann Ist Carlo Forlanini 1952
The late results of paraaminosalicylic acid therapy in secondary intestinal tuberculosis. Acta Tuberc Scand 1952
[Action of PAS on blood picture in tuberculosis]. Sang 1952
[Effect of PAS on metabolism in Mycobacterium tuberculosis]. Med Dosw Mikrobiol 1952
[Local therapeutic use of tuberculostatic solutions in tuberculosis of the kidneys and bladder]. Z Urol 1952
[Acute hemolytic anemia associated with hemoglobinuria due to combined PAS and streptomycin in the treatment of tuberculous cold abscess consecutive to injection of human serum]. Sang 1952
Tuberculosis colliquativa cutis successfully treated with para-amino-benzoic acid. doi:10.1159/000256892 names it Dermatologica 1952
The effects of PAS on the adrenal cortex during tuberculosis therapy. Tip Fak Mecm 1952
[Pathological findings in experimental tuberculosis of guinea pig treated with TB 1 and PAS]. Frankf Z Pathol 1952
[Secondary manifestations in tuberculosis treatment with paraaminosalicylic acid]. Schweiz Med Wochenschr 1951
[Effect of PAS therapy on survival after thoracoplasty in lung tuberculosis]. Nord Med 1951
[Outline for the organization of an antituberculosis service in commercial and industrial establishments]. J Med (Oporto) 1951
The results of the treatment of tuberculous meningitis at the Children's Clinic, Helsingfors. doi:10.1111/j.1651-2227.1951.tb04614.x Acta Paediatr Suppl (Upps) 1951
[Effect of PAS on nitrogen and urate metabolism in tuberculosis]. C R Seances Soc Biol Fil 1951
[In vitro effect of PAB on Mycobacterium tuberculosis and M. paratuberculosis]. Boll Soc Ital Biol Sper 1951
[Side effects of PAS]. Tidsskr Nor Laegeforen 1951
[Side effects in PAS therapy]. Tidsskr Nor Laegeforen 1951
[Complications in PAS therapy of pulmonary tuberculosis]. Tidsskr Nor Laegeforen 1951
[Use of paraaminosalicylic acid in therapy of certain gynecological disorders]. Quad Clin Ostet Ginecol 1951
[Investigation on pleural absorption and secretion of PAS]. Tuberk Kerdesei 1951
The indications for streptomycin and para-aminosalicylic acid in primary tuberculosis in children. doi:10.1177/003591575104401224 names it Proc R Soc Med 1951
Hepatitis following PAS therapy. doi:10.5694/j.1326-5377.1951.tb74750.x Med J Aust 1951
Studies on the metabolism of p-aminobenzoic acid by Mycobacterium smegmatis. J Biol Chem 1951
[Para-allergic manifestations in hilar tuberculosis]. names it Tuberkuloza 1951
A case of acute miliary tuberculosis with meningitis during pregnancy treated with streptomycin and sodium para-amino-salicylate (P.A.S). doi:10.1111/j.1471-0528.1951.tb04084.x names it J Obstet Gynaecol Br Emp 1951
Reaction to para-aminosalicylic acid simulating tuberculous meningitis. doi:10.1164/art.1951.64.6.682 names it Am Rev Tuberc 1951
[PAS in urogenital tuberculosis]. Folha Med 1951
[Cobalt paraaminosalicylate in pulmonary tuberculosis; preliminary note]. Riforma Med 1951
[Paraaminosalicylic acid in tuberculosis therapy]. Ned Tijdschr Geneeskd 1951
[Knowledge and therapy of the diseases of the respiratory system]. Rev Prat 1951
[Results of antibiotic and chemical therapy of pulmonary tuberculosis]. Bras Med 1951
[Reconsideration of principles of renal tuberculosis therapy]. Ned Tijdschr Geneeskd 1951
[Experiences with calpatyl in the treatment of pulmonary tuberculosis]. Schweiz Med Wochenschr 1951
[Permeability of the hemoencephalic barrier to paraaminosalicylic acid]. Dtsch Med Wochenschr 1951
[PAS therapy of extrapulmonary tuberculosis]. Orv Hetil 1951
The frequency of drug resistant tubercle bacilli following administration of dihydrostreptomycin and paraaminosalicylic acid three days per week. Proc Staff Meet Mayo Clin 1951
[Perfusions with solutions of para-aminosalicylic acid (PAS) in the treatment of pulmonary tuberculosis]. names it Bull Acad Natl Med 1951
[Resistance to PAS]. Ned Tijdschr Geneeskd 1951
[In vitro effect of various substances on Mycobacterium tuberculosis. I. Titration of streptomycin, aureomycin, PAS, caffeic acid, 5-nitro-2-furaldehyde-semicarbazone and salicylic acid in Dubos medium]. Boll Ist Sieroter Milan 1951
[Combined collapse therapy and antibiotics in the treatment of pulmonary tuberculosis]. Maroc Med 1951
[PAS in the treatment of non-miliary pulmonary tuberculosis]. Maroc Med 1951
[Streptomycin and paraaminosalicylic acid in the treatment of genital tuberculosis]. Bol Soc Chil Obstet Ginecol 1951
[Lumbar administration of PAS in combined therapy of tuberculous meningitis]. Ann Paediatr 1951
[PAS in the treatment of metastatic ocular tuberculosis]. Vestn Oftalmol 1951
Para-aminosalicylic acid; a review. names it Med Bull (Ann Arbor) 1951
The subcutaneous administration of the sodium salt of para-aminosalicylic acid in the treatment of tuberculosis. doi:10.1164/art.1951.64.5.557 names it Am Rev Tuberc 1951
[Toxic effects of PAS]. Orv Hetil 1951
Calciferol, streptomycin, and para-aminosalicylic acid in pulmonary tuberculosis. doi:10.1016/s0140-6736(51)92889-9 names it Lancet 1951
[A new derivative of PAS, phenyl paraaminosalicylate or FR7; tuberculostatic activity in vitro and in the mouse]. Ann Inst Pasteur (Paris) 1951
[Abuse of streptomycin, PAS and thiosemicarbazone]. Acta Tuberc Belg 1951
[Late results of combined chemotherapy of tuberculous meningitis in 37 cases; PAS and streptomycin]. Helv Med Acta 1951
[Present status in the therapy of skin tuberculosis]. Borgyogy Venerol Sz 1951
A case of tuberculosis of the skin treated with potassium paraaminosalicylate (PAS). doi:10.5694/j.1326-5377.1951.tb68391.x Med J Aust 1951
[Paraaminosalicylic acid therapy of pulmonary tuberculosis in diabetics]. Med Hyg (Geneve) 1951
[Chemotherapy of lung tuberculosis complicated by diabetes mellitus]. doi:10.1055/s-0028-1117420 Dtsch Med Wochenschr 1951
[Subcutaneous PAS infusion]. doi:10.1055/s-0028-1117419 Dtsch Med Wochenschr 1951
[Pharmacoplasma (PAS-plasma) transfusion and immune body formation. XV]. Schweiz Med Wochenschr 1951
[Hyperthermia and cutaneous eruptions, manifestations of intolerance to paraaminosalicylic acid]. Montp Med 1951
[Combined thiosemicarbazone-streptomycin-paraaminosalicylic acid therapy in tuberculosis]. G Ital Tuberc Mal Torace 1951
[Augmentation of the volume of Koch bacillus in the presence of paraaminosalicylic acid]. Ann Inst Pasteur (Paris) 1951
[Varying aspects of the sensitivity of the tubercle bacillus to para-acetyl-benzaldehyde-thiosemicarbazone (TbI) in Youmans medium]. names it Ann Inst Pasteur (Paris) 1951
[Clinical evaluation of ophthalmoscopic data in tuberculous meningitis treated with streptomycin and PAS]. Acta Paediatr Lat 1951
Thiosemicarbazone (T.B.I.); a year's experience of its use alone and in combination with PAS. doi:10.1016/s0041-3879(51)80107-7 Tubercle 1951
[Effect of anti-tuberculous chemotherapeutics on tissue culture]. Probl Tuberk 1951
[Present state of PAS therapy of tuberculous infections]. Gazz Med Ital 1951
[Clinical experiences with para-aminosalicylic acid in laryngeal tuberculosis]. names it Gazz Med Ital 1951
[Chemotherapy of tuberculosis]. Ter Arkh 1951
[Prolonged remissions following intralumbar streptomycin-solvoteben-PAS combined injections, a progressive step in tuberculous meningitis therapy in children]. doi:10.1055/s-0028-1117376 Dtsch Med Wochenschr 1951
[Comparative effect of conteben and PAS in pulmonary tuberculosis therapy]. Sven Lakartidn 1951
[Organization of the treatment of tuberculous caverns]. Dia Med 1951
Medical treatment of pulmonary tuberculosis. Pa Med J 1951
Para-amino-salicylic acid with streptomycin in pulmonary tuberculosis. names it Can Med Assoc J 1951
Effect of para-aminosalicylic acid (PAS) alone and in association with streptomycin on experimental ocular tuberculosis. doi:10.1136/bjo.35.8.459 names it Br J Ophthalmol 1951
[Effect of metal ions on tuberculostatic activity of oxins and PAS]. doi:10.1007/BF02154537 Experientia 1951
[Diagnostic and prognostic significance of cerebrospinal fluid changes, particularly of the sugar and chloride levels, in tuberculous meningitis treated with streptomycin and in some cases with PAS]. Schweiz Med Wochenschr 1951
[Combined therapy (streptomycin, PAS and chaulmoogra oil) of tuberculous meningitis]. Schweiz Med Wochenschr 1951
EFFECT of PAS on the emergence of tubercle bacilli resistant to streptomycin. Public Health Rep (1896) 1951
[In vitro effects of dihydrostreptomycin p-aminosalicylate on Mycobacteria]. G Ital Tuberc Mal Torace 1951
[Local administration of 40% PAS in endocavitary aspiration]. Omnia Med Suppl 1951
[Experiences with PAS in tuberculosis]. Gruzlica (1926) 1951
[Immediate results in the treatment of upper respiratory tuberculosis with paraaminosalicylic acid]. Vestn Otorinolaringol 1951
[Para-aminosalicylic acid in the treatment of tuberculous empyema]. names it Rev Med Moyen Orient 1951
[Considerations on the use of PAS on the occasion of another fatal case of nephritis]. J Med Bord 1951
[Action of ascorbic acid and PAS in primary infection]. Gaz Med Fr 1951
[Early diagnosis and treatment of tuberculous meningitis]. Feldsher Akush 1951
[Permeation and excretion of PAS following ointment application]. Z Haut Geschlechtskr 1951
A consideration of the clinical use of antimicrobial agents in pulmonary tuberculosis. J Natl Med Assoc 1951
A case of tuberculous mastoiditis treated with P.A.S. and streptomycin. doi:10.1017/s0022215100010379 J Laryngol Otol 1951
Streptomycin and PAS in experimental tuberculosis of guinea pigs infected intracerebrally with virulent tubercle bacilli. doi:10.1164/art.1951.64.1.87 Am Rev Tuberc 1951
Potassium iodide and para-aminosalicylic acid in chronic fibroid pulmonary tuberculosis. doi:10.1164/art.1951.64.1.77 names it Am Rev Tuberc 1951
[Vitamin C treatment of digestive disorders from intolerance to PAS absorption]. Sem Med 1951
[Para-aminosalicylic acid therapy of tuberculous lymph nodes of the neck]. doi:10.1055/s-0028-1116827 names it Dtsch Med Wochenschr 1951
[Experiences with PAS in the treatment of tuberculosis]. Prakt Lek 1951
[Streptopas and pulmonary tuberculosis]. Minerva Med 1951
[Concentration of paraaminosalicylic acid in the blood of pulmonary tuberculosis patients treated with P.A.S.; comparison with radio-clinical results]. Sem Hop 1951
[Reduction of the risk of resistance to P.A.S. by the association of sulfones with P.A.S]. Sem Hop 1951
[Resistance of the tubercle bacillus to para-aminosalicylic acid]. names it Sem Hop 1951
[Two sulfones associated with P.A.S. in the treatment of pulmonary tuberculosis; radio-clinical study]. Sem Hop 1951
[P.A.S. in the treatment of non-miliary pulmonary tuberculosis; radio-clinical study]. Sem Hop 1951
[Para-aminosalicylic acid (P.A.S.) in the treatment of non-miliary pulmonary tuberculosis; introduction]. names it Sem Hop 1951
[Final treatment of tuberculous caverns of the lung, in endocavitary aspiration, with a 40% solution of sodium para-aminosalicylate]. names it Riforma Med 1951
Treatment of tuberculous cervical adenitis with para-aminosalicylic acid. doi:10.1016/s0140-6736(51)92706-7 names it Lancet 1951
STREPTOMYCIN and para-amino-salicylic acid in tuberculosis. names it Indian Physician 1951
[Investigation on para-aminosalicylic acid metabolism]. names it Biol Listy 1951
[Para-aminosalicylic acid therapy of osteo-articular tuberculosis]. names it Sov Med 1951
[Therapy of tuberculous meningitis; three years experience]. Med Hyg (Geneve) 1951
The specific resistance of tubercle bacilli to para-aminosalicylic acid and sulfonamides. doi:10.1128/jb.61.6.747-749.1951 names it J Bacteriol 1951
[Pathogenesis and pathologic anatomy of caverns; principles for tuberculous speleology]. Dia Med 1951
Streptomycin and P.A.S. sensitivity in tuberculosis; a rapid method for testing numerous specimens. S Afr Med J 1951
[Absorption of PAS in osteoarticular tuberculosis]. Clin Nuova Rass Prog Med Int 1951
[Preliminary note on the value of combined streptomycin and PAS in short perfusion in pulmonary tuberculosis]. Bull Mem Soc Med Hop Paris 1951
[Value of strong doses of PAS (especially in perfusion) in the treatment of cavitary tuberculosis]. Bull Mem Soc Med Hop Paris 1951
[Local application of para-aminosalicylic acid in tuberculous adenitis]. names it Riforma Med 1951
The effect of para-amino-salicylic acid on the oxidase system of the tubercle bacillus. names it Kekkaku 1951
[Recovery from tuberculous ulcer by local application of PAS]. Bull Soc Fr Dermatol Syphiligr 1951
[Treatment of pulmonary tuberculosis with pneumoperitoneum combined with streptomycin and PAS]. Probl Tuberk 1951
[Certain complications in PAS therapy]. Probl Tuberk 1951
[Effect of PAS on liver function in tuberculosis]. Probl Tuberk 1951
[Efficacy of the association of PAS with potassium iodide in the treatment of experimental tuberculosis in the guinea pig]. Arch Maragliano Patol Clin 1951
[PAS infusions]. Med Hyg (Geneve) 1951
[Observations on the psyche of infants with tuberculous meningitis treated with intraspinal PAS and streptomycin]. Acta Paediatr Lat 1951
[Local treatment of tuberculous empyema with paraaminosalicylic acid]. Tuberkuloza 1951
[Allergic reactions during PAS therapy of pulmonary tuberculosis]. doi:10.1007/BF01651180 Klin Wochenschr 1951
Studies in experimental ocular tuberculosis. XV. Effect of paraaminosalicylic acid and of streptomycin plus paraaminosalicylic acid in normal rabbits. AMA Arch Ophthalmol 1951
[Titration in body fluids of PAS injected locally in therapy of tuberculous adenitis]. Rass Int Clin Ter 1951
[PAS therapy of pulmonary tuberculosis; further findings on clinical hemorrhagic manifestations and on the hematological findings in tuberculotics in general and in those treated with PAS]. Prog Med (Napoli) 1951
[Chemotherapy of tuberculosis]. Orv Hetil 1951
Treatment of tuberculosis of the larynx by chemotherapy. doi:10.1001/jama.1951.02920340030009 J Am Med Assoc 1951
[Treatment of tuberculosis with 5-para-aminosalicylic acid]. names it Pol Tyg Lek (Wars) 1951
[New aspects of streptomycine and paraaminosalicylic acid therapy of renal tuberculosis]. Med Hyg (Geneve) 1951
Potassium iodide and para-amino-salicylic acid in chronic fibroid tuberculosis. names it Proc Inst Med Chic 1951
[What can be expected of streptomycin, PAS and TB 1 in the treatment of tuberculosis]. Medicamenta (Madr) 1951
Acute tuberculous peritonitis treated with streptomycin. doi:10.1136/bmj.1.4709.740 Br Med J 1951
[Intrapleural PAS as a treatment for effusion occurring during pneumothorax]. Rev Esp Tuberc 1951
[Combined PAS and chemotherapy]. Rev Esp Tuberc 1951
[Conference of German phthisiology at Neuenahr]. Rev Esp Tuberc 1951
[Fatal intoxication in two tuberculotics treated by PAS]. Alger Medicale 1951
[Treatment of tuberculosis with para-aminosalicylic acid]. names it Klin Med (Mosk) 1951
[Shortage of nursing personnel in tuberculosis institutions]. Bol Oficina Sanit Panam 1951
[In vitro study of P.A.S]. J Med Bord 1951
[P.A.S. treatment of intestinal tuberculosis in pulmonary tuberculotics]. J Med Bord 1951
[Para-aminosalicylic acid and its medicamentous associations in tuberculous infection]. names it Clin Lab (Zaragoza) 1951
Streptomycin para-aminosalicylate in the treatment of pulmonary tuberculosis. doi:10.1378/chest.19.4.438 names it Dis Chest 1951
[New aspects in streptomycin and para-aminosalicylic acid therapy of urinary tuberculosis. Does there exist PAS resistance in urinary tuberculosis?]. names it Presse Med (1893) 1951
[Chemotherapy of pulmonary tuberculosis]. Scalpel (Brux) 1951
[Etiological treatment of Addison's disease of tuberculous origin]. Acta Endocrinol Iber 1951
[PAS therapy of tuberculous empyema]. Accad Medica 1951
[Intra-bronchial administration of streptomycin and PAS in distented cavern; preliminary]. Probl Tuberk 1951
[Appearance of a reducing property in the urine of tuberculotics during PAS therapy]. Lotta Tuberc 1951
[Irregular discharges and the necessity for beds for tuberculosis patients]. Hoja Tisiol 1951
[Mechanism of streptomycin resistance and concrete methods of preventing it]. Hoja Tisiol 1951
[Technics for demonstrating streptomycin resistance; modes and frequency]. Hoja Tisiol 1951
[Inhibition by vitamin B of the effect of sodium p-aminosalicylate on tubercle bacilli; trials in vitro and in vivo]. C R Seances Soc Biol Fil 1951
[Contribution to experience with PAS]. Medicamenta (Madr) 1951
[Comparative elimination of streptomycin, of PAS and of sulfones after injection into tuberculous cold abscesses]. Ann Biol Clin (Paris) 1951
[Combined streptomycin and PAS in tuber culous meningitis therapy]. Acta Med Ital Mal Infett Parassit 1951
[PAS therapy of abscess after BCG vaccination]. Tidsskr Nor Laegeforen 1951
[Tuberculous pleurisy; PAS therapy]. Tidsskr Nor Laegeforen 1951
[Indications for PAS and combined chemotherapy in pulmonary tuberculosis]. Tidsskr Nor Laegeforen 1951
[Combined antibiotic-pneumoperitonium in treatment of pulmonary tuberculosis]. Poumon 1951
Drug fever following the use of para-amino-salicylic acid; a case report. names it Chin Med J 1951
[Cutaneous tuberculosis and PAS]. Ann Dermatol Syphiligr (Paris) 1951
[Rôle of para-aminosalicylic acid in pulmonary tuberculosis therapy]. names it Gaz Med Fr 1951
The therapeutic effect on experimental tuberculosis in guinea pigs of 4-acetylaminobenzal thiosemicarbazone (tibione) in combination with dihydrostreptomycin as in combination with dihydrostreptomycin. doi:10.1164/art.1951.63.3.339 Am Rev Tuberc 1951
Combined intermittent regimens employing streptomycin and para-aminosalicylic acid in the treatment of pulmonary tuberculosis; a comparison with daily and intermittent dosage schedules. doi:10.1164/art.1951.63.3.295 names it Am Rev Tuberc 1951
The domiciliary use of paramisan sodium in the treatment of pulmonary tuberculosis. doi:10.1016/s0041-3879(51)80097-7 Tubercle 1951
[PAS and streptomycin in the surgical therapy of pulmonary tuberculosis]. Nord Med 1951
[Calcium para-aminosalicylate in therapy of severe & complicated pulmonary tuberculosis]. names it Praxis 1951
[PAS therapy of skin tuberculosis]. Lek List 1951
[Different courses of tuberculosis of the small and large intestine treated with streptomycin and PAS]. Cas Lek Cesk 1951
[Behavior of gastric secretory function in a group of tuberculous subjects treated with PAS and its sodium salt]. Minerva Med 1951
[Project for antituberculosis campaign in the Mexican Army]. Bol Sanid Mil 1951
[Streptomycin and PAS in pulmonary tuberculosis caverns]. Rass Giuliana Med 1951
[PAS therapy of tuberculosis with collateral use of antidiuretics]. Tuberkulosearzt 1951
[Effect of streptomycin and PAS alone and in combination in experimental tuberculosis in guinea pigs]. Srp Arh Celok Lek 1951
[Further experiences with PAS]. doi:10.1159/000300938 Ophthalmologica 1951
The effect of PAS in Indian patient with pulmonary tuberculosis. Indian Med J 1951
The effect of heat on streptomycin and para-aminosalicylic acid in tuberculósis culture medium. doi:10.1378/chest.19.2.158 names it Dis Chest 1951
Streptomycin para-aminosalicylate and streptomycin resistant tubercle bacilli. doi:10.1097/00000441-195102000-00005 names it Am J Med Sci 1951
[Para-aminosalicylic acid in the treatment of primary tuberculosis infections in the young child]. names it Sem Hop 1951
[Antibiotic and chemotherapy of tuberculosis]. Wien Med Wochenschr 1951
[Erythroderma following PAS therapy and complicated by fatal subacute nephritis]. Bull Mem Soc Med Hop Paris 1951
[Treatment of pulmonary tuberculosis in diabetics with p-aminosalicylic acid]. Bull Mem Soc Med Hop Paris 1951
[Streptomycin and p-aminosalicylic acid in the treatment of tuberculosis in children; therapeutic contribution]. Minerva Med 1951
[Effect of PAS in tuberculosis in children]. Minerva Med 1951
[P.A.S. allergy with serious consequences]. Ugeskr Laeger 1951
[Determination of streptomycin and PAS resistance of Mycobacterium tuberculosis; preliminary communication]. Lek List 1951
[Resistance of bacillus tuberculosis to PAS]. Presse Med (1893) 1951
[Results of combined therapy of pulmonary tuberculosis with para-aminosalicylic acid and streptomycin]. names it Pol Tyg Lek (Wars) 1951
[Para-aminosalicylic acid in therapy of tuberculosis in children; preliminary report]. names it Vopr Pediatrii 1951
[Morphological findings in chemotherapy of fatal tuberculosis]. Beitr Pathol Anat 1951
Studies on the effect of para-aminosalicylic acid on tubercle bacilli, and the occurrence of PAS-resistant strains. doi:10.1111/j.1699-0463.1951.tb00128.x names it Acta Pathol Microbiol Scand 1951
[Onset of renal colic in renal tuberculosis treated with streptomycin and PAS]. J Urol Medicale Chir 1951
[Results with PAS at a sanatorium]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1951
[PAS combined with chemotherapy]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1951
[Paraaminosalicylic acid combined with chemotherapy]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1951
[Examination of the PAS level in cavity secretion; cavity wall permeation to PAS & PAS in secretion]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1951
Combined effect of streptomycin + penicillin, streptomycin + sulfathiazole and streptomycin + para-aminosalicylic acid on tubercle bacilli. doi:10.1111/j.1699-0463.1951.tb00138.x names it Acta Pathol Microbiol Scand 1951
[Intraperitoneal administration of PAS in tuberculous ascites]. Therapie 1951
[Local roentgenotherapy with PAS in pulmonary tuberculosis]. Radioter Radiobiol Fis Medica 1951
[Medicamental therapy of infantile tuberculosis]. Osterr Z Kinderheilkd Kinderfuersorge 1951
[Acute miliary tuberculosis; treatment and evolution of 19 cases]. Gaz Med Port 1951
P.A.S. allergy running a severe course. Acta Derm Venereol 1951
[Synergistic action of streptomycin, PAS, viomycin, and neomycin on Mycobacterium tuberculosis in vitro in 11 various types of association]. Rev Tuberc 1951
[Mechanism of action of associated PAS and streptomycin; bacteriological study in vitro]. Rev Tuberc 1951
[Clinical and bacteriological study of 58 cases of cavitary pulmonary tuberculosis with streptomycin associated with PAS in short perfusion]. Rev Tuberc 1951
[Para-aminosalicylic acid in the treatment of pulmonary tuberculosis]. names it Rev Sanid Asist Soc 1951
[Diet and the tuberculostatic potency of PAS in vivo]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1951
[Treatment of pulmonary tuberculosis with dihydrostreptomycin p-aminosalicylate]. Ann Ist Carlo Forlanini 1951
[Changes in pulmonary lesions in tuberculosis treated with PAS]. Ann Ist Carlo Forlanini 1951
[Contact dispensary; its prophylactic role in a tuberculosis establishment]. Rev Tuberc Urug 1951
Laboratory and other basic research: the effect of PAS on the emergence of tubercle bacilli resistant to dihydrostreptomycin; a U.S. Public Health Service investigation. Trans Annu Meet Natl Tuberc Assoc 1951
[Additional data on PAS; discussion]. Klin Monbl Augenheilkd Augenarztl Fortbild 1951
[Tuberculostatic effects of streptomycin, PAS, PAS-propylester and thiomycid in animal experimentation]. Kiserl Orvostud 1951
[A case of primary tuberculosis of the cranial bones]. Acta Otorhinolaryngol Belg 1951
[Resistance of Koch bacillus to paraaminosalicylic acid in cavernous pulmonary tuberculosis]. Rev Tuberc 1951
[Sulfones associated with PAS in the treatment of non-miliary pulmonary tuberculosis]. Rev Tuberc 1951
[PAS in the treatment of non-miliary pulmonary tuberculosis]. Rev Tuberc 1951
[Variations in the clinical radiological picture induced by para-aminosalicylic acid and relation between the efficacy of the therapeutic action and the anatomo-clinical form]. names it Ann Ist Carlo Forlanini 1951
[Results with streptomycin and PAS in urogenital tuberculosis therapy]. Schweiz Z Tuberk 1951
[Streptomycin and PAS therapy in epididymal tuberculosis]. Magy Seb 1951
[Clinical aspects and surgical therapy of urogenital tuberculosis. (Outline of the lecture given at the conference of urologists in Szeged.)]. Magy Seb 1951
[Experimental study of the effect of thiosemicarbazones and p-aminosalicylic acid on intraocular tuberculosis in guinea pigs]. Klin Monbl Augenheilkd Augenarztl Fortbild 1951
[Experiments on the determination of the tubercle bacillus' resistance to PAS in vitro]. Z Hyg Infektionskr 1951
[Streptomycin resistance. Technique for demonstrating streptomycin resistance Modalities and frequency. Mechanism of streptomycin resistance and definite measures for its prevention]. Rev Asoc Med Argent 1951
[Circumscribed bronchospastic manifestations in tuberculosis treated with streptomycin and with PAS]. Lotta Tuberc 1951
[Treatment of tuberculosis with para-aminosalicylic acid; treatment of specific thoracic empyema with para-aminosalicylic acid]. names it Bratisl Lek Listy 1951
[Effect in vitro of conteben, streptomycin, and PAS on TB-VI-resistant tubercle bacilli]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1951
[Experiences with direct PAS injection in the treatment of cavernous pulmonary tuberculosis]. Schweiz Z Tuberk 1951
[Absence of important blood modifications during treatment of pulmonary tuberculosis in adults with average doses of PAS]. Pathol Gen 1951
[Systematic study of the small intestine in patients showing abnormal reactions (probably allergic) during tuberculosis with PAS]. J Radiol Electrol Arch Electr Medicale 1951
[Plasma lipase in pulmonary tuberculosis during para-aminosalicylic therapy]. names it Friuli Med 1951
[Two cases of para-infectious hemolytic anemia]. names it Duodecim 1951
[The effect of PAS and PAS derivatives in experimental tuberculosis of the mouse; a contribution on technic in experimental studies of tuberculosis in the mouse]. Schweiz Z Pathol Bakteriol 1951
[Tuberculostatic effect on the mouse of phenyl paraamino-salicylate (FR7) in oily solutions or aqueous suspension, alone or with streptomycin]. Ann Inst Pasteur (Paris) 1951
Some cases of tuberculosis cutis treated with para-aminosalicylic acid (PAS). names it Acta Derm Venereol 1951
[Behavior of blood lipase in tuberculous and normal children treated with PAS; behavior under the action of associated PAS and streptomycin]. Lattante 1951
[PAS therapy of primary tuberculous infections of the respiratory organs]. Arch Kinderheilkd 1951
[Critical remarks concerning chemotherapy in pulmonary tuberculosis]. Med Monatsschr 1951
Para-aminosalicylic acid (PAS) in cavernous pulmonary tuberculosis; oral treatment; comparison between the effects of PAS in oral and transthoracic administration. names it Acta Tuberc Scand 1951
[Para-aminobenzoic acid therapy of tuberculosis. II. Dosis and toleration of PAS and its sodium salt]. names it Ther Umsch Med Bibliogr 1951
The chemotherapy of tuberculosis. Med Clin North Am 1951
[Hematological studies in tuberculosis therapy with antibiotics and chemotherapeutics]. Z Tuberk 1951
[Treatment of tuberculosis with paraaminosalicylic acid; effect of vitamin C on paraaminosalicylic acid metabolism]. Bratisl Lek Listy 1951
[Treatment of tuberculosis with paraaminosalicyclic acid; effect of paraaminosalicylic acid on the liver]. Bratisl Lek Listy 1951
[Advantage and disadvantage of para-aminosalicylic acid (pas) treatment of tuberculosis]. names it Sven Lakartidn 1950
[Action and results of PAS therapy in pulmonary and pleural tuberculosis]. Minerva Med 1950
Pulmonary tuberculosis, treated with P.A.S. and streptomycin prior to segmental resection. Nurs Times 1950
[PAS therapy of tuberculosis]. Tidsskr Nor Laegeforen 1950
[Indications for PAS and combined chemotherapy in pulmonary tuberculosis]. Tidsskr Nor Laegeforen 1950
[Bacteriostatic activity of 4-amino-5-iodosalicylic acid towards Koch's bacillus and first results in the treatment of pulmonary tuberculosis]. Riforma Med 1950
[PAS and cavitary tuberculosis]. Bull Mem Soc Med Hop Paris 1950
[Streptomycin and PAS in several cases of tuberculous cavitation]. Policlinico Prat 1950
[Pneumothorax following PAS and streptomycin therapy]. Schweiz Med Wochenschr 1950
[Evolution and histological behavior of tuberculosis in the guinea pig treated with PAS]. Arch Tisiol Mal Appar Respir 1950
[Treatment of pulmonary tuberculosis with para-aminosalicylic acid]. names it Tuberkuloza 1950
[Clinic treatment of pulmonary tuberculosis with PAS]. Toulouse Med 1950
[Antituberculous effects of streptomycin p-aminosalicylate]. Ann Inst Pasteur (Paris) 1950
[Tubercle bacillus resistance and the drug blood level during conteben, PAS and streptomycin therapy of pulmonary tuberculosis]. Tuberkulosearzt 1950
[Chemotherapy of tuberculosis]. Ther Umsch Med Bibliogr 1950
[Local application of PAS in the treatment of bronchial tuberculosis]. Rass Medica 1950
[PAS and associated drugs in tuberculous infection]. Med Esp 1950
An evaluation of certain dosage forms of paraaminosalicylic acid (PAS). doi:10.1164/art.1950.62.6.610 Am Rev Tuberc 1950
Tuberculous pericarditis-Treatment with paraaminosalicylic acid and intermittent streptomycin. Report of a case. Calif Med 1950
[Antibiotics (streptomycin and PAS) in the treatment of pulmonary tuberculosis]. Med Hyg (Geneve) 1950
[Fever due to PAS]. Presse Med (1893) 1950
TREATMENT of pulmonary tuberculosis with streptomycin and para-aminosalicylic acid; a Medical Research Council investigation. names it Br Med J 1950
P.A.S. therapy in tuberculous enteritis. Nurs Mirror Midwives J 1950
[Comparative investigations on therapeutic effect of TB 1/698, PAS and streptomycin]. doi:10.1055/s-0028-1117716 Dtsch Med Wochenschr 1950
[Miliary lupoid of the face, successfully treated with PAS and streptomycin, evolving in old pulmonary and renal tuberculosis]. Bull Soc Fr Dermatol Syphiligr 1950
[Antituberculosis action of succinyl-propaesin and its synergism with vitamin K]. Farmaco Sci Tec 1950
Comparative in vitro response of tubercle bacillus (H37RV) to dihydrostreptomycin, para-aminosalicylic acid, and dihydrostreptomycin-para-aminosalicylate. doi:10.3181/00379727-75-18223 names it Proc Soc Exp Biol Med 1950
[Contribution to the study of gastric tuberculosis; tuberculous ulcer or ulcerated tuberculosis? Action of streptomycin and PAS]. Acta Gastroenterol Belg 1950
The use of para-amino salicylic acid in the treatment of tuberculosis. names it J Natl Med Assoc 1950
Some aspects of the use of streptomycin and PAS. doi:10.1016/s0041-3879(50)80029-6 Tubercle 1950
Studies on the behavior of para-aminosalicylic acid in tuberculous pleural effusions. doi:10.1378/chest.18.5.430 names it Dis Chest 1950
Preliminary report of clinical experience with p-aminosalicylic acid. doi:10.1378/chest.18.5.413 Dis Chest 1950
[PAS concentration in the blood in pulmonary tuberculosis treated by PAS; comparison with radioclinical results]. Paris Med 1950
Hypokalaemia complicating sodium para-amino-salicylate therapy for pulmonary tuberculosis. names it Med J Aust 1950
[Para-aminosalicylic acid in the treatment of laryngeal tuberculosis]. names it Minerva Med 1950
[PAS therapy in 50 cases of pulmonary tuberculosis at the Faxinge Sanatorium]. Nord Med 1950
[Treatment of prolonged reaction to BCG vaccination]. Wien Klin Wochenschr 1950
In vitro experiments on the tuberculo-bacteriostatic activity of o-aminophenol, p-aminosalicylic acid, streptomycin and tibione in the presence of p-aminobenzoic acid. doi:10.7883/yoken1948.3.299 Jpn Med J (Natl Inst Health Jpn) 1950
A new drug for the treatment of tuberculosis. Cyprus Med J 1950
[Treatment of pleuro-pulmonary tuberculosis with para-aminosalicylic acid]. names it Rev Med Moyen Orient 1950
[Results of treatment of 60 cases of pulmonary tuberculosis with tuberculin associated with streptomycin and para-aminosalicylic acid]. names it Rev Med Moyen Orient 1950
[Sensitivity in vitro of tubercle bacilli to p-aminosalicylic acid]. C R Seances Soc Biol Fil 1950
[PAS and sodium benzoate; first clinical tests with this combination in the treatment of tuberculosis]. Arch Tisiol Mal Appar Respir 1950
[Streptomycin and PAS therapy of active and open tuberculosis associated with pulmonary silicosis]. Med Lav 1950
[Experiments on combined therapeutic use of streptomycin, conteben and PAS; erythrocyte modifications due to conteben]. Helv Med Acta 1950
[Treatment of tuberculosis of the skin with paraaminosalicylic acid]. Z Haut Geschlechtskr 1950
[Transformation products of PAS and their toxicity]. Tuberkulosearzt 1950
[Reactions of the white blood picture during treatment with conteben and PAS]. Tuberkulosearzt 1950
[Report on experiences with the new antibiotics Tb I, PAS and streptomycin, alone and in combination, in the treatment of pulmonary tuberculosis]. Tuberkulosearzt 1950
The use of streptomycin and PAS in the surgical treatment of pulmonary tuberculosis. doi:10.1016/s0041-3879(50)80094-6 Tubercle 1950
[Combined streptomycin-PAS therapy of aspirated tuberculous cavities]. Klin Med Osterr Z Wiss Prakt Med 1950
Paraaminosalicylic acid resistant "Mycobacterium tuberculosis" incidence in cases treated at Fitzsimons Army Hospital. U S Armed Forces Med J 1950
[Combined PAS-TB 1 therapy of tuberculosis]. doi:10.1055/s-0028-1117665 Dtsch Med Wochenschr 1950
[Suggestion for treatment of tuberculous meningitis in children]. Sem Med 1950
[Contribution to the antituberculosis campaign in Portugal]. J Med (Oporto) 1950
[Para-aminosalicylic acid therapy of tuberculosis of the urinary tract; clinical and bacteriological study]. names it Policlinico Prat 1950
[PAS in the treatment of suppurative adenitis of tuberculous origin]. Rev Tuberc Urug 1950
[First results in serofibrinous pleurisy treated with PAS; observations on 8 cases studied in the Medical Clinic of Raul Piaggio Blanco]. Rev Tuberc Urug 1950
[Differentiation of tubercle bacillus and paratuberculosis bacillus by thiosemicarbazone of para-acetylaminobenzaldehyde]. names it C R Seances Soc Biol Fil 1950
[Fate of pathological tuberculous matter artificially introduced into untreated and antibiotic treated animals]. Arch Tisiol Mal Appar Respir 1950
[Resistance of Mycobacterium tuberculosis to p-aminosalicylic acid]. Arch Tisiol Mal Appar Respir 1950
[Administration forms and dosage of PAS in pulmonary tuberculosis]. Tuberkulosearzt 1950
[Treatment of tuberculous cystitis by P.A.S. instillation into the bladder]. Lille Chir 1950
[Experimental effect of PAS on tubercle bacilli]. Probl Tuberk 1950
[PAS therapy of tuberculosis of the upper respiratory tract, mouth, trachea, bronchi and lungs]. Probl Tuberk 1950
[Immediate results of pulmonary tuberculosis treatment with paraaminosalicylic acid alone and combined with streptomycin]. Probl Tuberk 1950
[Para-aminosalicylic acid in tuberculosis therapy]. names it Probl Tuberk 1950
[Considerations on para-aminosalicylic acid in pulmonary tuberculosis]. names it Laval Med 1950
Streptomycin and PAS in pulmonary tuberculosis. doi:10.1007/BF02951173 Ir J Med Sci 1950
[Effect of PAS therapy on tuberculosis of the skin]. Orv Hetil 1950
[Conteben, PAS and streptomycin therapy of tuberculosis in children]. Munch Med Wochenschr 1950
[Report of the Commission on control of results of streptomycin therapy of tuberculosis]. Rev Asoc Med Argent 1950
[Cutaneous reactions during PAS therapy]. Rev Asoc Med Argent 1950
[Development and experimental foundation of p-aminosalicylic acid therapy of tuberculosis]. Wien Klin Wochenschr 1950
The effect of dihydrostreptomycin para-aminosalicylate on experimental tuberculosis in guinea pigs. doi:10.1164/art.1950.62.2.149 names it Am Rev Tuberc 1950
[Treatment of tuberculosis with para-aminosalicylic acid; distribution of PAS in the organism]. names it Bratisl Lek Listy 1950
[Behavior of PAS-resistance in various localizations in the same subject]. Arch Tisiol Mal Appar Respir 1950
[Acute miliary tuberculosis in 7-weeks-old infant treated with streptomycin and para-aminosalicylic acid. Cure]. names it Rev Chil Pediatr 1950
[P-aminosalicylic acid in the treatment of tuberculosis]. Medicina (Madr) 1950
[First observations on the therapeutic results of the association of intraspinal sodium PAS in tuberculous meningitis of infants]. Lattante 1950
[Physiology of acid-alcohol-resistant bacteria. III. Action of PAS on the enzymes of Koch's bacillus]. Ann Inst Pasteur (Paris) 1950
[Epidemiology of pulmonary tuberculosis in children in the city of São Paulo; bases for antituberculosis prophylaxis in children]. Rev Paul Med 1950
[Modifications of early and recent infiltrates treated with associated streptomycin and PAS]. Rass Medica 1950
Domiciliary treatment of pulmonary tuberculosis with sodium para-aminosalicylate. doi:10.1016/s0140-6736(50)91040-3 names it Lancet 1950
[Standards for the diagnosis and classification of tuberculous osteoarthritis]. Rev Mex Tuberc Enferm Apar Respir 1950
A comparative study of susceptibility of tubercle bacillus (H37RV) to aureomycin, streptomycin, and para-aminosalicylic acid. doi:10.3181/00379727-74-17986 names it Proc Soc Exp Biol Med 1950
[Mass BCG vaccination]. Hospital (Rio J) 1950
Combined streptomycin-para-aminosalicylic acid treatment of pulmonary tuberculosis. doi:10.1016/s0041-3879(50)80137-x names it Tubercle 1950
[Romheld's syndrome in PAS therapy]. Gruzlica (1926) 1950
[Results of the treatment of pleural empyema with para-aminosalicylic acid (PAS-cilag) and with combined para-aminosalicylic acid and streptomycin]. names it Gruzlica (1926) 1950
[Observations on the effect of para-aminosalicylic acid in vitro on the decrease of sedimentation rate (Biernacki's reaction); preliminary report]. names it Gruzlica (1926) 1950
[Effect of PAS-resistant bacilli on activity of PAS in vitro]. Boll Soc Ital Biol Sper 1950
[Considerations on para-aminosalicylic acid and on dihydrostreptomycin]. names it G Sci Mediche 1950
[Treatment of pulmonary tuberculosis with PAS]. Arch Maragliano Patol Clin 1950
[PAS in treatment of tuberculous adnexitis and pelvic peritonitis]. Riv Ostet Ginecol 1950
[New technic of the diffusion index with para-aminosalicylic acid in the local therapy of tuberculous meningitis]. names it Riv Clin Pediatr 1950
[Use of PAS in therapy of tuberculous meningitis]. Riv Clin Pediatr 1950
[Case of para-articular coxalgia cured in 7 months by streptomycin]. names it Rev Orthop Chir Appar Mot 1950
The use of chicks in the evaluation of antituberculous agents. doi:10.1002/path.1700620308 J Pathol Bacteriol 1950
[Value of streptomycin and para-aminosalicylic acid in the treatment of cutaneous tuberculosis]. names it G Ital Dermatol 1950
[Practical considerations on the use of streptomycin and PAS in pulmonary tuberculosis]. G Clin Med 1950
[Administration of p-aminosalicylic acid in treatment of tuberculosis]. Bull Mem Soc Med Hop Paris 1950
[Association of para-amino-salicylic acid and pneumothorax in the treatment of caverns of primarily biological character]. names it Minerva Med 1950
Para-aminosalicylic acid (PAS) in chronic pulmonary tuberculosis. doi:10.1056/NEJM195006012422203 names it N Engl J Med 1950
[Hemorrhagic syndrome with momentary disappearance of prothrombin during a complicated tuberculosis primary complex treated by streptomycin and paraaminosalicylic acid; probably due to PAS]. Lyon Med 1950
[Tuberculous meningitis]. Nord Med 1950
[Treatment of tuberculosis with para-amino-salicylic acid]. names it Rev Med Suisse Romande 1950
[Information on the production of BCG vaccine in the Laboratories for the preparation of BCG vaccine and investigations of Mexico, D.F]. Medicina (Mex) 1950
[Blood reaction to intradermal injections of para-aminosalicylic acid]. names it Minerva Med 1950
[Latest observations on the action of para-amino-salicylic acid on the sedimentation rate, on blood lipase, on the flocculation reaction of Di Maria and on Weltmann's serumcoagulation in pulmonary tuberculosis]. names it Minerva Med 1950
[Synergic action of p-amino-salicylic acid and streptomycin in antituberculosis bacteriostasis]. Medicina (Madr) 1950
[Action of sodium paraminosalicylate 1. on sensitivity to streptomycin of B.K. strains 2. on the bacteriostatic potentiality of streptomycin]. Ann Inst Pasteur (Paris) 1950
[Action of streptomycin and sodium paraminosalicylate in experimental tuberculosis in a guinea pig]. Ann Inst Pasteur (Paris) 1950
[Microscospic examination of sputum smears of tuberculous patients treated with para-aminosalicylic acid]. names it Tuberkulosearzt 1950
[Contribution to the study of the para-tuberculous bacillus (bacillus F3)]. names it Ann Biol Clin (Paris) 1950
Para-aminosalicylic acid in the treatment of clinical tuberculosis. names it Stanford Med Bull 1950
A clinical appraisal of the value of para-aminosalicylic acid with and without streptomycin in the treatment of tuberculosis. doi:10.1378/chest.17.5.509 names it Dis Chest 1950
Para-aminosalicylic acid therapy in intestinal tuberculosis. names it Am Rev Tuberc 1950
Para-aminosalicylic acid (Pas) in pulmonary and extrapulmonary tuberculosis. names it Am Rev Tuberc 1950
PARA-AMINOSALICYLIC acid treatment in pulmonary tuberculosis. names it Am Rev Tuberc 1950
[Action of streptomycin and para-aminosalicylic acid in ocular tuberculosis. II. Clinical research]. names it Boll Ocul 1950
[Action of streptomycin and para-aminosalicylic acid in ocular tuberculosis. I. Experimental research]. names it Boll Ocul 1950
[Action of PAS and association of PAS with streptomycin in experimental ocular tuberculosis]. Boll Ocul 1950
[Passage and concentration of para-aminosalicylic acid in aqueous humor]. names it Boll Ocul 1950
[First observations on several cases of pleuro-pulmonary tuberculosis treated with PAS]. Lotta Tuberc 1950
[Action of PAS on Mycobacteria; differentiation of tubercle bacilli from the paratuberculous]. Lotta Tuberc 1950
[Stability of PAS resistance in vitro and in vivo]. Arch Tisiol Mal Appar Respir 1950
[Para-aminosalicylic acid in the treatment of tuberculosis]. names it Sicil Sanit 1950
[Results of pulmonary tuberculosis therapy with para-aminosalicylic acid]. names it Cas Lek Cesk 1950
[PAS therapy of tuberculosis of the larynx]. Nord Med 1950
[Pathogenic bases for the use of antibiotics and chemotherapeutics (PAS) as aids in the surgical therapy of tuberculosis localized in the genitourinary tract]. Rev Bras Med 1950
[Bacteriostatic action in vitro of p-aminosalicylic acid (PAS) on Mycobacterium tuberculosis]. Medicina (B Aires) 1950
[PAS therapy of pleural empyema]. Gruzlica (1926) 1950
[Reversibility of the bacteriostatic effect of streptomycin and PAS on Mycobacterium tuberculosis]. Boll Soc Ital Biol Sper 1950
Influence of surgical treatment in pulmonary tuberculosis upon the function of the vegetative nervous system. Kekkaku 1950
[Allergy and para-allergy in leprosy; Mitsuda reaction; leprous and tuberculoid allergy; BCG vaccination]. names it Int J Lepr 1950
[Activity of PAS in the presence of pathological matter]. Arch Tisiol Mal Appar Respir 1950
[Action of p-aminosalicylic acid on the prothrombin and thromboplastin level in pulmonary tuberculosis]. Arch Tisiol Mal Appar Respir 1950
[Retarded action dihydrostreptomycin associated with para-aminosalicylic acid in pulmonary tuberculosis]. names it Minerva Med 1950
[Contribution to the treatment of tuberculosis with p-aminosalicylic acid]. Rev Kuba Med Trop Parasitol 1950
[p-Aminosalicylic acid in association with streptomycin in exudative pulmonary tuberculosis of recent incipience, clinico-therapeutic contribution]. G Ital Della Tuberc 1950
Para-aminosalicylic acid with streptomycin in tuberculosis. names it Can Med Assoc J 1950
Treatment of miliary and meningeal tuberculosis in infants and children. Calif Med 1950
[Antibiotics administered locally in tuberculous caverns of the lung as final treatment of endocavitary aspiration]. Arch Tisiol Mal Appar Respir 1950
Para-aminosalicylic acid treatment of tuberculosis; a review. doi:10.1164/art.1950.61.2.226 names it Am Rev Tuberc 1950
[Para-amino-salicylic acid in tuberculous laryngitis]. names it Riforma Med 1950
Para-amino-salicylic acid in tuberculosis [Hebrew text]. names it Harefuah 1950
[Classification of the therapeutic means used for the treatment of pulmonary tuberculosis from a biological point of view]. Prensa Med Argent 1950
A yellow pigment formed from para-aminobenzoic acid and para-aminosalicylic acid by various strains of Mycobacterium. doi:10.1038/165037a0 names it Nature 1950
[Variations of bacteriological positivity in sputum in tuberculosis treated with p-aminosalicylic acid]. Ann Ist Carlo Forlanini 1950
[Relation between development of tuberculin reaction and erythrocyte sedimentation rate in tuberculosis treated with streptomycin and PAS]. Ann Ist Carlo Forlanini 1950
Resistance to PAS. Rozhl Tuberk 1950
[Variations of specific antibodies in pulmonary tuberculosis treated with PAS]. Ann Ist Carlo Forlanini 1950
[Modality of increment and possible variations of degree of PAS-resistance]. Ann Ist Carlo Forlanini 1950
[Resistance of Koch's bacilli to PAS and its importance in pulmonary tuberculosis therapy]. Ann Ist Carlo Forlanini 1950
[Anatomo-radiologic comparison between tuberculous lesions of the lung of rabbits treated with streptomycin and those of rabbits treated with para-aminosalicylic acid]. names it Ann Ist Carlo Forlanini 1950
[Method of investigating the acid-alcohol resistance of the Mycobacterium tuberculose]. Rev Mex Tuberc Enferm Apar Respir 1950
[Treatment of tuberculosis with p-aminosalicylic acid]. Therapie 1950
[Use of egg yolk gelose for demonstration of tubercle bacilli resistant to streptomycin or to paraaminosalicylic acid]. Ann Inst Pasteur (Paris) 1950
[First results of para-amino-salicylic acid treatment of some cases of childhood pulmonary tuberculosis]. names it Pediatrie 1950
Pulmonary tuberculosis treated with streptomycin and para-amino-salicylic acid. names it Antiseptic 1950
Antibiotics in the treatment of genital tuberculosis in women. Acta Obstet Gynecol Scand Suppl 1950
[Reducing the risk of PAS resistance by combination of sulfones with PAS]. Rev Tuberc 1950
[Resistance of Koch bacillus to PAS]. Rev Tuberc 1950
[Studies and research on Mycobacteria. VI. Effect of PAS on Mycobacteria; differentiation of tubercle and paratuberculosis bacilli]. Rend Ist Sup Sanit 1950
[Para-aminosalicylic acid in pulmonary tuberculosis therapy in adults]. names it Mars Med 1950
[Bone marrow and blood picture in tuberculous infants during PAS therapy]. Haematologica 1950
Combined streptomycin-PAS (para-aminosalicylic acid) treatment of tuberculosis of the urinary tract. names it Acta Chir Scand 1950
PAS and streptomycin in the preoperative treatment of far advanced pulmonary tuberculosis. Acta Chir Scand 1950
[Chemotherapy of tuberculosis with conteben and PAS]. Z Tuberk 1950
[Treatment of ocular tuberculosis with antibiotics]. Zdrav Vestn 1950
[Bacteriostatic effect of streptomycin, PAS, salicylic acid, para-aminobenzoic acid, calciferol and nitrogranulogen on tuberculosis bacilli]. names it Med Dosw Mikrobiol 1950
[Effect of streptomycin, PAS, salicylic acid, calciferol and nitrogranulogen on experimental tuberculosis in white mice]. Med Dosw Mikrobiol 1950
[Cure of a kidney lesion with streptomycin and PAS confirmed anatomically by partial nephrectomy]. J Urol Medicale Chir 1950
[p-Aminosalicylic acid in experimental tuberculous arthritis]. Acta Chir Patav 1950
[Personal experience in the treatment of tuberculosis with p-aminosalicylic acid]. Rev Tuberc 1950
[Para-aminosalicylic acid in the treatment of genitourinary tuberculosis]. names it J Urol Medicale Chir 1950
[PAS therapy of tuberculosis]. Arch Argent Tisiol 1950
[Purulent tuberculous meningitis treated with intraspinal PAS]. Arch Argent Tisiol 1950
[Paraaminosalicylic acid in experimental renal tuberculosis]. Arch Ital Urol 1950
PAS treatment in the Central Dispensary in the city of Stockholm. Acta Tuberc Scand Suppl 1950
Indications for para-aminosalicylic acid and streptomycin in pneumothorax cases. names it Acta Tuberc Scand Suppl 1950
Para-aminosalicylic acid in chronic pulmonary tuberculosis. Comparison between treated and untreated cases. names it Acta Tuberc Scand Suppl 1950
[PAS in experimental tuberculosis of the guinea pig]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1950
[Pas therapy of osteoarticular tuberculosis]. Beitr Klin Tuberk Spezif Tuberkuloseforsch 1950
[Chemotherapy of tuberculosis of the skin]. Arch Dermatol Syph 1950
Antibiotics in the surgery of tuberculosis. Trans Annu Meet Natl Tuberc Assoc 1950
Combined intermittent regimens employing streptomycin and para-aminosalicylic acid in the treatment of pulmonary tuberculosis. names it Trans Annu Meet Natl Tuberc Assoc 1950
[Action of BPAS (sodium salt of benzoyl-orthoxy-para-aminobenzoic acid) in renal tuberculosis]. names it J Urol Medicale Chir 1950
[Method for associated streptomycin-paraaminosalicylic acid therapy]. Atti Accad Fisiocrit Siena Med Fis 1950
[Pneumoperitoneum and its use in hilar and para-hilar cavities]. names it Rev Bras Tuberc Doencas Torac 1950
Treatment of experimental tuberculosis of guinea pigs by a combination of PAS and TB-I 698. Acta Pathol Microbiol Scand 1950
[Para-amino-salicylic acid in phthisiology]. names it Scalpel (Brux) 1949
[Para-aminosalicylic acid in the treatment of pulmonary tuberculosis]. names it Minerva Med 1949
[Para-aminosalicylic acid in the treatment of tuberculosis]. names it Bol Asoc Med P R 1949
[Treatment with para-aminosalicylic acid (PAS-Cilag) in a case of pulmonary tuberculosis, without typical indication]. names it Ther Umsch 1949
The treatment of tuberculosis in Sweden with para-aminosalicylic acid; a review. doi:10.1378/chest.16.6.684 names it Dis Chest 1949
The effect of streptomycin with para-amino salicylic acid on the emergence of resistant strains of tubercle bacilli. doi:10.1378/chest.16.6.661 names it Dis Chest 1949
A preliminary report on the use of para-amino salicylic acid in the treatment of pulmonary tuberculosis. doi:10.1378/chest.16.6.633 names it Dis Chest 1949
Para-aminosalicylic acid in the treatment of clinical tuberculosis; preliminary report. names it Stanford Med Bull 1949
Attempts to induce resistance to para-aminosalicylic acid, in strains of Mycobacterium tuberculosis. names it J Pharm Pharmacol 1949
[Contribution to the study of serial investigations in school children as a perspective for BCG immunization]. Rev Clin Esp 1949
[Para-amino-salicylic acid in the treatment of pulmonary and pleural tuberculosis]. names it Paris Med 1949
The effect of p-aminosalicylic acid on tuberculosis in guinea pigs infected with tubercle bacilli resistant in vitro to para-aminosalicylic acid. names it Proc Staff Meet Mayo Clin 1949
Reactions to para-aminosalicylic acid. names it Proc Staff Meet Mayo Clin 1949
[Treatment of tuberculosis with para-amino-salicylic acid]. names it Prog Med (Paris) 1949
[Announcement over the current results of bronchi tuberculosis treatment with para aminoalicylic acid]. names it Ned Tijdschr Geneeskd 1949
Para-amino-salicylic acid as an aerosol in the treatment of respiratory tuberculosis. doi:10.1016/s0041-3879(49)80020-1 names it Tubercle 1949
[Certain strains of para-tuberculosis bacilli Para-Mycobacterium tuberculosis; deemed non-virulent, are they really?]. names it Presse Med (1893) 1949
The effect of combined therapy with streptomycin and para-aminosalicylic acid on experimental tuberculosis in guinea pigs. names it Proc Staff Meet Mayo Clin 1949
[Experience with streptomycin and para-aminosalicylic acid therapy for tuberculosis in adults]. names it Paracelsus Arch Prakt Med 1949
Para-amino-salicylic acid in the treatment of tuberculosis. names it Ann West Med Surg 1949
[The para-amino-salicylic acid for the treatment of pulmonary tuberculosis]. names it Rev Bras Med 1949
[Hematologic changes in patients with pulmonary tuberculosis treated with para-aminosalicylic acid]. names it G Ital Della Tuberc 1949
[Contribution to the study of the action of para-amino-salicylic acid in the treatment of purulent tuberculous pleurisy]. names it Scalpel (Brux) 1949
[Para-aminosalicylic acid and streptomycin therapy in urinary tract tuberculosis]. names it Nord Med 1949
[The in vitro action of streptomycin associated with para-amino-salicylic acid against the tuberculous bacillus]. names it Minerva Med 1949
Use of para-aminosalicylic acid in chronic pulmonary tuberculosis. doi:10.1378/chest.16.1.1 names it Dis Chest 1949
[New material for plumbing in pulmonary tuberculosis]. Prensa Med Argent 1949
[Para-amino-salicylic acid in the treatment of pulmonary tuberculosis]. names it Praxis 1949
Clinical study of the use of para-aminosalicylic acid in the treatment of pulmonary tuberculosis. names it Edinb Med J 1949
[Clinical and experimental research on the action of para-aminosalicylic acid in pulmonary and extrapulmonary tuberculosis]. names it G Clin Med 1949
Treatment of tuberculous empyaema with para-aminosalicylic acid. names it Edinb Med J 1949
Para-aminosalicylic acid in pulmonary tuberculosis. names it Edinb Med J 1949
Para-amino-salicylic acid in pulmonary tuberculosis. names it Lancet 1949
[Treatment of empiematic para-pneumothoracic spills with para-amino-salicylic acid]. names it Minerva Med 1949
[New trials of experimental anti-tuberculosis chemotherapy with para-aminosalicylic acid]. names it Bull Acad Natl Med 1949
[Para-amino-salicylic acid in the treatment of pulmonary tuberculosis with secondary intestinal tuberculosis]. names it Poumon 1949
[Results of treatment of pulmonary tuberculosis with para-amino-salicylic acid]. names it Poumon 1949
Para-aminosalicylic acid; a clinical trial in 10 patients with pulmonary tuberculosis. doi:10.1016/s0041-3879(49)80064-x names it Tubercle 1949
The effect of streptomycin, para-aminosalicylic acid and their combination of the tubercle bacillus in vitro and in vivo. doi:10.1164/art.1949.59.5.554 names it Am Rev Tuberc 1949
[Para-aminosalicylic acid in the treatment of various forms of pleuro-pulmonary tuberculosis; clinical-experimental contribution]. names it Riforma Med 1949
[Streptomycin and Para-Amino-Salicylic Acid at the Cortina Conference, February 26-March 3, 1949]. names it Riforma Med 1949
[Dangers of flights for patients with tuberculosis]. Med Cir Farm 1949
The in vitro effect of para-aminosalicylic acid in preventing acquired resistance to streptomycin by Mycobacterium tuberculosis. doi:10.1128/JB.57.4.459-464.1949 names it J Bacteriol 1949
THE IN VITRO EFFECT OF PARA-AMINOSALICYLIC ACID (PAS) IN PREVENTING ACQUIRED RESISTANCE TO STREPTOMYCIN BY MYCOBACTERIUM TUBERCULOSIS. names it J Bacteriol 1949
The effect of combined therapy with streptomycin, para-aminosalicylic acid and promin on the emergence of streptomycin-resistant strains of tubercle bacilli; a preliminary report. names it Proc Staff Meet Mayo Clin 1949
[Contribution to the study of tuberculosis, the para-amino-salicylic acid in the treatment of pulmonary tuberculosis]. names it J Med (Oporto) 1949
Treatment of tuberculosis by para-amino-salicylic acid; preliminary report (transl.). names it Philipp Med World 1949
[Birth of a new fully synthetic antibiotic, active against Koch bacillus; mode of action of para-amino-salicylic acid in tuberculosis]. names it Sem Hop 1949
[The association streptomycin para-amino-salicylic acid in the treatment of miliary and tuberculous meningitis]. names it Bull Mem Soc Med Hop Paris 1949
[para-Aminosalicylic acid and tuberculosis]. names it An Azevedos 1949
Experimental and clinical investigations on para-amino-salicylic acid (pas)--alone or in association with streptomycin--in ocular tuberculosis. names it Trans Am Ophthalmol Soc 1949
[Para-aminosalicylic acid in the therapy of tuberculosis; synthetic magazine]. names it Minerva Med 1948
[Para-amino-salicylic acid in the treatment of pulmonary and pleural tuberculosis]. names it Presse Med (1893) 1948
Para-aminosalicylic acid in the. doi:10.1136/pgmj.24.275.455 names it Postgrad Med J 1948
[Diagram for the orientation of tuberculosis control]. Arch Argent Repub Secr Salud Publica 1948
Treatment of experimental tuberculosis in mice and guinea pigs with para-aminosalicylic acid and streptomycin. names it Acta Med Scand 1948
[Does para-aminobenzoic acid have a beneficial effect on the course of some tuberculous disease processes?]. names it Ned Tijdschr Geneeskd 1948
In vitro effect of streptomycin and para-aminosalicylic acid on the growth of tubercle bacilli. doi:10.3181/00379727-68-16446 names it Proc Soc Exp Biol Med 1948
[A better method for searching for the tubercle bacillus]. Rev Esp Pediatr 1948
[A new method for the diagnosis of genital tuberculosis]. Rev Esp Obstet Ginecol 1948
[Study Of Para-Amino-Salicylic Acid In the Treatment Of Pulmonary Tuberculosis]. names it Sem Hop 1948
[The contagion factor in the spread of tuberculosis; social and personal measures to avoid it]. Medicamenta (Madr) 1948
[Report on the services for the rehabilitation and readaptation of cured tuberculosis patients in the USA. USA from North America]. Arch Argent Tisiol 1948
[New methods to discover tuberculosis in a timely manner]. Rev Med Veracruzana 1948
[Treatment of tuberculosis with para-, amino-, salicylic acid (preparation Wander 19)]. names it Schweiz Z Tuberk 1948
Para-aminosalicylic acid in tuberculosis; early results of clinical trials. names it Lancet 1947
PARA-AMINOSALICYLIC acid in tuberculosis. names it Am Prof Pharm 1947
The combined effect of streptomycin and para-aminosalicylic acid on experimental tuberculosis in mice. names it J Lancet 1947
Para-aminosalicylic acid in experimental tuberculosis in guinea pigs. names it Proc Staff Meet Mayo Clin 1947
[Worship of the clinical mother; right renal tuberculosis entered through the open porthole for appendicitis]. Med Esp 1947
[Homes for convalescent children with pulmonary tuberculosis]. Rev Cubana Pediatr 1947
[Duties of the nation towards the tuberculosis patient]. Rev Tuberc Urug 1947
The effect of para-aminosalicylic acid on tubercle bacilli. names it J Bacteriol 1947
[Intra-articular arthrodesis for the treatment of osteoarthritis of the knee in childhood tuberculosis]. Rev Bras Cir 1947
[The tuberculosis hospital]. Rev Tuberc Urug 1947
[Tuberculosis insurance for police forces]. Rev Sanid Polic 1947
[Aspects of the management of the honorary commission for the fight against tuberculosis]. Hoja Tisiol 1947
The effect of p-aminobenzoic acid on experimental tuberculosis in guinea-pigs. S Afr J Med Sci 1947
Antitubercular studies; 1,1,1,-trichloro-2,2-bis (para-aminophenyl)-ethane. doi:10.1021/ja01213a013 names it J Am Chem Soc 1946
[Sancho-sanatorium-hospital for tuberculosis, from Sancho]. J Med Pernamb 1946
[Basis for knowledge of tuberculosis epidemiology and prophylaxis]. Trib Farm 1946
Para-aminosalicylic acid in the treatment of tuberculosis. doi:10.1016/s0140-6736(46)91185-3 names it Lancet 1946
The effect of para-amino-salicylic acid in vitro and in vivo on virulent human type tubercle bacilli. names it Q Bull Northwest Univ Med Sch 1946
[Utility of endometrial microlegration for the diagnosis of adnexal tuberculosis]. Sem Med Esp 1946
[Brief suggestions for the construction and operation of the new dispensaries]. Rev Paul Tisiol Torax 1945
[Comparative study between fasting gastric content and tracheo-bronchial lavage to search for acid-resistant bacilli]. Rev Paul Tisiol Torax 1945
[Considerations On Animal Tuberculosis As A Source Of Infection For Man]. Rev Mex Tuberc Enferm Apar Respir 1945
[Some Solid Nutrient Media For Cultivation Of the Koch Bacillus]. An Catedra Patol Clin Tuberc 1945
[Standards for the diagnosis and classification of tuberculosis]. Bol Epidemiol (Mex City Mex) 1945
[The non-toxic para-aminobenzoic acid substituting intravenous novocaine]. names it Rev Tuberc 1945

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Intrinsic disorder (sequence + structure) partially disordered

Predicted disorder30% of residues (metapredict) · mean AlphaFold pLDDT 83.2
Disordered regions2 IDR(s), longest 90 aa [0-90, 332-347]

carries a substantial disordered region (105/347 residues); disorder is a property, not a function

A property (biophysics), not a function. No LLPS/condensate claim is made from disorder alone. Verdict unchanged. Source: metapredict v3 (Emenecker/Holehouse) per-residue disorder + AlphaFold mean pLDDT (annotation_mtbc P16.13).

Genomic-neighbour overlap (structural caveat) co-directional · 0 % of gene

NeighbourparB (Rv3917c, - strand)
Overlap4 bp, 0 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

CRISPRi vulnerability

Vulnerability index -8.25 (95% CI -9.00 to -7.54). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInvolved in chromosome partition. Localize to both POLES of the predivisional cell following completion of DNA replication.

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb3949c · 99.7% identity
M. leprae ML2707c · 86.3% identity
M. marinum MMAR_5482 · 84.3% identity
M. smegmatis MSMEG_6939 · 77.1% identity
M. orygis RJtmp_004033 · 99.7% identity
M. abscessus MAB_4950c · 70.3% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt Q1LVD4 TrEMBL · unreviewed · Evidence at protein level
UniProt nameProbable chromosome partitioning protein ParA
Curated functionMay play a role in septum formation.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category D Cell cycle control, cell division, chromosome partitioning
Preferred nameparA
eggNOG descriptionchromosome partitioning
Orthologous groupCOG1192
KEGG orthology K03496

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.384 · purifying
Polymorphic sites (≥ 0.1% of strains) 8 synonymous, 9 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

M. canettii dN/dS (deep-divergence selection) 0.0 (low power) · 1 consensus substitution(s)
low power (1 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 88.5% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 12/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 63.5%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 19 in the ORF — 17 in the essential state, 0 growth-defect, 2 non-essential, 0 growth-advantage. Saturation 0.316, mean read count 24. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 19 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Chemical-genetic target & druggability (PROSPECT) hypomorph tool strain validated drug target

This gene is part of the PROSPECT collection of TetON transcriptional-knockdown (hypomorph) strains of essential M. tuberculosis genes, built as a sensitised background for chemical-genetic mechanism-of-action deconvolution. Being in the panel means the gene is an essential / vulnerable target for which a validated knockdown tool strain exists.

Hypomorph strainparA-Flag-Das-tetON-2 (TetON promoter 2)
Baseline knockdown fitness2.724 median doublings (across 6 screen pool(s)) — fewer doublings = stronger growth defect on knockdown
Used in target deconvolutionyes (informs phenotypic-cluster / MOA assignment)
Drug-target cross-referenceannotated mechanism-of-action target ParA: 3 reference compound(s) phenocopy its inhibition — chemically-validated druggable target

Panel membership reflects essentiality/vulnerability and the availability of a genetic tool, not a specific molecular function; it never changes the verdict here. Source: Bond AN et al., Nat Commun 2025;16:9673 (doi:10.1038/s41467-025-64662-x); PROSPECT chemical-genetic platform.

Proteomics (mass spectrometry) detected

MS detectiondetected in 13 of 16 independent MS datasets
Integrated abundance47.9 ppm · rank 1781/3519 (49.4th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length347 aa
Molecular weight37.5 kDa
Theoretical pI5.93
GRAVY-0.152 (hydrophilic)
Aliphatic index88.0
Aromaticity0.049
Instability index47.0 (unstable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
ParAPF10609.16 1.2e-0884–136 NUBPL iron-transfer P-loop NTPase
AAA_31PF13614.13 5.1e-5885–263 AAA domain
MipZPF09140.18 8.2e-0886–125 ATPase MipZ
CbiAPF01656.30 1.1e-2987–313 CobQ/CobB/MinD/ParA nucleotide binding domain
ArsA_ATPasePF02374.22 1.2e-0792–221 Anion-transporting ATPase

3D structure (interactive — Mol*/pdbe-molstar)

No experimental structure is deposited for this gene: showing the AlphaFold DB predicted model (mean pLDDT 83.2, confident), coloured by per-residue confidence (dark blue = very high, orange/red = low — treat low-confidence regions as unreliable, especially termini and loops). Drag to rotate, scroll to zoom.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 83.2

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
2bej-assembly1_A 1.00 0.92 0.66 0.92 45% 74% / 98% 3.3e-26 sig 2bej-assembly1_A Structure of the bacterial chromosome segregation protein Soj
2bek-assembly2_D 1.00 0.94 0.67 0.94 44% 74% / 100% 1.1e-25 sig 2bek-assembly2_D Structure of the bacterial chromosome segregation protein Soj
6iud-assembly1_A 1.00 0.89 0.69 0.89 37% 73% / 99% 6.4e-24 sig 6iud-assembly1_A Structure of Helicobacter pylori Soj-ADP complex bound to DNA
8jmj-assembly1_B 1.00 0.88 0.68 0.88 37% 73% / 99% 2.6e-23 sig 8jmj-assembly1_B Structure of Helicobacter pylori Soj-DNA-Spo0J complex
5if9-assembly2_B 1.00 0.89 0.63 0.89 41% 74% / 96% 3.6e-21 sig 5if9-assembly2_B Crystal Structure of Cobyrinic Acid a,c-diamide synthase from Mycobacterium smegmatis with bound ATP analog and Magnesium

Foldseek search of the AlphaFold DB model (mean pLDDT 83.2, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 3

Upstream (5' on genome)parB (- strand, -4 bp gap)
Downstream (3' on genome)gid (- strand, -4 bp gap)
Predicted operon parB · parA · gid

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 7: parA · gid · Rv3920c · Rv3921c · Rv3922c · rnpA · rpmH — disagrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT4037) exponential phase: operon of 10, Rv3916c · Rv3917c · Rv3918c · Rv3919c · Rv3920c · Rv3921c · Rv3922c · Rv3923c · Rv3924c (coverage 60.51)
stationary phase: operon of 5, Rv3916c · Rv3917c · Rv3918c · Rv3919c (coverage 16.5) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (2 TF) mftR (activates) · Rv2034 (represses)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: parB (chromosome partitioning protein ParB), high confidence (score 998, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair's experimental or database support is transferred from orthologous pairs in other proteomes only: nothing was measured in M. tuberculosis, so it is an association inferred by orthology rather than measured in this organism.

Showing the 15 strongest of this gene's 30 partners at medium confidence (7 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 30 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv3917c parB chromosome partitioning protein ParB 999 998 ctx neighborhood:882 cooccurence:773 coexpression:892 textmining:580
Rv3919c gid 16S rRNA (guanine(527)-N(7))-methyltransferase RsmG 982 976 ctx neighborhood:881 coexpression:803
Rv3920c hypothetical protein 771 772 ctx neighborhood:758
Rv3921c yidC membrane protein insertase YidC 766 752 ctx neighborhood:705
Rv3922c yidD membrane protein insertion efficiency factor 697 697 ctx neighborhood:688
Rv2647 hypothetical protein 693 674 coexpression:484
Rv2748c ftsK DNA translocase FtsK 665 649 ctx cooccurence:637
Rv3923c rnpA ribonuclease P protein component 647 627 ctx neighborhood:621
Rv0001 dnaA chromosomal replication initiator protein DnaA 725 606
Rv3916c hypothetical protein 539 538 ctx neighborhood:524
Rv3924c rpmH 50S ribosomal protein L34 519 501 ctx neighborhood:501
Rv2916c ffh signal recognition particle protein 478 478 coexpression:409
Rv2646 integrase 470 444 ctx cooccurence:420
Rv3014c ligA DNA ligase A 439 440 coexpression:421
Rv2150c ftsZ cell division protein FtsZ 577 437 coexpression:418

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: chromosome partitioning protein ParA
  • MTBC0 PGAP product: chromosome partitioning protein ParA
  • Pfam (hmmscan --cut_ga): ParA PF10609.16 (E=1e-08), AAA_31 PF13614.13 (E=5e-58), MipZ PF09140.18 (E=8e-08), CbiA PF01656.30 (E=1e-29), ArsA_ATPase PF02374.22 (E=1e-07)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_218434.2)
  • Domains: Pfam-A via hmmscan --cut_ga — ParA (PF10609.16), AAA_31 (PF13614.13), MipZ (PF09140.18), CbiA (PF01656.30), ArsA_ATPase (PF02374.22)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG1192
  • Curated reference: UniProt Q1LVD4 (TrEMBL, unreviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 83.2)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 30 functional partner(s); context anchor parB
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_004152|Rv3918c|parA
MSAPWGPVAAGPSALVRSGQASTIEPFQREMTPPTPTPEAAHNPTMNVSRETSTEFDTPIGAAAERAMRVLHTTHEPLQRPGRRRVLTIANQKGGVGKTTTAVNIAAALAVQGLKTLVIDLDPQGNASTALGITDRQSGTPSSYEMLIGEVSLHTALRRSPHSERLFCIPATIDLAGAEIELVSMVARENRLRTALAALDNFDFDYVFVDCPPSLGLLTINALVAAPEVMIPIQCEYYALEGVSQLMRNIEMVKAHLNPQLEVTTVILTMYDGRTKLADQVADEVRQYFGSKVLRTVIPRSVKVSEAPGYSMTIIDYDPGSRGAMSYLDASRELAERDRPPSAKGRP